<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>RSSMix.com Mix ID 8202795</title>
    <link>http://www.rssmix.com/</link>
    <description>This feed was created by mixing existing feeds from various sources.</description>
    <generator>RSSMix</generator>
    <item>
      <title>Response to: Letter to the Editor: comment on “Body mass index and Mini Nutritional Assessment-Short Form as predictors of in-geriatric hospital mortality in older adults with COVID-19” (by Café Balcı, MD, Hacettepe University Faculty of Medicine Department of Internal Medicine Division of Geriatric Medicine)</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00584-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-22</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <pubDate>Wed, 22 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00584-7/fulltext?rss=yes</guid>
      <dc:title>Response to: Letter to the Editor: comment on “Body mass index and Mini Nutritional Assessment-Short Form as predictors of in-geriatric hospital mortality in older adults with COVID-19” (by Café Balcı, MD, Hacettepe University Faculty of Medicine Department of Internal Medicine Division of Geriatric Medicine)</dc:title>
      <dc:creator>Laura Kananen, Dorota Religa, Maria Eriksdotter, Sara Hägg, Juulia Julhävä, Tommy Cederholm</dc:creator>
      <dc:date>2021-12-22T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.027</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Reply to - Letter to the editor by Zhang et al entitled ‘ESPEN guideline on hospital diet nutrition’</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00586-0/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-21</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <pubDate>Tue, 21 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00586-0/fulltext?rss=yes</guid>
      <dc:title>Reply to - Letter to the editor by Zhang et al entitled ‘ESPEN guideline on hospital diet nutrition’</dc:title>
      <dc:creator>Ronan Thibault, Stephan C. Bischoff</dc:creator>
      <dc:date>2021-12-21T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.028</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>ESPEN guideline on hospital diet nutrition</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00585-9/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-21</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <pubDate>Tue, 21 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00585-9/fulltext?rss=yes</guid>
      <dc:title>ESPEN guideline on hospital diet nutrition</dc:title>
      <dc:creator>Zhige Zhang, Shanjun Tan, Guohao Wu</dc:creator>
      <dc:date>2021-12-21T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.029</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Preoperative carbohydrate loading before elective abdominal surgery: a systematic review and network meta-analysis of phase II/III randomized controlled trials</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00566-5/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-21</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Meta-analyses</prism:section>
      <description>The preoperative use of carbohydrate loading (CHO) is recommended in patients undergoing abdominal surgery, even if the advantages remain debatable. The aim was to evaluate the CHO benefits in patients undergoing abdominal surgery.</description>
      <pubDate>Tue, 21 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00566-5/fulltext?rss=yes</guid>
      <dc:title>Preoperative carbohydrate loading before elective abdominal surgery: a systematic review and network meta-analysis of phase II/III randomized controlled trials</dc:title>
      <dc:creator>Claudio Ricci, Carlo Ingaldi, Laura Alberici, Francesco Serbassi, Nico Pagano, Emilio De Raffele, Francesco Minni, Loris Pironi, Anna Simona Sasdelli, Riccardo Casadei</dc:creator>
      <dc:date>2021-12-21T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.016</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Combining the quantitative faecal immunochemical test and full blood count reliably rules out colorectal cancer in a symptomatic patient referral pathway</title>
      <link>http://link.springer.com/10.1007/s00384-021-04079-2</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Purpose&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Faecal Immunochemical Test (FIT) has proven utility for Colorectal Cancer (CRC) detection in symptomatic patients. Most studies have examined FIT in symptomatic patients subsequently referred from primary care. We investigated associations between CRC and FIT in both referred and non-referred symptomatic patients.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;A retrospective, observational study of all patients with a FIT submitted Aug 2018 to Jan 2019 in NHS GG&amp;amp;C was performed. Referral to colorectal/gastroenterology and decision to perform colonoscopy were recorded. FIT results were grouped as f-Hb &amp;lt; 10/10–149/150–399/ ≥ 400 μg/g. The MCN cancer registry identified new cases of CRC. Covariables were compared using the &lt;em class="a-plus-plus"&gt;χ&lt;/em&gt;&lt;sup class="a-plus-plus"&gt;2&lt;/sup&gt; test. Multivariate binary logistic regression identified independent predictors of CRC.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;A total of 4968 patients were included. Raised FIT correlated with decision to refer (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.001) and scope (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.001). With 23-month median follow-up, 61 patients were diagnosed with CRC. These patients were older (median 69 vs 59 years, cancer and no cancer respectively, &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.001), more likely to be male (55.7% vs 42.1%, &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.033), and to report rectal bleeding (51.7% vs 36.1%, &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.013). FIT (&amp;lt; 10 µg/g 8.2% vs 76.7% and ≥ 400 µg/g 55.7% vs 3.8%, &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.001) and anaemia (45.9% vs 19.7%, &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.001) were associated with CRC. On multivariate analysis, age (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.023), male sex (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.04), FIT (≥ 400 OR 54.256 (95% CI:20.683–142.325; &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.001)), and anaemia (OR 1.956 (1.071–3.574; &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.029)) independently predicted CRC. One patient (0.04%) with a negative FIT and normal haemoglobin had CRC.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Conclusion&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;GP referral and secondary care investigation patterns were influenced by FIT. The combination of normal Hb and f-Hb excluded CRC in 99.96% of cases, providing excellent reassurance to those prioritising access to endoscopy services.&lt;/p&gt;
                  &lt;/span&gt;</description>
      <pubDate>Tue, 21 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04079-2</guid>
      <dc:date>2021-12-21T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Preoperative intravenous iron treatment reduces postoperative complications and postoperative anemia in preoperatively anemic patients with colon carcinoma</title>
      <link>http://link.springer.com/10.1007/s00384-021-04080-9</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Purpose&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Anemia is common among patients with colorectal cancer and is associated with an increased risk of complications and poorer survival rate. The main objective of our study was to determine the effect of preoperative intravenous iron supplementation therapy on the need for red blood cell transfusions, other postoperative complications, and length of hospital stay in colon cancer patients undergoing colon resection.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;In this retrospective cohort study, data were collected from medical records of all 549 colon carcinoma patients who underwent a colon resection in Helsinki University Hospital during the years 2017 and 2018. The patients were divided into two cohorts: one with anemic patients treated with preoperative intravenous iron supplementation therapy (180 patients) and one with anemic patients without preoperative intravenous iron supplementation therapy (138 patients). Non-anemic patients and patients requiring emergency surgery were excluded (231 patients).&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Patients treated with intravenous iron had less postoperative complications (33.9% vs. 45.9%, &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.045) and a lower prevalence of anemia at 1 month after surgery (38.7% vs. 65.3%, &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.01) when compared with patients without preoperative iv iron treatment. No difference was found in the amount of red blood cell transfusions, length of stay, or mortality between the groups.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Conclusion&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;This is the first study demonstrating a significant decrease in postoperative complications in anemic colon cancer patients receiving preoperative intravenous iron supplementation therapy. This treatment also diminishes the rate of postoperative anemia, which is often associated with a facilitated recovery.&lt;/p&gt;
                  &lt;/span&gt;</description>
      <pubDate>Mon, 20 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04080-9</guid>
      <dc:date>2021-12-20T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Laparoscopic left hemicolectomy in morbid obesity for sigmoid adenocarcinoma – a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16027?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16027</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16027?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, Accepted Article.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;p&gt;-&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Sat, 18 Dec 2021 14:56:00 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16027</guid>
      <dc:title>Laparoscopic left hemicolectomy in morbid obesity for sigmoid adenocarcinoma – a video vignette</dc:title>
      <dc:creator>Luca Pennacchi, 
Giulio Montecamozzo, 
Francesco Cammarata, 
Piergiorgio Danelli</dc:creator>
      <dc:description>Abstract
‐</dc:description>
      <dc:date>2021-12-18T14:56:00Z</dc:date>
      <dc:identifier>10.1111/codi.16027</dc:identifier>
    </item>
    <item>
      <title>Reply to Response letter to the editor: Associations of vitamin D deficiency with MRI markers of brain health in a community sample</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00582-3/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-18</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <pubDate>Sat, 18 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00582-3/fulltext?rss=yes</guid>
      <dc:title>Reply to Response letter to the editor: Associations of vitamin D deficiency with MRI markers of brain health in a community sample</dc:title>
      <dc:creator>Dongren Sun, Xin Mo, Yefan Lv, Fafa Tian</dc:creator>
      <dc:date>2021-12-18T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.025</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Laparoscopic‐assistedright hemicolectomy with transvaginal natural orifice specimen extraction.A Video Vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16026?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16026</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16026?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, Accepted Article.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;p&gt;-&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Fri, 17 Dec 2021 15:45:46 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16026</guid>
      <dc:title>Laparoscopic‐assistedright hemicolectomy with transvaginal natural orifice specimen extraction.A Video Vignette</dc:title>
      <dc:creator>Xiaoming Zhu, 
Jinke Sui, 
Haifeng Gong, 
Wei Zhang</dc:creator>
      <dc:description>Abstract
‐</dc:description>
      <dc:date>2021-12-17T15:45:46Z</dc:date>
      <dc:identifier>10.1111/codi.16026</dc:identifier>
    </item>
    <item>
      <title>Laparoscopic complete mesocolic excision with extended D3 lymphadenectomy for advanced hepatic flexure cancer: Addressing infrapyloric node dissection – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16013?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16013</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16013?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Fri, 17 Dec 2021 14:37:06 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16013</guid>
      <dc:title>Laparoscopic complete mesocolic excision with extended D3 lymphadenectomy for advanced hepatic flexure cancer: Addressing infrapyloric node dissection – A video vignette</dc:title>
      <dc:creator>Guglielmo Niccolò Piozzi, 
Ji‐Seon Kim, 
Tae‐Hoon Lee, 
Jeong Min Choo, 
Seon Hui Shin, 
Seon Hahn Kim</dc:creator>
      <dc:description />
      <dc:date>2021-12-17T14:37:06Z</dc:date>
      <dc:identifier>10.1111/codi.16013</dc:identifier>
    </item>
    <item>
      <title>Agreement between GLIM and PG-SGA for diagnosis of malnutrition depends on the screening tool used in GLIM</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00574-4/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-17</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <description>The Global Leadership Initiative on Malnutrition (GLIM) has suggested a process for the diagnosis of malnutrition. The process consists of applying an existing screening tool for malnutrition screening, followed by malnutrition diagnostics, and finally categorization of malnutrition severity (moderate or severe) according to specific GLIM criteria. However, it is not known how well the GLIM process agrees with other diagnostic tools used in the current clinical practice. The aim of this study was to validate the GLIM process against the Patient Generated-Subjective Global Assessment (PG-SGA) when different screening tools were applied in the screening step of the GLIM process.</description>
      <pubDate>Fri, 17 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00574-4/fulltext?rss=yes</guid>
      <dc:title>Agreement between GLIM and PG-SGA for diagnosis of malnutrition depends on the screening tool used in GLIM</dc:title>
      <dc:creator>Christine Henriksen, Ingvild Paur, Astrid Pedersen, Ane Sørlie Kværner, Hanna Ræder, Hege Berg Henriksen, Siv Kjølsrud Bøhn, Gro Wiedswang, Rune Blomhoff</dc:creator>
      <dc:date>2021-12-17T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.024</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Adhesion‐related readmissions after open and laparoscopic colorectal surgery in 16 524 patients</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16024?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16024</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16024?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, Accepted Article.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Colorectal surgery is associated with a high risk of adhesion formation and subsequent complications. Laparoscopic colorectal surgery reduces adhesion formation by 50%, however the effect on adhesion-related complications is still unknown. This study aims to compare differences in incidence rates of adhesion-related readmissions after laparoscopic and open colorectal surgery.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;Population data from the Scottish National Health Service were used to identify patients who underwent colorectal surgery between June 2009 and June 2011. Readmissions were registered until December 2017 andcategorized as being either directly or possibly related to adhesions, or as reoperations potentially complicated by adhesions. The primary outcome measure was the difference in incidence ofdirectly adhesion-related readmissions between the open and laparoscopic cohort.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Colorectal surgery was performed in 16 524 patients;4 455 (27%) underwent laparoscopic surgery. Patients undergoing laparoscopic surgery were readmitted less frequently for directly adhesion-related complications, 2.4% (95% CI 2.0 - 2.8%) vs. 7.5% (95% CI 7.1 - 7.9%) in the open cohort. Readmissions for possibly adhesion-related complications were less frequent in the laparoscopic cohort, 16.8% (95% CI 15.6 - 18.0%) vs. 21.7% (95% CI 20.9 - 22.5%), as well as reoperations potentially complicated by adhesions, 9.7% (95% CI 8.9 - 10.5%) vs. 16.9% (95% CI 16.3 - 17.5%).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Overall, any adhesion-related readmissions occurred in over one in three patients after open colorectal surgery and one in four afterlaparoscopic colorectal surgery. Compared with open surgery incidence rates of adhesion-related complications decrease but remain substantial after laparoscopic surgery.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Thu, 16 Dec 2021 16:50:32 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16024</guid>
      <dc:title>Adhesion‐related readmissions after open and laparoscopic colorectal surgery in 16 524 patients</dc:title>
      <dc:creator>Pepijn Krielen, 
Richard P.G. ten Broek, 
Koen W. Dongen, 
Mike C. Parker, 
Ewen A. Griffiths, 
Harry Goor, 
Martijn W.J. Stommel</dc:creator>
      <dc:description>Abstract

Aim
Colorectal surgery is associated with a high risk of adhesion formation and subsequent complications. Laparoscopic colorectal surgery reduces adhesion formation by 50%, however the effect on adhesion‐related complications is still unknown. This study aims to compare differences in incidence rates of adhesion‐related readmissions after laparoscopic and open colorectal surgery.


Method
Population data from the Scottish National Health Service were used to identify patients who underwent colorectal surgery between June 2009 and June 2011. Readmissions were registered until December 2017 andcategorized as being either directly or possibly related to adhesions, or as reoperations potentially complicated by adhesions. The primary outcome measure was the difference in incidence ofdirectly adhesion‐related readmissions between the open and laparoscopic cohort.


Results
Colorectal surgery was performed in 16 524 patients;4 455 (27%) underwent laparoscopic surgery. Patients undergoing laparoscopic surgery were readmitted less frequently for directly adhesion‐related complications, 2.4% (95% CI 2.0 ‐ 2.8%) vs. 7.5% (95% CI 7.1 ‐ 7.9%) in the open cohort. Readmissions for possibly adhesion‐related complications were less frequent in the laparoscopic cohort, 16.8% (95% CI 15.6 ‐ 18.0%) vs. 21.7% (95% CI 20.9 ‐ 22.5%), as well as reoperations potentially complicated by adhesions, 9.7% (95% CI 8.9 ‐ 10.5%) vs. 16.9% (95% CI 16.3 ‐ 17.5%).


Conclusion
Overall, any adhesion‐related readmissions occurred in over one in three patients after open colorectal surgery and one in four afterlaparoscopic colorectal surgery. Compared with open surgery incidence rates of adhesion‐related complications decrease but remain substantial after laparoscopic surgery.</dc:description>
      <dc:date>2021-12-16T16:50:32Z</dc:date>
      <dc:identifier>10.1111/codi.16024</dc:identifier>
    </item>
    <item>
      <title>Redo‐surgery after failed colorectal or coloanal anastomosis: morbidity, mortality and factors predictive of success. A retrospective study of 200 patients</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16025?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16025</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16025?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, Accepted Article.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;In case of anastomotic failure after colorectal (CRA) or coloanal anastomosis (CAA), revision of the anastomosis is an ambitious surgical option that can be proposed in order to maintain bowel continuity. Our aim was to assess post-operative morbidity, risk of failure and risk factor for failure in patients after CRA or CAA.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;All consecutive patients who underwent redo-CRA/CAA in our institution between 2007-2018 were retrospectively included. The success of redo-CRA/CAA was defined by the restoration of bowel continuity 12 months after the surgery.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Two hundred patients (114 male: 57%) were analyzed. The indication for redo-CRA/CAA was chronic pelvic infection in 74 patients (37%), recto-vaginal or urinary fistula in 59 patients (30%), anastomotic stenosis in 36 patients (18%) and redo anastomosis after previous anastomosis takedown in 31 patients (15%). Twenty-three percent of the patients developed a severe post-operative complication. Anastomotic leakage was diagnosed in 39 patients (20%). One-year-success of the redo-CRA/CAA was obtained in 80% of patients. In multivariate analysis, only obesity was associated with redo-CRA/CAA failure (p=0.042). We elaborated a pre-operative predictive score of success using the 4 variables: male sex, age&amp;gt;60 years, obesity and history of pelvic radiotherapy. The success of redo-CRA/CAA was 92%, 86%, 80% and 62% for a pre-operative predictive score value of 0, 1, 2 and ≥3, respectively (p=0.010).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;In case of failure of primary CRA/CAA, bowel continuity can be saved in 4 out of 5 patients by redo-CRA/CAA despite 23% suffering severe post-operative morbidity.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Thu, 16 Dec 2021 15:46:13 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16025</guid>
      <dc:title>Redo‐surgery after failed colorectal or coloanal anastomosis: morbidity, mortality and factors predictive of success. A retrospective study of 200 patients</dc:title>
      <dc:creator>Mélanie Calmels, 
Maxime K. Collard, 
Lauren O’Connell, 
Thibault Voron, 
Clotilde Debove, 
Najim Chafai, 
Yann Parc, 
Jérémie H. Lefevre</dc:creator>
      <dc:description>Abstract

Aim
In case of anastomotic failure after colorectal (CRA) or coloanal anastomosis (CAA), revision of the anastomosis is an ambitious surgical option that can be proposed in order to maintain bowel continuity. Our aim was to assess post‐operative morbidity, risk of failure and risk factor for failure in patients after CRA or CAA.


Method
All consecutive patients who underwent redo‐CRA/CAA in our institution between 2007‐2018 were retrospectively included. The success of redo‐CRA/CAA was defined by the restoration of bowel continuity 12 months after the surgery.


Results
Two hundred patients (114 male: 57%) were analyzed. The indication for redo‐CRA/CAA was chronic pelvic infection in 74 patients (37%), recto‐vaginal or urinary fistula in 59 patients (30%), anastomotic stenosis in 36 patients (18%) and redo anastomosis after previous anastomosis takedown in 31 patients (15%). Twenty‐three percent of the patients developed a severe post‐operative complication. Anastomotic leakage was diagnosed in 39 patients (20%). One‐year‐success of the redo‐CRA/CAA was obtained in 80% of patients. In multivariate analysis, only obesity was associated with redo‐CRA/CAA failure (p=0.042). We elaborated a pre‐operative predictive score of success using the 4 variables: male sex, age&gt;60 years, obesity and history of pelvic radiotherapy. The success of redo‐CRA/CAA was 92%, 86%, 80% and 62% for a pre‐operative predictive score value of 0, 1, 2 and ≥3, respectively (p=0.010).


Conclusions
In case of failure of primary CRA/CAA, bowel continuity can be saved in 4 out of 5 patients by redo‐CRA/CAA despite 23% suffering severe post‐operative morbidity.</dc:description>
      <dc:date>2021-12-16T15:46:13Z</dc:date>
      <dc:identifier>10.1111/codi.16025</dc:identifier>
    </item>
    <item>
      <title>Nerve‐preserving laparoscopic total mesorectal excision (TME) – a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16012?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16012</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16012?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Thu, 16 Dec 2021 12:58:38 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16012</guid>
      <dc:title>Nerve‐preserving laparoscopic total mesorectal excision (TME) – a video vignette</dc:title>
      <dc:creator>Ashwin L. Desouza, 
Jayesh Gori, 
Mufaddal Kazi, 
Ambarish Chatterjee, 
Avanish P. Saklani</dc:creator>
      <dc:description />
      <dc:date>2021-12-16T12:58:38Z</dc:date>
      <dc:identifier>10.1111/codi.16012</dc:identifier>
    </item>
    <item>
      <title>Step by step demonstration of laparoscopic pelvic lymph node dissection in rectal cancer – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16010?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16010</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16010?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Thu, 16 Dec 2021 12:57:21 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16010</guid>
      <dc:title>Step by step demonstration of laparoscopic pelvic lymph node dissection in rectal cancer – A video vignette</dc:title>
      <dc:creator>Vivek Sukumar, 
Mufaddal Kazi, 
Ashwin Desouza, 
Avanish Saklani</dc:creator>
      <dc:description />
      <dc:date>2021-12-16T12:57:21Z</dc:date>
      <dc:identifier>10.1111/codi.16010</dc:identifier>
    </item>
    <item>
      <title>Correspondence: The right kind of rectal cancer operation for the right patient requires information on all relevant outcomes</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16020?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16020</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16020?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, Accepted Article.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;p&gt;-&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Thu, 16 Dec 2021 09:37:23 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16020</guid>
      <dc:title>Correspondence: The right kind of rectal cancer operation for the right patient requires information on all relevant outcomes</dc:title>
      <dc:creator>Martin Rutegård, 
Klas Holmgren, 
Jenny Häggström, 
Markku M Haapamäki, 
Peter Matthiessen, 
Jörgen Rutegård</dc:creator>
      <dc:description>Abstract
‐</dc:description>
      <dc:date>2021-12-16T09:37:23Z</dc:date>
      <dc:identifier>10.1111/codi.16020</dc:identifier>
    </item>
    <item>
      <title>Completion surgery vs. primary TME for early rectal cancer: a national study</title>
      <link>http://link.springer.com/10.1007/s00384-021-04083-6</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Purpose&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;While local excision by transanal endoscopic microsurgery (TEM) or transanal minimally invasive surgery (TAMIS) is an option for low-risk early rectal cancers, inaccuracies in preoperative staging may be revealed only upon histopathological evaluation of the resected specimen, demanding completion surgery (CS) by formal resection. The aim of this study was to evaluate the results of CS in a national cohort.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Method&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;This was a retrospective analysis of national registry data, identifying and comparing all Norwegian patients who, without prior radiochemotherapy, underwent local excision by TEM or TAMIS and subsequent CS, or a primary total mesorectal excision (pTME), for early rectal cancer during 2000–2017. Primary endpoints were 5-year overall and disease-free survival, 5-year local and distant recurrence, and the rate of R0 resection at completion surgery. The secondary endpoint was the rate of permanent stoma.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Forty-nine patients received CS, and 1098 underwent pTME. There was no difference in overall survival (OR 0.73, 95% CI 0.27–2.01), disease-free survival (OR 0.72, 95% CI 0.32–1.63), local recurrence (OR 1.08, 95% CI 0.14–8.27) or distant recurrence (OR 0.67, 95% CI 0.21–2.18). In the CS group, 53% had a permanent stoma vs. 32% in the pTME group (&lt;em class="a-plus-plus"&gt;P&lt;/em&gt; = 0.002); however, the difference was not significant when adjusted for age, sex, and tumor level (OR 2.17, 0.95–5.02).&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Conclusions&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Oncological results were similar in the two groups. However, there may be an increased risk for a permanent stoma in the CS group.&lt;/p&gt;
                  &lt;/span&gt;</description>
      <pubDate>Thu, 16 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04083-6</guid>
      <dc:date>2021-12-16T00:00:00Z</dc:date>
    </item>
    <item>
      <title>A comment on ‘development of the Gastrointestinal Dysfunction Score (GIDS) for critically ill patients e a prospective multicenter observational study (iSOFA study)’ (Reintam et al. 2021. Clinical nutrition, V 40 (8):p 4932–4940)</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00573-2/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-15</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>Although the gastrointestinal (GI) tract can fail and exacerbate critical illness, gut dysfunction (GDF) has not been included in organ-based severity scoring systems [1,2]. Recently, a GDF scoring system was published in this journal [3] by the group that previously introduced the Acute Gastrointestinal Injury (AGI) grading system [4]. Reintam and colleagues have now developed the GIDS (or GastroIntestinal Dysfunction Score), based on a prospective multicentre study incorporating it into the SOFA score as the intestinal sequential organ function assessment, or i-SOFA) [3].</description>
      <pubDate>Wed, 15 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00573-2/fulltext?rss=yes</guid>
      <dc:title>A comment on ‘development of the Gastrointestinal Dysfunction Score (GIDS) for critically ill patients e a prospective multicenter observational study (iSOFA study)’ (Reintam et al. 2021. Clinical nutrition, V 40 (8):p 4932–4940)</dc:title>
      <dc:creator>Varsha M. Asrani, Colin McArthur, Ian Bissett, John A. Windsor</dc:creator>
      <dc:date>2021-12-15T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.023</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Comment on “effects of adequate dietary protein with whey protein, leucine, and vitamin D supplementation on sarcopenia in older adults: An open-label, parallel-group study”</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00572-0/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-15</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>A recent article by Lin et al. published in the Clinical Nutrition points to affects of whey protein, leucine, and vitamin D supplementation on sarcopenia in older adults [1]. In older adults, sarcopenia was reported as important, because adults with sarcopenia have significantly lower health-related quality of life compared to non-sarcopenic older adults [2] In this content, we found results of study by Lin et al. particularly valuable meanwhile, some methodological points need to be highlighted before focusing on current results.</description>
      <pubDate>Wed, 15 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00572-0/fulltext?rss=yes</guid>
      <dc:title>Comment on “effects of adequate dietary protein with whey protein, leucine, and vitamin D supplementation on sarcopenia in older adults: An open-label, parallel-group study”</dc:title>
      <dc:creator>Deniz Sevindik Günay, Umut Safer, Vildan Binay Safer</dc:creator>
      <dc:date>2021-12-15T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.022</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Comment on “vegan diet reduces neutrophils, monocytes and platelets related to branched-chain amino acids - A randomized, controlled trial”</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00571-9/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-15</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>We read the article “Vegan diet reduces neutrophils, monocytes and platelets related to branched-chain amino acids - A randomized, controlled trial” by Ann-Kathrin Lederer et al. with great interest [1]. The recent trend of nutrition research focuses on dietary pattern analysis rather than the traditional single nutrient analysis [2]. The authors meticulously designed this first ever randomized control trial taking exclusively vegan diet in one arm. We have the following concerns about the article.</description>
      <pubDate>Wed, 15 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00571-9/fulltext?rss=yes</guid>
      <dc:title>Comment on “vegan diet reduces neutrophils, monocytes and platelets related to branched-chain amino acids - A randomized, controlled trial”</dc:title>
      <dc:creator>Rajesh Kumar, Dibakar Borthakur, Rima Dada</dc:creator>
      <dc:date>2021-12-15T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.021</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Difficulty of treatment in patients with anorexia nervosa</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00570-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-15</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>Guinhut et al. summarized types and prevalence of medical complications in 354 patients with anorexia nervosa (AN) during their hospitalization for refeeding [1]. A total of 339 patients were female and mean (1 SD) of age was 28.7 (10.7) years old. Duration of AN was 9.5 years, and mean body mass index (BMI) (1 SD) at admission was 12.2 (1.6) kg/m2. During mean hospitalization of 36.9 days, the mean weight gain was 4.1 kg. Enteral nutrition was provided in 304 patients, and more than half of the patients presented medical complications such as anemia, neutropenia, and increased transaminase.</description>
      <pubDate>Wed, 15 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00570-7/fulltext?rss=yes</guid>
      <dc:title>Difficulty of treatment in patients with anorexia nervosa</dc:title>
      <dc:creator>Tomoyuki Kawada</dc:creator>
      <dc:date>2021-12-15T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.020</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Effects of probiotic supplementation on anthropometric and metabolic characteristics in adults with metabolic syndrome: Letter to the editor</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00569-0/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-15</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>We read with interest the article by Hadi et al. [1], ' Effects of probiotic supplementation on anthropometric and metabolic characteristics in adults with metabolic syndrome’ in which the probiotic dose for the study by Xavier-Santos et al. [2] was recorded as 1 × 109 CFU. Further scrutiny into this study reveals that the dose of Lactobacillus acidophilus La-5 ranged between 9.2 and 9.5 log CFU per daily serving portion (40 g), which was mentioned to be equivalent to 1.65 × 109 CFU/ser = 9.2 log CFU/ser, and 2.86 × 109 CFU/ser = 9.5 log CFU/ser.</description>
      <pubDate>Wed, 15 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00569-0/fulltext?rss=yes</guid>
      <dc:title>Effects of probiotic supplementation on anthropometric and metabolic characteristics in adults with metabolic syndrome: Letter to the editor</dc:title>
      <dc:creator>Leila Sadat Bahrami, Seyyed Mostafa Arabi</dc:creator>
      <dc:date>2021-12-15T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.019</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Letter to the editor: Comment on “Body mass index and mini nutritional assessment-short form as predictors of in-geriatric hospital mortality in older adults with COVID-19”</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00568-9/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-15</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>I read with great interest the article by Kananen and colleagues that contributed greatly to our understanding of the relationship between body mass index (BMI), nutrition status, and in-hospital mortality among older adults hospitalized for coronavirus disease 2019 (COVID-19) [1]. The authors found that being underweight (BMI &lt;18.5) and malnutrition increased the risk of in-hospital mortality after adjusting for some potential confounding factors, but being overweight and obese were not found to be associated with an increased risk of mortality in COVID-19 patients.</description>
      <pubDate>Wed, 15 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00568-9/fulltext?rss=yes</guid>
      <dc:title>Letter to the editor: Comment on “Body mass index and mini nutritional assessment-short form as predictors of in-geriatric hospital mortality in older adults with COVID-19”</dc:title>
      <dc:creator>Cafer Balcı</dc:creator>
      <dc:date>2021-12-15T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.018</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Doubly labelled water for determining total energy expenditure in adult critically ill and acute care hospitalized inpatients: A scoping review</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00567-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-15</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Narrative Review</prism:section>
      <description>Doubly labelled water (DLW) is considered the reference standard method of measuring total energy expenditure (TEE), but there is limited information on its use in the Intensive Care Unit (ICU) and acute care setting. This scoping review aims to systematically summarize the available literature on TEE measured using DLW in these contexts.</description>
      <pubDate>Wed, 15 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00567-7/fulltext?rss=yes</guid>
      <dc:title>Doubly labelled water for determining total energy expenditure in adult critically ill and acute care hospitalized inpatients: A scoping review</dc:title>
      <dc:creator>Oana A. Tatucu-Babet, Kay Nguo, Kate J. Lambell, Lorena Romero, Carrie P. Earthman, Emma J. Ridley</dc:creator>
      <dc:date>2021-12-15T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.017</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Association between dairy protein and body composition in middle-aged and older women: A community-based, 12-year, prospective cohort study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00565-3/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-15</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <description>Changes in body composition during aging include decreased muscle mass and increased fat mass. Women with low muscle mass with abdominal obesity (LMAO), in particular, could be at higher risk of morbidities and mortality than those with either sarcopenia or obesity alone. Dairy products, which contain whey protein and all essential amino acids, could have a beneficial role in preserving muscle mass and reducing obesity. We aimed to analyze the association between dairy protein and the development of LMAO in women using a large-scale, community-based prospective cohort.</description>
      <pubDate>Wed, 15 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00565-3/fulltext?rss=yes</guid>
      <dc:title>Association between dairy protein and body composition in middle-aged and older women: A community-based, 12-year, prospective cohort study</dc:title>
      <dc:creator>Jun-Hyuk Lee, A-Ra Cho, Yu-Jin Kwon</dc:creator>
      <dc:date>2021-12-15T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.015</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00564-1/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-15</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <description>Previous studies have suggested consumption of red meat may be associated with an increased risk of developing nonalcoholic fatty liver disease (NAFLD). However, large-scale, prospective data regarding red meat consumption in relation to the incidence of NAFLD are lacking, nor is it known whether any association is mediated by obesity.</description>
      <pubDate>Wed, 15 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00564-1/fulltext?rss=yes</guid>
      <dc:title>Red meat consumption, obesity, and the risk of nonalcoholic fatty liver disease among women: Evidence from mediation analysis</dc:title>
      <dc:creator>Mi Na Kim, Chun-Han Lo, Kathleen E. Corey, Xiao Luo, Lu Long, Xuehong Zhang, Andrew T. Chan, Tracey G. Simon</dc:creator>
      <dc:date>2021-12-15T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.014</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Correction to: The treatment of acute appendicitis in two age‑based groups during COVID‑19 pandemic: a retrospective experience in a COVID‑19 referral hospital</title>
      <link>http://link.springer.com/10.1007/s00384-021-04084-5</link>
      <description />
      <pubDate>Wed, 15 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04084-5</guid>
      <dc:date>2021-12-15T00:00:00Z</dc:date>
    </item>
    <item>
      <title>TNF inhibitors in Crohn’s disease and the effect on surgery rates</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16021?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16021</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16021?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, Accepted Article.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Surgery is an important therapeutic option for Crohn’s disease. The need for first bowel surgery seems to have decreased with the introduction of TNF-inhibitors (TNFi; adalimumab or infliximab). However, the impact of TNFi on the need for intestinal surgery in Crohn’s disease patients irrespective of prior bowel resection is not known. Our aim is to compare the incidence of bowel surgery in Crohn’s disease patients who remain on versus those who discontinue TNFi treatment.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;We performed a nationwide register-based observational cohort study in Sweden 2006-2017 of all incident and prevalent cases of Crohn’s disease who started first line TNFi treatment. Patients were categorized according to TNFi treatment retention less than or beyond one year. The study cohort was evaluated with regards to incidence of bowel surgery from 12 months after first ever TNFi dispensation.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;We identified 5003 TNFi exposed Crohn’s disease patients, 3748 surgery-naïve and 1255 with bowel surgery prior to TNFi initiation. Of all these patients, 7% (n=353) were subjected to abdominal surgery during the first 12 months after start of TNFi and subsequently excluded from the main analysis. A majority (62%) continued TNFi ≥12 months. TNFi drug survival &amp;lt;12 months was associated with a significantly higher surgery rate compared to patients who continued TNFi ≥12 months (HR 1.26, 95% CI, 1.09-1.46; p=.002).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Treatment with TNFi &amp;lt;12 months was associated with a higher risk of bowel surgery in Crohn’s disease patients compared to continuing TNFi ≥12 months.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Tue, 14 Dec 2021 14:35:03 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16021</guid>
      <dc:title>TNF inhibitors in Crohn’s disease and the effect on surgery rates</dc:title>
      <dc:creator>M Eberhardson, 
P Myrelid, 
J K Söderling, 
A Ekbom, 
The SWIBREG study group, 
Å H Everhov, 
C Hedin, 
M Neovius, 
J F Ludvigsson, 
O Olén, 
Hans Strid, 
Henrik Hjortswang, 
Malin Olsson, 
Jan Björk, 
Jonas L Bengtsson, 
Jonas Halfvarson, 
Marie A Andersson, 
Pontus Karling, 
Martin Rejler, 
Susanna Jäghult, 
Ulrika L Fagerberg, 
Olof Grip, 
Caroline Nordenvall</dc:creator>
      <dc:description>Abstract

Aim
Surgery is an important therapeutic option for Crohn’s disease. The need for first bowel surgery seems to have decreased with the introduction of TNF‐inhibitors (TNFi; adalimumab or infliximab). However, the impact of TNFi on the need for intestinal surgery in Crohn’s disease patients irrespective of prior bowel resection is not known. Our aim is to compare the incidence of bowel surgery in Crohn’s disease patients who remain on versus those who discontinue TNFi treatment.


Method
We performed a nationwide register‐based observational cohort study in Sweden 2006‐2017 of all incident and prevalent cases of Crohn’s disease who started first line TNFi treatment. Patients were categorized according to TNFi treatment retention less than or beyond one year. The study cohort was evaluated with regards to incidence of bowel surgery from 12 months after first ever TNFi dispensation.


Results
We identified 5003 TNFi exposed Crohn’s disease patients, 3748 surgery‐naïve and 1255 with bowel surgery prior to TNFi initiation. Of all these patients, 7% (n=353) were subjected to abdominal surgery during the first 12 months after start of TNFi and subsequently excluded from the main analysis. A majority (62%) continued TNFi ≥12 months. TNFi drug survival &lt;12 months was associated with a significantly higher surgery rate compared to patients who continued TNFi ≥12 months (HR 1.26, 95% CI, 1.09‐1.46; p=.002).


Conclusion
Treatment with TNFi &lt;12 months was associated with a higher risk of bowel surgery in Crohn’s disease patients compared to continuing TNFi ≥12 months.</dc:description>
      <dc:date>2021-12-14T14:35:03Z</dc:date>
      <dc:identifier>10.1111/codi.16021</dc:identifier>
    </item>
    <item>
      <title>Long‐term Oncological Outcomes in Patients Undergoing Laparoscopic vs. Open Surgery for Colon Cancer: A Nationwide Cohort Study</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16022?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16022</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16022?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, Accepted Article.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;To estimate the effect of laparoscopy vs. laparotomy on recurrence status in patients undergoing intended curative resection for stage I-III colon cancer using nationwide data.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;A retrospective cohort study using prospectively collected nationwide quality assurance data on all patients undergoing elective, intended curative surgery for UICC stage I-III colon cancer in Denmark from January 1, 2010, through December 31, 2013. The association between laparoscopic vs. open surgery and recurrence status was investigated using cause-specific hazard and subdistribution hazard models with death from any cause as a competing event.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;In total,4369 patients undergoing elective intended curative surgery for colon cancer were included in the analysis. Overall, 3243 (74.2%) patients underwent laparoscopic surgery. During a median follow-up time of 84 months, 1191 (27.2%) patients experienced recurrence, and 1304 (29.8%) patients died. The cause-specific hazard of recurrence following laparoscopic vs. open surgery was HR&lt;sub&gt;CS&lt;/sub&gt;=1.08, 95% CI: 0.90 to 1.28, p=0.422. The subdistribution hazard of recurrence following laparoscopic vs. open surgery was HR&lt;sub&gt;SD&lt;/sub&gt;=0.99, 95% CI: 0.84 to 1.16, p=0.880.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Elective laparoscopic resection for UICC stage I-III colon cancer was oncologically safe and comparable with open resection. These results confirm the external validity of previous RCTs in everyday clinical settings.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Tue, 14 Dec 2021 14:33:15 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16022</guid>
      <dc:title>Long‐term Oncological Outcomes in Patients Undergoing Laparoscopic vs. Open Surgery for Colon Cancer: A Nationwide Cohort Study</dc:title>
      <dc:creator>Rasmus Peuliche Vogelsang, 
Tina Fransgaard, 
Mads Falk Klein, 
Ismail Gögenur</dc:creator>
      <dc:description>Abstract

Aim
To estimate the effect of laparoscopy vs. laparotomy on recurrence status in patients undergoing intended curative resection for stage I‐III colon cancer using nationwide data.


Method
A retrospective cohort study using prospectively collected nationwide quality assurance data on all patients undergoing elective, intended curative surgery for UICC stage I‐III colon cancer in Denmark from January 1, 2010, through December 31, 2013. The association between laparoscopic vs. open surgery and recurrence status was investigated using cause‐specific hazard and subdistribution hazard models with death from any cause as a competing event.


Results
In total,4369 patients undergoing elective intended curative surgery for colon cancer were included in the analysis. Overall, 3243 (74.2%) patients underwent laparoscopic surgery. During a median follow‐up time of 84 months, 1191 (27.2%) patients experienced recurrence, and 1304 (29.8%) patients died. The cause‐specific hazard of recurrence following laparoscopic vs. open surgery was HRCS=1.08, 95% CI: 0.90 to 1.28, p=0.422. The subdistribution hazard of recurrence following laparoscopic vs. open surgery was HRSD=0.99, 95% CI: 0.84 to 1.16, p=0.880.


Conclusion
Elective laparoscopic resection for UICC stage I‐III colon cancer was oncologically safe and comparable with open resection. These results confirm the external validity of previous RCTs in everyday clinical settings.</dc:description>
      <dc:date>2021-12-14T14:33:15Z</dc:date>
      <dc:identifier>10.1111/codi.16022</dc:identifier>
    </item>
    <item>
      <title>Robotic natural orifice specimen extraction surgery for complicated diverticulitis requiring sigmoid colon resection and colovesical fistulectomy followed by colorectal anastomosis and repair of the urinary bladder – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16015?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16015</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16015?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Mon, 13 Dec 2021 11:15:36 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16015</guid>
      <dc:title>Robotic natural orifice specimen extraction surgery for complicated diverticulitis requiring sigmoid colon resection and colovesical fistulectomy followed by colorectal anastomosis and repair of the urinary bladder – A video vignette</dc:title>
      <dc:creator>Hsiang‐Chih Chen, 
Tzu‐Chun Chen, 
Jin‐Tung Liang</dc:creator>
      <dc:description />
      <dc:date>2021-12-13T11:15:36Z</dc:date>
      <dc:identifier>10.1111/codi.16015</dc:identifier>
    </item>
    <item>
      <title>Standardized documentation and synoptic reporting of complex intestinal anatomy in enteric fistulation and intestinal failure</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16007?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16007</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16007?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">TECHNICAL NOTE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;In intestinal failure, delineation of both structure and function are key to controlling symptoms and planning further intervention. We have developed a template for developing an ‘anatomy at a glance’ patient-specific map to aid decision making and counselling.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;A core dataset was developed and used to create an editable template to demonstrate the gastrointestinal tract, its relationship to the genitourinary tract, and specific anterior abdominal wall features. This was then used to create an anatomical template, specific to each patient, and stored in the electronic patient record and imaging archive.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;We have developed a technique for integration of multi-modal information into one diagram, easily referenced by the multidisciplinary team. Radiology, endoscopy and previous operation notes can be used to fill out a core dataset, which is then transposed into a standardized template. A worked example is shown.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;The mapping template has been successfully integrated into practice and aided decision making at all stages of the patient's therapeutic journey. It has been found helpful in planning routes of nutrition, preoperative optimization, surgical planning, interpreting postoperative imaging and managing patient expectations.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>TECHNICAL NOTE</category>
      <pubDate>Mon, 13 Dec 2021 11:01:41 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16007</guid>
      <dc:title>Standardized documentation and synoptic reporting of complex intestinal anatomy in enteric fistulation and intestinal failure</dc:title>
      <dc:creator>Katherine J. Williams, 
Suzanne Donnelly, 
Simon Gabe, 
Arun Gupta, 
Richard Holman, 
Stephen Preston, 
Carolynne J. Vaizey, 
Alison Corr, 
Akash M. Mehta</dc:creator>
      <dc:description>Abstract

Aim
In intestinal failure, delineation of both structure and function are key to controlling symptoms and planning further intervention. We have developed a template for developing an ‘anatomy at a glance’ patient‐specific map to aid decision making and counselling.


Method
A core dataset was developed and used to create an editable template to demonstrate the gastrointestinal tract, its relationship to the genitourinary tract, and specific anterior abdominal wall features. This was then used to create an anatomical template, specific to each patient, and stored in the electronic patient record and imaging archive.


Results
We have developed a technique for integration of multi‐modal information into one diagram, easily referenced by the multidisciplinary team. Radiology, endoscopy and previous operation notes can be used to fill out a core dataset, which is then transposed into a standardized template. A worked example is shown.


Conclusion
The mapping template has been successfully integrated into practice and aided decision making at all stages of the patient's therapeutic journey. It has been found helpful in planning routes of nutrition, preoperative optimization, surgical planning, interpreting postoperative imaging and managing patient expectations.</dc:description>
      <dc:date>2021-12-13T11:01:41Z</dc:date>
      <dc:identifier>10.1111/codi.16007</dc:identifier>
    </item>
    <item>
      <title>Iron status in early childhood is modified by diet, sex and growth: Secondary analysis of a randomized controlled vitamin D trial</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00563-X/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-13</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <description>During early childhood the risk of iron deficiency (ID) is high. Serum ferritin serves as a marker of iron status. We explored prevalence of ID and iron deficiency anemia (IDA), and identified determinants of iron status in infants and toddlers.</description>
      <pubDate>Mon, 13 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00563-X/fulltext?rss=yes</guid>
      <dc:title>Iron status in early childhood is modified by diet, sex and growth: Secondary analysis of a randomized controlled vitamin D trial</dc:title>
      <dc:creator>Elisa M. Holmlund-Suila, Helena H. Hauta-alus, Maria Enlund-Cerullo, Jenni Rosendahl, Saara M. Valkama, Sture Andersson, Outi Mäkitie</dc:creator>
      <dc:date>2021-12-13T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.013</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Alcohol – The myth of cardiovascular protection</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00559-8/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-13</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <description>To investigate potential biases that exist in available epidemiological evidence resulting in negative associations or underestimation of cardiovascular (CV) risk associated with alcohol consumption.</description>
      <pubDate>Mon, 13 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00559-8/fulltext?rss=yes</guid>
      <dc:title>Alcohol – The myth of cardiovascular protection</dc:title>
      <dc:creator>Rudolph Schutte, Lee Smith, Goya Wannamethee</dc:creator>
      <dc:date>2021-12-13T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.009</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Mortality following elective and emergency colectomy in patients with cirrhosis: a population-based cohort study from England</title>
      <link>http://link.springer.com/10.1007/s00384-021-04061-y</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Background&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Patients with cirrhosis undergoing colectomy have a higher risk of postoperative mortality, but contemporary estimates are lacking and data on associated risk and longer term outcomes are limited. This study aimed to quantify the risk of mortality following colectomy by urgency of surgery and stage of cirrhosis.&lt;/p&gt;
                    &lt;p class="a-plus-plus"&gt;Data sources.&lt;/p&gt;
                    &lt;p class="a-plus-plus"&gt;Linked primary and secondary-care electronic healthcare data from England were used to identify all patients undergoing colectomy from January 2001 to December 2017. These patients were classified by the absence or presence of cirrhosis and severity. Case fatality rates at 90 days and 1 year were calculated, and cox regression was used to estimate the hazard ratio of postoperative mortality controlling for age, gender and co-morbidity.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Of the total, 36,380 patients undergoing colectomy, 248 (0.7%) had liver cirrhosis, and 70% of those had compensated cirrhosis. Following elective colectomy, 90-day case fatality was 4% in those without cirrhosis, 7% in compensated cirrhosis and 10% in decompensated cirrhosis. Following emergency colectomy, 90-day case fatality was higher; it was 16% in those without cirrhosis, 35% in compensated cirrhosis and 41% in decompensated cirrhosis. This corresponded to an adjusted 2.57 fold (95% CI 1.75–3.76) and 3.43 fold (95% CI 2.02–5.83) increased mortality risk in those with compensated and decompensated cirrhosis, respectively. This higher case fatality in patients with cirrhosis persisted at 1 year.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Conclusion&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Patients with cirrhosis undergoing emergency colectomy have a higher mortality risk than those undergoing elective colectomy both at 90 days and 1 year. The greatest mortality risk at 90 days was in those with decompensation undergoing emergency surgery.&lt;/p&gt;
                  &lt;/span&gt;</description>
      <pubDate>Sat, 11 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04061-y</guid>
      <dc:date>2021-12-11T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Managing folate deficiency implies filling the gap between laboratory and clinical assessment</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00562-8/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-10</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Narrative Review</prism:section>
      <description>The characterization of folate status in subjects at risk of deficiency and with altered vitamin homeostasis is crucial to endorse preventive intervention health policies, especially in developed countries. Several physiological changes (i.e. pregnancy), clinical situations and diseases have been associated to increased requirement, impaired intake and absorption of folate. However clinical practice guidelines (CPG) endorse folic acid supplementation generally discarding the use of its determination in serum to assess the risk of deficiency and/or its concentration at baseline.</description>
      <pubDate>Fri, 10 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00562-8/fulltext?rss=yes</guid>
      <dc:title>Managing folate deficiency implies filling the gap between laboratory and clinical assessment</dc:title>
      <dc:creator>Simona Ferraro, Giacomo Biganzoli, Michele Gringeri, Sonia Radice, Alessandra Stefania Rizzuto, Carla Carnovale, Elia Mario Biganzoli, Emilio Clementi</dc:creator>
      <dc:date>2021-12-10T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.012</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Early vs late initiation of sodium glycerophosphate: Impact on hypophosphatemia in preterm infants &lt;32 weeks</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00561-6/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-10</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <description>Early electrolyte and mineral imbalances have emerged as a conspicuous problem in very preterm babies since the revision of nutrition guidelines and the eventual implementation of early aggressive parenteral nutrition (PN). We opted to carry out a study with the introduction of phosphorus as sodium glycerophosphate in PN from the first day onward to reveal the impact on serum phosphorus and calcium levels following the surge in the incidence of hypercalcemia and hypophosphatemia.</description>
      <pubDate>Fri, 10 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00561-6/fulltext?rss=yes</guid>
      <dc:title>Early vs late initiation of sodium glycerophosphate: Impact on hypophosphatemia in preterm infants &lt;32 weeks</dc:title>
      <dc:creator>Buse Ozer Bekmez, Serife Suna Oguz</dc:creator>
      <dc:date>2021-12-10T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.011</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Laparoscopic sphincter‐preserving total pelvic exenteration with transanal total mesorectal excision for locally advanced rectal cancer—A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16011?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16011</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16011?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Thu, 09 Dec 2021 18:33:19 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16011</guid>
      <dc:title>Laparoscopic sphincter‐preserving total pelvic exenteration with transanal total mesorectal excision for locally advanced rectal cancer—A video vignette</dc:title>
      <dc:creator>Isaac Seow‐En, 
Yu Guang Tan, 
Kae Jack Tay</dc:creator>
      <dc:description />
      <dc:date>2021-12-09T18:33:19Z</dc:date>
      <dc:identifier>10.1111/codi.16011</dc:identifier>
    </item>
    <item>
      <title>Laparoscopic Repair of Traumatic Rectal Injury with Transanal Endoscopic Microsurgery (TEM) Beads</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16019?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16019</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16019?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, Accepted Article.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;p&gt;We present a case of a 34-year-old male with an intra-peritoneal rectal perforation from a rectal foreign body. He presented more than 24 hours after the case from an outside hospital, with abdominal pain, rectal bleeding, and pain with bowel movements. On initial CT there was evidence of free air and pelvic free fluid. He was stable with no other injuries. He was taken to the operating room. A Hasson technique was utilized for entry. Five ports were ultimately placed, with a 5 mm left upper quadrant port, a 5 mm right upper quadrant port, 5 mm suprapubic port and a 12 mm disposable trocar in the right lower quadrant. The patient then underwent a laparoscopic primary repair of a longitudinal tear just at the anterior peritoneal reflection in a single layer fashion with interrupted 2-0 PDS sutures. We utilized the transanal endoscopic microsurgery (TEM) beads (Wolf, TM) to secure the sutures, resulting in a fast and easy repair in the deep pelvis. The patient was diverted with a loop colostomy. He did well post operatively, with no leak on CT with rectal contrast 3 months later.&lt;/p&gt;
&lt;p&gt;This video demonstrates the feasibility and principles of laparoscopic repair of rectal perforation, as well as the novel application of TEM beads for securing the sutures.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Thu, 09 Dec 2021 11:44:34 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16019</guid>
      <dc:title>Laparoscopic Repair of Traumatic Rectal Injury with Transanal Endoscopic Microsurgery (TEM) Beads</dc:title>
      <dc:creator>Ameer Farooq, 
Jinny Choi, 
Ahmer Karimuddin</dc:creator>
      <dc:description>Abstract
We present a case of a 34‐year‐old male with an intra‐peritoneal rectal perforation from a rectal foreign body. He presented more than 24 hours after the case from an outside hospital, with abdominal pain, rectal bleeding, and pain with bowel movements. On initial CT there was evidence of free air and pelvic free fluid. He was stable with no other injuries. He was taken to the operating room. A Hasson technique was utilized for entry. Five ports were ultimately placed, with a 5 mm left upper quadrant port, a 5 mm right upper quadrant port, 5 mm suprapubic port and a 12 mm disposable trocar in the right lower quadrant. The patient then underwent a laparoscopic primary repair of a longitudinal tear just at the anterior peritoneal reflection in a single layer fashion with interrupted 2‐0 PDS sutures. We utilized the transanal endoscopic microsurgery (TEM) beads (Wolf, TM) to secure the sutures, resulting in a fast and easy repair in the deep pelvis. The patient was diverted with a loop colostomy. He did well post operatively, with no leak on CT with rectal contrast 3 months later.
This video demonstrates the feasibility and principles of laparoscopic repair of rectal perforation, as well as the novel application of TEM beads for securing the sutures.</dc:description>
      <dc:date>2021-12-09T11:44:34Z</dc:date>
      <dc:identifier>10.1111/codi.16019</dc:identifier>
    </item>
    <item>
      <title>Multiple vitamin co-exposure and mortality risk: A prospective study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00560-4/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-09</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <description>Existing epidemiological studies explored the associations of circulating vitamins and mortality focusing on individual vitamin effects, and controversial findings were obtained. The joint effects of multiple vitamin co-exposure are worth studying. The study aimed to elucidate the associations of circulating vitamins and the joint effects of these vitamins’ co-exposure with all-cause and cause-specific mortality risks.</description>
      <pubDate>Thu, 09 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00560-4/fulltext?rss=yes</guid>
      <dc:title>Multiple vitamin co-exposure and mortality risk: A prospective study</dc:title>
      <dc:creator>Yuan Cui, Hao-long Zhou, Mu-hong Wei, Wen-jing Song, Dong-sheng Di, Ru-yi Zhang, Sheng Wei, Jun-an Liu, Qi Wang</dc:creator>
      <dc:date>2021-12-09T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.010</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Outcomes of dietary management approaches in active ulcerative colitis: A systematic review</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00558-6/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-09</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Narrative Review</prism:section>
      <description>The dietary management of active ulcerative colitis (UC) is currently poorly understood. Due to the lack of clinical guidelines for this population, diet choice may be based on the personal judgement of the clinician, and without sound evidence. The aim of this systematic review was to appraise the current literature on the dietary management of individuals with active UC, in both inpatient and outpatient settings, to determine if clinical outcomes differ by diet prescription.</description>
      <pubDate>Thu, 09 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00558-6/fulltext?rss=yes</guid>
      <dc:title>Outcomes of dietary management approaches in active ulcerative colitis: A systematic review</dc:title>
      <dc:creator>Abigail Marsh, Sophie Rindfleish, Kalina Bennett, Anthony Croft, Veronique Chachay</dc:creator>
      <dc:date>2021-12-09T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.007</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Meta-analysis of randomized controlled trials of the effects of probiotics on type 2 diabetes in adults</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00547-1/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-09</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Meta-analyses</prism:section>
      <description>Despite advancements in preventive medicine and pharmacotherapy, diabetes remains an overwhelming health problem. Evidence from randomized controlled trials (RCTs) suggests that probiotics may offer beneficial effects on glycemic control. Our objective was to perform a systematic review and meta-analysis of RCTs to quantify the effect of probiotic administration on glycemic homeostasis in type 2 diabetes.</description>
      <pubDate>Thu, 09 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00547-1/fulltext?rss=yes</guid>
      <dc:title>Meta-analysis of randomized controlled trials of the effects of probiotics on type 2 diabetes in adults</dc:title>
      <dc:creator>Chengcheng Zhang, Jinchi jiang, Chen Wang, Sijia Li, Leilei Yu, Fengwei Tian, Jianxin Zhao, Hao Zhang, Wei Chen, Qixiao Zhai</dc:creator>
      <dc:date>2021-12-09T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.037</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Evaluation of diagnostic factors used to refer children with constipation for rectal biopsies</title>
      <link>http://link.springer.com/10.1007/s00384-021-04069-4</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Purpose&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Children with constipation and suspected Hirschsprung’s disease are referred for rectal biopsy. Since this is an invasive procedure, appropriate indications should be applied to minimize the number of “unnecessary” biopsies.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;We reviewed all constipated children who underwent a rectal biopsy to diagnose a possible Hirschsprung’s disease at a tertiary referral hospital over a 6-year period (2013–2018). We registered clinical and demographic factors in these children and conducted correlation and multivariate regression analysis to evaluate the relation between these factors and a diagnosis of Hirschsprung’s disease.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;We identified 225 children, aged 0–17 years. In total, Hirschsprung’s disease was diagnosed in only 49/225 (22%). Among the 49 children with Hirschsprung’s disease, 29 (59%) were diagnosed in the neonatal period. Among girls, HD was confirmed in only 10/101 (10%) children, and only 1 of these 10 girls was older than 6 months at the time of the biopsy. The following factors correlated significantly with Hirschsprung’s disease diagnosis in children older than 1 month: “male sex”, “failure to thrive”, “gross abdominal distention plus vomiting” and “fulfils the Rome 4 criteria for functional constipation”.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Conclusion&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;In children referred for rectal biopsy, the factors most indicative of Hirschsprung’s disease were “male sex”, “failure to thrive”, “gross abdominal distention plus vomiting” and “fulfils the Rome 4 criteria for functional constipation”. Notably, the prevalence of Hirschsprung’s disease decreased with the increasing age of the children. Girls referred for a biopsy rarely had Hirschsprung’s disease, especially those older than 1 month.&lt;/p&gt;
                  &lt;/span&gt;</description>
      <pubDate>Thu, 09 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04069-4</guid>
      <dc:date>2021-12-09T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Video Vignette: Laparoscopic Sigmoid Colon Vaginoplasty</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16018?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16018</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16018?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, Accepted Article.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;p&gt;-&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 08 Dec 2021 19:49:06 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16018</guid>
      <dc:title>Video Vignette: Laparoscopic Sigmoid Colon Vaginoplasty</dc:title>
      <dc:creator>Deena Harji, 
Alexander Chauvet, 
Julian Pouplin, 
Quentin Denost</dc:creator>
      <dc:description>Abstract
‐</dc:description>
      <dc:date>2021-12-08T19:49:06Z</dc:date>
      <dc:identifier>10.1111/codi.16018</dc:identifier>
    </item>
    <item>
      <title>Chylous ascites after complete mesocolic excision for right‐sided colon cancer with D3 lymphadenectomy: a retrospective cohort‐study</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16017?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16017</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16017?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, Accepted Article.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;This retrospective study was designed to evaluate risk factors of occurrence and severity of chylous ascites after complete mesocolic excision (CME) and D3 lymphadenectomy in patients with right-sided colon cancer.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;Consecutive colorectal cancer patients receiving CME and D3 lymphadenectomy for right-sided colon cancer were included. Risk factors of occurrence and severity of chylous ascites by using logistic analysis were assessed. A nomogram predicting chylous ascites was constructed.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Among 661 patients included, postoperative chylous ascites occurred in 48 (7.3%) patients. Logistic regression analysis demonstrated that prognostic nutritional index (PNI ≤ 47, OR = 2.172, &lt;i&gt;P&lt;/i&gt; = 0.016), laparoscopic surgery (OR = 2.798, &lt;i&gt;P&lt;/i&gt; = 0.034), operating time (&amp;gt; 225min, OR = 2.645, &lt;i&gt;P&lt;/i&gt; = 0.002), and apical lymph node (APN) metastasis (OR = 3.698, &lt;i&gt;P&lt;/i&gt; = 0.034) were correlated with the occurrence of postoperative chylous ascites. A nomogram predicting postoperative chylous ascites was constructed (C-index 0.701). 31.2% (15/48) of patients with chylous ascites were resolved in more than 7 days. The number of retrieved lymph nodes (OR = 1.074, 95% CI: 1.002-1.152, &lt;i&gt;P&lt;/i&gt; = 0.044) and PNI ≤ 47 (OR = 7.890, 95% CI: 1.224-50.869, &lt;i&gt;P&lt;/i&gt; = 0.030) were independently predictive of prolonged chylous ascites resolution (≥ 7 days).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;In our series, 7.3% of patients developed chylous ascites after right hemicolectomy with CME. Laparoscopic surgery, PNI, operation time, and APN metastasis were independently predictive of postoperative chylous ascites. Lower PNI and more retrieved lymph nodes were correlated with prolonged resolution of chylous ascites.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 08 Dec 2021 13:41:21 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16017</guid>
      <dc:title>Chylous ascites after complete mesocolic excision for right‐sided colon cancer with D3 lymphadenectomy: a retrospective cohort‐study</dc:title>
      <dc:creator>Yanwu Sun, 
Yu Deng, 
Yu Lin, 
Huiming Lin, 
Ying Huang, 
Jiang Weizhong, 
Pan Chi</dc:creator>
      <dc:description>Abstract

Aim
This retrospective study was designed to evaluate risk factors of occurrence and severity of chylous ascites after complete mesocolic excision (CME) and D3 lymphadenectomy in patients with right‐sided colon cancer.


Method
Consecutive colorectal cancer patients receiving CME and D3 lymphadenectomy for right‐sided colon cancer were included. Risk factors of occurrence and severity of chylous ascites by using logistic analysis were assessed. A nomogram predicting chylous ascites was constructed.


Results
Among 661 patients included, postoperative chylous ascites occurred in 48 (7.3%) patients. Logistic regression analysis demonstrated that prognostic nutritional index (PNI ≤ 47, OR = 2.172, P = 0.016), laparoscopic surgery (OR = 2.798, P = 0.034), operating time (&gt; 225min, OR = 2.645, P = 0.002), and apical lymph node (APN) metastasis (OR = 3.698, P = 0.034) were correlated with the occurrence of postoperative chylous ascites. A nomogram predicting postoperative chylous ascites was constructed (C‐index 0.701). 31.2% (15/48) of patients with chylous ascites were resolved in more than 7 days. The number of retrieved lymph nodes (OR = 1.074, 95% CI: 1.002‐1.152, P = 0.044) and PNI ≤ 47 (OR = 7.890, 95% CI: 1.224‐50.869, P = 0.030) were independently predictive of prolonged chylous ascites resolution (≥ 7 days).


Conclusion
In our series, 7.3% of patients developed chylous ascites after right hemicolectomy with CME. Laparoscopic surgery, PNI, operation time, and APN metastasis were independently predictive of postoperative chylous ascites. Lower PNI and more retrieved lymph nodes were correlated with prolonged resolution of chylous ascites.</dc:description>
      <dc:date>2021-12-08T13:41:21Z</dc:date>
      <dc:identifier>10.1111/codi.16017</dc:identifier>
    </item>
    <item>
      <title>Hybrid robotic and laparoscopic hand‐assisted proctocolectomy with complete mesocolic excision, ileal pouch–anal anastomosis and loop ileostomy – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16009?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16009</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16009?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 08 Dec 2021 09:40:50 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16009</guid>
      <dc:title>Hybrid robotic and laparoscopic hand‐assisted proctocolectomy with complete mesocolic excision, ileal pouch–anal anastomosis and loop ileostomy – A video vignette</dc:title>
      <dc:creator>Jennifer Wang, 
Helen Mohan, 
José Tomás Larach, 
Alexander Heriot, 
Satish Warrier</dc:creator>
      <dc:description />
      <dc:date>2021-12-08T09:40:50Z</dc:date>
      <dc:identifier>10.1111/codi.16009</dc:identifier>
    </item>
    <item>
      <title>Correction: PTU-67 Differential expression of the potassium of voltage-gated channel subfamily members, kchn</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/e1?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Miscellaneous</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">e1</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">e1</prism:endingPage>
      <description>&lt;p&gt;Dong X. PTU-67 Differential expression of the potassium of voltage-gated channel subfamily members, kchn. &lt;I&gt;Gut&lt;/I&gt; 2021;70:A145. doi: 10.1136/gutjnl-2021-BSG.269&lt;/p&gt;
&lt;p&gt;Due to submitting loading errors, the fully list of authors and the institutions of this abstract were incomplete. The following are the correct information for the authors and institutions:&lt;/p&gt;
&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Xuefei Dong, &lt;sup&gt;1&lt;/sup&gt;Yuxin Cui, &lt;sup&gt;1&lt;/sup&gt;Tracey A Martin, &lt;sup&gt;2&lt;/sup&gt;Jiafu Ji, &lt;sup&gt;2&lt;/sup&gt;Chunyi Hao, &lt;sup&gt;1&lt;/sup&gt;Wen G Jiang&lt;/p&gt;
&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Cardiff China Medical Collaborative, School of Medicine, Cardiff University, Cadiff, UK&lt;/p&gt;
&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Peking University Cancer Hospital and Key Laboratory for Carcinogenesis, Haidian District, Beijing, China&lt;/p&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:04 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/e1?rss=1</guid>
      <dc:title>Correction: PTU-67 Differential expression of the potassium of voltage-gated channel subfamily members, kchn</dc:title>
      <dc:creator />
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:04Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-bsg.269corr1</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-bsg.269corr1</dc:identifier>
    </item>
    <item>
      <title>Correction: PTH-94 DRIM expression in colorectal cancer and its possible tumour suppressive role, clinical and prognostic significance</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/e1-a?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Miscellaneous</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">e1</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">e1</prism:endingPage>
      <description>&lt;p&gt;Dong X, Cui Y, Dong X. PTH-94 DRIM expression in colorectal cancer and its possible tumour suppressive role, clinical and prognostic significance. &lt;I&gt;Gut&lt;/I&gt; 2021;70:A160. doi: 10.1136/gutjnl-2021-bsg.297&lt;/p&gt;
&lt;p&gt;Due to submitting loading errors, the fully list of authors and the institutions of this abstract were incomplete. The following are the correct information for the authors and institutions:&lt;/p&gt;
&lt;p&gt;Xuefei Dong, Yuxin Cui, Fiona Ruge, Tracey A Martin, Rachel Hargest, Wen G Jiang&lt;/p&gt;
&lt;p&gt;Cardiff University School of Medicine, Heath Park, Cardiff, UK&lt;/p&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:04 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/e1-a?rss=1</guid>
      <dc:title>Correction: PTH-94 DRIM expression in colorectal cancer and its possible tumour suppressive role, clinical and prognostic significance</dc:title>
      <dc:creator />
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:04Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-bsg.297corr1</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-bsg.297corr1</dc:identifier>
    </item>
    <item>
      <title>Correction: PTH-27 Risk-stratified FIT for urgent colonoscopy in Lynch Syndrome: A clinical service throughout the COVID-19 pandemic</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/e3?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Miscellaneous</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">e3</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">e3</prism:endingPage>
      <description>&lt;p&gt;Lincoln A, Lincoln A, Benton S, &lt;I&gt;et al&lt;/I&gt;. PTH-27 Risk-stratified FIT for urgent colonoscopy in Lynch Syndrome: A clinical service throughout the COVID-19 pandemic. &lt;I&gt;Gut&lt;/I&gt; 2021;70:A184. doi: 10.1136/gutjnl-2021-BSG.342&lt;/p&gt;
&lt;p&gt;The authors listed are in correct and should read:&lt;/p&gt;
&lt;p&gt;Anne Lincoln&lt;sup&gt;1&lt;/sup&gt;, Sally C Benton&lt;sup&gt;2&lt;/sup&gt;, Prof Peter Sasieni&lt;sup&gt;1&lt;/sup&gt;, Kevin J Monahan&lt;sup&gt;3&lt;/sup&gt;,&lt;sup&gt;4&lt;/sup&gt;&lt;/p&gt;
&lt;p&gt;Author Affiliations:&lt;/p&gt;
&lt;p&gt;1 Comprehensive Cancer Centre, King&amp;#8217;s College London, London, UK,&lt;/p&gt;
&lt;p&gt;2 Bowel Cancer Screening South of England Hub, Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK&lt;/p&gt;
&lt;p&gt;3 The Lynch Syndrome Family Cancer Clinic, St Mark&amp;#8217;s Hospital and Academic Institute, Harrow, UK&lt;/p&gt;
&lt;p&gt;4 Imperial College London, London, UK&lt;/p&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:04 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/e3?rss=1</guid>
      <dc:title>Correction: PTH-27 Risk-stratified FIT for urgent colonoscopy in Lynch Syndrome: A clinical service throughout the COVID-19 pandemic</dc:title>
      <dc:creator />
      <dc:subject>COVID-19</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:04Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-bsg.342corr1</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-bsg.342corr1</dc:identifier>
    </item>
    <item>
      <title>Liver injury, hypoalbuminaemia and severe SARS-CoV-2 infection</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/225?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">PostScript</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">225</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">226</prism:endingPage>
      <description>&lt;p&gt;We have read with interest the recent study published in &lt;I&gt;Gut&lt;/I&gt; by Weber &lt;I&gt;et al&lt;/I&gt;&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; outlining liver abnormalities in 217 patients admitted with COVID-19 infection in Germany. Along with respiratory failure, deranged liver blood tests have been demonstrated in many cohort studies of patients admitted with SARS-CoV-2 infection, the clinical relevance of which has been unclear to date.&lt;cross-ref type="bib" refid="R2"&gt;2 3&lt;/cross-ref&gt;&lt;cross-ref type="bib" refid="R3"&gt;&lt;/cross-ref&gt;&lt;/p&gt; &lt;p&gt;The authors of this study demonstrated that deranged liver blood tests on admission were associated with more severe morbidity and mortality. Notably, hypoalbuminaemia on admission in this cohort was associated with a severe COVID-19 disease course.&lt;/p&gt; &lt;p&gt;A review of 310 patients admitted with COVID-19 to our institution in Dublin revealed abnormal liver blood tests were present in almost 50% of patients, in particular raised gamma-glutamyl transferase (gGT) levels (&lt;cross-ref type="tbl" refid="T1"&gt;table 1&lt;/cross-ref&gt;), similar to that noted by Weber and colleagues.&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; In our...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:04 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/225?rss=1</guid>
      <dc:title>Liver injury, hypoalbuminaemia and severe SARS-CoV-2 infection</dc:title>
      <dc:creator>Foley, C. E., Mulvey, C., Boylan, M., Reidy, N., Reidy, P., Moynan, D., Worrall, A., Curley, G., Boland, K., de Barra, E., Ryan, J. D.</dc:creator>
      <dc:subject>Gut, COVID-19</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:04Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-324570</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-324570</dc:identifier>
    </item>
    <item>
      <title>Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/226?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">PostScript</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">226</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">229</prism:endingPage>
      <description>&lt;p&gt;We read with great interest the article published by Zuo &lt;I&gt;et al&lt;/I&gt;, which highlighted the presence of SARS-CoV-2 RNA in stool samples during active and convalescence phases of COVID-19 infection.&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; However, no study has reported the presence of viral antigens within GI and hepatic organs during the convalescent phase.&lt;/p&gt; &lt;p&gt;Using conventional immunohistochemistry, we detected SARS-CoV-2 nucleocapsid protein (NP) in the colon, appendix, ileum, haemorrhoid, liver, gallbladder and lymph nodes (&lt;cross-ref type="fig" refid="F1"&gt;figure 1A&amp;#8211;K&lt;/cross-ref&gt;) from five patients who recovered from COVID-19, ranging from 9 to 180 days after testing negative for SARS-CoV-2 (). Notably, when multiple tissues were obtained from one patient (patients 1 and 4), all the tissues showed the presence of the viral antigen, suggesting widespread multiorgan involvement of the viral infection. Interestingly, for the colon, the viral antigen was only present in normal colonic crypts and polyps but not in the neoplastic tissues (&lt;cross-ref type="fig"...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:04 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/226?rss=1</guid>
      <dc:title>Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19</dc:title>
      <dc:creator>Cheung, C. C. L., Goh, D., Lim, X., Tien, T. Z., Lim, J. C. T., Lee, J. N., Tan, B., Tay, Z. E. A., Wan, W. Y., Chen, E. X., Nerurkar, S. N., Loong, S., Cheow, P. C., Chan, C. Y., Koh, Y. X., Tan, T. T., Kalimuddin, S., Tai, W. M. D., Ng, J. L., Low, J. G.-H., Yeong, J., Lim, K. H.</dc:creator>
      <dc:subject>Gut, COVID-19</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:04Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-324280</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-324280</dc:identifier>
    </item>
    <item>
      <title>SARS-COV-2 in endoscopy: still a long way to go</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/229?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">PostScript</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">229</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">230</prism:endingPage>
      <description>&lt;p&gt;We thank Chaussade &lt;I&gt;et al&lt;/I&gt; that raised important questions regarding the potential ways of airborne transmission of microorganisms through endoscopes light source processors&lt;cross-ref type="bib" refid="R1"&gt;1 2&lt;/cross-ref&gt;&lt;cross-ref type="bib" refid="R2"&gt;&lt;/cross-ref&gt; and their discussion on our previously published work on endoscopes used in positive and critically ill patients with SARS-CoV-2.&lt;cross-ref type="bib" refid="R2"&gt;2&lt;/cross-ref&gt; Today we know that high viral loads on nasal and throat specimens characterise the early stage of COVID-19 disease, with viral load peaks during the first 7&amp;#8211;10 days after symptoms onset and subsequent progressive decline over time.&lt;cross-ref type="bib" refid="R3"&gt;3&amp;#8211;5&lt;/cross-ref&gt;&lt;cross-ref type="bib" refid="R4"&gt;&lt;/cross-ref&gt;&lt;cross-ref type="bib" refid="R5"&gt;&lt;/cross-ref&gt; The dynamic of SARS-CoV2 infection is not yet completely understood but can be strongly influenced by clinical factors such as age, comorbidities, serological response and many other factors.&lt;cross-ref type="bib" refid="R5"&gt;5&lt;/cross-ref&gt; For instance, elderly patients might have higher viral loads.&lt;cross-ref type="bib" refid="R5"&gt;5&lt;/cross-ref&gt; Our analysis included 12 patients with moderate-to-severe COVID-19 disease and a mean age of 73 (53&amp;#8211;93) years,...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:04 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/229?rss=1</guid>
      <dc:title>SARS-COV-2 in endoscopy: still a long way to go</dc:title>
      <dc:creator>Matteo, M. V., Boskoski, I., Costamagna, G.</dc:creator>
      <dc:subject>Gut, COVID-19</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:04Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-325052</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-325052</dc:identifier>
    </item>
    <item>
      <title>Duality of the association between COVID-19 and acute pancreatitis</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/229-a?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">PostScript</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">229</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">229</prism:endingPage>
      <description>&lt;p&gt;We read with great interest the study by Pandanaboyana &lt;I&gt;et al&lt;/I&gt;.&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; The COVID-19 PAN collaborative study was a large international study that provided updated clinical evidence that has deepened our understanding of the relationship between COVID-19 and acute pancreatitis (AP). However, we question some details in the article.&lt;/p&gt; &lt;p&gt;In this study, although the severity of AP was defined, the definition of AP itself was not clear. The definition of AP used in studies can vary widely,&lt;cross-ref type="bib" refid="R2"&gt;2&lt;/cross-ref&gt; which may lead to differences in the population included and thus to different conclusions. To explore the relationship between the two diseases, the definition of AP needs to be relatively strict, including a combination of enzymatic changes, imaging changes and typical symptoms, as enzymatic changes alone in patients with COVID-19 appear to be unreliable for the definition of pancreatitis.&lt;cross-ref type="bib" refid="R3"&gt;3 4&lt;/cross-ref&gt;&lt;cross-ref type="bib" refid="R4"&gt;&lt;/cross-ref&gt; Furthermore, this study did not...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:04 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/229-a?rss=1</guid>
      <dc:title>Duality of the association between COVID-19 and acute pancreatitis</dc:title>
      <dc:creator>Lv, X.-H., Deng, K., Yang, J.-L.</dc:creator>
      <dc:subject>Gut, COVID-19</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:04Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-325221</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-325221</dc:identifier>
    </item>
    <item>
      <title>Rapid resolution of COVID-19 after faecal microbiota transplantation</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/230?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">PostScript</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">230</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">232</prism:endingPage>
      <description>&lt;p&gt;Recent publications demonstrate that SARS-CoV-2 may undergo prolonged shedding in stool, and that gut microbiome perturbations associate with COVID-19 severity.&lt;cross-ref type="bib" refid="R1"&gt;1 2&lt;/cross-ref&gt;&lt;cross-ref type="bib" refid="R2"&gt;&lt;/cross-ref&gt; Faecal microbiota transplant (FMT) restores a damaged gut microbiome and may impact on immune responses,&lt;cross-ref type="bib" refid="R3"&gt;3&lt;/cross-ref&gt; including in the respiratory system (&amp;#8216;gut&amp;#8211;lung axis&amp;#8217;)&lt;cross-ref type="bib" refid="R4"&gt;4&lt;/cross-ref&gt;; such microbiome-immune signalling may result in lung-epithelial resistance to SARS-CoV-2.&lt;cross-ref type="bib" refid="R5"&gt;5&lt;/cross-ref&gt; We describe two interesting cases of patients treated with FMT primarily to treat &lt;I&gt;Clostridioides difficile&lt;/I&gt; infection (CDI), but which coincidentally were performed just before initial symptoms of coexisting COVID-19 (&lt;cross-ref type="fig" refid="F1"&gt;figure 1&lt;/cross-ref&gt;).&lt;/p&gt; &lt;p&gt;Patient 1: an 80-year-old man with multiple comorbidities, including prior CDI, was admitted to hospital with pneumonia/sepsis. Following meropenem treatment, pneumonic features resolved, but CDI relapse occurred. Sequential vancomycin treatment and nasojejunal FMT were administered. On the day of FMT, he developed further fever and C-reactive protein (CRP) increased; repeat microbiology cultures were...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:04 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/230?rss=1</guid>
      <dc:title>Rapid resolution of COVID-19 after faecal microbiota transplantation</dc:title>
      <dc:creator>Bilinski, J., Winter, K., Jasinski, M., Szczes, A., Bilinska, N., Mullish, B. H., Ma&amp;#x0142;ecka-Panas, E., Basak, G. W.</dc:creator>
      <dc:subject>Press releases, Gut, COVID-19</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:04Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-325010</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-325010</dc:identifier>
    </item>
    <item>
      <title>Towards a new era with safer {micro}-opiate receptor analgesia</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/1?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Commentary</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2</prism:endingPage>
      <description>&lt;p&gt;Chronic abdominal pain may result from diverse conditions that include inflammatory diseases such as chronic pancreatitis and inflammatory bowel diseases (IBD), particularly Crohn&amp;#8217;s disease, disorders that are associated with visceral hypersensitivity such as chronic functional abdominal pain, also referred to as centrally mediated disorders of gastrointestinal pain,&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; as well as the pain component of irritable bowel syndrome which is emphasised as a significant feature of symptom-based criteria with pain at least 1 day per week.&lt;cross-ref type="bib" refid="R2"&gt;2&lt;/cross-ref&gt; Treatment of chronic abdominal pain remains a challenge in clinical practice, with more and more clinicians resorting to prescribing opioid medications for pain relief. Indeed, in a systematic review and meta-analysis of patients with IBD, 21% of outpatients and 62% of hospitalised patients were opioid users.&lt;cross-ref type="bib" refid="R3"&gt;3&lt;/cross-ref&gt; Among 346 patients with gastroparesis included in the National Institutes of Health Gastroparesis Consortium, upper abdominal pain was severe or very severe...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/1?rss=1</guid>
      <dc:title>Towards a new era with safer {micro}-opiate receptor analgesia</dc:title>
      <dc:creator>Camilleri, M.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-324618</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-324618</dc:identifier>
    </item>
    <item>
      <title>Infliximab at diagnosis: moving towards personalisation in paediatric inflammatory bowel disease</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/2?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Commentary</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">3</prism:endingPage>
      <description>&lt;p&gt;The optimal strategy for induction of remission in paediatric Crohn&amp;#8217;s disease, and in particular the timing of introduction of monoclonal antibody therapy, remains controversial. This has long-term implications in a condition where short-term benefit, including impact on growth, must be balanced against the potential need for treatment escalation and risks associated with therapy. This is not helped by the fact the condition is heterogeneous in type, distribution and severity. International guidance currently recommends that children presenting with moderate to severe luminal disease are commenced on exclusive enteral nutrition (EEN), oral corticosteroids, intravenous corticosteroids or anti-TNF therapy, with widespread use of EEN as first line.&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt;&lt;/p&gt; &lt;p&gt;In their ground-breaking article, Jongsma &lt;I&gt;et al&lt;/I&gt; describe the use of anti-TNF therapy for induction of remission, and compare this to &amp;#8216;conventional&amp;#8217; therapy in an open-label randomised control trial.&lt;cross-ref type="bib" refid="R2"&gt;2&lt;/cross-ref&gt; All patients had moderate to severe disease. The data are novel and...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/2?rss=1</guid>
      <dc:title>Infliximab at diagnosis: moving towards personalisation in paediatric inflammatory bowel disease</dc:title>
      <dc:creator>Ashton, J. J., Ennis, S., Beattie, R. M.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-324214</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-324214</dc:identifier>
    </item>
    <item>
      <title>ERBB2 in anti-EGFR-resistant colorectal cancer: cancer stem cells come into play</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/4?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Commentary</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">4</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">5</prism:endingPage>
      <description>&lt;p&gt;With over 900 000 deaths per year worldwide in 2020 according to Globocan, colorectal cancer (CRC) represents the third deadliest cancer. Over the past 20 years, the median overall survival for CRC has substantially increased, especially in patients with metastatic disease, which has doubled to reach 30 months, as a result of the advent of targeted therapies. Despite this progress, the 5-year survival rate for patients with metastatic CRC remains below 15%, calling for an improved management of these patients, which account for roughly 20%&amp;#8211;30% of new diagnosed cases.&lt;/p&gt; &lt;p&gt;A consensus view is that CRC arises from uncontrolled expansion of intestinal stem cells (ISCs).&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; By analogy with ISCs, CRC stem cells (CSCs) are endowed with self-renewal potential and display significant plasticity. They are believed to fuel CRC growth as well as metastasis, and display resistance to therapy, making their targeting one of the most critical challenges in...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/4?rss=1</guid>
      <dc:title>ERBB2 in anti-EGFR-resistant colorectal cancer: cancer stem cells come into play</dc:title>
      <dc:creator>Mouillet-Richard, S.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-323924</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-323924</dc:identifier>
    </item>
    <item>
      <title>Acute-on-chronic liver failure: a global disease</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/5?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Commentary</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">5</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">6</prism:endingPage>
      <description>&lt;p&gt;Acute-on-chronic liver failure (ACLF) is a frequent complication in hospitalised patients with liver cirrhosis. A large body of data has been published in recent years, demonstrating that acute decompensation constitutes a dramatic turning point in the course of cirrhosis, with development of ACLF being the most severe form of acute decompensation (AD).&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; Within the last decades, heterogeneous definitions of ACLF have been proposed in different regions of the world, that is, the European European Association for the Study of the Liver - Chronic Liver Failure (EASL-CLIF) definition, the NASCELD definition in North American and the East Asian APASL criteria. Due to those, epidemiological data on ACLF are heterogenous and not easy to compare.&lt;/p&gt; &lt;p&gt;In &lt;I&gt;Gut&lt;/I&gt;, Mezzano and colleagues have undertaken huge efforts to homogenise and compare the existing evidence.&lt;cross-ref type="bib" refid="R2"&gt;2&lt;/cross-ref&gt; They present an extensive systematic review and meta-analysis on the burden of ACLF worldwide (&lt;cross-ref type="fig"...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/5?rss=1</guid>
      <dc:title>Acute-on-chronic liver failure: a global disease</dc:title>
      <dc:creator>Schulz, M., Trebicka, J.</dc:creator>
      <dc:subject>Open access, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-323973</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-323973</dc:identifier>
    </item>
    <item>
      <title>Automated sizing of colorectal polyps using computer vision</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/7?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Endoscopy news</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">7</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">9</prism:endingPage>
      <description>&lt;sec id="s1"&gt;&lt;st&gt;Message&lt;/st&gt; &lt;p&gt;Colorectal polyp size is an important biomarker that influences management decisions, but currently used subjective methods are flawed. We explored two computer vision (CV) techniques for binary classification of polyp size as either &amp;#8804;5 mm or &amp;#62;5 mm. First, we used premeasured phantom polyps (22 such polyps&amp;#8217; videos) fixed on a pig colon model to explore the concept of automated sizing using structure from motion (SfM) approach and compared it with the sizing by 10 independent endoscopists: overall, average diagnostic accuracy of the SfM system (85.2%) was superior to endoscopists judgement (59.5%). Second, we developed a deep learning model based on convolutional neural networks (CNN) and found 80% accuracy in 10 videos of human polyps. Real-time automated polyp sizing when combined with artificial intelligence (AI) assissted polyp characterisation could improve polyp management strategies.&lt;/p&gt; &lt;/sec&gt; &lt;sec id="s2"&gt;&lt;st&gt;In more details&lt;/st&gt;&lt;sec id="s2-1"&gt;&lt;st&gt;CV techniques&lt;/st&gt; &lt;p&gt;CV can be defined as the ability of machines...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/7?rss=1</guid>
      <dc:title>Automated sizing of colorectal polyps using computer vision</dc:title>
      <dc:creator>Abdelrahim, M., Saiga, H., Maeda, N., Hossain, E., Ikeda, H., Bhandari, P.</dc:creator>
      <dc:subject>Open access, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-324510</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-324510</dc:identifier>
    </item>
    <item>
      <title>Endoscopic findings in a patient with epigastric pain</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/9?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Editor's quiz: GI snapshot</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">9</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">77</prism:endingPage>
      <description>&lt;sec id="s1"&gt;&lt;st&gt;Clinical presentation&lt;/st&gt; &lt;p&gt;A 16-year-old girl had repeated epigastric pain and nausea without any lower abdominal symptoms for 2 years prior to being referred to our hospital. Two years previously, she had undergone oesophagogastroduodenoscopy (EGD) and was diagnosed with chronic gastritis. She denied any other medical history. Physical examination was normal. Laboratory data revealed an iron deficiency anaemia and she had hypoalbuminaemia (serum albumin, 3.1 g/dL). Serum gastrin was 200 pg/mL and vitamin B&lt;SUB&gt;12&lt;/SUB&gt; was 270 pg/mL. Antigastric parietal cell and anti-intrinsic factor antibodies and &lt;I&gt;Helicobacter pylori&lt;/I&gt; infection were negative. Colonoscopy did not show any abnormalities, and EGD in our hospital revealed diffuse atrophic mucosa with nodular changes observed only in the gastric body circumferentially (&lt;cross-ref type="fig" refid="F1"&gt;figure 1A&lt;/cross-ref&gt;). In addition, there were multiple polypoid lesions that consisted of round isolated mucosa, which was enhanced by indigo carmine dye spraying (&lt;cross-ref type="fig" refid="F1"&gt;figure 1B&lt;/cross-ref&gt;). The fornix and the antrum were spared (&lt;cross-ref type="fig"...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/9?rss=1</guid>
      <dc:title>Endoscopic findings in a patient with epigastric pain</dc:title>
      <dc:creator>Eda, H., Oshima, T., Hirota, S., Miwa, H.</dc:creator>
      <dc:subject>GUT Snapshot, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-322332</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-322332</dc:identifier>
    </item>
    <item>
      <title>Pneumatic dilation for persistent dysphagia after antireflux surgery, a multicentre single-blind randomised sham-controlled clinical trial</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/10?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Oesophagus</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">10</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">15</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;There is no evidence-based treatment for persistent dysphagia after laparoscopic fundoplication. The aim of this study was to evaluate the effect of pneumatic dilation on persistent dysphagia after laparoscopic fundoplication.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;We performed a multicentre, single-blind, randomised sham-controlled trial of patients with persistent dysphagia (&amp;#62;3 months) after laparoscopic fundoplication. Patients with an Eckardt symptom score &amp;#8805;4 were randomly assigned to pneumatic dilation (PD) using a 35 mm balloon or sham dilation. Primary outcome was treatment success, defined as an Eckardt score &amp;#60;4 and a minimal reduction of 2 points in the Eckardt score after 30 days. Secondary outcomes included change in stasis on timed barium oesophagogram, change in high-resolution manometry parameters and questionnaires on quality of life, reflux and dysphagia symptoms.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;Forty-two patients were randomised. In the intention-to-treat analysis, the success rates of PD (7/21 patients (33%)) and sham dilation (8/21 patients (38%)) were similar after 30 days (risk difference &amp;#8211;4.7% (95% CI (&amp;#8211;33.7% to 24.2%) p=0.747). There was no significant difference in change of stasis on the timed barium oesophagogram after 2 min (PD vs sham: median 0.0 cm, p25&amp;#8211;p75 range 0.0&amp;#8211;4.3 cm vs median 0.0 cm, p25&amp;#8211;p75 range 0.0&amp;#8211;0.0; p=0.122) or change in lower oesophageal sphincter relaxation pressure (PD vs sham: 10.54&amp;#177;6.25 vs 14.60&amp;#177;6.17 mm Hg; p=0.052). Quality of life, reflux and dysphagia symptoms were not significantly different between the two groups.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusion&lt;/st&gt;
&lt;p&gt;Pneumatic dilation with a 35 mm balloon is not superior to sham dilation for the treatment of persistent dysphagia after fundoplication.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/10?rss=1</guid>
      <dc:title>Pneumatic dilation for persistent dysphagia after antireflux surgery, a multicentre single-blind randomised sham-controlled clinical trial</dc:title>
      <dc:creator>Schuitenmaker, J. M., van Hoeij, F. B., Schijven, M. P., Tack, J., Conchillo, J. M., Hazebroek, E. J., Smout, A. J. P. M., Bredenoord, A. J.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-322355</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-322355</dc:identifier>
    </item>
    <item>
      <title>Proton pump inhibitors and risk of gastric cancer: population-based cohort study</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/16?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Stomach</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">16</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">24</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs).&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;Using the UK Clinical Practice Research Datalink, we conducted a population-based cohort study using a new-user active comparator design. From 1 January 1990 to 30 April 2018, we identified 973 281 new users of PPIs and 193 306 new users of H2RAs. Cox proportional hazards models were fit to estimate HRs and 95% CIs of gastric cancer, and the number needed to harm was estimated using the Kaplan-Meier method. The models were weighted using standardised mortality ratio weights using calendar time-specific propensity scores. Secondary analyses assessed duration and dose&amp;#8211;response associations.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;After a median follow-up of 5.0 years, the use of PPIs was associated with a 45% increased risk of gastric cancer compared with the use of H2RAs (HR 1.45, 95% CI 1.06 to 1.98). The number needed to harm was 2121 and 1191 for five and 10 years after treatment initiation, respectively. The HRs increased with cumulative duration, cumulative omeprazole equivalents and time since treatment initiation. The results were consistent across several sensitivity analyses.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusion&lt;/st&gt;
&lt;p&gt;The findings of this large population-based cohort study indicate that the use of PPIs is associated with an increased risk of gastric cancer compared with the use of H2RAs, although the absolute risk remains low.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/16?rss=1</guid>
      <dc:title>Proton pump inhibitors and risk of gastric cancer: population-based cohort study</dc:title>
      <dc:creator>Abrahami, D., McDonald, E. G., Schnitzer, M. E., Barkun, A. N., Suissa, S., Azoulay, L.</dc:creator>
      <dc:subject>Editor's choice, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-325097</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-325097</dc:identifier>
    </item>
    <item>
      <title>Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/25?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Endoscopy</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">25</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">33</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;Although gastric per-oral endoscopic myotomy (G-POEM) is considered a promising technique for the management of refractory gastroparesis, high-quality evidence is limited. We prospectively investigated the efficacy and safety of G-POEM in unselected patients with refractory gastroparesis.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;In five tertiary centres, patients with symptomatic gastroparesis refractory to standard medical therapy and confirmed by impaired gastric emptying were included. The primary endpoint was clinical success, defined as at least one score decrease in Gastroparesis Cardinal Symptom Index (GCSI) with &amp;#8805;25% decrease in two subscales, at 12 months. GCSI Score and subscales, adverse events (AEs) and 36-Item Short Form questionnaire of quality of life were evaluated at baseline and 1, 3, 6 and 12 months after G-POEM. Gastric emptying study was performed before and 3 months after the procedure.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;Of 80 enrolled patients, 75 patients (94%) completed 12-month follow-up. Clinical success at 12 months was 56% (95% CI, 44.8 to 66.7). GCSI Score (including subscales) improved moderately after G-POEM (p&amp;#60;0.05). In a regression model, a baseline GCSI Score &amp;#62;2.6 (OR=3.23, p=0.04) and baseline gastric retention &amp;#62;20% at 4 hours (OR=3.65, p=0.03) were independent predictors of clinical success at 12 months, as was early response to G-POEM at 1 month after therapy (OR 8.75, p&amp;#60;0.001). Mild procedure-related AEs occurred in 5 (6%) patients.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusion&lt;/st&gt;
&lt;p&gt;G-POEM is a safe procedure, but showed only modest overall effectiveness in the treatment of refractory gastroparesis. Further studies are required to identify the best candidates for G-POEM; unselective use of this procedure should be discouraged.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Trial registration number&lt;/st&gt;
&lt;p&gt;ClinicalTrials.gov Registry &lt;A HREF="NCT02732821"&gt;NCT02732821&lt;/A&gt;.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/25?rss=1</guid>
      <dc:title>Gastric per-oral endoscopic myotomy (G-POEM) for refractory gastroparesis: results from an international prospective trial</dc:title>
      <dc:creator>Vosoughi, K., Ichkhanian, Y., Benias, P., Miller, L., Aadam, A. A., Triggs, J. R., Law, R., Hasler, W., Bowers, N., Chaves, D., Ponte-Neto, A. M., Draganov, P., Yang, D., El Halabi, M., Sanaei, O., Brewer Gutierrez, O. I., Bulat, R. S., Pandolfino, J., Khashab, M.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-322756</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-322756</dc:identifier>
    </item>
    <item>
      <title>First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohns disease: an open-label multicentre randomised controlled trial</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/34?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Inflammatory bowel disease</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">34</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">42</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;In newly diagnosed paediatric patients with moderate-to-severe Crohn&amp;#8217;s disease (CD), infliximab (IFX) is initiated once exclusive enteral nutrition (EEN), corticosteroid and immunomodulator therapies have failed. We aimed to investigate whether starting first-line IFX (FL-IFX) is more effective to achieve and maintain remission than conventional treatment.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;In this multicentre open-label randomised controlled trial, untreated patients with a new diagnosis of CD (3&amp;#8211;17 years old, weighted Paediatric CD Activity Index score (wPCDAI) &amp;#62;40) were assigned to groups that received five infusions of 5 mg/kg IFX at weeks 0, 2, 6, 14 and 22 (FL-IFX), or EEN or oral prednisolone (1 mg/kg, maximum 40 mg) (conventional). The primary outcome was clinical remission on azathioprine, defined as a wPCDAI &amp;#60;12.5 at week 52, without need for treatment escalation, using intention-to-treat analysis.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;100 patients were included, 50 in the FL-IFX group and 50 in the conventional group. Four patients did not receive treatment as per protocol. At week 10, a higher proportion of patients in the FL-IFX group than in the conventional group achieved clinical (59% vs 34%, respectively, p=0.021) and endoscopic remission (59% vs 17%, respectively, p=0.001). At week 52, the proportion of patients in clinical remission was not significantly different (p=0.421). However, 19/46 (41%) patients in the FL-IFX group were in clinical remission on azathioprine monotherapy without need for treatment escalation vs 7/48 (15%) in the conventional group (p=0.004).&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusions&lt;/st&gt;
&lt;p&gt;FL-IFX was superior to conventional treatment in achieving short-term clinical and endoscopic remission, and had greater likelihood of maintaining clinical remission at week 52 on azathioprine monotherapy.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Trial registration number&lt;/st&gt;
&lt;p&gt;ClinicalTrials.gov Registry (&lt;A HREF="NCT02517684"&gt;NCT02517684&lt;/A&gt;).&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/34?rss=1</guid>
      <dc:title>First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohns disease: an open-label multicentre randomised controlled trial</dc:title>
      <dc:creator>Jongsma, M. M. E., Aardoom, M. A., Cozijnsen, M. A., van Pieterson, M., de Meij, T., Groeneweg, M., Norbruis, O. F., Wolters, V. M., van Wering, H. M., Hojsak, I., Kolho, K.-L., Hummel, T., Stapelbroek, J., van der Feen, C., van Rheenen, P. F., van Wijk, M. P., Teklenburg-Roord, S. T. A., Schreurs, M. W. J., Rizopoulos, D., Doukas, M., Escher, J. C., Samsom, J. N., de Ridder, L.</dc:creator>
      <dc:subject>Open access, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-322339</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-322339</dc:identifier>
    </item>
    <item>
      <title>NTPDase8 protects mice from intestinal inflammation by limiting P2Y6 receptor activation: identification of a new pathway of inflammation for the potential treatment of IBD</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/43?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Inflammatory bowel disease</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">43</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">54</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;Nucleotides are danger signals that activate inflammatory responses via binding P2 receptors. The nucleoside triphosphate diphosphohydrolase-8 (NTPDase8) is an ectonucleotidase that hydrolyses P2 receptor ligands. We investigated the role of NTPDase8 in intestinal inflammation.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;We generated NTPDase8-deficient (&lt;I&gt;Entpd8&lt;/I&gt;  &lt;sup&gt;&amp;#8211;/&amp;#8211;&lt;/sup&gt;) mice to define the role of NTPDase8 in the dextran sodium sulfate (DSS) colitis model. To assess inflammation, colons were collected and analysed by histopathology, reverse transcriptase-quantitative real-time PCR (RT-qPCR) and immunohistochemistry. P2 receptor expression was analysed by RT-qPCR on primary intestinal epithelium and NTPDase8 activity by histochemistry. The role of intestinal P2Y&lt;SUB&gt;6&lt;/SUB&gt; receptors was assessed by bone marrow transplantation experiments and with a P2Y&lt;SUB&gt;6&lt;/SUB&gt; receptor antagonist.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;NTPDase8 is the dominant enzyme responsible for the hydrolysis of nucleotides in the lumen of the colon. Compared with wild-type (WT) control mice, the colon of &lt;I&gt;Entpd8&lt;/I&gt;  &lt;sup&gt;&amp;#8211;/&amp;#8211;&lt;/sup&gt; mice treated with DSS displayed significantly more histological damage, immune cell infiltration, apoptosis and increased expression of several proinflammatory cytokines. P2Y&lt;SUB&gt;6&lt;/SUB&gt; was the dominant P2Y receptor expressed at the mRNA level by the colonic epithelia. Irradiated &lt;I&gt;P2ry6&lt;/I&gt;  &lt;sup&gt;&amp;#8211;/&amp;#8211;&lt;/sup&gt; mice transplanted with WT bone marrow were fully protected from DSS-induced intestinal inflammation. In agreement, the daily intrarectal injection of a P2Y&lt;SUB&gt;6&lt;/SUB&gt; antagonist protected mice from DSS-induced intestinal inflammation in a dose-dependent manner. Finally, human intestinal epithelial cells express NTPDase8 and P2Y&lt;SUB&gt;6&lt;/SUB&gt; similarly as in mice.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusion&lt;/st&gt;
&lt;p&gt;NTPDase8 protects the intestine from inflammation most probably by limiting the activation of P2Y&lt;SUB&gt;6&lt;/SUB&gt; receptors in colonic epithelial cells. This may provide a novel therapeutic strategy for the treatment of inflammatory bowel disease.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/43?rss=1</guid>
      <dc:title>NTPDase8 protects mice from intestinal inflammation by limiting P2Y6 receptor activation: identification of a new pathway of inflammation for the potential treatment of IBD</dc:title>
      <dc:creator>Salem, M., Lecka, J., Pelletier, J., Gomes Marconato, D., Dumas, A., Vallieres, L., Brochu, G., Robaye, B., Jobin, C., Sevigny, J.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-320937</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-320937</dc:identifier>
    </item>
    <item>
      <title>Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohns disease</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/55?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Inflammatory bowel disease</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">55</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">67</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;Creeping fat, the wrapping of mesenteric fat around the bowel wall, is a typical feature of Crohn&amp;#8217;s disease, and is associated with stricture formation and bowel obstruction. How creeping fat forms is unknown, and we interrogated potential mechanisms using novel intestinal tissue and cell interaction systems.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;Tissues from normal, UC, non-strictured and strictured Crohn&amp;#8217;s disease intestinal specimens were obtained. The muscularis propria matrisome was determined via proteomics. Mesenteric fat explants, primary human preadipocytes and adipocytes were used in multiple ex vivo and in vitro cell migration systems on muscularis propria muscle cell derived or native extracellular matrix. Functional experiments included integrin characterisation via flow cytometry and their inhibition with specific blocking antibodies and chemicals.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;Crohn&amp;#8217;s disease muscularis propria cells produced an extracellular matrix scaffold which is in direct spatial and functional contact with the immediately overlaid creeping fat. The scaffold contained multiple proteins, but only fibronectin production was singularly upregulated by transforming growth factor-&amp;#946;1. The muscle cell-derived matrix triggered migration of preadipocytes out of mesenteric fat, fibronectin being the dominant factor responsible for their migration. Blockade of &amp;#945;5&amp;#946;1 on the preadipocyte surface inhibited their migration out of mesenteric fat and on 3D decellularised intestinal tissue extracellular matrix.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusion&lt;/st&gt;
&lt;p&gt;Crohn&amp;#8217;s disease creeping fat appears to result from the migration of preadipocytes out of mesenteric fat and differentiation into adipocytes in response to an increased production of fibronectin by activated muscularis propria cells. These new mechanistic insights may lead to novel approaches for prevention of creeping fat-associated stricture formation.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/55?rss=1</guid>
      <dc:title>Activated intestinal muscle cells promote preadipocyte migration: a novel mechanism for creeping fat formation in Crohns disease</dc:title>
      <dc:creator>Mao, R., Doyon, G., Gordon, I. O., Li, J., Lin, S., Wang, J., Le, T. H. N., Elias, M., Kurada, S., Southern, B., Olman, M., Chen, M., Zhao, S., Dejanovic, D., Chandra, J., Mukherjee, P. K., West, G., Van Wagoner, D. R., Fiocchi, C., Rieder, F.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-323719</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-323719</dc:identifier>
    </item>
    <item>
      <title>Gluten-induced RNA methylation changes regulate intestinal inflammation via allele-specific XPO1 translation in epithelial cells</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/68?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Coeliac disease</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">68</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">76</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objectives&lt;/st&gt;
&lt;p&gt;Coeliac disease (CD) is a complex autoimmune disorder that develops in genetically susceptible individuals. Dietary gluten triggers an immune response for which the only available treatment so far is a strict, lifelong gluten free diet. Human leucocyte antigen (HLA) genes and several non-HLA regions have been associated with the genetic susceptibility to CD, but their role in the pathogenesis of the disease is still essentially unknown, making it complicated to develop much needed non-dietary treatments. Here, we describe the functional involvement of a CD-associated single-nucleotide polymorphism (SNP) located in the 5&amp;#8217;UTR of &lt;I&gt;XPO1&lt;/I&gt; in the inflammatory environment characteristic of the coeliac intestinal epithelium.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;The function of the CD-associated SNP was investigated using an intestinal cell line heterozygous for the SNP, N6-methyladenosine (m&lt;sup&gt;6&lt;/sup&gt;A)-related knock-out and HLA-DQ2 mice, and human samples from patients with CD.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;Individuals harbouring the risk allele had higher m&lt;sup&gt;6&lt;/sup&gt;A methylation in the 5&amp;#8217;UTR of &lt;I&gt;XPO1&lt;/I&gt; RNA, rendering greater XPO1 protein amounts that led to downstream nuclear factor kappa B (NFkB) activity and subsequent inflammation. Furthermore, gluten exposure increased overall m&lt;sup&gt;6&lt;/sup&gt;A methylation in humans as well as in in vitro and in vivo models.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusion&lt;/st&gt;
&lt;p&gt;We identify a novel m&lt;sup&gt;6&lt;/sup&gt;A-XPO1-NFkB pathway that is activated in CD patients. The findings will prompt the development of new therapeutic approaches directed at m&lt;sup&gt;6&lt;/sup&gt;A proteins and XPO1, a target under evaluation for the treatment of intestinal disorders.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/68?rss=1</guid>
      <dc:title>Gluten-induced RNA methylation changes regulate intestinal inflammation via allele-specific XPO1 translation in epithelial cells</dc:title>
      <dc:creator>Olazagoitia-Garmendia, A., Zhang, L., Mera, P., Godbout, J. K., Sebastian-DelaCruz, M., Garcia-Santisteban, I., Mendoza, L. M., Huerta, A., Irastorza, I., Bhagat, G., Green, P. H., Herrero, L., Serra, D., Rodriguez, J. A., Verdu, E. F., He, C., Bilbao, J. R., Castellanos-Rubio, A.</dc:creator>
      <dc:subject>Open access, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-322566</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-322566</dc:identifier>
    </item>
    <item>
      <title>Disrupted spermatogenesis in a metabolic syndrome model: the role of vitamin A metabolism in the gut-testis axis</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/78?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Gut microbiota</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">78</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">87</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;Effects of the diet-induced gut microbiota dysbiosis reach far beyond the gut. We aim to uncover the direct evidence involving the gut&amp;#8211;testis axis in the aetiology of impaired spermatogenesis.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;An excessive-energy diet-induced metabolic syndrome (MetS) sheep model was established. The testicular samples, host metabolomes and gut microbiome were analysed. Faecal microbiota transplantation (FMT) confirmed the linkage between gut microbiota and spermatogenesis.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;We demonstrated that the number of arrested spermatogonia was markedly elevated by using 10&lt;FONT FACE="arial,helvetica"&gt;x&lt;/FONT&gt; single-cell RNA-seq in the MetS model. Furthermore, through using metabolomics profiling and 16S rDNA-seq, we discovered that the absorption of vitamin A in the gut was abolished due to a notable reduction of bile acid levels, which was significantly associated with reduced abundance of &lt;I&gt;Ruminococcaceae_NK4A214_group&lt;/I&gt;. Notably, the abnormal metabolic effects of vitamin A were transferable to the testicular cells through the circulating blood, which contributed to abnormal spermatogenesis, as confirmed by FMT.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusion&lt;/st&gt;
&lt;p&gt;These findings define a starting point for linking the testicular function and regulation of gut microbiota via host metabolomes and will be of potential value for the treatment of male infertility in MetS.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/78?rss=1</guid>
      <dc:title>Disrupted spermatogenesis in a metabolic syndrome model: the role of vitamin A metabolism in the gut-testis axis</dc:title>
      <dc:creator>Zhang, T., Sun, P., Geng, Q., Fan, H., Gong, Y., Hu, Y., Shan, L., Sun, Y., Shen, W., Zhou, Y.</dc:creator>
      <dc:subject>Open access, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-323347</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-323347</dc:identifier>
    </item>
    <item>
      <title>Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/89?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Gut microbiota</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">89</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">99</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objectives&lt;/st&gt;
&lt;p&gt;Alterations in the intestinal microbiota are linked with a wide range of autoimmune and inflammatory conditions, including inflammatory bowel diseases (IBD), where pathobionts penetrate the intestinal barrier and promote inflammatory reactions. In patients with IBD, the ability of intestinal macrophages to efficiently clear invading pathogens is compromised resulting in increased bacterial translocation and excessive immune reactions. Here, we investigated how an IBD-associated loss-of-function variant in the protein tyrosine phosphatase non-receptor type 2 (&lt;I&gt;PTPN2&lt;/I&gt;) gene, or loss of PTPN2 expression affected the ability of macrophages to respond to invading bacteria.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;IBD patient-derived macrophages with wild-type (WT) &lt;I&gt;PTPN2&lt;/I&gt; or carrying the IBD-associated &lt;I&gt;PTPN2&lt;/I&gt; SNP, peritoneal macrophages from WT and constitutive PTPN2-knockout mice, as well as mice specifically lacking &lt;I&gt;PTPN2&lt;/I&gt; in macrophages were infected with non-invasive K12 &lt;I&gt;Escherichia coli&lt;/I&gt;, the human adherent-invasive &lt;I&gt;E. coli&lt;/I&gt; (AIEC) &lt;I&gt;LF82&lt;/I&gt;, or a novel mouse AIEC (&lt;I&gt;m&lt;/I&gt;AIEC) strain.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;Loss of PTPN2 severely compromises the ability of macrophages to clear invading bacteria. Specifically, loss of functional PTPN2 promoted pathobiont invasion/uptake into macrophages and intracellular survival/proliferation by three distinct mechanisms: Increased bacterial uptake was mediated by enhanced expression of carcinoembryonic antigen cellular adhesion molecule (CEACAM)1 and CEACAM6 in &lt;I&gt;PTPN2&lt;/I&gt;-deficient cells, while reduced bacterial clearance resulted from defects in autophagy coupled with compromised lysosomal acidification. In vivo, mice lacking &lt;I&gt;PTPN2&lt;/I&gt; in macrophages were more susceptible to &lt;I&gt;m&lt;/I&gt;AIEC infection and &lt;I&gt;m&lt;/I&gt;AIEC-induced disease.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusions&lt;/st&gt;
&lt;p&gt;Our findings reveal a tripartite regulatory mechanism by which PTPN2 preserves macrophage antibacterial function, thus crucially contributing to host defence against invading bacteria.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/89?rss=1</guid>
      <dc:title>Autoimmune susceptibility gene PTPN2 is required for clearance of adherent-invasive Escherichia coli by integrating bacterial uptake and lysosomal defence</dc:title>
      <dc:creator>Spalinger, M. R., Shawki, A., Chatterjee, P., Canale, V., Santos, A., Sayoc-Becerra, A., Scharl, M., Tremblay, M. L., Borneman, J., McCole, D. F.</dc:creator>
      <dc:subject>Open access, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-323636</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-323636</dc:identifier>
    </item>
    <item>
      <title>Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/100?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Colon</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">100</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">110</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Background&lt;/st&gt;
&lt;p&gt;There were limited data on the risk of post-polypectomy bleeding (PPB) in patients on direct oral anticoagulants (DOAC). We aimed to evaluate the PPB and thromboembolic risks among DOAC and warfarin users in a population-based cohort.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Methods&lt;/st&gt;
&lt;p&gt;We performed a territory-wide retrospective cohort study involving patients in Hong Kong from 2012 to 2020. Patients who received an oral anticoagulant and had undergone colonoscopy with polypectomy were identified. Propensity-score models with inverse probability of treatment weighting were developed for the warfarin-DOAC and between-DOAC comparisons. The primary outcome was clinically significant delayed PPB, defined as repeat colonoscopy requiring haemostasis within 30 days. The secondary outcomes were 30-day blood transfusion requirement and new thromboembolic event.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;Apixaban was associated with lower PPB risk than warfarin (adjusted HR (aHR) 0.39, 95% CI 0.24 to 0.63, p&amp;#60;0.001). Dabigatran (aHR 2.23, 95% CI 1.04 to 4.77, adjusted p (ap)=0.035) and rivaroxaban (aHR 2.72, 95% CI 1.35 to 5.48, ap=0.002) were associated with higher PPB risk than apixaban. In subgroup analysis, apixaban was associated with lower PPB risk in patients aged &amp;#8805;70 years and patients with right-sided colonic polyps.&lt;/p&gt;
&lt;p&gt;For thromboembolic events, apixaban was associated with lower risk than warfarin (aHR 0.22, 95% CI 0.11 to 0.45, p&amp;#60;0.001). Dabigatran (aHR 2.60, 95% CI 1.06 to 6.41, ap=0.033) and rivaroxaban (aHR 2.96, 95% CI 1.19 to 7.37, ap =0.013) were associated with higher thromboembolic risk than apixaban.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusions&lt;/st&gt;
&lt;p&gt;Apixaban was associated with a significantly lower risk of PPB and thromboembolism than warfarin, dabigatran and rivaroxaban, particularly in older patients with right-sided polyps.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/100?rss=1</guid>
      <dc:title>Risks of post-colonoscopic polypectomy bleeding and thromboembolism with warfarin and direct oral anticoagulants: a population-based analysis</dc:title>
      <dc:creator>Lau, L. H., Guo, C. L., Yip, T. C., Mak, J. W., Wong, S. H., Lam, K. L., Wong, G. L., Ng, S. C., Chan, F. K.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-323600</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-323600</dc:identifier>
    </item>
    <item>
      <title>Proton pump inhibitors and risk of colorectal cancer</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/111?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Colon</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">111</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">118</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;To determine whether proton pump inhibitors (PPIs) are associated with an increased risk of colorectal cancer, compared with histamine-2 receptor antagonists (H2RAs).&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;The United Kingdom Clinical Practice Research Datalink was used to identify initiators of PPIs and H2RA from 1990 to 2018, with follow-up until 2019. Cox proportional hazards models were fit to estimate marginal HRs and 95% CIs of colorectal cancer. The models were weighted using standardised mortality ratio weights using calendar time-specific propensity scores. Prespecified secondary analyses assessed associations with cumulative duration, cumulative dose and time since treatment initiation. The number needed to harm was calculated at five and 10 years of follow-up.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;The cohort included 1 293 749 and 292 387 initiators of PPIs and H2RAs, respectively, followed for a median duration of 4.9 years. While the use of PPIs was not associated with an overall increased risk of colorectal cancer (HR: 1.02, 95% CI 0.92 to 1.14), HRs increased with cumulative duration of PPI use (&amp;#60;2 years, HR: 0.93, 95% CI 0.83 to 1.04; 2&amp;#8211;4 years, HR: 1.45, 95% CI 1.28 to 1.60; &amp;#8805;4 years, HR: 1.60, 95% CI 1.42 to 1.80). Similar patterns were observed with cumulative dose and time since treatment initiation. The number needed to harm was 5343 and 792 for five and 10 years of follow-up, respectively.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusion&lt;/st&gt;
&lt;p&gt;While any use of PPIs was not associated with an increased risk of colorectal cancer compared with H2RAs, prolonged use may be associated with a modest increased risk of this malignancy.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/111?rss=1</guid>
      <dc:title>Proton pump inhibitors and risk of colorectal cancer</dc:title>
      <dc:creator>Abrahami, D., McDonald, E. G., Schnitzer, M. E., Barkun, A. N., Suissa, S., Azoulay, L.</dc:creator>
      <dc:subject>Editor's choice, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-325096</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-325096</dc:identifier>
    </item>
    <item>
      <title>PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/119?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Colon</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">119</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">128</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;Cancer stem cells are responsible for tumour spreading and relapse. Human epidermal growth factor receptor 2 (HER2) expression is a negative prognostic factor in colorectal cancer (CRC) and a potential target in tumours carrying the gene amplification. Our aim was to define the expression of HER2 in colorectal cancer stem cells (CR-CSCs) and its possible role as therapeutic target in CRC resistant to anti- epidermal growth factor receptor (EGFR) therapy.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;A collection of primary sphere cell cultures obtained from 60 CRC specimens was used to generate CR-CSC mouse avatars to preclinically validate therapeutic options. We also made use of the ChIP-seq analysis for transcriptional evaluation of HER2 activation and global RNA-seq to identify the mechanisms underlying therapy resistance.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;Here we show that in CD44v6-positive CR-CSCs, high HER2 expression levels are associated with an activation of the phosphatidylinositol 3-kinase (PI3K)/AKT pathway, which promotes the acetylation at the regulatory elements of the Erbb2 gene. HER2 targeting in combination with phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase kinase (MEK) inhibitors induces CR-CSC death and regression of tumour xenografts, including those carrying &lt;I&gt;Kras&lt;/I&gt; and &lt;I&gt;Pik3ca&lt;/I&gt; mutation. Requirement for the triple targeting is due to the presence of cancer-associated fibroblasts, which release cytokines able to confer CR-CSC resistance to PI3K/AKT inhibitors. In contrast, targeting of PI3K/AKT as monotherapy is sufficient to kill liver-disseminating CR-CSCs in a model of adjuvant therapy.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusions&lt;/st&gt;
&lt;p&gt;While PI3K targeting kills liver-colonising CR-CSCs, the concomitant inhibition of PI3K, HER2 and MEK is required to induce regression of tumours resistant to anti-EGFR therapies. These data may provide a rationale for designing clinical trials in the adjuvant and metastatic setting.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/119?rss=1</guid>
      <dc:title>PI3K-driven HER2 expression is a potential therapeutic target in colorectal cancer stem cells</dc:title>
      <dc:creator>Mangiapane, L. R., Nicotra, A., Turdo, A., Gaggianesi, M., Bianca, P., Di Franco, S., Sardina, D. S., Veschi, V., Signore, M., Beyes, S., Fagnocchi, L., Fiori, M. E., Bongiorno, M. R., Lo Iacono, M., Pillitteri, I., Ganduscio, G., Gulotta, G., Medema, J. P., Zippo, A., Todaro, M., De Maria, R., Stassi, G.</dc:creator>
      <dc:subject>Open access, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-323553</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-323553</dc:identifier>
    </item>
    <item>
      <title>Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/129?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Pancreas</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">129</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">147</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;Pancreatic ductal adenocarcinoma (PDAC) is the most lethal malignancy and lacks effective treatment. We aimed to understand molecular mechanisms of the intertwined interactions between tumour stromal components in metastasis and to provide a new paradigm for PDAC therapy.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;Two unselected cohorts of 154 and 20 patients with PDAC were subjected to correlation between interleukin (IL)-33 and CXCL3 levels and survivals. Unbiased expression profiling, and genetic and pharmacological gain-of-function and loss-of-function approaches were employed to identify molecular signalling in tumour-associated macrophages (TAMs) and myofibroblastic cancer-associated fibroblasts (myoCAFs). The role of the IL-33&amp;#8211;ST2&amp;#8211;CXCL3&amp;#8211;CXCR2 axis in PDAC metastasis was evaluated in three clinically relevant mouse PDAC models.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;IL-33 was specifically elevated in human PDACs and positively correlated with tumour inflammation in human patients with PDAC. CXCL3 was highly upregulated in IL-33-stimulated macrophages that were the primary source of CXCL3. CXCL3 was correlated with poor survival in human patients with PDAC. Mechanistically, activation of the IL-33&amp;#8211;ST2&amp;#8211;MYC pathway attributed to high CXCL3 production. The highest level of CXCL3 was found in PDAC relative to other cancer types and its receptor CXCR2 was almost exclusively expressed in CAFs. Activation of CXCR2 by CXCL3 induced a CAF-to-myoCAF transition and &amp;#945;-smooth muscle actin (&amp;#945;-SMA) was uniquely upregulated by the CXCL3&amp;#8211;CXCR2 signalling. Type III collagen was identified as the CXCL3&amp;#8211;CXCR2-targeted adhesive molecule responsible for myoCAF-driven PDAC metastasis.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusions&lt;/st&gt;
&lt;p&gt;Our work provides novel mechanistic insights into understanding PDAC metastasis by the TAM-CAF interaction and targeting each of these signalling components would provide an attractive and new paradigm for treating pancreatic cancer.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/129?rss=1</guid>
      <dc:title>Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism</dc:title>
      <dc:creator>Sun, X., He, X., Zhang, Y., Hosaka, K., Andersson, P., Wu, J., Wu, J., Jing, X., Du, Q., Hui, X., Ding, B., Guo, Z., Hong, A., Liu, X., Wang, Y., Ji, Q., Beyaert, R., Yang, Y., Li, Q., Cao, Y.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-322744</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-322744</dc:identifier>
    </item>
    <item>
      <title>Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/148?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Hepatology</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">148</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">155</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Background and aims&lt;/st&gt;
&lt;p&gt;Acute-on-chronic liver failure (ACLF) is characterised by acute decompensation of cirrhosis associated with organ failures. We systematically evaluated the geographical variations of ACLF across the world in terms of prevalence, mortality, aetiology of chronic liver disease (CLD), triggers and organ failures.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Methods&lt;/st&gt;
&lt;p&gt;We searched EMBASE and PubMed from 3/1/2013 to 7/3/2020 using the ACLF-EASL-CLIF (European Association for the Study of the Liver-Chronic Liver Failure) criteria. Two investigators independently conducted the abstract selection/abstraction of the aetiology of CLD, triggers, organ failures and prevalence/mortality by presence/grade of ACLF. We grouped countries into Europe, East/South Asia and North/South America. We calculated the pooled proportions, evaluated the methodological quality using the Newcastle-Ottawa Scale and statistical heterogeneity, and performed sensitivity analyses.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;We identified 2369 studies; 30 cohort studies met our inclusion criteria (43 206 patients with ACLF and 140 835 without ACLF). The global prevalence of ACLF among patients admitted with decompensated cirrhosis was 35% (95% CI 33% to 38%), highest in South Asia at 65%. The global 90-day mortality was 58% (95% CI 51% to 64%), highest in South America at 73%. Alcohol was the most frequently reported aetiology of underlying CLD (45%, 95% CI 41 to 50). Infection was the most frequent trigger (35%) and kidney dysfunction the most common organ failure (49%). Sensitivity analyses showed regional estimates grossly unchanged for high-quality studies. Type of design, country health index, underlying CLD and triggers explained the variation in estimates.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusions&lt;/st&gt;
&lt;p&gt;The global prevalence and mortality of ACLF are high. Region-specific variations could be explained by the type of triggers/aetiology of CLD or grade. Health systems will need to tailor early recognition and treatment of ACLF based on region-specific data.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/148?rss=1</guid>
      <dc:title>Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis</dc:title>
      <dc:creator>Mezzano, G., Juanola, A., Cardenas, A., Mezey, E., Hamilton, J. P., Pose, E., Graupera, I., Gines, P., Sola, E., Hernaez, R.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-322161</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-322161</dc:identifier>
    </item>
    <item>
      <title>Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/156?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Hepatology</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">156</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">162</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;Studies reported a significant association between non-alcoholic fatty liver disease (NAFLD) and increased risk of chronic kidney disease (CKD). However, whether this risk changes with increasing severity of NAFLD remains uncertain. We performed a meta-analysis of observational studies to quantify the magnitude of the association between NAFLD and risk of incident CKD.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;We systematically searched PubMed, Web of Science and Scopus from January 2000 to August 2020 using predefined keywords to identify observational studies with a follow-up duration of &amp;#8805;1 year, in which NAFLD was diagnosed by blood biomarkers/scores, International Classification of Diseases codes, imaging techniques or biopsy. Data from selected studies were extracted, and meta-analysis was performed using random-effects modelling.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;13 studies with 1 222 032 individuals (28.1% with NAFLD) and 33 840 cases of incident CKD stage &amp;#8805;3 (defined as estimated glomerular filtration rate &amp;#60;60 mL/min/1.73 m&lt;sup&gt;2&lt;/sup&gt;, with or without accompanying overt proteinuria) over a median follow-up of 9.7 years were included. NAFLD was associated with a moderately increased risk of incident CKD (n=10 studies; random-effects HR 1.43, 95% CI 1.33 to 1.54; &lt;I&gt;I&lt;/I&gt;  &lt;sup&gt;  &lt;I&gt;2&lt;/I&gt;  &lt;/sup&gt;=60.7%). All risks were independent of age, sex, obesity, hypertension, diabetes and other conventional CKD risk factors. Sensitivity analyses did not alter these findings. Funnel plot did not reveal any significant publication bias.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusion&lt;/st&gt;
&lt;p&gt;This large and updated meta-analysis indicates that NAFLD is significantly associated with a~1.45-fold increased long-term risk of incident CKD stage &amp;#8805;3. Further studies are needed to examine the association between the severity of NAFLD and risk of incident CKD.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/156?rss=1</guid>
      <dc:title>Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis</dc:title>
      <dc:creator>Mantovani, A., Petracca, G., Beatrice, G., Csermely, A., Lonardo, A., Schattenberg, J. M., Tilg, H., Byrne, C. D., Targher, G.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-323082</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-323082</dc:identifier>
    </item>
    <item>
      <title>PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/163?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Hepatology</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">163</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">175</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;Hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) pathophysiology remains unclear. This study aims to characterise the molecular basis of HBV-ACLF using transcriptomics.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Methods&lt;/st&gt;
&lt;p&gt;Four hundred subjects with HBV-ACLF, acute-on-chronic hepatic dysfunction (ACHD), liver cirrhosis (LC) or chronic hepatitis B (CHB) and normal controls (NC) from a prospective multicentre cohort were studied, and 65 subjects (ACLF, 20; ACHD, 10; LC, 10; CHB, 10; NC, 15) among them underwent mRNA sequencing using peripheral blood mononuclear cells (PBMCs).&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;The functional synergy analysis focusing on seven bioprocesses related to the PBMC response and the top 500 differentially expressed genes (DEGs) showed that viral processes were associated with all disease stages. Immune dysregulation, as the most prominent change and disorder triggered by HBV exacerbation, drove CHB or LC to ACHD and ACLF. Metabolic disruption was significant in ACHD and severe in ACLF. The analysis of 62 overlapping DEGs further linked the HBV-based immune-metabolism disorder to ACLF progression. The signatures of interferon-related, neutrophil-related and monocyte-related pathways related to the innate immune response were significantly upregulated. Signatures linked to the adaptive immune response were downregulated. Disruptions of lipid and fatty acid metabolism were observed during ACLF development. External validation of four DEGs underlying the aforementioned molecular mechanism in patients and experimental rats confirmed their specificity and potential as biomarkers for HBV-ACLF pathogenesis.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusions&lt;/st&gt;
&lt;p&gt;This study highlights immune-metabolism disorder triggered by HBV exacerbation as a potential mechanism of HBV-ACLF and may indicate a novel diagnostic and treatment target to reduce HBV-ACLF-related mortality.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/163?rss=1</guid>
      <dc:title>PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF</dc:title>
      <dc:creator>Li, J., Liang, X., Jiang, J., Yang, L., Xin, J., Shi, D., Lu, Y., Li, J., Ren, K., Hassan, H. M., Zhang, J., Chen, P., Yao, H., Li, J., Wu, T., Jin, L., Ye, P., Li, T., Zhang, H., Sun, S., Guo, B., Zhou, X., Cai, Q., Chen, J., Xu, X., Huang, J., Hao, S., He, J., Xin, S., Wang, D., Trebicka, J., Chen, X., Li, J., Chinese Group on the Study of Severe Hepatitis B (COSSH)</dc:creator>
      <dc:subject>Open access, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-323395</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-323395</dc:identifier>
    </item>
    <item>
      <title>Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/176?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Hepatology</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">176</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">184</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;Data regarding the real-world effectiveness and safety of sofosbuvir/velpatasvir (SOF/VEL) with or without low-dose ribavirin (RBV) in patients with chronic hepatitis C virus (HCV) infection and severe renal impairment (RI) are limited. We evaluated the performance of SOF/VEL with or without low-dose RBV in HCV-infected patients with chronic kidney disease stage 4 or 5.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;191 patients with compensated (n=181) and decompensated (n=10) liver diseases receiving SOF/VEL (400/100 mg/day) alone and SOF/VEL with low-dose RBV (200 mg/day) for 12 weeks were retrospectively recruited at 15 academic centres in Taiwan. The effectiveness was determined by sustained virological response at off-treatment week 12 (SVR&lt;SUB&gt;12&lt;/SUB&gt;) in evaluable (EP) and per-protocol populations (PP). The safety profiles were assessed.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;The SVR&lt;SUB&gt;12&lt;/SUB&gt; rates by EP and PP analyses were 94.8% (95% CI 90.6% to 97.1%) and 100% (95% CI 97.9% to 100%). In patients with compensated liver disease, the SVR&lt;SUB&gt;12&lt;/SUB&gt; rates were 95.0% and 100% by EP and PP analyses. In patients with decompensated liver disease, the SVR&lt;SUB&gt;12&lt;/SUB&gt; rates were 90.0% and 100% by EP and PP analyses. Ten patients who failed to achieve SVR&lt;SUB&gt;12&lt;/SUB&gt; were attributed to non-virological failures. Among the 20 serious adverse events (AEs), none were judged related to SOF/VEL or RBV. The AEs occurring in &amp;#8805;10% included fatigue (14.7%), headache (14.1%), nausea (12.6%), insomnia (12.0%) and pruritus (10.5%). None had &amp;#8805;grade 3 total bilirubin or alanine aminotransferase elevations.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Conclusion&lt;/st&gt;
&lt;p&gt;SOF/VEL with or without low-dose RBV is effective and well-tolerated in HCV-infected patients with severe RI.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/176?rss=1</guid>
      <dc:title>Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment</dc:title>
      <dc:creator>Liu, C.-H., Chen, C.-Y., Su, W.-W., Tseng, K.-C., Lo, C.-C., Liu, C.-J., Chen, J.-J., Peng, C.-Y., Shih, Y.-L., Yang, S.-S., Huang, C.-S., Huang, K.-J., Chang, C.-Y., Tsai, M.-C., Kao, W.-Y., Fang, Y.-J., Chen, P.-Y., Su, P.-Y., Tseng, C.-W., Huang, J.-J., Lee, P.-L., Lai, H.-C., Hsieh, T.-Y., Chang, C.-H., Huang, Y.-J., Lee, F.-J., Chang, C.-C., Kao, J.-H.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-323569</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-323569</dc:identifier>
    </item>
    <item>
      <title>Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/185?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Hepatology</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">185</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">193</prism:endingPage>
      <description>&lt;sec&gt;&lt;st&gt;Objective&lt;/st&gt;
&lt;p&gt;Intrahepatic cholangiocarcinoma (ICC)&amp;#8212;a rare liver malignancy with limited therapeutic options&amp;#8212;is characterised by aggressive progression, desmoplasia and vascular abnormalities. The aim of this study was to determine the role of placental growth factor (PlGF) in ICC progression.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Design&lt;/st&gt;
&lt;p&gt;We evaluated the expression of PlGF in specimens from ICC patients and assessed the therapeutic effect of genetic or pharmacologic inhibition of PlGF in orthotopically grafted ICC mouse models. We evaluated the impact of PlGF stimulation or blockade in ICC cells and cancer-associated fibroblasts (CAFs) using in vitro 3-D coculture systems.&lt;/p&gt;
&lt;/sec&gt;
&lt;sec&gt;&lt;st&gt;Results&lt;/st&gt;
&lt;p&gt;PlGF levels were elevated in human ICC stromal cells and circulating blood plasma and were associated with disease progression. Single-cell RNA sequencing showed that the major impact of PlGF blockade in mice was enrichment of quiescent CAFs, characterised by high gene transcription levels related to the Akt pathway, glycolysis and hypoxia signalling. PlGF blockade suppressed Akt phosphorylation and myofibroblast activation in ICC-derived CAFs. PlGF blockade also reduced desmoplasia and tissue stiffness, which resulted in reopening of collapsed tumour vessels and improved blood perfusion, while reducing ICC cell invasion. Moreover, PlGF blockade enhanced the efficacy of standard chemotherapy in mice-bearing ICC.&lt;/p&gt;
&lt;p&gt;  &lt;b&gt;Conclusion&lt;/b&gt;  &lt;/p&gt;
&lt;p&gt;PlGF blockade leads to a reduction in intratumorous hypoxia and metastatic dissemination, enhanced chemotherapy sensitivity and increased survival in mice-bearing aggressive ICC.&lt;/p&gt;
&lt;/sec&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/185?rss=1</guid>
      <dc:title>Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma</dc:title>
      <dc:creator>Aoki, S., Inoue, K., Klein, S., Halvorsen, S., Chen, J., Matsui, A., Nikmaneshi, M. R., Kitahara, S., Hato, T., Chen, X., Kawakubo, K., Nia, H. T., Chen, I., Schanne, D. H., Mamessier, E., Shigeta, K., Kikuchi, H., Ramjiawan, R. R., Schmidt, T. C., Iwasaki, M., Yau, T., Hong, T. S., Quaas, A., Plum, P. S., Dima, S., Popescu, I., Bardeesy, N., Munn, L. L., Borad, M. J., Sassi, S., Jain, R. K., Zhu, A. X., Duda, D. G.</dc:creator>
      <dc:subject>Open access, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-322493</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-322493</dc:identifier>
    </item>
    <item>
      <title>Novel therapeutic targets for cholestatic and fatty liver disease</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/194?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">Recent advances in clinical practice</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">194</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">209</prism:endingPage>
      <description>&lt;p&gt;Cholestatic and non-alcoholic fatty liver disease (NAFLD) share several key pathophysiological mechanisms which can be targeted by novel therapeutic concepts that are currently developed for both areas. Nuclear receptors (NRs) are ligand-activated transcriptional regulators of key metabolic processes including hepatic lipid and glucose metabolism, energy expenditure and bile acid (BA) homoeostasis, as well as inflammation, fibrosis and cellular proliferation. Dysregulation of these processes contributes to the pathogenesis and progression of cholestatic as well as fatty liver disease, placing NRs at the forefront of novel therapeutic approaches. This includes BA and fatty acid activated NRs such as farnesoid-X receptor (FXR) and peroxisome proliferator-activated receptors, respectively, for which high affinity therapeutic ligands targeting specific or multiple isoforms have been developed. Moreover, novel liver-specific ligands for thyroid hormone receptor beta 1 complete the spectrum of currently available NR-targeted drugs. Apart from FXR ligands, BA signalling can be targeted by mimetics of FXR-activated fibroblast growth factor 19, modulation of their enterohepatic circulation through uptake inhibitors in hepatocytes and enterocytes, as well as novel BA derivatives undergoing cholehepatic shunting (instead of enterohepatic circulation). Other therapeutic approaches more directly target inflammation and/or fibrosis as critical events of disease progression. Combination strategies synergistically targeting metabolic disturbances, inflammation and fibrosis may be ultimately necessary for successful treatment of these complex and multifactorial disorders.&lt;/p&gt;</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/194?rss=1</guid>
      <dc:title>Novel therapeutic targets for cholestatic and fatty liver disease</dc:title>
      <dc:creator>Trauner, M., Fuchs, C. D.</dc:creator>
      <dc:subject>GUT Recent advances in clinical practice, Open access, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-324305</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-324305</dc:identifier>
    </item>
    <item>
      <title>GI highlights from the literature</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/210?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">JournalScan</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">210</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">211</prism:endingPage>
      <description>&lt;sec id="s1"&gt;&lt;st&gt;Basic science&lt;/st&gt;&lt;sec id="s1-1"&gt;&lt;st&gt;Distinct pathways driving inflammatory bowel disease pathotypes with different response to therapy&lt;/st&gt; &lt;p&gt;Friedrich M, Pohin M, Jackson M &lt;I&gt;et al&lt;/I&gt;. IL-1-driven stromal&amp;#8211;neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapies. &lt;I&gt;Nat Med&lt;/I&gt; 2021; doi: 10.1038/s41591-021-01520-5&lt;/p&gt; &lt;p&gt;Despite progress in the development of novel therapeutics targeting intestinal inflammation in inflammatory bowel disease (IBD), it appears that a ceiling of treatment has been reached, with a large proportion of patients not achieving mucosal healing. In addition, there is an unmet need for precision medicine approaches such as not giving the right drug to the right person at the right time. Our current methods of phenotyping patients, based on clinical parameters and endoscopic or histological findings do not appear to be fit for this purpose.&lt;/p&gt; &lt;p&gt;Friedrich &lt;I&gt;et al&lt;/I&gt; use bulk RNA sequencing (RNAseq) to quantify transcriptional changes in the inflamed mucosa of...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/210?rss=1</guid>
      <dc:title>GI highlights from the literature</dc:title>
      <dc:creator>Smith, P. J.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-326614</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-326614</dc:identifier>
    </item>
    <item>
      <title>Surveillance failure in ultrasound for hepatocellular carcinoma: a systematic review and meta-analysis</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/212?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">PostScript</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">212</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">213</prism:endingPage>
      <description>&lt;p&gt;Recently, various advances have been achieved in the diagnosis and treatment of hepatocellular carcinoma (HCC).&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; We read with great interest the paper by De Toni &lt;I&gt;et al&lt;/I&gt;&lt;cross-ref type="bib" refid="R2"&gt;2&lt;/cross-ref&gt; demonstrating the importance of early diagnosis of HCC by surveillance with respect to survival benefits, and that by Zeng &lt;I&gt;et al&lt;/I&gt;&lt;cross-ref type="bib" refid="R3"&gt;3&lt;/cross-ref&gt; emphasising risk stratifications in HCC surveillance. As these papers suggest, effective surveillance to detect early stage HCC is crucial in the management of patients at-risk.&lt;/p&gt; &lt;p&gt;Although ultrasound (US) is recommended as a standard surveillance modality,&lt;cross-ref type="bib" refid="R4"&gt;4 5&lt;/cross-ref&gt;&lt;cross-ref type="bib" refid="R5"&gt;&lt;/cross-ref&gt; the sensitivity of US for detecting early stage HCC is suboptimal, being only 47%.&lt;cross-ref type="bib" refid="R6"&gt;6&lt;/cross-ref&gt; Updated guidelines suggest alternative surveillance tools including MRI in patients likely to have inadequate US examinations.&lt;cross-ref type="bib" refid="R4"&gt;4 5&lt;/cross-ref&gt;&lt;cross-ref type="bib" refid="R5"&gt;&lt;/cross-ref&gt; Recently, MRI surveillance, including abbreviated MRI-protocols, has been drawing attention because of its high diagnostic performance compared with...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/212?rss=1</guid>
      <dc:title>Surveillance failure in ultrasound for hepatocellular carcinoma: a systematic review and meta-analysis</dc:title>
      <dc:creator>Kim, D. H., Hong, S. B., Choi, S. H., Kim, S. Y., Shim, J. H., Lee, J. S., Choi, J.-I., Kim, S.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-323615</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-323615</dc:identifier>
    </item>
    <item>
      <title>Letter to the editor regarding: Multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study)</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/214?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">PostScript</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">214</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">215</prism:endingPage>
      <description>&lt;p&gt;In a prospective, multicentre, randomised controlled trial in an average colon cancer risk population, the TOPAZ trial, Dr Cash and colleagues&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; report that colon capsule endoscopy (CCE) revealed higher diagnostic yield (defined by finding a colonic polyp &amp;#8805;6 mm that warrants an optical colonoscopy) and higher sensitivity compared with CT colonography (CTC). Based on these findings, Cash &lt;I&gt;et al&lt;/I&gt;&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; advocate the use of CCE as a more accurate/superior diagnostic test among patients who cannot/prefer not to undergo optical colonoscopy.&lt;/p&gt; &lt;p&gt;As abdominal radiologists experienced in CTC and as members of the American College of Radiology&amp;#8217;s Colon Cancer Committee, we appreciate the effort by the authors in this clinical trial, but we have comments and concerns about the results, discussion and drawn conclusions:&lt;/p&gt; &lt;p&gt;&lt;l type="unord"&gt;&lt;li&gt;&lt;p&gt;The very low CTC sensitivities reported by Cash &lt;I&gt;et al&lt;/I&gt; (26.8% for polyps &amp;#8805;6 mm and 50% for polyps &amp;#8805;10 mm) are significantly lower compared with...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/214?rss=1</guid>
      <dc:title>Letter to the editor regarding: Multicentre, prospective, randomised study comparing the diagnostic yield of colon capsule endoscopy versus CT colonography in a screening population (the TOPAZ study)</dc:title>
      <dc:creator>Ahmed, F., Brewington, C., Chang, K. J., Moreno, C. C., Gollub, M., Yee, J.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-324396</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-324396</dc:identifier>
    </item>
    <item>
      <title>Role of the gut microbiome in mediating lactose intolerance symptoms</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/215?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">PostScript</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">215</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">217</prism:endingPage>
      <description>&lt;p&gt;Misselwitz &lt;I&gt;et al&lt;/I&gt; recently reviewed the multifactorial aspects of lactose intolerance (LI).&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; Their work highlights the known effects of genetic makeup and dietary patterns in the occurrence of gastrointestinal symptoms in LI individuals. The authors define LI as the occurrence of gastrointestinal complaints on lactose exposure and discuss the wide variety of symptoms among LI patients.&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; Regarding lactose metabolism, Misselwitz &lt;I&gt;et al&lt;/I&gt; mention the influence of the gut microbiome, in particular that &lt;I&gt;Bifidobacterium&lt;/I&gt; or other lactose-fermenting bacteria are reported to affect the levels of lactose in the gut. However, the impact of the gut microbiome on the occurrence of gut-related LI symptoms remains unclear.&lt;/p&gt; &lt;p&gt;We previously observed that the &lt;I&gt;Bifidobacterium&lt;/I&gt; abundance in the adult human gut depends on the interaction between LI genetic variants and dairy intake.&lt;cross-ref type="bib" refid="R2"&gt;2&lt;/cross-ref&gt; This observation complements other findings indicating a mutual relationship between the gut microbiome and host lactose...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/215?rss=1</guid>
      <dc:title>Role of the gut microbiome in mediating lactose intolerance symptoms</dc:title>
      <dc:creator>Brandao Gois, M. F., Sinha, T., Spreckels, J. E., Vich Vila, A., Bolte, L. A., Weersma, R. K., Wijmenga, C., Fu, J., Zhernakova, A., Kurilshikov, A.</dc:creator>
      <dc:subject>Open access, Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2020-323911</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2020-323911</dc:identifier>
    </item>
    <item>
      <title>CT colonography remains an important test for colorectal cancer</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/217?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">PostScript</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">217</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">218</prism:endingPage>
      <description>&lt;p&gt;We read with interest the recent article by Cash &lt;I&gt;et al&lt;/I&gt; comparing colon capsule (CCE) and CT colonography (CTC) with optical colonoscopy (OC) for detecting colonic polyps and colorectal cancer (CRC) in a screening population.&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; The study reports low CTC detection rates for &amp;#8805;6 mm and &amp;#8805;10 mm polyps of only 8.6% and 6.3%, respectively. These were much lower than the detection rates seen for CCE and OC. These results contradict larger trials, where the performance of CTC and OC tests are similar. The Dutch COCOS randomised controlled trial (RCT) in a screening population ultimately reported identical advanced neoplasia detection rates for CTC and OC.&lt;cross-ref type="bib" refid="R2"&gt;2 3&lt;/cross-ref&gt;&lt;cross-ref type="bib" refid="R3"&gt;&lt;/cross-ref&gt; The UK SIGGAR RCT reported identical detection rates of 11% for large polyps or CRC.&lt;cross-ref type="bib" refid="R4"&gt;4&lt;/cross-ref&gt; Earlier studies from the USA also support the use of CTC.&lt;cross-ref type="bib" refid="R5"&gt;5 6&lt;/cross-ref&gt;&lt;cross-ref type="bib" refid="R6"&gt;&lt;/cross-ref&gt; The 8.6% detection rate for &amp;#8805;6 mm...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/217?rss=1</guid>
      <dc:title>CT colonography remains an important test for colorectal cancer</dc:title>
      <dc:creator>Burr, N. E., Plumb, A., Sood, R., Rembacken, B., Tolan, D. J. M.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-324399</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-324399</dc:identifier>
    </item>
    <item>
      <title>Chronic small intestinal dysmotility presenting as jejunal diverticulosis with refractory malabsorption: role for partial enterectomy?</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/218?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">PostScript</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">218</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">219</prism:endingPage>
      <description>&lt;p&gt;We read with interest the guidelines on the management of adult patients with severe chronic small intestinal dysmotility by Nightingale &lt;I&gt;et al&lt;/I&gt;.&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; Enteric myopathies can indeed manifest as jejunal diverticulosis, either acquired or congenital.&lt;cross-ref type="bib" refid="R2"&gt;2&lt;/cross-ref&gt; Besides asymptomatic or acute complicated cases, chronic malabsorption due to bacterial overgrowth is a possible presentation of jejunal diverticulosis.&lt;cross-ref type="bib" refid="R3"&gt;3&lt;/cross-ref&gt; As stated in the guidelines, this mechanism may lead to malnutrition or even intestinal failure.&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; Although surgical options (resection, bypass or stoma formation) were discussed for pseudo-obstruction, resection of diverticula is usually not considered, as surgical outcomes of treatment-refractory cases have been rarely reported.&lt;/p&gt; &lt;p&gt;We report here on our experience with a small series of patients with documented and refractory malabsorption due to small bowel diverticulosis who underwent partial enterectomy at the Leuven Intestinal Failure and Transplantation Centre (Leuven, Belgium) after consent. Bacterial overgrowth, steatorrhoea and medical treatment,...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/218?rss=1</guid>
      <dc:title>Chronic small intestinal dysmotility presenting as jejunal diverticulosis with refractory malabsorption: role for partial enterectomy?</dc:title>
      <dc:creator>Wauters, L., Clarysse, M., Jochmans, I., Monbaliu, D., Ceulemans, L. J., Verbiest, A., Miserez, M., Lauwers, N., Nys, W., Pauwels, N., Hiele, M., Pirenne, J., Vanuytsel, T.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-324385</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-324385</dc:identifier>
    </item>
    <item>
      <title>Utility of mismatch repair protein expression screening via an endoscopic ultrasound assessment of treatment-naive pancreas ductal adenocarcinoma</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/219?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">PostScript</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">219</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">221</prism:endingPage>
      <description>&lt;p&gt;We read with great interest the recent articles by Luchini &lt;I&gt;et al&lt;/I&gt;&lt;cross-ref type="bib" refid="R1"&gt;1 2&lt;/cross-ref&gt;&lt;cross-ref type="bib" refid="R2"&gt;&lt;/cross-ref&gt; and Grant &lt;I&gt;et al&lt;/I&gt;&lt;cross-ref type="bib" refid="R3"&gt;3&lt;/cross-ref&gt; highlighting the low prevalence (1%&amp;#8211;2%) of mismatch repair deficient pancreatic ductal adenocarcinoma (dMMR PDAC) and offering further knowledge pertaining to the molecular spectrum of this disease subtype. A plea was raised to augment translational and clinical research efforts to improve our understanding of dMMR PDAC.&lt;/p&gt; &lt;p&gt;However, from a practical perspective, only 20% of patients with PDAC reach surgical oncologic resection.&lt;cross-ref type="bib" refid="R4"&gt;4&lt;/cross-ref&gt; These resection specimens have served as the source of prior dMMR PDAC analysis. Following the United States Food and Drug Administration approval of pembrolizumab as the first cancer therapy targeting a specific molecular signature, we identified a dMMR prevalence of 3% in a small retrospective cohort of archived pancreas endoscopic ultrasound fine-needle biopsy (EUS FNB) specimens.&lt;cross-ref type="bib" refid="R5"&gt;5&lt;/cross-ref&gt; We recently completed an 18-month prospective...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/219?rss=1</guid>
      <dc:title>Utility of mismatch repair protein expression screening via an endoscopic ultrasound assessment of treatment-naive pancreas ductal adenocarcinoma</dc:title>
      <dc:creator>Garcia Garcia de Paredes, A., Graham, R. P., Levy, M. J., McWilliams, R. R., Rajan, E., Zhang, L., Gleeson, F. C.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-324460</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-324460</dc:identifier>
    </item>
    <item>
      <title>If pneumatic dilation is not enough efficient for post fundoplication dysphagia, is Per Oral Endoscopic Myotomy a good answer to manage it?</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/221?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">PostScript</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">221</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">222</prism:endingPage>
      <description>&lt;p&gt;We read with interest the article by Schuitenmaker &lt;I&gt;et al&lt;/I&gt;&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; that evaluated oesophageal pneumatic dilation (PD) for persistent dysphagia after antireflux surgery (ARS).&lt;/p&gt; &lt;p&gt;The authors concluded that PD is not more effective than sham procedure in patients with persistent dysphagia after laparoscopic fundoplication.&lt;/p&gt; &lt;p&gt;The therapeutic target of PD is the esogastric junction (EGJ) and its effect is theoretically explained by mechanical forces applied on an EGJ obstacle, being either cardial muscular in achalasia or extrinsic valve after antireflux fundoplication. But most of the patients included in the study (76%) did not have an EGJ outflow obstruction (EGJOO).&lt;/p&gt; &lt;p&gt;The realisation of an antireflux valve can lead to the development of inefficient oesophageal motility in nearly 20% of cases&lt;cross-ref type="bib" refid="R2"&gt;2&lt;/cross-ref&gt; and the study of Schuitenmake &lt;I&gt;et al&lt;/I&gt; reinforces the idea that post-ARS dysphagia is not necessarily related to EGJ outflow obstruction (EGJOO), despite a seemingly logical anatomical explanation...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/221?rss=1</guid>
      <dc:title>If pneumatic dilation is not enough efficient for post fundoplication dysphagia, is Per Oral Endoscopic Myotomy a good answer to manage it?</dc:title>
      <dc:creator>Debourdeau, A., Vitton, V., Barthet, M. A., Gonzalez, J.-M.</dc:creator>
      <dc:subject>Gut</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-324238</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-324238</dc:identifier>
    </item>
    <item>
      <title>Six-month follow-up of gut microbiota richness in patients with COVID-19</title>
      <link>http://gut.bmj.com/cgi/content/short/71/1/222?rss=1</link>
      <prism:publicationDate xmlns:prism="http://purl.org/rss/1.0/modules/prism/">2022-01-01</prism:publicationDate>
      <prism:section xmlns:prism="http://purl.org/rss/1.0/modules/prism/">PostScript</prism:section>
      <prism:volume xmlns:prism="http://purl.org/rss/1.0/modules/prism/">71</prism:volume>
      <prism:number xmlns:prism="http://purl.org/rss/1.0/modules/prism/">1</prism:number>
      <prism:startingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">222</prism:startingPage>
      <prism:endingPage xmlns:prism="http://purl.org/rss/1.0/modules/prism/">225</prism:endingPage>
      <description>&lt;p&gt;We read with great interest the recent article published in Gut in which Yeoh &lt;I&gt;et al&lt;/I&gt; demonstrated that gut microbiota composition of recovered patients with COVID-19 remained significantly distinct from uninfected controls.&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; Persisting symptoms, also known as &amp;#8216;long COVID-19&amp;#8217;, have been reported in a significant proportion of patients following hospital discharge.&lt;cross-ref type="bib" refid="R2"&gt;2 3&lt;/cross-ref&gt;&lt;cross-ref type="bib" refid="R3"&gt;&lt;/cross-ref&gt; Gut dysbiosis might link to long COVID-19 risks.&lt;cross-ref type="bib" refid="R1"&gt;1&lt;/cross-ref&gt; Few studies have focused on the recovery process of gut microbiota following SARS-CoV-2 infection.&lt;/p&gt; &lt;p&gt;Here, we conducted a prospective study to longitudinally monitor alterations of gut microbiota in patients with COVID-19 using 16S rDNA sequencing (detailed methods in ). Faecal microbiota was monitored at three timepoints, acute phase (from illness onset to viral clearance), convalescence (from viral clearance to 2 weeks after hospital discharge), postconvalescence (6 months after hospital discharge).&lt;/p&gt; &lt;p&gt;The gut microbiota richness, measured by Chao 1 index, was obviously...</description>
      <pubDate>Wed, 08 Dec 2021 09:28:03 GMT</pubDate>
      <guid isPermaLink="false">http://gut.bmj.com/cgi/content/short/71/1/222?rss=1</guid>
      <dc:title>Six-month follow-up of gut microbiota richness in patients with COVID-19</dc:title>
      <dc:creator>Chen, Y., Gu, S., Chen, Y., Lu, H., Shi, D., Guo, J., Wu, W.-R., Yang, Y., Li, Y., Xu, K.-J., Ding, C., Luo, R., Huang, C., Yu, L., Xu, M., Yi, P., Liu, J., Tao, J.-j., Zhang, H., Lv, L., Wang, B., Sheng, J., Li, L.</dc:creator>
      <dc:subject>Open access, Gut, COVID-19</dc:subject>
      <dc:publisher>BMJ Publishing Group</dc:publisher>
      <dc:date>2021-12-08T09:28:03Z</dc:date>
      <dc:identifier>info:doi/10.1136/gutjnl-2021-324090</dc:identifier>
      <dc:identifier>hwp:master-id:gutjnl;gutjnl-2021-324090</dc:identifier>
    </item>
    <item>
      <title>ROAD: A standardized method for endoscopic assessment of rectal tumours – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16006?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16006</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16006?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 08 Dec 2021 09:13:28 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16006</guid>
      <dc:title>ROAD: A standardized method for endoscopic assessment of rectal tumours – A video vignette</dc:title>
      <dc:creator>Issam Al‐Najami, 
Jens Kristian Bælum, 
Helen J. S. Jones, 
William Perry, 
Chris Cunningham</dc:creator>
      <dc:description />
      <dc:date>2021-12-08T09:13:28Z</dc:date>
      <dc:identifier>10.1111/codi.16006</dc:identifier>
    </item>
    <item>
      <title>Clinical and functional outcome of surgery for posttraumatic cloacal deformity</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16008?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16008</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16008?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Cloacal deformity is a disabling condition that severely affects a patient’s quality of life. Surgery to repair cloacal deformity remains the mainstay of treatment. The aim of this study is to assess the clinical and functional outcome of patients treated for traumatic cloacal deformity by three different techniques.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;A retrospective multicentre study was carried out using data from women operated on for cloacal deformity between 2015 and 2019. Demographic characteristics, the presence of urinary and/or faecal incontinence and manometric findings were collected. The main outcome measures were represented by St Mark’s and Rockwood faecal incontinence quality of life scores.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Thirty eight women with a median age of 34 years [interquartile range (IQR) 31–39 years] were enrolled. Perineoplasty was performed in 23 patients by direct suture of the rectovaginal septum, in five using the X-flap and in 10 by the Singapore flap. Median resting and squeezing pressures increased significantly from 28.15 (IQR 23–32.7) cmH&lt;sub&gt;2&lt;/sub&gt;O to 45 (IQR 31–60.7) cmH&lt;sub&gt;2&lt;/sub&gt;O (&lt;i&gt;p&lt;/i&gt; = 0.0001) and from 47 (IQR 41.2–54.7) cmH&lt;sub&gt;2&lt;/sub&gt;O to 97.2 (IQR 80–118) cmH&lt;sub&gt;2&lt;/sub&gt;O (&lt;i&gt;p&lt;/i&gt; = 0.0001), respectively. Maximum tolerable volume improved from 120 (IQR 90–137.5) ml to 137.5 (IQR 120–150) ml (&lt;i&gt;p&lt;/i&gt; = 0.002). The St Mark’s score decreased from 18 (IQR 14–20) to 4.5 (IQR 2–8) after 20 months (&lt;i&gt;p&lt;/i&gt; = 0001). Sexual activity was confirmed by 16 patients preoperatively and by 27 postoperatively. A diverting stoma was performed in three patients after X-flap perineoplasty and in 14 treated by direct closure. No significant differences were found pre- and postoperatively between the three groups.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Regardless of the technique used, surgical repair significantly improves both clinical and functional outcomes irrespective of the presence of a covering stoma.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 08 Dec 2021 09:06:28 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16008</guid>
      <dc:title>Clinical and functional outcome of surgery for posttraumatic cloacal deformity</dc:title>
      <dc:creator>Arcangelo Picciariello, 
Gaetano Gallo, 
Alessandro Sturiale, 
Francesco Litta, 
Veronica De Simone, 
Gennaro Martines, 
Gabriele Naldini, 
Carlo Ratto, 
Mario Trompetto, 
Marcella Rinaldi</dc:creator>
      <dc:description>Abstract

Aim
Cloacal deformity is a disabling condition that severely affects a patient’s quality of life. Surgery to repair cloacal deformity remains the mainstay of treatment. The aim of this study is to assess the clinical and functional outcome of patients treated for traumatic cloacal deformity by three different techniques.


Method
A retrospective multicentre study was carried out using data from women operated on for cloacal deformity between 2015 and 2019. Demographic characteristics, the presence of urinary and/or faecal incontinence and manometric findings were collected. The main outcome measures were represented by St Mark’s and Rockwood faecal incontinence quality of life scores.


Results
Thirty eight women with a median age of 34 years [interquartile range (IQR) 31–39 years] were enrolled. Perineoplasty was performed in 23 patients by direct suture of the rectovaginal septum, in five using the X‐flap and in 10 by the Singapore flap. Median resting and squeezing pressures increased significantly from 28.15 (IQR 23–32.7) cmH2O to 45 (IQR 31–60.7) cmH2O (p = 0.0001) and from 47 (IQR 41.2–54.7) cmH2O to 97.2 (IQR 80–118) cmH2O (p = 0.0001), respectively. Maximum tolerable volume improved from 120 (IQR 90–137.5) ml to 137.5 (IQR 120–150) ml (p = 0.002). The St Mark’s score decreased from 18 (IQR 14–20) to 4.5 (IQR 2–8) after 20 months (p = 0001). Sexual activity was confirmed by 16 patients preoperatively and by 27 postoperatively. A diverting stoma was performed in three patients after X‐flap perineoplasty and in 14 treated by direct closure. No significant differences were found pre‐ and postoperatively between the three groups.


Conclusion
Regardless of the technique used, surgical repair significantly improves both clinical and functional outcomes irrespective of the presence of a covering stoma.</dc:description>
      <dc:date>2021-12-08T09:06:28Z</dc:date>
      <dc:identifier>10.1111/codi.16008</dc:identifier>
    </item>
    <item>
      <title>Pull‐through as an anastomotic salvage technique after taTME for low rectal cancer complicated by colon ischaemia – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16004?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16004</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16004?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Tue, 07 Dec 2021 18:46:20 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16004</guid>
      <dc:title>Pull‐through as an anastomotic salvage technique after taTME for low rectal cancer complicated by colon ischaemia – A video vignette</dc:title>
      <dc:creator>Ana Alagoa João, 
Ricardo Rocha, 
Rita Camarneiro, 
Paulo Alves, 
Carla Carneiro, 
Vítor Nunes</dc:creator>
      <dc:description />
      <dc:date>2021-12-07T18:46:20Z</dc:date>
      <dc:identifier>10.1111/codi.16004</dc:identifier>
    </item>
    <item>
      <title>Evaluation of the implementation of the sigmoid take‐off landmark in the Netherlands</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16005?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16005</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16005?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;The sigmoid take-off (STO), the point on imaging where the sigmoid sweeps ventral from the sacrum, was chosen as the definition of the rectum during an international Delphi consensus meeting and has been incorporated into the Dutch guidelines since October 2019. The aim of this study was to evaluate the implementation of this landmark 1 year after the guideline implementation and to perform a quality assessment of the STO training.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;Dutch radiologists, surgeons, surgical residents, interns, PhD students and physician assistants were asked to complete a survey and classify 20 tumours on MRI as ‘below’, ‘on’ or ‘above’ the STO. Outcomes were agreement with the expert reference, inter-rater variability and accuracy before and after the training.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Eighty-six collaborators participated. Six radiologists (32%) and 11 surgeons (73%) used the STO as the standard landmark to distinguish between rectal and sigmoidal tumours during multidisciplinary meetings. Overall agreement with the expert reference improved from 53% to 70% (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001) after the training. The positive predictive value for diagnosing rectal tumours was high before and after the training (92% vs. 90%); the negative predictive value for diagnosing sigmoidal tumours improved from 39% to 63%.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Approximately half of the represented hospitals have implemented the new definition of rectal cancer 1 year after the implementation of the Dutch national guidelines. Overall baseline agreement with the expert reference and accuracy for the tumours around the STO was low, but improved significantly after training. These results highlight the added value of training in implementation of radiological landmarks to ensure unambiguous assessment.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Tue, 07 Dec 2021 18:34:12 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16005</guid>
      <dc:title>Evaluation of the implementation of the sigmoid take‐off landmark in the Netherlands</dc:title>
      <dc:creator>Sanne‐Marije J. A. Hazen, 
Tania C. Sluckin, 
Karin Horsthuis, 
Doenja M. J. Lambregts, 
Regina G. H. Beets‐Tan, 
Pieter J. Tanis, 
Miranda Kusters, 
the Dutch Snapshot Research Group, 
Anne M. Dinaux, 
Bas Lamme, 
Gijsbert D. Musters, 
Fleur Bangert, 
Eva Knöps, 
Sofieke Temmink, 
Peter A. M. Kint, 
Robert R. J. Coebergh van den Braak, 
Puck M. E. Schuivens, 
Willem A. Bemelman, 
Wernard A. A. Borstlap, 
Pieter J. Haasnoot, 
Roel Hompes, 
Jurriaan B. Tuynman, 
Erik J. Mulder, 
G. Y. M. The, 
Jeroen F. Prette, 
Pepijn Krielen, 
Joost D. J. Plate, 
Joost Nederend, 
Stijn H. J. Ketelaers, 
Stefi Nordkamp, 
Shira H. de Bie, 
Jonanne F. Nieuwenhuis, 
A. Koen Talsma, 
G. F. A. J. B. van Tilborg, 
Wouter M. Verduin, 
Sander van der Wolk, 
Jan M. van Rees, 
Joost Rothbarth, 
E. Joline de Groof, 
Jennifer W. Bradshaw, 
Marit E. van der Sande, 
Edwin S. van der Zaag, 
Boudewijn E. Schaafsma, 
Fleur I. de Korte, 
Clementine L. A. Vogelij, 
Annette Zeilstra, 
Marjolein Ankersmit, 
Bas Frietman, 
Sicco J. Braak, 
Laurentine. S. E. van Egdom, 
Joost Nonner, 
Amarins T. A. Brandsma, 
Floris B. Poelmann, 
Henderik L. van Westreenen, 
Shirin Feshtali, 
Vera Heesink, 
Stefan H. E. M. Clermonts, 
Bas Keizers, 
Allard Wijma, 
Saskia G. C. van Elderen, 
Esther C. J. Consten, 
Anna Hogewoning, 
Daniela Jou‐Valencia, 
Ida Paulusma, 
Martsje van der Sluis, 
Sjoerd van den Hoek, 
Nadia A. G. Hakkenbrak, 
Renée M. Barendse, 
Arja. Gerritsen, 
Anouk J. M. Rombouts, 
Seyed M. Qaderi, 
Johannes H. W. de Wilt, 
Leonard F. Kroese, 
Pim B. Olthof, 
Herman J. A. Zandvoort, 
Kemal Dogan, 
Ernst Jan Spillenaar Bilgen, 
Sjirk W. van der Burg, 
Anouk Emmen, 
Paul P. van Westerveld, 
Sylvia Kok, 
Lisanne A. E. Posma, 
Jeroen A. W. Tielbeek, 
Tyche Derksen, 
Victor van Woerden, 
Robin D. Blok, 
Jacoline Jonkers, 
Robbert J. de Haas, 
Ilsalien. S. Bakker, 
Eline A. Feitsma, 
Edgar J. B. Furnée, 
Thijs A. Burghgraef, 
S. T. van Vugt, 
Frank C. den Boer, 
Maaike Corver, 
Sifrid Hendrickx, 
Dietrich J. L. de Mey, 
Roy F. A. Vliegen, 
Evert‐Jan G. Boerma, 
Ingrid G. M. Poodt, 
Milou H. Martens</dc:creator>
      <dc:description>Abstract

Aim
The sigmoid take‐off (STO), the point on imaging where the sigmoid sweeps ventral from the sacrum, was chosen as the definition of the rectum during an international Delphi consensus meeting and has been incorporated into the Dutch guidelines since October 2019. The aim of this study was to evaluate the implementation of this landmark 1 year after the guideline implementation and to perform a quality assessment of the STO training.


Method
Dutch radiologists, surgeons, surgical residents, interns, PhD students and physician assistants were asked to complete a survey and classify 20 tumours on MRI as ‘below’, ‘on’ or ‘above’ the STO. Outcomes were agreement with the expert reference, inter‐rater variability and accuracy before and after the training.


Results
Eighty‐six collaborators participated. Six radiologists (32%) and 11 surgeons (73%) used the STO as the standard landmark to distinguish between rectal and sigmoidal tumours during multidisciplinary meetings. Overall agreement with the expert reference improved from 53% to 70% (p &lt; 0.001) after the training. The positive predictive value for diagnosing rectal tumours was high before and after the training (92% vs. 90%); the negative predictive value for diagnosing sigmoidal tumours improved from 39% to 63%.


Conclusion
Approximately half of the represented hospitals have implemented the new definition of rectal cancer 1 year after the implementation of the Dutch national guidelines. Overall baseline agreement with the expert reference and accuracy for the tumours around the STO was low, but improved significantly after training. These results highlight the added value of training in implementation of radiological landmarks to ensure unambiguous assessment.</dc:description>
      <dc:date>2021-12-07T18:34:12Z</dc:date>
      <dc:identifier>10.1111/codi.16005</dc:identifier>
    </item>
    <item>
      <title>Usefulness of the waist-to-height ratio for predicting cardiometabolic risk in children and its suggested boundary values</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00557-4/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-07</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <description>Only limited information is available on the usefulness of the waist-to-height ratio (WHtR) as an abdominal obesity marker in children. Our aim was to compare the ability of a WHtR &gt;90th percentile, a WHtR ≥0.50, a WHtR ≥0.55 and a BMI z-score ≥2 SD to predict cardiometabolic risk in children followed-up at different ages.</description>
      <pubDate>Tue, 07 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00557-4/fulltext?rss=yes</guid>
      <dc:title>Usefulness of the waist-to-height ratio for predicting cardiometabolic risk in children and its suggested boundary values</dc:title>
      <dc:creator>Judit Muñoz-Hernando, Joaquin Escribano, Natalia Ferré, Ricardo Closa-Monasterolo, Veit Grote, Berthold Koletzko, Dariusz Gruszfeld, Alice ReDionigi, Elvira Verduci, Annick Xhonneux, Veronica Luque</dc:creator>
      <dc:date>2021-12-07T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.008</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Protein intake pattern in non-breastfed infants and toddlers: A survey in a nationally representative sample of French children</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00556-2/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-07</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <description>Protein intake plays a key role in infants and children's growth, but high protein intake may have adverse long-term effects. Data on actual intakes in various populations are scarce.The aims of this study were (i) to assess daily protein intake (DPI) in non-breastfed infants and children aged 0.5–35 months in comparison with the population reference intake (PRI) set by the European Food Safety Authority, and to examine (ii) the various sources of this intake and their consumption patterns, and (iii) time-related changes in DPI over the last 4 decades.</description>
      <pubDate>Tue, 07 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00556-2/fulltext?rss=yes</guid>
      <dc:title>Protein intake pattern in non-breastfed infants and toddlers: A survey in a nationally representative sample of French children</dc:title>
      <dc:creator>Jean-Pierre Chouraqui, Dominique Darmaun, Aurée Salmon-Legagneur, Raanan Shamir</dc:creator>
      <dc:date>2021-12-07T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.006</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Body composition assessment and sarcopenia in patients with biliary tract cancer: A systematic review and meta-analysis</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00555-0/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-07</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Meta-analyses</prism:section>
      <description>Sarcopenia, as assessed by body composition, can affect morbidity and survival in several gastrointestinal cancer. However, the impact of sarcopenia, referring to both quantity and quality of skeletal muscle, in biliary tract cancer (BTC) is debatable. We aimed to investigate the impact of sarcopenia on morbidity and mortality in patients with BTC.</description>
      <pubDate>Tue, 07 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00555-0/fulltext?rss=yes</guid>
      <dc:title>Body composition assessment and sarcopenia in patients with biliary tract cancer: A systematic review and meta-analysis</dc:title>
      <dc:creator>Jun Watanabe, Ryota Matsui, Hideki Sasanuma, Yoichi Ishizaki, Tetsu Fukunaga, Kazuhiko Kotani, Naohiro Sata</dc:creator>
      <dc:date>2021-12-07T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.005</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Step‐by‐step approach to laparoscopic D3 lymph node dissection while preserving the inferior mesenteric artery for advanced descending colon cancer – a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16003?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16003</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16003?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Mon, 06 Dec 2021 20:48:55 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16003</guid>
      <dc:title>Step‐by‐step approach to laparoscopic D3 lymph node dissection while preserving the inferior mesenteric artery for advanced descending colon cancer – a video vignette</dc:title>
      <dc:creator>Aya Sato, 
Ken Imaizumi, 
Hiroyuki Kasajima, 
Kentaro Ichimura, 
Kentaro Sato, 
Kazuaki Nakanishi</dc:creator>
      <dc:description />
      <dc:date>2021-12-06T20:48:55Z</dc:date>
      <dc:identifier>10.1111/codi.16003</dc:identifier>
    </item>
    <item>
      <title>Risk factors for anastomotic leakage after anterior resection for rectal cancer (RALAR study): A nationwide retrospective study of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15997?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15997</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15997?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Anastomotic leakage after restorative surgery for rectal cancer shows high morbidity and related mortality. Identification of risk factors could change operative planning, with indications for stoma construction. This retrospective multicentre study aims to assess the anastomotic leak rate, identify the independent risk factors and develop a clinical prediction model to calculate the probability of leakage.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;The study used data from 24 Italian referral centres of the Colorectal Cancer Network of the Italian Society of Surgical Oncology. Patients were classified into two groups, AL (anastomotic leak) or NoAL (no anastomotic leak). The effect of patient-, disease-, treatment- and postoperative outcome-related factors on anastomotic leak after univariable and multivariable analysis was measured.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A total of 5398 patients were included, 552 in group AL and 4846 in group NoAL. The overall incidence of leaks was 10.2%, with a mean time interval of 6.8 days. The 30-day leak-related mortality was 2.6%. Sex, body mass index, tumour location, type of approach, number of cartridges employed, weight loss, clinical T stage and combined multiorgan resection were identified as independent risk factors. The stoma did not reduce the leak rate but significantly decreased leak severity and reoperation rate. A nomogram with a risk score (RALAR score) was developed to predict anastomotic leak risk at the end of resection.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;While a defunctioning stoma did not affect the leak risk, it significantly reduced its severity. Surgeons should recognize independent risk factors for leaks at the end of rectal resection and could calculate a risk score to select high-risk patients eligible for protective stoma construction.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Mon, 06 Dec 2021 20:20:55 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15997</guid>
      <dc:title>Risk factors for anastomotic leakage after anterior resection for rectal cancer (RALAR study): A nationwide retrospective study of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group</dc:title>
      <dc:creator>Maurizio Degiuli, 
Ugo Elmore, 
Raffaele De Luca, 
Paola De Nardi, 
Mariano Tomatis, 
Alberto Biondi, 
Roberto Persiani, 
Leonardo Solaini, 
Gianluca Rizzo, 
Domenico Soriero, 
Desiree Cianflocca, 
Marco Milone, 
Giulia Turri, 
Daniela Rega, 
Paolo Delrio, 
Corrado Pedrazzani, 
Giovanni D. De Palma, 
Felice Borghi, 
Stefano Scabini, 
Claudio Coco, 
Davide Cavaliere, 
Michele Simone, 
Riccardo Rosati, 
Rossella Reddavid, 
and collaborators from the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group, 
Francesco Evola, 
Michela Mineccia, 
Francesca Pecchini, 
Gaetano Gallo, 
Paola Incollingo, 
Fabio Maiello, 
Andrea Barberis, 
Monica Ortenzi, 
Vittoria Bellato, 
Caterina Foppa, 
Vincenzo Adamo, 
Cristina Bombardini, 
Alessandro Giuliani, 
Francesca Cravero, 
Marco Amisano, 
Pietro Paolo Bianchi, 
Gabriele Anania, 
Marco Calgaro, 
Antonino Spinelli, 
Giuseppe S. Sica, 
Marito Guerrieri, 
Marco Filauro, 
Roberto Polastri, 
Francesco Bianco, 
Giuseppe Sammarco, 
Micaela Piccoli, 
Alessandro Ferrero, 
Domenico D’Ugo</dc:creator>
      <dc:description>Abstract

Aim
Anastomotic leakage after restorative surgery for rectal cancer shows high morbidity and related mortality. Identification of risk factors could change operative planning, with indications for stoma construction. This retrospective multicentre study aims to assess the anastomotic leak rate, identify the independent risk factors and develop a clinical prediction model to calculate the probability of leakage.


Methods
The study used data from 24 Italian referral centres of the Colorectal Cancer Network of the Italian Society of Surgical Oncology. Patients were classified into two groups, AL (anastomotic leak) or NoAL (no anastomotic leak). The effect of patient‐, disease‐, treatment‐ and postoperative outcome‐related factors on anastomotic leak after univariable and multivariable analysis was measured.


Results
A total of 5398 patients were included, 552 in group AL and 4846 in group NoAL. The overall incidence of leaks was 10.2%, with a mean time interval of 6.8 days. The 30‐day leak‐related mortality was 2.6%. Sex, body mass index, tumour location, type of approach, number of cartridges employed, weight loss, clinical T stage and combined multiorgan resection were identified as independent risk factors. The stoma did not reduce the leak rate but significantly decreased leak severity and reoperation rate. A nomogram with a risk score (RALAR score) was developed to predict anastomotic leak risk at the end of resection.


Conclusions
While a defunctioning stoma did not affect the leak risk, it significantly reduced its severity. Surgeons should recognize independent risk factors for leaks at the end of rectal resection and could calculate a risk score to select high‐risk patients eligible for protective stoma construction.</dc:description>
      <dc:date>2021-12-06T20:20:55Z</dc:date>
      <dc:identifier>10.1111/codi.15997</dc:identifier>
    </item>
    <item>
      <title>The effect of vitamin B12-supplementation on actigraphy measured sleep pattern; a randomized control trial</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00554-9/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-06</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Randomized Control Trials</prism:section>
      <description>Vitamin B12 deficiency is common worldwide and has been associated with poor sleep. The effect of vitamin B12 supplementation on sleep in infants is not known.</description>
      <pubDate>Mon, 06 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00554-9/fulltext?rss=yes</guid>
      <dc:title>The effect of vitamin B12-supplementation on actigraphy measured sleep pattern; a randomized control trial</dc:title>
      <dc:creator>Mari Hysing, Tor Strand, Ram K. Chandyo, Manjeswori Ulak, Suman Ranjitkar, Catherine Schwinger, Merina Shrestha, Ingrid Kvestad</dc:creator>
      <dc:date>2021-12-06T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.040</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00553-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-06</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Randomized Control Trials</prism:section>
      <description>Capsule dispensing was performed by members (CK and LOB) of UPMC Whitfield Pharmacy, Waterford, Ireland. Using the Trial Controller system these individuals had access to patient study codes, assigned intervention group and capsule batch numbers. Importantly, pharmacy members had no contact with participants and no access to participant names or contact details. By comparison, researchers directly involved in CARES had access to participant details and study codes, but no access to information regarding intervention allocation or capsule batch numbers. The researcher (RP) received a box of tablets from the pharmacy members (CK or LOB) with a subject identification label (i.e. both the researcher and study participant were blinded to the intervention). The intervention code was only revealed at study completion.</description>
      <pubDate>Mon, 06 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00553-7/fulltext?rss=yes</guid>
      <dc:title>Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial</dc:title>
      <dc:creator>Rebecca Power, John M. Nolan, Alfonso Prado-Cabrero, Warren Roche, Robert Coen, Tommy Power, Ríona Mulcahy</dc:creator>
      <dc:date>2021-12-06T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.004</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Defining reference values for low skeletal muscle index at the L3 vertebra level based on computed tomography in healthy adults: A multicentre study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00552-5/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-06</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <description>Skeletal muscle mass loss is an important aspect of malnutrition and is closely related to adverse clinical outcomes. Computed tomography (CT) is the gold standard for analysing muscle mass, and the skeletal muscle index at the third lumbar vertebra (L3-SMI), measured using CT, is an important indicator to evaluate total skeletal tissue. The aims of this study were to establish reference values for low L3-SMI in Northern China, and to investigate the correlation between L3-SMI and age, and the correlation between L3-SMI and body mass index (BMI).</description>
      <pubDate>Mon, 06 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00552-5/fulltext?rss=yes</guid>
      <dc:title>Defining reference values for low skeletal muscle index at the L3 vertebra level based on computed tomography in healthy adults: A multicentre study</dc:title>
      <dc:creator>Ming Kong, Nan Geng, Ying Zhou, Ning Lin, Wenyan Song, Manman Xu, Shanshan Li, Yuetong Piao, Zuoqing Han, Rong Guo, Chao Yang, Nan Luo, Zhong Wang, Mengyuan Jiang, Lili Wang, Wanchun Qiu, Junfeng Li, Daimeng Shi, Rongkuan Li, Eddie C. Cheung, Yu Chen, Zhongping Duan</dc:creator>
      <dc:date>2021-12-06T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.003</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Pocket‐creation colonic endoscopic submucosal dissection assisted by bidirectional double clip traction – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16001?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16001</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16001?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Sun, 05 Dec 2021 19:55:16 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16001</guid>
      <dc:title>Pocket‐creation colonic endoscopic submucosal dissection assisted by bidirectional double clip traction – A video vignette</dc:title>
      <dc:creator>Chun‐Chia Chang, 
Wen‐Chi Chen, 
Feng‐Woei Tsay, 
Huay‐Min Wang, 
Tzung‐Jiun Tsai, 
Chao‐Wen Hsu</dc:creator>
      <dc:description />
      <dc:date>2021-12-05T19:55:16Z</dc:date>
      <dc:identifier>10.1111/codi.16001</dc:identifier>
    </item>
    <item>
      <title>Robotic sigmoid colectomy with transanal extraction – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15932?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15932</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15932?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Sun, 05 Dec 2021 19:54:17 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15932</guid>
      <dc:title>Robotic sigmoid colectomy with transanal extraction – A video vignette</dc:title>
      <dc:creator>Liam A. Devane, 
Sean T. Martin</dc:creator>
      <dc:description />
      <dc:date>2021-12-05T19:54:17Z</dc:date>
      <dc:identifier>10.1111/codi.15932</dc:identifier>
    </item>
    <item>
      <title>The use of a new automated device for the sclerosing treatment of haemorrhoidal disease – A video‐vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15992?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15992</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15992?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Sun, 05 Dec 2021 19:49:23 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15992</guid>
      <dc:title>The use of a new automated device for the sclerosing treatment of haemorrhoidal disease – A video‐vignette</dc:title>
      <dc:creator>Gaetano Gallo, 
Mario Trompetto, 
Elia Diaco</dc:creator>
      <dc:description />
      <dc:date>2021-12-05T19:49:23Z</dc:date>
      <dc:identifier>10.1111/codi.15992</dc:identifier>
    </item>
    <item>
      <title>Extraction of Migrated Colonic Stent</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16014?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16014</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16014?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, Accepted Article.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;p&gt;We present a case of a 70 year old male diagnosed with metastatic rectosigmoid colon cancer with bilobar liver metastases. He was stented for acute large bowel obstruction secondary to the colonic tumour.&lt;/p&gt;
&lt;p&gt;After completion of three cycles of FOLFOX (5 Fluorouracil, Leucovorin, Oxaliplatin) plus Bevacizumab chemotherapy, he developed severe acute onset pain in the anal region with no other associated complaints. He consulted the primary physician and was advised a PET CT scan which showed a significant resolution of the primary obstructing tumour, as well as the liver metastases along with distal stent migration. He presented to us with severe and constant pain related to the migrated stent.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Sun, 05 Dec 2021 11:34:47 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16014</guid>
      <dc:title>Extraction of Migrated Colonic Stent</dc:title>
      <dc:creator>Pinak Dasgupta, 
Ajay Pai</dc:creator>
      <dc:description>Abstract
We present a case of a 70 year old male diagnosed with metastatic rectosigmoid colon cancer with bilobar liver metastases. He was stented for acute large bowel obstruction secondary to the colonic tumour.
After completion of three cycles of FOLFOX (5 Fluorouracil, Leucovorin, Oxaliplatin) plus Bevacizumab chemotherapy, he developed severe acute onset pain in the anal region with no other associated complaints. He consulted the primary physician and was advised a PET CT scan which showed a significant resolution of the primary obstructing tumour, as well as the liver metastases along with distal stent migration. He presented to us with severe and constant pain related to the migrated stent.</dc:description>
      <dc:date>2021-12-05T11:34:47Z</dc:date>
      <dc:identifier>10.1111/codi.16014</dc:identifier>
    </item>
    <item>
      <title>Methodological issues on açaí (Euterpe oleracea Mart.) and juçara (Euterpe edulis Mart.) juices improved HDL-c levels and antioxidant defense of healthy adults in a 4-week randomized cross-over study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00548-3/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-04</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>I was interested to read the paper authored by de Liz et al. [1] which is published in the Journal of Clinical Nutrition in Dec 2020. The authors aimed that the a positive impact of regular consumption of açaí and juçara juices on the HDL-c levels, as well as on the antioxidant enzyme activities, which may contribute to cardiovascular health with a cross-over study. Although the results of the study are very interesting, however, it seems that several statistical and methodological issues should be considered when interpreting the results.</description>
      <pubDate>Sat, 04 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00548-3/fulltext?rss=yes</guid>
      <dc:title>Methodological issues on açaí (Euterpe oleracea Mart.) and juçara (Euterpe edulis Mart.) juices improved HDL-c levels and antioxidant defense of healthy adults in a 4-week randomized cross-over study</dc:title>
      <dc:creator>Mojtaba Soltani-Kermanshahi</dc:creator>
      <dc:date>2021-12-04T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.001</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>The outcome of patients with inflammatory bowel disease–associated colorectal cancer is not worse than that of patients with sporadic colorectal cancer–a matched-pair analysis of survival</title>
      <link>http://link.springer.com/10.1007/s00384-021-04072-9</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Purpose&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Patients with inflammatory bowel disease (IBD) have an increased risk for colorectal cancer (CRC). In IBD patients, cancer is often diagnosed in advanced stages and conflicting data on survival compared to sporadic CRC have been reported. The aim of this study was to directly compare clinical characteristics and prognosis of patients with IBD-CRC and sporadic CRC.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;The clinical and pathological data of 63 patients with IBD-CRC and 3710 patients with sporadic CRC treated at the University Hospital of Erlangen between 1995 and 2015 were compared. Forty-seven M0 patients with IBD were matched with sporadic CRC patients after curative resection (R0) according to tumor localization, stage, sex, and year of treatment. Overall and disease-free survival were compared.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Sixty-three patients presented IBD-CRC. Fifty were affected with ulcerative colitis (UC) and 13 with Crohn’s disease (CD). CRC was diagnosed within 1.45 years since last endoscopic surveillance. Twelve patients (19%) had a diagnosis of primary sclerosing cholangitis. In matched analysis, IBD patients were diagnosed with CRC at younger age compared to sporadic CRC and were more likely to have right-sided CRC (40% versus 23.3%) and rare histological subtypes (19% versus 9.2%). No differences in 5-year overall (78.7 versus 80.9 months) and 5-year disease-free survival (74.5 versus 70.2 months) were noted.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Conclusion&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;IBD-CRC patients were younger and more frequently had right-sided carcinomas compared to sporadic CRC. CRC in IBD patients did not show survival difference compared to matched-pair sporadic CRC patients without distant metastases after curative resection. Surveillance might be important for early detection of CRC in IBD patients.&lt;/p&gt;
                  &lt;/span&gt;</description>
      <pubDate>Sat, 04 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04072-9</guid>
      <dc:date>2021-12-04T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Are colorectal surgery patients willing to accept an increased risk of surgical site infection to avoid mechanical bowel preparation? Implications for future trial design</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16000?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16000</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16000?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Recent evidence has shown no difference in the risk of surgical site infection (SSI) with oral antibiotics alone (OA) and oral antibiotics in combination with mechanical bowel preparation (OA + MBP), suggesting that the use of MBP may be safely avoided. The aim of this work was to determine the absolute risk of SSI that patients would accept with OA relative to OA + MBP.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;Standardized, in-person interviews were conducted using the threshold task with patients attending colorectal surgery clinics who had previously had MBP. Participants were asked which option they preferred when the absolute risk of SSI was 7% for both options. Next, their switch point was determined by increasing the risk of SSI with OA by 1% intervals until their preference changed from OA to OA + MBP. Median switch point scores were reported and represented the absolute increased risk of SSI that patients would accept with OA relative to OA + MBP.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Fifty patients completed the interview. All participants chose OA over OA + MBP when the risk of SSI was 7% for both options. Switch points ranged from 8% to 25%, with a median of 10%, indicating that participants were willing to accept up to a 3% increase in absolute risk of developing a SSI with OA to avoid MBP.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;The results showed that patients are willing to accept an increased risk of up to 3% for SSI with OA relative to OA + MBP. Incorporating patient preferences into the planning of future trials has the potential to improve the uptake of trial results into clinical practice.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Fri, 03 Dec 2021 09:37:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16000</guid>
      <dc:title>Are colorectal surgery patients willing to accept an increased risk of surgical site infection to avoid mechanical bowel preparation? Implications for future trial design</dc:title>
      <dc:creator>Steven Gu, 
Mantaj Brar, 
Selina Schmocker, 
Erin Kennedy</dc:creator>
      <dc:description>Abstract

Aim
Recent evidence has shown no difference in the risk of surgical site infection (SSI) with oral antibiotics alone (OA) and oral antibiotics in combination with mechanical bowel preparation (OA + MBP), suggesting that the use of MBP may be safely avoided. The aim of this work was to determine the absolute risk of SSI that patients would accept with OA relative to OA + MBP.


Method
Standardized, in‐person interviews were conducted using the threshold task with patients attending colorectal surgery clinics who had previously had MBP. Participants were asked which option they preferred when the absolute risk of SSI was 7% for both options. Next, their switch point was determined by increasing the risk of SSI with OA by 1% intervals until their preference changed from OA to OA + MBP. Median switch point scores were reported and represented the absolute increased risk of SSI that patients would accept with OA relative to OA + MBP.


Results
Fifty patients completed the interview. All participants chose OA over OA + MBP when the risk of SSI was 7% for both options. Switch points ranged from 8% to 25%, with a median of 10%, indicating that participants were willing to accept up to a 3% increase in absolute risk of developing a SSI with OA to avoid MBP.


Conclusions
The results showed that patients are willing to accept an increased risk of up to 3% for SSI with OA relative to OA + MBP. Incorporating patient preferences into the planning of future trials has the potential to improve the uptake of trial results into clinical practice.</dc:description>
      <dc:date>2021-12-03T09:37:05Z</dc:date>
      <dc:identifier>10.1111/codi.16000</dc:identifier>
    </item>
    <item>
      <title>TAMIS management of large peritoneal entry for recurrent rectal polyp – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15996?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15996</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15996?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Fri, 03 Dec 2021 09:37:02 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15996</guid>
      <dc:title>TAMIS management of large peritoneal entry for recurrent rectal polyp – A video vignette</dc:title>
      <dc:creator>Michael Flanagan, 
Jessica M. Ryan, 
Tara Connelly, 
Fiachra Cooke, 
Peter McCullough, 
Peter Neary</dc:creator>
      <dc:description />
      <dc:date>2021-12-03T09:37:02Z</dc:date>
      <dc:identifier>10.1111/codi.15996</dc:identifier>
    </item>
    <item>
      <title>Prevalence of pouchitis in both ulcerative colitis and familial adenomatous polyposis: A systematic review and meta‐analysis</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15995?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15995</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15995?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">META‐ANALYSIS</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Pouchitis is a clinically significant complication of ileal pouch–anal anastomosis with its prevalence varying in the literature. Pouchitis is thought to occur more commonly in patients with ulcerative colitis (UC) than in patients with familial adenomatous polyposis (FAP). We conducted a systematic review with meta-analysis of all published literature to report the prevalence of pouchitis in all pouch patients as well as specifically in UC and FAP. We also investigated the prevalence of acute and chronic pouchitis in UC and FAP.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A meta-analysis was conducted by searching the Embase, Embase Classic and PubMed databases between 1978 and 2021 exploring the prevalence of pouchitis in UC and FAP. We then performed a random effects model in order to find the pooled prevalence of pouchitis and used odds ratios to report differences in the prevalence of pouchitis in UC and FAP.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Fifty-nine full papers and conference abstracts were included in the meta-analysis comprising 18 117 patients with UC and 860 with FAP. The prevalence of pouchitis in UC was 0.32 (95% CI 0.27–0.37) and in FAP was found to be 0.06 (95% CI 0.03–0.15). The odds ratio of pouchitis in UC patients compared with FAP patients was 4.95 (95% CI 3.17–7.72, &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.0001).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Our findings support the consensus that the prevalence of pouchitis is higher in UC than in FAP. More significantly our findings suggest that the true prevalence of pouchitis is higher than commonly reported in the literature. This literature may help counsel patients prior to undergoing restorative proctocolectomy.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>META‐ANALYSIS</category>
      <pubDate>Fri, 03 Dec 2021 09:32:49 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15995</guid>
      <dc:title>Prevalence of pouchitis in both ulcerative colitis and familial adenomatous polyposis: A systematic review and meta‐analysis</dc:title>
      <dc:creator>Danujan Sriranganathan, 
Yakup Kilic, 
Mohammed Nabil Quraishi, 
Jonathan P. Segal</dc:creator>
      <dc:description>Abstract

Aim
Pouchitis is a clinically significant complication of ileal pouch–anal anastomosis with its prevalence varying in the literature. Pouchitis is thought to occur more commonly in patients with ulcerative colitis (UC) than in patients with familial adenomatous polyposis (FAP). We conducted a systematic review with meta‐analysis of all published literature to report the prevalence of pouchitis in all pouch patients as well as specifically in UC and FAP. We also investigated the prevalence of acute and chronic pouchitis in UC and FAP.


Methods
A meta‐analysis was conducted by searching the Embase, Embase Classic and PubMed databases between 1978 and 2021 exploring the prevalence of pouchitis in UC and FAP. We then performed a random effects model in order to find the pooled prevalence of pouchitis and used odds ratios to report differences in the prevalence of pouchitis in UC and FAP.


Results
Fifty‐nine full papers and conference abstracts were included in the meta‐analysis comprising 18 117 patients with UC and 860 with FAP. The prevalence of pouchitis in UC was 0.32 (95% CI 0.27–0.37) and in FAP was found to be 0.06 (95% CI 0.03–0.15). The odds ratio of pouchitis in UC patients compared with FAP patients was 4.95 (95% CI 3.17–7.72, P &lt; 0.0001).


Conclusions
Our findings support the consensus that the prevalence of pouchitis is higher in UC than in FAP. More significantly our findings suggest that the true prevalence of pouchitis is higher than commonly reported in the literature. This literature may help counsel patients prior to undergoing restorative proctocolectomy.</dc:description>
      <dc:date>2021-12-03T09:32:49Z</dc:date>
      <dc:identifier>10.1111/codi.15995</dc:identifier>
    </item>
    <item>
      <title>Robotic extra‐sphincteric pelvic floor excision: A Video Vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15990?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15990</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15990?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Fri, 03 Dec 2021 09:29:26 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15990</guid>
      <dc:title>Robotic extra‐sphincteric pelvic floor excision: A Video Vignette</dc:title>
      <dc:creator>Michelle Smigielski, 
Kheng‐Seong Ng, 
Peter Lee</dc:creator>
      <dc:description />
      <dc:date>2021-12-03T09:29:26Z</dc:date>
      <dc:identifier>10.1111/codi.15990</dc:identifier>
    </item>
    <item>
      <title>Effectiveness of carbohydrate counting and Dietary Approach to Stop Hypertension dietary intervention on managing Gestational Diabetes Mellitus among pregnant women who used metformin: A randomized controlled clinical trial</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00551-3/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-03</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Randomized Control Trials</prism:section>
      <description>Gestational diabetes mellitus (GDM) is one of the most common complication of pregnancy that has significant impacts on both mother and her offspring health. The present study aimed to examine the effect of carbohydrate counting, carbohydrate counting combined with DASH, and control dietary interventions on glycemic control, and maternal and neonatal outcomes.</description>
      <pubDate>Fri, 03 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00551-3/fulltext?rss=yes</guid>
      <dc:title>Effectiveness of carbohydrate counting and Dietary Approach to Stop Hypertension dietary intervention on managing Gestational Diabetes Mellitus among pregnant women who used metformin: A randomized controlled clinical trial</dc:title>
      <dc:creator>Sabika Allehdan, Asma Basha, Dana Hyassat, Mohammed Nabhan, Husam Qasrawi, Reema Tayyem</dc:creator>
      <dc:date>2021-12-03T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.039</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Reply - Letter to the editor: Methodological issues on açaí (Euterpe oleracea Mart.) and juçara (Euterpe edulis Mart.) juices improved HDL-c levels and antioxidant defense of healthy adults in a 4-week randomized cross-over study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00550-1/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-03</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>Thank you for forwarding the letter by Soltani-Kermanshahi [1]. We would also like to thank Soltani-Kermanshahi for his interest in reading our work and for pointing out that “Although the results of the study are very interesting, it seems that several statistical and methodological issues should be considered when interpreting the results”, such as washout period (definition of four weeks) and statistical analysis (normality test and test of equality for carryover effects) in our published original article [2].</description>
      <pubDate>Fri, 03 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00550-1/fulltext?rss=yes</guid>
      <dc:title>Reply - Letter to the editor: Methodological issues on açaí (Euterpe oleracea Mart.) and juçara (Euterpe edulis Mart.) juices improved HDL-c levels and antioxidant defense of healthy adults in a 4-week randomized cross-over study</dc:title>
      <dc:creator>Patricia Faria Di Pietro, Patrícia de Fragas Hinnig, Cândice Laís Knöner Copetti, Sheyla de Liz, Edson Luiz da Silva</dc:creator>
      <dc:date>2021-12-03T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.12.002</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>The use of ileal pouch–anal anastomosis in patients with ulcerative colitis from 2009 to 2018</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15985?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15985</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15985?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;The existing literature was updated, assessing the use of surgery in patients with ulcerative colitis in more recent years.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This was a retrospective observational study identifying all patients with ulcerative colitis within the National Inpatient Sample, years 2009–2018. All patients with International Classification of Diseases, Ninth and Tenth Revisions, Clinical Modification diagnostic codes for ulcerative colitis were included. The primary outcome was the trend in total number of total abdominal colectomy, proctocolectomy and simultaneous versus delayed pouch construction.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A total of 1 184 711 ulcerative-colitis-related admissions were identified. An increase of 18.6% in the number of patients was observed, while the number of surgeries decreased. A total of 40 499 patients underwent total colectomy, annually decreasing from 5241 to 3185. The number of proctocolectomies without pouch decreased from 1191 to 530, while the number of patients undergoing pouch construction decreased from 2225 to 1284. The proportion of patients undergoing initial pouch at time of proctocolectomy decreased from 995 (45%) to 265 (21%), while the proportion of patients undergoing delayed pouch construction in 2018 was 79% (&lt;i&gt;n&lt;/i&gt; = 1120).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Surgery use in ulcerative colitis has decreased in the last decade despite increasing numbers of hospital admissions in patients with this condition. While the overall proportion of patients undergoing pouch construction remained stable, the majority of patients were initially treated with total colectomy and their ileal pouches werre constructed in a delayed fashion.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Thu, 02 Dec 2021 19:09:12 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15985</guid>
      <dc:title>The use of ileal pouch–anal anastomosis in patients with ulcerative colitis from 2009 to 2018</dc:title>
      <dc:creator>Paul T. Kröner, 
Amit Merchea, 
Dorin Colibaseanu, 
Michael F. Picco, 
Francis A. Farraye, 
Luca Stocchi</dc:creator>
      <dc:description>Abstract

Aim
The existing literature was updated, assessing the use of surgery in patients with ulcerative colitis in more recent years.


Methods
This was a retrospective observational study identifying all patients with ulcerative colitis within the National Inpatient Sample, years 2009–2018. All patients with International Classification of Diseases, Ninth and Tenth Revisions, Clinical Modification diagnostic codes for ulcerative colitis were included. The primary outcome was the trend in total number of total abdominal colectomy, proctocolectomy and simultaneous versus delayed pouch construction.


Results
A total of 1 184 711 ulcerative‐colitis‐related admissions were identified. An increase of 18.6% in the number of patients was observed, while the number of surgeries decreased. A total of 40 499 patients underwent total colectomy, annually decreasing from 5241 to 3185. The number of proctocolectomies without pouch decreased from 1191 to 530, while the number of patients undergoing pouch construction decreased from 2225 to 1284. The proportion of patients undergoing initial pouch at time of proctocolectomy decreased from 995 (45%) to 265 (21%), while the proportion of patients undergoing delayed pouch construction in 2018 was 79% (n = 1120).


Conclusion
Surgery use in ulcerative colitis has decreased in the last decade despite increasing numbers of hospital admissions in patients with this condition. While the overall proportion of patients undergoing pouch construction remained stable, the majority of patients were initially treated with total colectomy and their ileal pouches werre constructed in a delayed fashion.</dc:description>
      <dc:date>2021-12-02T19:09:12Z</dc:date>
      <dc:identifier>10.1111/codi.15985</dc:identifier>
    </item>
    <item>
      <title>Redo colorectal anastomosis for rectovaginal fistula following posterior pelvic exenteration – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.16002?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.16002</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.16002?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Thu, 02 Dec 2021 18:30:18 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.16002</guid>
      <dc:title>Redo colorectal anastomosis for rectovaginal fistula following posterior pelvic exenteration – A video vignette</dc:title>
      <dc:creator>Rafael Vaz Pandini, 
Lucas Soares Gerbasi, 
Francisco Tustumi, 
Marleny Novas Figueiredo de Araújo, 
Victor Edmond Seid, 
Sérgio Eduardo Alonso Araujo</dc:creator>
      <dc:description />
      <dc:date>2021-12-02T18:30:18Z</dc:date>
      <dc:identifier>10.1111/codi.16002</dc:identifier>
    </item>
    <item>
      <title>Oncologic colorectal surgical site infection: oral or not oral antibiotic preparation, that is the question</title>
      <link>http://link.springer.com/10.1007/s00384-021-04074-7</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Purpose&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Surgical wound infection is the most frequent postoperative complication in abdominal surgery, especially at the colorectal level. The aim of this study is analysing the results of mechanical colon preparation combined with oral antibiotic versus mechanical colon preparation without antibiotic therapy in patients with colorectal cancer undergoing elective surgery.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;This retrospective cohort study had been developed from November 2017 to February 2020. We have included a total of 281 consecutive patients undergoing elective colon and rectal oncological surgeries by the same surgical group using laparoscopic and open approaches. Transanal minimally invasive surgery (TAMIS) and transanal total mesorectal excision (TaTME) approaches were excluded. Exposed patients undergoing colon and rectal cancer surgery received mechanical bowel preparation and oral antibiotics with three doses of neomycin 1 g and erythromycin 500 mg the day before surgery.&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;The primary outcome was reduction in surgical wound infection rates before and after starting the oral antibiotic therapy from 17 to 6% (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.05). As a secondary analysis, we evaluated the anastomotic dehiscence rate, corresponding with a decrease from 12 to 3% (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.05).&lt;/p&gt;
                  &lt;/span&gt;
                  &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                    &lt;h3 class="a-plus-plus"&gt;Conclusion&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Mechanical bowel preparation combined with oral antibiotic therapy is still not unanimously carried out in all the medical hospitals. In this report, we show that mechanical bowel preparation in combination with oral antibiotic reduces the risk of surgical wound infection and anastomotic leakage in patients undergoing colon and rectal cancer surgery.&lt;/p&gt;
                  &lt;/span&gt;</description>
      <pubDate>Thu, 02 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04074-7</guid>
      <dc:date>2021-12-02T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Pregnancy after bariatric surgery: Effects of personalized nutrition counseling on pregnancy outcomes</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00545-8/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-01</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <description>Nutritional challenges following bariatric surgery can be intensified during pregnancy and may have crucial effects on the fetus, including lower birth weight. To the best of our knowledge, the effect of nutritional counseling during post-bariatric pregnancy to improve maternal diet quality and eating habits on neonatal outcome has not been evaluated. The aim of this research was to examine the effects of personal nutritional counseling during post-bariatric pregnancy on nutritional intake and neonatal outcomes.</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00545-8/fulltext?rss=yes</guid>
      <dc:title>Pregnancy after bariatric surgery: Effects of personalized nutrition counseling on pregnancy outcomes</dc:title>
      <dc:creator>Shir Araki, Carmi Shani Levi, Shani Abutbul Vered, Ido Solt, Geila S. Rozen</dc:creator>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.035</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Serum lysophospholipidome of dietary origin as a suitable susceptibility/risk biomarker of human hypercholesterolemia: A cross-sectional study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00543-4/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12-01</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <description>Whether bioactive lysophospholipids (lyso-PLs) and trimethylamine-N-oxide (TMAO) serve as non-invasive biomarkers in early human hypercholesterolemia (HC) is unknown. The present work aimed at assessing whether serum lyso-PLs and plasma TMAO may be suitable susceptibility/risk biomarkers of HC in humans. Secondarily, we aimed to evaluate the relationships between targeted metabolites with diet composition and circulating liver transaminases, and verified the results in hamsters.</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00543-4/fulltext?rss=yes</guid>
      <dc:title>Serum lysophospholipidome of dietary origin as a suitable susceptibility/risk biomarker of human hypercholesterolemia: A cross-sectional study</dc:title>
      <dc:creator>Lorena Calderón-Pérez, Susana Suárez-García, Anna Pedret, Manuel Suárez, Elisabet Llauradó, Laura Rubió, Josep M. del Bas, Antoni Caimari, Francesc Puiggrós, Lluís Arola, Rosa Solà, Rosa M. Valls</dc:creator>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.033</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Announcement</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00522-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5823</prism:startingPage>
      <description>The Editorial Office, staff, fellow Associate Editors and ESPEN Committees would like to take this opportunity to extend our gratitude to Dr Claude Pichard. Dr Pichard has been a large part of the continued growth of these journals, Clinical Nutrition and Clinical Nutrition ESPEN. He has devoted many years and numerous hours to the improvement and quality and impact factors of these journals. His background in Critical Care, Cancer and many other spectrums has been of great value to Clinical Nutrition.</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00522-7/fulltext?rss=yes</guid>
      <dc:title>Announcement</dc:title>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
      <dc:identifier>10.1016/S0261-5614(21)00522-7</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Editorial board</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00517-3/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-12</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">i</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ii</prism:endingPage>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00517-3/fulltext?rss=yes</guid>
      <dc:title>Editorial board</dc:title>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
      <dc:identifier>10.1016/S0261-5614(21)00517-3</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Letter to Editor Regarding the Article Entitled “Treatment Effects for Dysphagia in Adults with Multiple Sclerosis: A Systematic Review”</title>
      <link>http://link.springer.com/10.1007/s00455-020-10220-0</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;This letter is written to inform an important error in the methodology section of a systematic review article entitled “Treatment Effects for Dysphagia in Adults with Multiple Sclerosis: A Systematic Review” by Dalal Alali et al., which consequently resulted in a precise paradox probably and inadvertently affecting the search strategy, results, discussion, and/or conclusion of this systematic review.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10220-0</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Correction to: Annular Flow in the Upper Esophageal Sphincter Demonstrated with Dynamic 320-row Area Detector Computed Tomography</title>
      <link>http://link.springer.com/10.1007/s00455-021-10282-8</link>
      <description>&lt;p class="a-plus-plus"&gt;A correction to this paper has been published: https://doi.org/10.1007/s00455-021-10282-8&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-021-10282-8</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Response to Letter to the Editor Regarding the Article Entitled “Treatment Effects for Dysphagia in Adults with Multiple Sclerosis: A Systematic Review”</title>
      <link>http://link.springer.com/10.1007/s00455-020-10219-7</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;This letter is a response to the Letter to the Editor by Ghaemi et al. (2020), in which we discuss the comments made by Ghaemi et al. and conclude that, despite a minor error in wording, our systematic review provided an accurate reflection of the literature at that point in time.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10219-7</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>A Rare Syndrome Causing Neurogenic Dysphagia</title>
      <link>http://link.springer.com/10.1007/s00455-020-10208-w</link>
      <description />
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10208-w</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>The Timed Swallowing Proficiency for Eating and Drinking (SPEAD) Test: Development and Initial Validation of an Instrument to Objectify (Impaired) Swallowing Capacity in Head and Neck Cancer Patients</title>
      <link>http://link.springer.com/10.1007/s00455-020-10240-w</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Objective swallowing outcomes measure the physical swallowing function, while subjective outcomes measure swallowing perception. A test for swallowing capacity, measuring the ingestion of all consistencies is currently not available. Therefore, the Swallowing Proficiency for Eating And Drinking (SPEAD) test was developed. It entails the timed ingestion of thin liquid, thick liquid and solid. In this study, its feasibility, reliability and validity were evaluated in patients with dysphagia after treatment for head and neck cancer (HNC) and healthy participants. Thirty-eight HNC patients and forty healthy participants were enrolled in this study and performed the SPEAD test three times. Video recordings of the test were evaluated three times by one observer, and once by three additional observers, to assess test–retest, intra-rater and inter-rater reliability. Validity was assessed by calculating effect sizes for the difference between results of patients and healthy participants and by evaluating correlations with objective (e.g., videofluoroscopy and functional oral intake scale) and subjective (e.g., SWAL-QOL) swallowing outcomes. Test–retest, intra-rater and inter-rater reliability of ingestion duration was good to excellent. All hypotheses with regard to magnitude and direction of correlations were confirmed, supporting construct validity of the test. Our initial results suggest that the SPEAD test reliably measures the transport capacity of the upper digestive tract (in grams per second) and that this test can be useful to objectively evaluate and monitor the (safe) swallowing capacity in HNC patients, in both research as well as daily clinical practice.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10240-w</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Self-reported Dysphagia and Pharyngeal Volume Following Whiplash Injury</title>
      <link>http://link.springer.com/10.1007/s00455-020-10233-9</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Difficulty swallowing has been reported following whiplash injury; however, the reasons remain poorly understood. A possible factor may be the observed changes in pharyngeal volume. The current exploratory study was designed to examine the prevalence of self-reported dysphagia after whiplash and the relationship with recovery status and change in pharyngeal volume. Data were available from a longitudinal study of adults with whiplash. Data included magnetic resonance imaging (MRI) of the cervical spine, the Dysphagia Handicap Index (DHI), and Neck Disability Index (NDI) collected over four timepoints (&amp;lt; 1 week, 2 weeks, 3 months, and 12 months post-injury). Initial cross-sectional analysis examined 60 patients with DHI data from at least one timepoint. A second, longitudinal analysis was conducted on 31 participants with MRI, NDI, and DHI data at both early (&amp;lt; 1–2 weeks) and late (3–12 months) timepoints. The pharynx was contoured on axial T2-weighted MRI slices using OsiriX image processing software and pharyngeal volume (mm&lt;sup class="a-plus-plus"&gt;3&lt;/sup&gt;) was quantified. In the 60-patient cohort, prevalence of self-reported dysphagia (DHI ≥ 3) was observed in 50% of participants at least once in 12 months (&lt;em class="a-plus-plus"&gt;M&lt;/em&gt; = 4.9, SD 8.16, range 0–40). In the longitudinal cohort (&lt;em class="a-plus-plus"&gt;n&lt;/em&gt; = 31), mean total DHI significantly (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.006) increased between early and late stages. There was no relationship (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 1.0) between dysphagia and recovery status, per the NDI% score. Pharyngeal volume remained stable and there was no relationship between dysphagia and pharyngeal volume change (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 1.0). This exploratory study supports the need for further work to understand the nature of dysphagia, extent of functional compromise, and the underlying pathophysiology post-whiplash.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10233-9</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Volume and Location of the Defect as Predictors of Swallowing Outcome After Glossectomy: Correlation with a Classification</title>
      <link>http://link.springer.com/10.1007/s00455-020-10224-w</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;This study aimed to characterize the swallowing outcomes after glossectomy and analyze factors affecting them. An attempt is made to propose a classification system and corroborate it to the results. This is a cross-sectional study to assess swallowing in carcinoma tongue patients treated surgically with or without reconstruction, followed by adjuvant therapy as indicated. One hundred and six patients were evaluated with videofluoroscopy (VFS). Volume defects were classified as I: less than one-third, II: one-third to half, III: half to two-thirds, IV: two-thirds to total glossectomy. Location was assigned as lateral, tip, and sulcus defects. Predictors were T stage, surgical approach, volume, location, and adjuvant radiotherapy. Chi-square and logistic regression were used for statistical analysis. Defects were Class I, II, III, and IV in 36, 42, 16, and 12 patients, respectively. Adjuvant radiotherapy was given in 40% of cases. Mean evaluation time was 14 months from treatment. On, Functional Oral Intake Scale (FOIS) score, as the Class of the defect increased, the percentage of patients with low scores (poor swallowing outcomes) showed an increasing trend (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.001). Defect volume, T stage, approach, and radiotherapy correlated significantly with an abnormality of all VFS parameters (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.001). On multivariate analysis, defect volume remained an independent predictor for oral parameters; radiotherapy emerged as the only independent predictor for pharyngeal parameters. The incremental volume of the defect is a significant independent predictor of swallowing. Based on this, we propose a classification for glossectomy.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10224-w</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>The Dysphagia Handicap Index (DHI)—Normative Values. Systematic Review and Meta-Analysis</title>
      <link>http://link.springer.com/10.1007/s00455-020-10231-x</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;As the dysphagia handicap index (DHI) becomes more commonly used in clinical practice as a diagnostic tool, it is essential to establish the normative value of DHI. The main purpose of this study is to determine the normative value of DHI among subjects who had no history of dysphagia or neurological disease as well as no history of head or neck malignancy. A systematic literature search was performed using PubMed, Scopus and ScienceDirect to access relevant databases and to locate outcome studies. Eligibility criteria included type of publication, participant characteristics and report of outcomes. Data analysis were conducted using meta-analysis method. Five articles were included for the final analysis. The normative value of DHI was 2.49 with confidence interval of 0.51–4.48 for a group of 323 subjects, age range of 20–86 years.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10231-x</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Outcomes of Combined Antegrade–Retrograde Dilations for Radiation-Induced Esophageal Strictures in Head and Neck Cancer Patients</title>
      <link>http://link.springer.com/10.1007/s00455-020-10236-6</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;The purpose of this study is to analyze outcomes of combined antegrade–retrograde dilations (CARD). This retrospective study was conducted on 14 patients with a history of head and neck cancer, treated with radiation therapy that was complicated by either complete or near-complete esophageal stenosis. All patients had minimal oral intake and depended on a gastrostomy tube for nutrition. Swallow function before and after CARD was assessed using the Functional Oral Intake Scale, originally developed for stroke patients and applied to head and neck cancer patients. Patients undergoing CARD demonstrated a quantifiable improvement in swallow function (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.007) that persisted at last known follow-up (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.015) but only a minority (23.1%) achieved oral intake sufficient to obviate the need for tube feeds. Complication rates were 24% per procedure or 36% per patient, almost all complications required procedural intervention, and all complications occurred in patients with complete stenosis. Our study suggests further caution when considering CARD, careful patient selection, and close post-operative monitoring.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10236-6</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Diagnostic Accuracy of an Esophageal Screening Protocol Interpreted by the Speech-Language Pathologist</title>
      <link>http://link.springer.com/10.1007/s00455-020-10239-3</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Oropharyngeal and esophageal dysphagia may occur simultaneously. However, symptoms are often evaluated separately. Few standardized, multi-texture esophageal screening protocols exist as an addition to the modified barium swallow study (MBSS). Given the gap in MBSS evaluation standards, providers may be lacking information needed to fully assess the swallowing process and create appropriate dysphagia management plans. The aim was to assess the diagnostic accuracy of a standardized esophageal screening protocol performed by an SLP compared to formal reference esophageal examinations. A cross-sectional analytic study was performed. Consecutively referred patients who underwent same-day consultation with the SLP and a gastroenterologist were included. MBSS with a standardized esophageal screen was performed. Same-day formal esophageal testing was completed and included timed barium emptying study or high-resolution manometry. Summary diagnostic accuracy measures were calculated. Seventy-three patients matched the inclusion criteria. Median age was 62.5 years (25–87), 55% were female. Sensitivity of the esophageal screen for the detection of esophageal abnormality was 83.7% (95% CI 70–91.9%); specificity was 73.7% (95% CI 55.6–85.8%). The positive likelihood ratio was 3.14 (95% CI 1.71–5.77), whereas the negative likelihood ratio was 0.22 (95% CI 0.11–0.45). Positive and negative predictive values were 82% and 76%, respectively. Use of a systematic, multi-texture esophageal screen protocol interpreted by SLPs accurately identifies multiphase dysphagia and should be considered in addition to standard MBSS testing. Inclusion of a cursory esophageal view may more adequately assess dysphagia symptoms and help to promote multidisciplinary care.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10239-3</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Impact of Tracheal Tube on Swallowing in Post-Operative Head and Neck Cancer Patients: Scintigraphic Analysis</title>
      <link>http://link.springer.com/10.1007/s00455-020-10222-y</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Dysphagia is common in tracheostomized patients who underwent head and neck surgery for cancer treatment. The objective of this study was to evaluate, by means of oropharyngoesophageal scintigraphy (OPES), the impact of an occluded tracheal tube (TT) on swallowing in patients treated for head and neck cancer before hospital discharge, to provide further information to the benefit of out-patient care management. From October 2018 to November 2019, we enrolled 19 tracheostomized patients (6 females and 13 males; mean age 61 years) who underwent primary surgical resection of head and neck tumor and swallowing rehabilitation during hospitalization. All subjects underwent a double-standard OPES, one with occluded tracheal tube and the other without TT, with their tracheal stoma being closed directly by a plaster. For each study, we assessed and compared the following quantitative parameters: oral transit time (OTTsec), pharyngeal transit time (PTTsec), esophageal transit time (ETTsec), oral retention index (ORI%), pharyngeal retention index (PRI%), esophageal retention index (ERI%), and aspiration percentage (AP%). The mean values of OTT, PTT, ORI%, PRI%, and ERI% were abnormal during OPES both with TT and without TT and did not statistically differ between the two tests (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;gt; 0.05). Aspiration was detected in 4 cases out of 19 (21.05%) cases during OPES with TT and in 4/19 (21.05%) cases without TT who showed a mean AP% of 11.4% and 11.5% respectively (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;gt; 0.05). Patients with abnormal AP% (&amp;gt; 0%) during OPES with TT showed aspiration signs without TT. Our study showed that the mere presence of a closed tracheal tube does not impact significantly the oropharyngeal transit of bolus during swallowing. This result suggests the possibility to maintain a small-diameter occluded tracheal tube in place for the postsurgical management of head and neck cancer patients.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10222-y</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Ultrasonographic Measurement of Masseter Muscle Thickness Associates with Oral Phase Dysphagia in Institutionalized Elderly Individuals</title>
      <link>http://link.springer.com/10.1007/s00455-020-10234-8</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Background &amp;amp; Aims&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Oral phase dysphagia is dependent on ability to chew. As people age, general muscle atrophy contributes to decreased masseter strength. The main objective of this study was to assess the relationship between the thickness of the masseter muscle measured by ultrasonography and the presence of dysphagia in a group of institutionalized elderly people. As a secondary objective, we aimed to establish cutoff points of masseters muscle thickness (MMT) to identify elderly individuals at risk of oral dysphagia.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Cross-sectional study of all residents from 3 nursing homes. All individuals underwent ultrasonographic measurements of left and right MMT and were classified according to the presence of dysphagia assessed by both the EAT-10 screening questionnaire and the volume‐viscosity swallow test (V‐VST).&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;469 patients (69% women, mean age 84.7 yrs) were recruited. Dysphagia was present in 41.6% and 26% of individuals according the EAT-10 and V-VST, respectively. Multivariate logistic regression showed that 1 mm increase in MMT reduced the risk of dysphagia by 21% according to the EAT-10 tool and by 30% using the V-VST after adjusting for age, sex, mini-nutritional assessment score, and body mass index. We used receiver operative characteristic (ROC) curves to identify cutoff points of MMT to detect dysphagic individuals according to either EAT-10 or V-VST.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Conclusions&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;The MMT measured by ultrasonography is reduced in elderly individuals with dysphagia. Based on MMT, clinicians may be better informed about the patients'´ ability to masticate solid foods and identify potential nutrient deficiencies in geriatric settings&lt;/p&gt;
                    &lt;/span&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10234-8</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Annular Flow in the Upper Esophageal Sphincter Demonstrated with Dynamic 320-row Area Detector Computed Tomography</title>
      <link>http://link.springer.com/10.1007/s00455-020-10241-9</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Understanding bolus flow patterns in swallowing (rheology, the study of flow) is fundamental to assessment and treatment of dysphagia. These patterns are complex and poorly understood. A liquid swallow is typically biphasic, including air, so the actual bolus has both liquid and gas phases. We report a novel observation of annular two-phase flow (a ring of liquid around a core of air) as thin liquids passed through the upper esophageal sphincter (UES). Dynamic CT was performed on 27 healthy asymptomatic volunteers swallowing liquid barium in a semi-reclining position. Each subject swallowed 3, 10, and 20 ml of either thin (14 subjects) or thick liquid (13 subjects). Sagittal and axial images were analyzed. Flow patterns in the UES were assessed on cross-sectional images. Annular flow was seen in the majority of subjects with thin liquid but few with thick liquid swallows. The percentage of Annular flow during UES opening was 3 ml 58%, 10 ml 58%, 20 ml 56% in thin and 3 ml 0%, 10 ml 4%, 20 ml 1% in thick. Annular flow was usually observed from the second or third frames after onset of UES opening. The other pattern, Plug flow was seldom seen with thin but was typical with thick liquid swallows. Annular flow was the most common pattern for thin liquids (but not thick liquids) passing through the UES. Annular flow has been defined as a liquid continuum adjacent to the channel wall with a gas continuum (core) in the center of the channel. The two regions are demarcated by a gas–liquid interface. Annular flow is typical for two-phase gas–liquid flow in a vertical or inclined channel. It results from the interaction of viscosity with cohesive and adhesive forces in the two phases. We infer that the difference in flow pattern between thin liquid–air and thick liquid–air boluses resulted from the differing magnitudes of viscous forces.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10241-9</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Ultrasound: Validity of a Pocket-Sized System in the Assessment of Swallowing</title>
      <link>http://link.springer.com/10.1007/s00455-020-10232-w</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Adequate hyoid and laryngeal displacement facilitate safe and efficient swallowing. Although videofluoroscopy is commonly used for assessment of this biomechanical event, ultrasound provides benefits as a radiation-free modality for this purpose. This study investigated validity of a pocket-sized ultrasound system (Clarius™) in the assessment of hyoid and laryngeal excursion. Hyoid excursion and thyrohyoid approximation were concurrently assessed in 20 healthy adults using ultrasound and videofluoroscopy during saliva, liquid, and puree swallowing. Correlation analyses were performed to evaluate validity. There was a strong and moderate positive association between ultrasound and videofluoroscopic measurements of hyoid excursion during dry and liquid swallowing, respectively. No evidence for a significant association was found for ultrasound and videofluoroscopic measurements of hyoid excursion for puree swallowing and of thyrohyoid approximation for any bolus type. Further work towards improved validity is necessary prior to clinical transfer of the pocket-sized Clarius™ system in clinical swallowing assessment.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10232-w</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Combination of Modified Free Anterolateral Thigh Skin-Fascia Flap and Pedicled Thoracoacromial Artery Perforator Flap for Entire Circumferential Pharyngoesophageal Defect and External Neck Skin Defect Reconstructions</title>
      <link>http://link.springer.com/10.1007/s00455-020-10237-5</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Simultaneous reconstructions of entire circumference pharyngoesophageal defect and external neck skin defect are challenges for head and neck surgeons. A 57-year old man, who underwent radical tumor resection, suffered with an advanced metachronous second primary esophageal squamous cell carcinoma (SPESCC). Our modified operative technique (mALT-TAAP), a combination of modified free anterolateral thigh (ALT) flap (a fasciocutaneous flap with an extension of fascia) and pedicled thoracoacromial artery perforator (TAAP) flap, was utilized to reconstruct the entire circumference of pharyngoesophageal and external neck skin defect reconstructions. The modified ALT flap, TAAP flap and donor wounds recovered well postoperatively. No morbidity of the donor site or operation-related complication was observed. The postoperative recovery of swallowing function was satisfactory. Our mALT-TAAP reconstruction method could be a decent option for simultaneous reconstructions of entire circumference of pharyngoesophageal defect and external neck skin defect.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10237-5</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Automatic Detection and Analysis of Swallowing Sounds in Healthy Subjects and in Patients with Pharyngolaryngeal Cancer</title>
      <link>http://link.springer.com/10.1007/s00455-020-10225-9</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Assessment of swallowing function is often invasive or involves irradiation. Analysis of swallowing sounds is a noninvasive method for assessment of swallowing but is not used in daily medical practice. Dysphagia could be the first symptom that occurs in head and neck cancer. This study evaluated a method for the automatic detection and analysis of swallowing sounds in healthy subjects and in patients with pharyngolaryngeal cancer. A smartphone application, developed for automatic detection and analysis of swallowing sounds was developed and tested in 12 healthy volunteers and in 26 patients with pharyngolaryngeal cancer. Swallowing sounds were recorded with a laryngophone during a standardized meal (100 mL mashed potatoes, 100 mL water, and 100 mL yogurt). Swallowing number and duration were noted; the results were compared to a standard swallowing sound analysis using the software AUDACITY&lt;sup class="a-plus-plus"&gt;®&lt;/sup&gt;. There were no statistically significant differences in swallowing number or duration between the two analysis methods for the three types of foods in healthy volunteers and only for water in patients. In healthy volunteers, the results of our automatic analysis were comparable with those obtained with the standard analysis. However, a better discrimination of swallowing sounds is necessary for the algorithm to obtain reliable results with thicker food in patients with head and neck cancer.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10225-9</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Dual Tasking Influences Cough Reflex Outcomes in Adults with Parkinson’s Disease: A Controlled Study</title>
      <link>http://link.springer.com/10.1007/s00455-020-10223-x</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Coughing is an essential airway protective reflex. In healthy young adults, cough somatosensation changes when attention is divided (dual tasking). Whether the same is true in populations at risk of aspiration remains unknown. We present findings from a controlled study testing the effects of divided attention (via a dual-task paradigm) on measures of reflex cough in Parkinson’s disease. Volunteers with Parkinson’s disease (&lt;em class="a-plus-plus"&gt;n&lt;/em&gt; = 14, age = 43–79 years) and 14 age-matched controls underwent five blocks of capsaicin-induced cough challenges. Within each block, capsaicin ranging from 0 to 200 μM was presented in a randomized order. Two blocks consisted of cough testing only (single task), and two blocks consisted of cough testing with simultaneous tone counting (dual task). Finally, participants completed a suppressed cough task. Measures of cough motor response, self-reported urge to cough, cough frequency, and cough airflow were collected. Historical data from healthy young adults was included for comparison. Between-group analyses revealed no differences between single- and dual-cough-task responses. However, &lt;em class="a-plus-plus"&gt;post hoc&lt;/em&gt; analysis revealed a significant relationship between dual-task errors and cough frequency that was strongest in people with Parkinson’s disease [&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.004, &lt;em class="a-plus-plus"&gt;r&lt;/em&gt;&lt;sup class="a-plus-plus"&gt;2&lt;/sup&gt; = 0.52]. Specifically, greater errors were associated with fewer reflexive coughs. Unlike healthy participants, participants with Parkinson’s disease did not change the number of coughs between the single-, dual-, and suppressed-task conditions [&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;gt; 0.05]. When distracted, people with Parkinson’s disease may prioritize coughing differently than healthy controls. Abnormal cortical resource allocation may be a mechanism involved in aspiration in this population.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10223-x</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>A Comparative Analysis of Chewing Function and Feeding Behaviors in Children with Autism</title>
      <link>http://link.springer.com/10.1007/s00455-020-10228-6</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;The present study was aimed to compare chewing performance level and feeding behaviors of children with autism to their typically developing peers. A total of 56 children (37 children with autism, 19 typically developing children) participated in the study. Feeding-related characteristics and observational oral-motor characteristics of children were recorded. The Karaduman Chewing Performance Scale (KCPS) was used to assess chewing performance level, the Behavioral Pediatrics Feeding Assessment Scale (BPFAS) was used to assess feeding behaviors of children, and the Turkish version of the Feeding/Swallowing Impact Survey (T-FS-IS) was used to evaluate the effect of the child’s feeding and swallowing problem on their parents. Results showed that transition time to solid food intake for children with autism was later than typically developing children (p = 0.014), and they had more tongue thrusting (p = 0.009). There were differences between groups in terms of KCPS (p = 0.002), BPFAS (Total frequency score, p = 0.008; Child frequency score, p = 0.017; Parent frequency score, p = 0.021; Restriction score, p = 0.004), and T-FS-IS (Daily activities, p = 0.004; Worry, p = 009; Feeding difficulties, p = 0.031; Total score, p = 0.001). The present study shows that children with autism had worse chewing function and worse mealtime functioning compared to typically developing children. Their parents perceived mealtime behavior as more problematic, and parents’ quality of life related to feeding/swallowing disorders was worse compared to parents of typically developing children. The study results reveal the importance of early assessment and intervention of chewing function and feeding behaviors in children with autism.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10228-6</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Correlating Dysphagia Severity with Fluoroscopic Parameters in Patients with Zenker's Diverticulum</title>
      <link>http://link.springer.com/10.1007/s00455-020-10230-y</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Zenker’s diverticulum (ZD) is an uncommon condition characterized by formation of a pseudodiverticulum in the hypopharynx that presents with considerable variability in swallowing symptomatology. Identifying radiographic features of ZD most associated with clinical impact could prove useful in counseling patients and predicting treatment response. This study was a retrospective case series of patients undergoing videofluoroscopic swallowing studies (VFSS) for Zenker’s diverticulum at a tertiary dysphagia center. Anatomic parameters identified on VFSS of patients with ZD were correlated with subjective perception of swallowing using Eating Assessment Tool (EAT-10) scores. Upper esophageal sphincter (UES) opening at the point of maximal distention, area of diverticulum on the lateral view, height of the diverticulum, and entrance angle of the esophagus were measured. We identified 40 patients with ZD (52.5% male, mean age = 71.2 years). Narrow UES opening was significantly correlated with dysphagia severity (r = − 0.3445, &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.035). Largest area of diverticulum (r = 0.0188, &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.87), diverticulum height (r = 0.1435, &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.45), and esophageal entrance angle (r = 0.1677, &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.42) were not correlated with EAT-10 scores. Maximum UES opening size was predictive of severity of swallowing dysfunction in patients with ZD. Size of ZD and the angle of bolus entry in patients with ZD are not predictive of swallowing dysfunction. Understanding the predictors of swallowing dysfunction will assist in counseling patients on postoperative expectations.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10230-y</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>The Influence of Age, Eating a Meal, and Systematic Fatigue on Swallowing and Mealtime Parameters</title>
      <link>http://link.springer.com/10.1007/s00455-020-10242-8</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Fatigue is widely accepted as a clinically relevant factor in the diagnosis, treatment, and management of dysphagia. Despite the relative importance that is placed on swallowing-related fatigue, the occurrence and effects of fatigue during swallowing is unclear. The goal of this study was to explore effects of eating a meal on measures of tongue strength, endurance, and other parameters of swallowing function under normal conditions compared to when the tongue is intentionally fatigued. Thirty healthy females, 15 “Young” (18–35 years old), and 15 “Old” (70 + years old) were seen for two data collection sessions one week apart. On both days, pre-meal measures were collected, then participants consumed a standardized meal based on a previously published protocol (half a bagel with peanut butter and 8 baby carrots) followed by post-meal measures. An additional pre-meal fatigue task was included on one of the test days (counterbalanced), involving maximal tongue presses until participants could not achieve 40% of baseline maximum pressure. Pre- and post-meal measures included anterior and posterior maximum tongue pressures, saliva swallow pressure, tongue endurance, surface electromyography (sEMG), the modified Borg scale, and the Test of Mastication and Swallowing of Solids (TOMASS). Linear mixed effects regressions compared pre- and post-meal outcome measures (1) on the non-fatigue day and (2) between fatigue and non-fatigue days while controlling for participant and age. The fatigue task caused significant reductions in maximum anterior and posterior tongue pressure. After a normal meal (i.e., without fatigue), we found decreased anterior pressures in the older group only. Older participants also had decreased saliva swallow pressures after the meal compared to pre-meal, while this measure increased post-mean in the young participants. When compared to the non-fatigue meal, eating a meal after tongue fatigue resulted in significantly lower post-meal posterior pressures, regardless of age group. The same pattern was observed with posterior functional reserve. Our results demonstrate that a systematic, participant-specific tongue fatigue task induced measurable changes in maximum tongue pressure. A meal by itself was observed to reduce anterior tongue strength and saliva swallow pressures only in older participants. Overall, it appears that older adults may be more vulnerable to fatigue-induced changes in tongue strength, though the relationship between these measures and changes to functional swallowing remains unknown.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00455-020-10242-8</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Correction to: Complex microsurgical perineal reconstruction after resection of a giant verrucous carcinoma associated with anal fistulas in Crohn’s disease—a unique case report</title>
      <link>http://link.springer.com/10.1007/s00384-021-04042-1</link>
      <description />
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04042-1</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>New-onset depression after colorectal cancer diagnosis: a population-based longitudinal study</title>
      <link>http://link.springer.com/10.1007/s00384-021-03994-8</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Introduction&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;To date, no large studies examining the temporal relationship between colorectal cancer (CRC) and the subsequent development of depressive disorders exist. We aimed to assess the incidence of depression post-colorectal cancer (CRC) diagnosis.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;To conduct this longitudinal study, we searched the large US population-based database, Explorys (IBM), from January 1, 1999, to January 1, 2021. We investigated new-onset depression and its associated mortality as well as the role of the mental health provider post-CRC diagnosis. Confidence intervals were calculated for all outcomes and multivariate regression analysis was performed.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Incident depression post-CRC diagnosis was 20.8 vs 8.9 per 100 person-years [OR 3.46, &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.0001] in the general population and conferred a 123% increased risk of all-cause mortality [&lt;em class="a-plus-plus"&gt;P&lt;/em&gt; &amp;lt; 0.0001]. Male patients (OR: 1.89) were more likely to become depressed post-CRC diagnosis as compared to females. Moreover, the absolute number of male patients with post-CRC depression was significantly higher than that of females (68% vs 32%; &lt;em class="a-plus-plus"&gt;P&lt;/em&gt; &amp;lt; 0.0001). In addition, depression after CRC was more common among Whites (OR: 1.68) and patients aged &amp;gt; 65 years (OR: 5.17). Referral to a mental health provider resulted in significantly lower all-cause mortality (3.6% vs 26.9%; &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.0001).&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Discussion&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Our findings advocate for initiating depression screening for high-risk patients post-CRC diagnosis and prompt mental health provider referral.&lt;/p&gt;
                    &lt;/span&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-03994-8</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Short-, long-, and very long-term results of secondary anterior sphincteroplasty in 20 patients with obstetric injury</title>
      <link>http://link.springer.com/10.1007/s00384-021-04026-1</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Purpose&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;More long-term follow-up studies beyond 10 years after secondary sphincteroplasty for obstetric damage are warranted. This prospective study aimed to compare reported data on incontinence and satisfaction in a cohort of such patients examined at short-, long-, and very long-term follow-up.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Twenty out of 33 obstetric patients (61%) operated with secondary anterior overlapping sphincteroplasty during February 1996 to April 2004 were evaluated preoperatively and at short-, long-, and very long-term follow-up. Anal incontinence was scored by a combination of Wexner’s and St. Mark’s incontinence scores. The patients also reported degree of treatment satisfaction.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Twenty patients were examined preoperatively and after a median (range) of 5 (2–62), 102 (64–162), and 220 (183–278) months. Corresponding incontinence scores were 11.5 (5–18), 5.5 (1–17) (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.01), 10.0 (0–18) (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;gt; 0.05), and 12.0. (1–18) (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;gt; 0.05). With increasing follow-up times, patients reporting a better outcome were 75%, 65%, and 45%. At very long-term follow-up patients, reports were more dismal than expected in those also reporting improved incontinence cores. Incontinence scores did not improve in patients with neuropathy (&lt;em class="a-plus-plus"&gt;n&lt;/em&gt; = 5) or patients (&lt;em class="a-plus-plus"&gt;n&lt;/em&gt; = 5) with more than 10 years of symptoms.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Conclusion&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Initial improvement of anal incontinence attenuated with time, in particular from short- to long-term follow-up. Patients with neuropathy experienced no improvement of incontinence. Beyond stoma formation, in compliant patients, one should consider other treatment options like sacral nerve stimulation and neosphincter formation.&lt;/p&gt;
                    &lt;/span&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04026-1</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Pre-emptive oral clarithromycin reduces the skin toxicity of panitumumab treatment for metastatic colorectal cancer</title>
      <link>http://link.springer.com/10.1007/s00384-021-04002-9</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Purpose&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Chemotherapy with panitumumab is expected to be well tolerated and improve survival in patients with metastatic colorectal cancer (mCRC). However, skin toxicities are its most common adverse events. The aim of this trial was to evaluate the efficacy and safety of pre-emptive antibiotic treatment with clarithromycin (CAM) to prevent panitumumab skin toxicities.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;We conducted a phase lll, multicenter, open-label, randomized clinical trial on mCRC patients treated with panitumumab. Eligible patients were randomly assigned 1:1 to pre-emptive antibiotic and control groups. In the pre-emptive group, CAM administration (200 mg twice per day) continued daily through the panitumumab treatment period. The control regimen consisted of skin care only. The primary end point was the incidence of grade ≥ 2 skin toxicities during the 6-week skin treatment period.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Of 156 enrolled patients, 78 received pre-emptive antibiotic treatment, and 78 received reactive treatment. The number and incidence of grade ≥ 2 skin toxicities during the 6-week skin treatment period were 16 (21.3%) and 41 (54.7%) for the pre-emptive and control groups, respectively (HR, 0.32; 95% CI, 0.17–0.56). There was almost no difference in the rate of other adverse events between the two groups, but the incidence of grade ≥ 3 diarrhea in the pre-emptive group was high, at 8% vs. 1.3% in the control group. There were no treatment-related deaths.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Conclusion&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Prophylactic oral CAM together with relatively simple skin care was found to be effective in suppressing the development of grade ≥ 2 skin toxicities induced by panitumumab.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec5"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Clinical trial registration&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;UMIN000011485&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec6"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Date of registration&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Sep 1st, 2013&lt;/p&gt;
                    &lt;/span&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04002-9</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Can MRI pelvimetry predict the technical difficulty of laparoscopic rectal cancer surgery?</title>
      <link>http://link.springer.com/10.1007/s00384-021-04000-x</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Purpose&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Selection of an open or minimally invasive approach to total mesorectal excision (TME) is generally based on surgeon preference and an intuitive assessment of patient characteristics but there consensus on criteria to predict surgical difficulty. Pelvimetry has been used to predict the difficult surgical pelvis, typically using only bony landmarks. This study aimed to assess the relationship between pelvic soft tissue measurements on preoperative MRI and surgical difficulty.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Preoperative MRIs for patients undergoing laparoscopic rectal resection in the Australasian Laparoscopic Cancer of the Rectum Trial (ALaCaRT) were retrospectively reviewed by two blinded surgeons and pelvimetric variables measured. Pelvimetric variables were analyzed for predictors of successful resection of the rectal cancer, defined by clear circumferential and distal resection margins and completeness of TME.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;There was no association between successful surgery and any measurement of distance, area, or ratio. However, the was a strong association between the primary outcome and the estimated total pelvic volume on adjusted logistic regression analysis (OR = 0.99, &lt;em class="a-plus-plus"&gt;P&lt;/em&gt; = 0.01). For each cubic centimeter increase in the pelvic volume, there was a 1% decrease in the odds of successful laparoscopic rectal cancer surgery. Intuitive prediction of unsuccessful surgery was correct in 43% of cases, and correlation between surgeons was poor (ICC = 0.18).&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Conclusions&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;A surgeon’s intuitive assessment of the difficult pelvis, based on visible MRI assessment, is not a reliable predictor of successful laparoscopic surgery. Further assessment of pelvic volume may provide an objective method of defining the difficult surgical pelvis.&lt;/p&gt;
                    &lt;/span&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04000-x</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Multicenter phase II clinical study of the efficiency and safety of capecitabine plus intermittent oxaliplatin with bevacizumab as first-line therapy in patients with metastatic colorectal cancer (VOICE trial)</title>
      <link>http://link.springer.com/10.1007/s00384-021-03995-7</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Purpose&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;The aim of this phase II study was to evaluate the efficacy and safety of combination therapy with five-cycle CAPOX (capecitabine plus oxaliplatin) plus bevacizumab, followed by five-cycle maintenance therapy with capecitabine plus bevacizumab and reintroduction of CAPOX plus bevacizumab for five cycles, with a preplanned intermittent oxaliplatin strategy in metastatic colorectal cancer (mCRC).&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Patients with untreated mCRC were administered CAPOX (130 mg/m&lt;sup class="a-plus-plus"&gt;2&lt;/sup&gt; oxaliplatin on day 1, 2000 mg/m&lt;sup class="a-plus-plus"&gt;2&lt;/sup&gt;/day capecitabine on days 1–14, every 21 days) + bevacizumab (7.5 mg/kg) every 3 weeks for five cycles, maintenance treatment without oxaliplatin for five cycles, and CAPOX + bevacizumab reintroduction for five cycles or upon tumor progression. The primary endpoint was progression-free survival (PFS), and the secondary endpoints were the time to treatment failure (TTF), overall survival, response rate (RR), and safety.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Forty-seven patients who fulfilled the inclusion criteria were enrolled in the evaluation of efficacy and safety. Median PFS was 14.1 months (95% confidence interval [CI], 8.6–19.5), and median TTF was 12.3 months (95% CI, 10.3–14.3). The objective RRs were 51.1% (24/47) during induction therapy, 58.3% (21/36) during maintenance therapy, and 63.6% (14/22) during reintroduction therapy. The frequency of patients with neutropenia, diarrhea, peripheral sensory neuropathy, venous thromboembolism, or grade ≥ 3 allergic reactions was 2.1%.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Conclusion&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;CAPOX plus bevacizumab therapy with a preplanned intermittent oxaliplatin strategy consisting of brief five-cycle induction therapy, five-cycle maintenance therapy with capecitabine plus bevacizumab, and five-cycle reintroduction therapy consisting of CAPOX plus bevacizumab is safe and effective for mCRC patients.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec5"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Trial registration&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;UMIN ID: 000,005,732, date of registration: June 7, 2011. &lt;a href="https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000006695" class="a-plus-plus"&gt;https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000006695&lt;/a&gt;&lt;/p&gt;
                    &lt;/span&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-03995-7</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Survival rates and prognostic factors in right- and left-sided colon cancer stage I–IV: an unselected retrospective single-center trial</title>
      <link>http://link.springer.com/10.1007/s00384-021-04005-6</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Purpose&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Colorectal cancer revealed over the last decades a remarkable shift with an increasing proportion of a right- compared to a left-sided tumor location. In the current study, we aimed to disclose clinicopathological differences between right- and left-sided colon cancer (rCC and lCC) with respect to mortality and outcome predictors.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;In total, 417 patients with colon cancer stage I–IV were analyzed in the present retrospective single-center study. Survival rates were assessed using the Kaplan–Meier method and uni/multivariate analyses were performed with a Cox proportional hazards regression model.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Our study showed no significant difference of the overall survival between rCC and lCC stage I–IV (&lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.354). Multivariate analysis revealed in the rCC cohort the worst outcome for ASA (American Society of Anesthesiologists) score IV patients (hazard ratio [HR]: 16.0; CI 95%: 2.1–123.5), CEA (carcinoembryonic antigen) blood level &amp;gt; 100 µg/l (HR: 3.3; CI 95%: 1.2–9.0), increased lymph node ratio of 0.6–1.0 (HR: 5.3; CI 95%: 1.7–16.1), and grade 4 tumors (G4) (HR: 120.6; CI 95%: 6.7–2179.6) whereas in the lCC population, ASA score IV (HR: 8.9; CI 95%: 0.9–91.9), CEA blood level 20.1–100 µg/l (HR: 5.4; CI 95%: 2.4–12.4), conversion to laparotomy (HR: 14.1; CI 95%: 4.0–49.0), and severe surgical complications (Clavien-Dindo III–IV) (HR: 2.9; CI 95%: 1.5–5.5) were identified as predictors of a diminished overall survival.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Conclusion&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Laterality disclosed no significant effect on the overall prognosis of colon cancer patients. However, group differences and distinct survival predictors could be identified in rCC and lCC patients.&lt;/p&gt;
                    &lt;/span&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04005-6</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Risk factors for developing anorectal dysfunction after anterior resection</title>
      <link>http://link.springer.com/10.1007/s00384-021-04024-3</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Background&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Anterior resection (AR) may result in defecatory dysfunction and the cause is multifactorial. The aim was to explore if dysfunction could be related to the part of the colon used for anastomosis (sigmoid or descending) and to identify other possible risk factors for bowel dysfunction after AR.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;This is a retrospective study based on prospectively registered data from a regional registry at the surgical department in Västmanland 1996–2019. Bowel function was registered at 1 year after AR or after stoma reversal. In total, 470 stage I–III rectal cancer patients had AR whereof 412 were included in this study.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Clustering was seen in 57%, incontinence 29%, urgency 22%, and evacuatory dysfunction 16%. The part of the colon used for anastomosis, level of vascular tie, and gender were not significantly associated with defecatory dysfunction. The higher the anastomotic level, the lower the risk of incontinence (OR 0.75; CI 0.63–0.90; &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.001) and clustering (OR 0.78; CI 0.67–0.90; &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.001). Compared with patients without a loop-ileostomy, an increased risk of clustering (OR 1.89; 1.08–3.31; &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; = 0.03), incontinence (OR 2.48; 1.29–4.77; &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.01), and urgency (OR 4.61; CI 2.02–10.60; &lt;em class="a-plus-plus"&gt;p&lt;/em&gt; &amp;lt; 0.001) was seen after loop-ileostomy closure. Preoperative radiotherapy had a negative impact on continence and clustering seen mainly in the unadjusted analysis.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Conclusion&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;The part of the colon used for anastomosis was not a significantly associated functional outcome after anterior resection. Low anastomotic level and having had a diverting ileostomy were independent risk factors associated with negative functional outcomes.&lt;/p&gt;
                    &lt;/span&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04024-3</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Surgical management of splenic flexure colon cancer: a retrospective propensity-matched study comparing open and minimally invasive approaches using the national cancer database</title>
      <link>http://link.springer.com/10.1007/s00384-021-04029-y</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Purpose&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Minimally invasive resection of colon cancer at the splenic flexure can be technically challenging with concerns for a suboptimal oncologic outcome. We aimed to compare open and minimally invasive approaches following curative resection.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;The National Cancer Database was queried for patients with non-metastatic colon adenocarcinoma at the splenic flexure who underwent resection from 2010 to 2016. Cohorts were separated into open and minimally invasive approaches, and demographic and clinicopathologic variables were compared. Propensity-score matching (PSM) was utilized to balance potential confounding covariates between cohorts to elucidate the independent association between surgical approach and outcomes. Kaplan–Meier estimation and Cox-proportional hazards regression were used to analyze survival. Secondary outcomes were analyzed by way of logistic regression or Mann–Whitney U test.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;After matching, 842 patients were compared between approaches. Patients who underwent minimally invasive surgery had no significant difference in regional nodes ≥ 12 examined, positive margins, negative circumferential margins, unplanned 30-day readmission, or time from surgery to initiation of chemotherapy when compared to patients who underwent open surgery. Minimally invasive surgery was significantly associated with decreased odds of 30-day mortality, 90-day mortality, and decreased mortality hazard for 5-year overall survival compared to open surgery.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Conclusion&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;The optimal approach for surgical management of splenic flexure colon cancer has not been standardized given its rarity and exclusion from randomized controlled trials. Our retrospective review suggests that minimally invasive resection of splenic flexure colon cancers in carefully selected patients is associated with equivalent oncologic outcomes as well as improved short and long-term survival compared to an open approach.&lt;/p&gt;
                    &lt;/span&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04029-y</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Ovarian metastases from colorectal cancer in young women: a systematic review of the literature</title>
      <link>http://link.springer.com/10.1007/s00384-021-04012-7</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Background and purpose&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;In female colorectal cancer patients, a mean proportion of synchronous and/or metachronous ovarian metastases of 3.4% was described. Previous literature showed that young or premenopausal women (≤ 55 years of age) may be more frequently affected. Once ovarian metastases are diagnosed, the prognosis of the patient is generally dismal, with 5-year survival varying from 12 to 27%.&lt;/p&gt;
                      &lt;p class="a-plus-plus"&gt;The present study is aimed at determining the proportion of young or premenopausal women diagnosed with colorectal cancer who presented with or developed ovarian metastases by reviewing the current literature on this topic.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;This review was performed by querying MEDLINE and EMBASE databases using a combination of terms: “colorectal neoplasms, colorectal cancer, ovarian neoplasms, Krukenberg tumor, young adult, young age, premenopause.” Studies that indicated ovarian metastases, either synchronous or metachronous (or a combination of the two), in young women were retrieved and analyzed.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;The review identified 14 studies encompassing 3379 young or premenopausal female colorectal cancer patients. In this selected group of patients, a mean proportion of ovarian metastases of 4.6% [95% CI: 4.0;5.4] was found.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Conclusions&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;This review showed that approximately one in twenty young female colorectal cancer patients will present with or develop ovarian metastases. Since outcome of this specific oncological pathology is often dismal, this finding is clinically relevant. It demonstrates the need to develop strategies to lower the incidence of ovarian metastases with adequate treatment and counseling of these patients.&lt;/p&gt;
                    &lt;/span&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04012-7</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Type of recurrence is associated with disease-free survival after salvage surgery for locally recurrent rectal cancer</title>
      <link>http://link.springer.com/10.1007/s00384-021-03998-4</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec1"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Purpose&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;To compare the characteristics and outcomes of rectal cancer patients with local recurrence at a perianastomotic site (PA), a surgical field (SF) site, or in lateral lymph nodes (LLN).&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec2"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Methods&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;A total of 114 consecutive patients who underwent surgery for recurrent, non-metastatic rectal cancer at a single comprehensive cancer center between 1997 and 2012 were grouped on the basis of radiographic assessment of type of recurrence: PA, 76 (67%) patients; SF, 25 (22%) patients; LLN, 13 (11%) patients. Demographic, clinical, and pathological features were compared between the three groups, as were disease-free survival (DFS) and overall survival (OS).&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec3"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Results&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Recurrence type was associated with positive circumferential margin in the primary resection (PA, 4 [6%]; SF, 4 [19%]; LLN, 3 [25%]; &lt;em class="a-plus-plus"&gt;P&lt;/em&gt; = 0.027), prior neoadjuvant therapy for the primary tumor (PA, 57 [75%]; SF, 18 [72%]; LLN, 4 [31%]; &lt;em class="a-plus-plus"&gt;P&lt;/em&gt; = 0.007), and location of the primary tumor in the upper rectum (PA, 33 [45%]; SF, 5 [23%]; LLN, 1 [8%]; &lt;em class="a-plus-plus"&gt;P&lt;/em&gt; &amp;lt; 0.001). Patients with PA had longer median DFS (PA, 5.1 years; SF, 1.5 years; LLN, 1.2 years; &lt;em class="a-plus-plus"&gt;P&lt;/em&gt; = 0.036). There was a non-significant trend toward longer OS and higher rates of R0 resection for PA.&lt;/p&gt;
                    &lt;/span&gt;
                    &lt;span class="a-plus-plus abstract-section id-a-sec4"&gt;
                      &lt;h3 class="a-plus-plus"&gt;Conclusion&lt;/h3&gt;
                      &lt;p class="a-plus-plus"&gt;Type of recurrence after salvage surgery for locally recurrent rectal cancer is associated with longer DFS in patients with PA recurrence.&lt;/p&gt;
                    &lt;/span&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-03998-4</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Low anterior resection syndrome: can it be prevented?</title>
      <link>http://link.springer.com/10.1007/s00384-021-04008-3</link>
      <description>&lt;h3 class="a-plus-plus"&gt;Abstract&lt;/h3&gt;
                    &lt;p class="a-plus-plus"&gt;Surgery remains the cardinal treatment in colorectal cancers but changes in bowel habits after rectal cancer surgery are common and disabling conditions that affect patients’ quality of life. Low anterior resection syndrome is a disorder of bowel function after rectal resection resulting in a lowering of the QoL and recently has been defined by an international working group not only by specified symptoms but also by their consequences. This review aims to explore an extensive bibliographic research on preventive strategies for LARS. All “modifiable variables,” quantified by the LARS Score, such as type of anastomosis, neoadjuvant therapy, surgical strategy, and diverting stoma, were evaluated, while “non-modifiable variables” such as age, sex, BMI, ASA, preoperative TMN, tumor height, and type of mesorectal excision were excluded from the comparative analysis. The role of defunctioning stoma, local excision, neoadjuvant radiotherapy, and non operative management seems to significantly affect risk of LARS, while type of anastomosis and surgical TME approach do not impact on LARS incidence or gravity in the long term period. Although it is established that some variables are associated with a greater onset of LARS, in clinical practice, technical difficulties and oncological limits often make difficult the application of some prevention plans. Transtomal irrigations, intraoperative neuromonitoring, pelvic floor rehabilitation before stoma closure, and early transanal irrigation represent new arguments of study in preventive strategies which could, if not eliminate the symptoms, at least mitigate them.&lt;/p&gt;</description>
      <pubDate>Wed, 01 Dec 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1007/s00384-021-04008-3</guid>
      <dc:date>2021-12-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Laparoscopic management of small bowel obstruction after abdominoperineal resection and a unique method to prevent it—A Video Vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15991?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15991</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15991?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Tue, 30 Nov 2021 20:44:15 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15991</guid>
      <dc:title>Laparoscopic management of small bowel obstruction after abdominoperineal resection and a unique method to prevent it—A Video Vignette</dc:title>
      <dc:creator>Vivek Sukumar, 
Mufaddal Kazi, 
Jayesh Gori, 
Ashwin Desouza, 
Avanish Saklani</dc:creator>
      <dc:description />
      <dc:date>2021-11-30T20:44:15Z</dc:date>
      <dc:identifier>10.1111/codi.15991</dc:identifier>
    </item>
    <item>
      <title>The diagnostic accuracy of the faecal immunohistochemical test in identifying significant bowel disease in a symptomatic population</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15994?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15994</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15994?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Provisional research on the faecal immunohistochemical test (FIT) for symptomatic colorectal patients has shown a high negative predictive value but has lacked long-term patient follow-up, raising the possibility of missed diagnoses of colorectal cancer (CRC). The aim of this work is to describe the long-term diagnostic accuracy of the FIT for CRC and significant bowel disease (SBD) in a symptomatic population in NHS Lanarkshire.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;From October 2016 to February 2019, all primary care referrals of symptomatic colorectal patients in NHS Lanarkshire were asked to provide a FIT. The baseline demographics, investigations and diagnoses for each patient were prospectively completed until February 2021. A FIT result of ≥10 μg haemoglobin (Hb)/g faeces was considered to be positive.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A total of 5250 patients were identified (median age 62 years; 46% male; median follow-up 31 months) with 65.1% (3418) being FIT negative. The SBD rate was 6.2% and the CRC rate was 2.9% (151). The SBD rate was significantly higher in the FIT-positive group (13.8% vs. 2.2%; &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001) and 32.9% of patients with FIT ≥ 400 μg Hb/g had SBD. The sensitivity of FIT ≥ 10 μg Hb/g for CRC was 87.4% and for SBD it was 76.9%. Specificity was 66.6% and 66.7%, and the negative-predictive value was 99.4% and 97.7%, respectively. Sensitivity for CRC could theoretically be increased to 94.8% if FIT-negative patients were to undergo flexible sigmoidoscopy.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;A FIT-only referral pathway for symptomatic colorectal patients will miss over 12% of cancers and over 23% of SBD. Theoretically, combining FIT-negative patients with flexible sigmoidoscopy increases the sensitivity for CRC. The FIT offers a mechanism for prioritizing patient access to investigations, particularly in resource-limited areas; however, further work to identify FIT-negative patients diagnosed with CRC is required.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Tue, 30 Nov 2021 20:21:07 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15994</guid>
      <dc:title>The diagnostic accuracy of the faecal immunohistochemical test in identifying significant bowel disease in a symptomatic population</dc:title>
      <dc:creator>Scott MacDonald, 
Linda MacDonald, 
Jon Godwin, 
Angus Macdonald, 
Michelle Thornton</dc:creator>
      <dc:description>Abstract

Aim
Provisional research on the faecal immunohistochemical test (FIT) for symptomatic colorectal patients has shown a high negative predictive value but has lacked long‐term patient follow‐up, raising the possibility of missed diagnoses of colorectal cancer (CRC). The aim of this work is to describe the long‐term diagnostic accuracy of the FIT for CRC and significant bowel disease (SBD) in a symptomatic population in NHS Lanarkshire.


Method
From October 2016 to February 2019, all primary care referrals of symptomatic colorectal patients in NHS Lanarkshire were asked to provide a FIT. The baseline demographics, investigations and diagnoses for each patient were prospectively completed until February 2021. A FIT result of ≥10 μg haemoglobin (Hb)/g faeces was considered to be positive.


Results
A total of 5250 patients were identified (median age 62 years; 46% male; median follow‐up 31 months) with 65.1% (3418) being FIT negative. The SBD rate was 6.2% and the CRC rate was 2.9% (151). The SBD rate was significantly higher in the FIT‐positive group (13.8% vs. 2.2%; p &lt; 0.001) and 32.9% of patients with FIT ≥ 400 μg Hb/g had SBD. The sensitivity of FIT ≥ 10 μg Hb/g for CRC was 87.4% and for SBD it was 76.9%. Specificity was 66.6% and 66.7%, and the negative‐predictive value was 99.4% and 97.7%, respectively. Sensitivity for CRC could theoretically be increased to 94.8% if FIT‐negative patients were to undergo flexible sigmoidoscopy.


Conclusion
A FIT‐only referral pathway for symptomatic colorectal patients will miss over 12% of cancers and over 23% of SBD. Theoretically, combining FIT‐negative patients with flexible sigmoidoscopy increases the sensitivity for CRC. The FIT offers a mechanism for prioritizing patient access to investigations, particularly in resource‐limited areas; however, further work to identify FIT‐negative patients diagnosed with CRC is required.</dc:description>
      <dc:date>2021-11-30T20:21:07Z</dc:date>
      <dc:identifier>10.1111/codi.15994</dc:identifier>
    </item>
    <item>
      <title>Comment on "Association between dietary fat intake and mortality from all-causes, cardiovascular disease, and cancer: A systematic review and meta-analysis of prospective cohort studies"</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00546-X/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-11-30</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>In a recent issue of the journal, Kim et al. described the results of an interesting systematic review and meta-analysis on the association between dietary fat and mortality. They concluded that saturated fat and trans-fat were associated with higher mortality, whereas polyunsaturated fat and monounsaturated fat were associated with lower mortality [1]. The authors should be congratulated for performing a well-designed study. Nevertheless, we would like to underline some issues when interpreting these findings.</description>
      <pubDate>Tue, 30 Nov 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00546-X/fulltext?rss=yes</guid>
      <dc:title>Comment on "Association between dietary fat intake and mortality from all-causes, cardiovascular disease, and cancer: A systematic review and meta-analysis of prospective cohort studies"</dc:title>
      <dc:creator>Liuliu Feng, Yanyan Bai, Yu Wang</dc:creator>
      <dc:date>2021-11-30T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.036</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Transanal total mesorectal excision with two stage Turnbull–Cutait pull‐through for delayed low anastomotic leakage – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15993?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15993</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15993?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Mon, 29 Nov 2021 11:24:51 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15993</guid>
      <dc:title>Transanal total mesorectal excision with two stage Turnbull–Cutait pull‐through for delayed low anastomotic leakage – A video vignette</dc:title>
      <dc:creator>Isaac Seow‐En, 
Aik Yong Chok, 
Emile Kwong‐Wei Tan</dc:creator>
      <dc:description />
      <dc:date>2021-11-29T11:24:51Z</dc:date>
      <dc:identifier>10.1111/codi.15993</dc:identifier>
    </item>
    <item>
      <title>Prevalence and determinants of depression up to 5 years after colorectal cancer surgery: results from the ColoREctal Wellbeing (CREW) study</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15949?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15949</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15949?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Depression experienced by people with colorectal cancer (CRC) is an important clinical problem affecting quality of life. Recognition of depression at key points in the pathway enables timely referral to support. This study aimed to examine depression before and 5 years after surgery to examine its prevalence and identify determinants.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;The ColoREctal Wellbeing (CREW) study is a prospective UK cohort study involving 872 adults with nonmetastatic CRC recruited before surgery with curative intent. Questionnaires completed before surgery and 3, 9, 15, 24, 36, 48 and 60 months after surgery captured socio-demographics and assessed depression (Centre for Epidemiologic Studies Depression Scale, CES-D) and other psychosocial factors. Clinical details were also gathered. We present the prevalence of clinically significant depression (CES-D ≥ 20) over time and its predictors assessed before and 2 years after surgery.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Before surgery, 21.0% of the cohort reported CES-D ≥ 20 reducing to 14.7% 5 years after surgery. Presurgery risk factors predicting subsequent depression were clinically significant depression and anxiety, previous mental health service use, low self-efficacy, poor health, having neoadjuvant treatment and low social support. Postsurgery risk factors at 2 years predicting subsequent depression were clinically significant depression, negative affect, cognitive dysfunction, accommodation type and poor health.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Depression is highly pervasive in people with CRC, exceeding prevalence in the general population across follow-up. Our findings emphasize the need to screen and treat depression across the pathway. Our novel data highlight key risk factors of later depression at important and opportune time points: before surgery and at the end of routine surveillance. Early recognition and timely referral to appropriate support is vital to improve long-term psychological outcomes.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Thu, 25 Nov 2021 19:19:27 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15949</guid>
      <dc:title>Prevalence and determinants of depression up to 5 years after colorectal cancer surgery: results from the ColoREctal Wellbeing (CREW) study</dc:title>
      <dc:creator>Lynn Calman, 
Joshua Turner, 
Deborah Fenlon, 
Natalia V. Permyakova, 
Sally Wheelwright, 
Mubarak Patel, 
Amy Din, 
Jane Winter, 
Alison Richardson, 
Peter W. F. Smith, 
Claire Foster, 
members of the CREW Study Advisory Committee, 
Jo Armes, 
Janis Baird, 
Andrew Bateman, 
Nick Beck, 
Graham Moon, 
Claire Hulme, 
Peter Hall, 
Karen Poole, 
Susan Restorick‐Banks, 
Paul Roderick, 
Claire Taylor, 
Jocelyn Walters, 
Fran Williams, 
Lynn Batehup, 
Jessica Corner, 
Deborah Fenlon</dc:creator>
      <dc:description>Abstract

Aim
Depression experienced by people with colorectal cancer (CRC) is an important clinical problem affecting quality of life. Recognition of depression at key points in the pathway enables timely referral to support. This study aimed to examine depression before and 5 years after surgery to examine its prevalence and identify determinants.


Method
The ColoREctal Wellbeing (CREW) study is a prospective UK cohort study involving 872 adults with nonmetastatic CRC recruited before surgery with curative intent. Questionnaires completed before surgery and 3, 9, 15, 24, 36, 48 and 60 months after surgery captured socio‐demographics and assessed depression (Centre for Epidemiologic Studies Depression Scale, CES‐D) and other psychosocial factors. Clinical details were also gathered. We present the prevalence of clinically significant depression (CES‐D ≥ 20) over time and its predictors assessed before and 2 years after surgery.


Results
Before surgery, 21.0% of the cohort reported CES‐D ≥ 20 reducing to 14.7% 5 years after surgery. Presurgery risk factors predicting subsequent depression were clinically significant depression and anxiety, previous mental health service use, low self‐efficacy, poor health, having neoadjuvant treatment and low social support. Postsurgery risk factors at 2 years predicting subsequent depression were clinically significant depression, negative affect, cognitive dysfunction, accommodation type and poor health.


Conclusion
Depression is highly pervasive in people with CRC, exceeding prevalence in the general population across follow‐up. Our findings emphasize the need to screen and treat depression across the pathway. Our novel data highlight key risk factors of later depression at important and opportune time points: before surgery and at the end of routine surveillance. Early recognition and timely referral to appropriate support is vital to improve long‐term psychological outcomes.</dc:description>
      <dc:date>2021-11-25T19:19:27Z</dc:date>
      <dc:identifier>10.1111/codi.15949</dc:identifier>
    </item>
    <item>
      <title>Regular endoscopic surveillance and polypectomy is effective in managing rectal adenoma progression following colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15981?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15981</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15981?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Total colectomy with ileorectal anastomosis (TC-IRA) is a surgical option for patients with familial adenomatous polyposis (FAP). Regular endoscopic surveillance of the rectum is recommended to prevent rectal cancer. We aimed to document polyp progression in the rectum following TC-IRA and evaluate the role of polypectomy during surveillance.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;Patients with FAP who underwent TC-IRA between 1990 and 2017 were identified. Demographic, endoscopic and genetic data were retrieved. Cumulative rectal adenoma (polyp) counts were obtained, whilst accounting for any polypectomies during the study period. The rate of polyp progression and factors influencing secondary proctectomy were evaluated.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;One hundred and ninety-nine patients fulfilled our inclusion criteria, of which 44% were male. The median age at colectomy was 19 (range 11–70) years and median preoperative rectal polyp count was 7 (range 0–50). All patients had an &lt;i&gt;APC&lt;/i&gt; pathogenic variant, of which 151 (79%) were 5' of the mutation cluster region (MCR), 19 (10%) in the MCR, six (3%) were 3' of the MCR and 15 (8%) had a gross deletion. After a median follow-up of 8.6 (range1–27) years and a median of 11 (range 2–37) flexible sigmoidoscopies per patient, the median rate of polyp progression was 5.5 polyps/year (range 0–70.2). There was no evidence of polyp regression. Eight (4%) patients underwent secondary proctectomy for neoplasia, of which one (0.5%) had rectal adenocarcinoma. A total of 13,527 polyps were removed, a median of 35 polyps/patient (range 0–829). The rate of polyp progression was not significantly associated with genotypic or phenotypic factors.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Progression of rectal adenoma burden following TC-IRA appears to be slow and dependent on the length of follow-up. In the modern era of stringent endoscopic surveillance and therapeutic procedures such as cold snare polypectomy, the rate of secondary proctectomy and the risk of rectal cancer after TC-IRA are very low. These findings are important when counselling patients with regard to the choice of surgery for FAP and implementing endoscopic surveillance.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Thu, 25 Nov 2021 19:19:11 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15981</guid>
      <dc:title>Regular endoscopic surveillance and polypectomy is effective in managing rectal adenoma progression following colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis</dc:title>
      <dc:creator>Chukwuemeka C. Anele, 
Jinpo Xiang, 
Isabel Martin, 
Menna Hawkins, 
Ripple Man, 
Susan K. Clark, 
Omar D. Faiz, 
Andrew Latchford</dc:creator>
      <dc:description>Abstract

Aim
Total colectomy with ileorectal anastomosis (TC‐IRA) is a surgical option for patients with familial adenomatous polyposis (FAP). Regular endoscopic surveillance of the rectum is recommended to prevent rectal cancer. We aimed to document polyp progression in the rectum following TC‐IRA and evaluate the role of polypectomy during surveillance.


Method
Patients with FAP who underwent TC‐IRA between 1990 and 2017 were identified. Demographic, endoscopic and genetic data were retrieved. Cumulative rectal adenoma (polyp) counts were obtained, whilst accounting for any polypectomies during the study period. The rate of polyp progression and factors influencing secondary proctectomy were evaluated.


Results
One hundred and ninety‐nine patients fulfilled our inclusion criteria, of which 44% were male. The median age at colectomy was 19 (range 11–70) years and median preoperative rectal polyp count was 7 (range 0–50). All patients had an APC pathogenic variant, of which 151 (79%) were 5' of the mutation cluster region (MCR), 19 (10%) in the MCR, six (3%) were 3' of the MCR and 15 (8%) had a gross deletion. After a median follow‐up of 8.6 (range1–27) years and a median of 11 (range 2–37) flexible sigmoidoscopies per patient, the median rate of polyp progression was 5.5 polyps/year (range 0–70.2). There was no evidence of polyp regression. Eight (4%) patients underwent secondary proctectomy for neoplasia, of which one (0.5%) had rectal adenocarcinoma. A total of 13,527 polyps were removed, a median of 35 polyps/patient (range 0–829). The rate of polyp progression was not significantly associated with genotypic or phenotypic factors.


Conclusion
Progression of rectal adenoma burden following TC‐IRA appears to be slow and dependent on the length of follow‐up. In the modern era of stringent endoscopic surveillance and therapeutic procedures such as cold snare polypectomy, the rate of secondary proctectomy and the risk of rectal cancer after TC‐IRA are very low. These findings are important when counselling patients with regard to the choice of surgery for FAP and implementing endoscopic surveillance.</dc:description>
      <dc:date>2021-11-25T19:19:11Z</dc:date>
      <dc:identifier>10.1111/codi.15981</dc:identifier>
    </item>
    <item>
      <title>Response to Igor Eckert: Sometimes, the absence of evidence is evidence of its absence</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00531-8/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-11-25</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>“The absence of evidence is not evidence of absence”, is an aphorism attributed to Carl Sagan [1], which is invoked when claims of the existence of God are encountered. Nonetheless, it is a succinct and elegant statement, which in this instance is simultaneously beautiful and wrong. At first glance, the lack of evidence is not evidence of absence, would suggest that for every treatment: medical, nutritional, or alternative therapy unless science has exhausted every mechanistic process available we cannot state it does not work even after randomised, double-blind studies, or as is the case here, multiple systematic reviews, none of which have found survival benefit.</description>
      <pubDate>Thu, 25 Nov 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00531-8/fulltext?rss=yes</guid>
      <dc:title>Response to Igor Eckert: Sometimes, the absence of evidence is evidence of its absence</dc:title>
      <dc:creator>Alfred Adiamah, Simon P. Allison, Dileep N. Lobo</dc:creator>
      <dc:date>2021-11-25T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.022</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Inaccurate conclusions due to absence of evidence fallacy on Adiamah et al</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00530-6/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-11-25</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>In a long-term survival analysis [1], Adiamah and colleagues conclude that early postoperative enteral feeding with arginine-enriched immunomodulating nutrition (IMN) confers no additional benefit compared with a control formula. This conclusion of absence of effect assumes the study provides evidence that the treatment confers no benefit. In this letter, I argue that the correct interpretation of these results would lead to different conclusions and potential real-life implications.</description>
      <pubDate>Thu, 25 Nov 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00530-6/fulltext?rss=yes</guid>
      <dc:title>Inaccurate conclusions due to absence of evidence fallacy on Adiamah et al</dc:title>
      <dc:creator>Igor Eckert</dc:creator>
      <dc:date>2021-11-25T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.021</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Letter to the Editor: A comment to “Is sarcopenia a predictor of prognosis for patients undergoing radiotherapy for head and neck cancer? A meta-analysis”</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00529-X/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-11-25</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>With great interest, we read the article by Merran Findlay et al., in which they investigated the prognostic value of sarcopenia in patients with head and neck cancer undergoing radiotherapy [1]. The results are consistent with the previous meta-analysis on the prognostic role of sarcopenia in patients with head and neck under multiple treatments [2]. The paper was excellent. However, the method used in this meta-analysis was not rigorous.</description>
      <pubDate>Thu, 25 Nov 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00529-X/fulltext?rss=yes</guid>
      <dc:title>Letter to the Editor: A comment to “Is sarcopenia a predictor of prognosis for patients undergoing radiotherapy for head and neck cancer? A meta-analysis”</dc:title>
      <dc:creator>Xin Jin, Xin-Tian Xu, Meng-Xing Tian</dc:creator>
      <dc:date>2021-11-25T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.020</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>The end of the era of routine diversion after rectal cancer resection?</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15959?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15959</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15959?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">EDITOR'S CHOICE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2792-2792, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>EDITOR'S CHOICE</category>
      <pubDate>Wed, 24 Nov 2021 20:41:23 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15959</guid>
      <dc:title>The end of the era of routine diversion after rectal cancer resection?</dc:title>
      <dc:creator>Pieter J. Tanis</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T20:41:23Z</dc:date>
      <dc:identifier>10.1111/codi.15959</dc:identifier>
    </item>
    <item>
      <title>Negative pressure wound therapy following excision of pilonidal sinus disease: A retrospective review</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15890?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15890</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15890?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2961-2966, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;There is no agreed definitive surgical treatment for pilonidal sinus disease (PSD) with several techniques in use with varying success. Negative pressure wound therapy (NPWT) is used to accelerate wound healing but literature in the context of PSD remains sparse. The aim of this study was to evaluate outcomes in patients with PSD treated by a standardised technique of complete surgical excision followed by the application of NPWT.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A retrospective observational cohort study of all patients with PSD managed by complete surgical excision followed by application of NPWT was performed over a five year period. The primary endpoints were PSD recurrence and failed wound healing.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Sixty-one patients underwent treatment during the study period. There was 100% compliance with NPWT. All patients’ wounds healed successfully, with the median time to healing being 28 days. One patient (1.6%) developed recurrent PSD and required further surgery. Two patients (3.3%) developed postoperative wound infections. Five patients, who had been managed previously by other operative approaches and subsequently developed recurrence, were successfully managed by this technique. Most patients (52.4%) were managed as a day case procedure.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Surgery for PSD should have low recurrence rates, prompt wound healing, minimal complications, short inpatient lengths of stay and be tolerated by the patient. Our results demonstrate that our technique meets these criteria. To our knowledge, this study contains the largest number of patients with PSD managed by excision and NPWT in the literature.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15890</guid>
      <dc:title>Negative pressure wound therapy following excision of pilonidal sinus disease: A retrospective review</dc:title>
      <dc:creator>Enda Hannan, 
Tim Harding, 
Hanna Feizal, 
Sean Martin</dc:creator>
      <dc:description>Abstract

Aim
There is no agreed definitive surgical treatment for pilonidal sinus disease (PSD) with several techniques in use with varying success. Negative pressure wound therapy (NPWT) is used to accelerate wound healing but literature in the context of PSD remains sparse. The aim of this study was to evaluate outcomes in patients with PSD treated by a standardised technique of complete surgical excision followed by the application of NPWT.


Methods
A retrospective observational cohort study of all patients with PSD managed by complete surgical excision followed by application of NPWT was performed over a five year period. The primary endpoints were PSD recurrence and failed wound healing.


Results
Sixty‐one patients underwent treatment during the study period. There was 100% compliance with NPWT. All patients’ wounds healed successfully, with the median time to healing being 28 days. One patient (1.6%) developed recurrent PSD and required further surgery. Two patients (3.3%) developed postoperative wound infections. Five patients, who had been managed previously by other operative approaches and subsequently developed recurrence, were successfully managed by this technique. Most patients (52.4%) were managed as a day case procedure.


Conclusions
Surgery for PSD should have low recurrence rates, prompt wound healing, minimal complications, short inpatient lengths of stay and be tolerated by the patient. Our results demonstrate that our technique meets these criteria. To our knowledge, this study contains the largest number of patients with PSD managed by excision and NPWT in the literature.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15890</dc:identifier>
    </item>
    <item>
      <title>Is synoptic operative reporting necessary for Crohn's disease surgery? Variability in surgical reports across inflammatory bowel disease referral centres</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15895?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15895</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15895?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2955-2960, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Ileocolic resection (ICR) is the most commonly performed operation in Crohn's disease (CD) patients. The surgical report is a vital tool for accessing information to gauge a patient's long-term prognosis and guide treatment decisions. Dictated narrative reports are the traditional method for surgical documentation but often lack essential information. The objective was to assess the quality of operation note in CD patients undergoing ICR.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;This was a multi-institutional retrospective cohort collaborative study involving four tertiary inflammatory bowel disease referral centres in the USA and Canada. The patients were consecutive CD patients undergoing ICR between 2014 and 2020. There were no interventions. The main outcome measures were the variability and frequency of 28 critical items in the operation note.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;An analysis of 400 consecutive operation reports in four institutions (&lt;i&gt;n&lt;/i&gt; = 100/institution) revealed significant variability in almost all variables. The initial surgical approach and wound protector use were the most consistently or frequently reported across all inflammatory bowel disease centres. The limitation was that this was a retrospective cohort study with inevitable selection bias.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;This study highlights the need for synoptic reporting in CD patients undergoing ICR.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15895</guid>
      <dc:title>Is synoptic operative reporting necessary for Crohn's disease surgery? Variability in surgical reports across inflammatory bowel disease referral centres</dc:title>
      <dc:creator>Angela Mujukian, 
Adam Truong, 
Emily Steinhagen, 
Vaidya Prashansha, 
Amy L. Lightner, 
Frédéric Morin, 
Karen Zaghiyan, 
Anthony Buck van Overstraeten, 
Phillip Fleshner</dc:creator>
      <dc:description>Abstract

Aim
Ileocolic resection (ICR) is the most commonly performed operation in Crohn's disease (CD) patients. The surgical report is a vital tool for accessing information to gauge a patient's long‐term prognosis and guide treatment decisions. Dictated narrative reports are the traditional method for surgical documentation but often lack essential information. The objective was to assess the quality of operation note in CD patients undergoing ICR.


Method
This was a multi‐institutional retrospective cohort collaborative study involving four tertiary inflammatory bowel disease referral centres in the USA and Canada. The patients were consecutive CD patients undergoing ICR between 2014 and 2020. There were no interventions. The main outcome measures were the variability and frequency of 28 critical items in the operation note.


Results
An analysis of 400 consecutive operation reports in four institutions (n = 100/institution) revealed significant variability in almost all variables. The initial surgical approach and wound protector use were the most consistently or frequently reported across all inflammatory bowel disease centres. The limitation was that this was a retrospective cohort study with inevitable selection bias.


Conclusions
This study highlights the need for synoptic reporting in CD patients undergoing ICR.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15895</dc:identifier>
    </item>
    <item>
      <title>Improvement in immune dysfunction after FOLFOX chemotherapy for Stage III colon cancer is associated with improved minimal residual disease prognostic subtype and outcome</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15899?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15899</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15899?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2879-2893, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Minimal residual disease (MRD) is the net result of the biological properties of disseminated tumour cells and the effect of the immune system and treatment to eliminate them. The aim of this work is to report the changes in MRD status and immune function (lymphocyte count) after FOLFOX chemotherapy, and the outcome in Stage III colon cancer patients.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;This study is a prospective, single-centre observational study. Lymphocyte counts were determined prior to and 1, 2 and 3 months after the completion of chemotherapy. Circulating tumour cells (CTCs) and bone marrow micrometastases were determined using immunocytochemistry with anticarcinoembryonic antigen prior to and 1 month after chemotherapy. MRD was classified as negative (Group I), micrometastasis positive only (Group II) and CTC positive (Group III). Changes in lymphocyte counts and MRD subtype following chemotherapy and relapse-free progression were analysed.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Of the total of 185 patients, 83 (44.9%) relapsed. The risk of relapse significantly increased from Groups I to III (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001) and with decreasing lymphocyte count (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.01). The lymphocyte count significantly decreased from Groups I to III (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Multivariance Cox regression analysis showed hazard ratios of 3.58 (Group II), 17.43 (Group III) and 0.39 (lymphocyte count) in predicting relapse. Following chemotherapy, improved lymphocyte count was associated with improved MRD subtype (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.0001). Neither baseline lymphocyte count nor MRD subtype predicted response to chemotherapy. Five-year relapse-free survival for combined lymphocyte–MRD subtypes was 95%, 57% and 5% for Groups I to III, respectively (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Following chemotherapy, improvements in immune function were associated with improved MRD subtype and a better relapse-free survival.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15899</guid>
      <dc:title>Improvement in immune dysfunction after FOLFOX chemotherapy for Stage III colon cancer is associated with improved minimal residual disease prognostic subtype and outcome</dc:title>
      <dc:creator>Nigel P. Murray, 
Ricardo Villalon, 
Dan Hartmann, 
Maria Patricia Rodriguez, 
Socrates Aedo</dc:creator>
      <dc:description>Abstract

Aim
Minimal residual disease (MRD) is the net result of the biological properties of disseminated tumour cells and the effect of the immune system and treatment to eliminate them. The aim of this work is to report the changes in MRD status and immune function (lymphocyte count) after FOLFOX chemotherapy, and the outcome in Stage III colon cancer patients.


Method
This study is a prospective, single‐centre observational study. Lymphocyte counts were determined prior to and 1, 2 and 3 months after the completion of chemotherapy. Circulating tumour cells (CTCs) and bone marrow micrometastases were determined using immunocytochemistry with anticarcinoembryonic antigen prior to and 1 month after chemotherapy. MRD was classified as negative (Group I), micrometastasis positive only (Group II) and CTC positive (Group III). Changes in lymphocyte counts and MRD subtype following chemotherapy and relapse‐free progression were analysed.


Results
Of the total of 185 patients, 83 (44.9%) relapsed. The risk of relapse significantly increased from Groups I to III (p &lt; 0.001) and with decreasing lymphocyte count (p &lt; 0.01). The lymphocyte count significantly decreased from Groups I to III (p &lt; 0.001). Multivariance Cox regression analysis showed hazard ratios of 3.58 (Group II), 17.43 (Group III) and 0.39 (lymphocyte count) in predicting relapse. Following chemotherapy, improved lymphocyte count was associated with improved MRD subtype (p &lt; 0.0001). Neither baseline lymphocyte count nor MRD subtype predicted response to chemotherapy. Five‐year relapse‐free survival for combined lymphocyte–MRD subtypes was 95%, 57% and 5% for Groups I to III, respectively (p &lt; 0.001).


Conclusion
Following chemotherapy, improvements in immune function were associated with improved MRD subtype and a better relapse‐free survival.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15899</dc:identifier>
    </item>
    <item>
      <title>Laparoscopic versus open resection in locally advanced rectal cancers: a propensity matched analysis of oncological and short‐term outcomes</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15870?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15870</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15870?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2894-2903, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;The aim was to compare oncological and short-term outcomes between open and laparoscopic surgery in locally advanced rectal cancers.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;It is a retrospective analysis conducted in a high volume tertiary centre. Matching was carried out for nine variables, including preoperative factors, neoadjuvant treatment and sphincter preservation.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Both the open and laparoscopic surgery arms had 239 patients each. The distributions of pretreatment MRI T3, T4, circumferential resection margin (CRM) positive tumours, neoadjuvant long-course chemoradiation and sphincter preservation were 80.3%, 13.6%, 50%, 89% and 56.4% respectively. The mean number of nodes harvested (12.9 vs. 12.7, &lt;i&gt;P&lt;/i&gt; = 0.716), pathological CRM positivity (6.3% in open vs. 5.4% in laparoscopic, &lt;i&gt;P&lt;/i&gt; = 0.697) and distal resection margins were similar. The mean blood loss was higher in open surgeries (910 ml vs. 349 ml, &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001). Anastomotic leaks and Clavien–Dindo Grade 3–4 complications were higher in the open arm than in the laparoscopy arm (5.9% vs. 1.7%, &lt;i&gt;P&lt;/i&gt; = 0.024, and 12.5% vs. 6.7%, &lt;i&gt;P&lt;/i&gt; = 0.015 respectively). The median postoperative hospital stay was significantly shorter in the laparoscopy arm (7 vs. 6, &lt;i&gt;P&lt;/i&gt; = 0.015). In CRM positive and threatened cases, the measured outcomes were similar between the two groups except for blood loss which was significantly higher in the open surgery (872 vs. 379, &lt;i&gt;P&lt;/i&gt; = 0.000).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;In high volume centres, in the hands of experienced colorectal surgeons, laparoscopic rectal surgery is oncologically safe in locally advanced rectal cancers and has lesser morbidity and shorter hospital stay than open surgery. In CRM positive and threatened cases the laparoscopic surgery showed less blood loss compared to open surgery, while other outcome measures were similar to open surgery.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15870</guid>
      <dc:title>Laparoscopic versus open resection in locally advanced rectal cancers: a propensity matched analysis of oncological and short‐term outcomes</dc:title>
      <dc:creator>Sajith Sasi, 
Praveen Kammar, 
Sivasanker Masillamany, 
Ashwin Souza, 
Reena Engineer, 
Vikas Ostwal, 
Avanish Saklani</dc:creator>
      <dc:description>Abstract

Aim
The aim was to compare oncological and short‐term outcomes between open and laparoscopic surgery in locally advanced rectal cancers.


Methods
It is a retrospective analysis conducted in a high volume tertiary centre. Matching was carried out for nine variables, including preoperative factors, neoadjuvant treatment and sphincter preservation.


Results
Both the open and laparoscopic surgery arms had 239 patients each. The distributions of pretreatment MRI T3, T4, circumferential resection margin (CRM) positive tumours, neoadjuvant long‐course chemoradiation and sphincter preservation were 80.3%, 13.6%, 50%, 89% and 56.4% respectively. The mean number of nodes harvested (12.9 vs. 12.7, P = 0.716), pathological CRM positivity (6.3% in open vs. 5.4% in laparoscopic, P = 0.697) and distal resection margins were similar. The mean blood loss was higher in open surgeries (910 ml vs. 349 ml, P &lt; 0.001). Anastomotic leaks and Clavien–Dindo Grade 3–4 complications were higher in the open arm than in the laparoscopy arm (5.9% vs. 1.7%, P = 0.024, and 12.5% vs. 6.7%, P = 0.015 respectively). The median postoperative hospital stay was significantly shorter in the laparoscopy arm (7 vs. 6, P = 0.015). In CRM positive and threatened cases, the measured outcomes were similar between the two groups except for blood loss which was significantly higher in the open surgery (872 vs. 379, P = 0.000).


Conclusions
In high volume centres, in the hands of experienced colorectal surgeons, laparoscopic rectal surgery is oncologically safe in locally advanced rectal cancers and has lesser morbidity and shorter hospital stay than open surgery. In CRM positive and threatened cases the laparoscopic surgery showed less blood loss compared to open surgery, while other outcome measures were similar to open surgery.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15870</dc:identifier>
    </item>
    <item>
      <title>Long‐term outcomes of open versus closed rectal defect after transanal endoscopic microscopic surgery</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15830?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15830</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15830?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2904-2910, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Management of the rectal defect after transanal endoscopic microsurgery (TEM) is a matter of debate. Data are lacking on long term outcomes and continence of patients with open or closed rectal defect. We sought to analyse these in a retrospective cohort study.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Patients undergoing TEM via the Specialist Early Rectal Cancer (SERC) MDT between 2012 and 2019 were included from a prospectively maintained database. These were divided into two groups – open and closed, based on management of rectal defect. Patient demographics and outcomes, including pre- and postoperative oncological staging, morbidity, mortality, length of stay and faecal incontinence severity score (FISI) scores were assessed.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A total of 170 matched patients were included (70-open, 100-closed rectal defects). Short-term complications (bleeding, infection, urinary retention and infection, length of stay and pain) were 18.8% with no significant difference between the two groups (22% vs. 16%). Most of the defects were well healed upon endoscopic follow-up; more unhealed/sinus formation was noticed in the open group (&lt;i&gt;p&lt;/i&gt; = 0.01); more strictures were encountered in the closed group (&lt;i&gt;p&lt;/i&gt; = 0.04). Comparing the open and closed defect groups, there was no difference in the functional outcome of patients in those who developed sinus (&lt;i&gt;p&lt;/i&gt; = 0.87) or stricture (&lt;i&gt;p&lt;/i&gt; = 0.79) but a significant difference in post-TEMS FISI scores in those with healed scar, with those in closed rectal defect group with worsening function (&lt;i&gt;p&lt;/i&gt; = 0.02).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;There are pros and cons associated with both rectal defect management approaches. Long-term complications should be expected and actively followed up. Patients should be thoroughly counselled about these and possible deterioration in continence post-TEM.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15830</guid>
      <dc:title>Long‐term outcomes of open versus closed rectal defect after transanal endoscopic microscopic surgery</dc:title>
      <dc:creator>Kiran Altaf, 
Simone Slawik, 
Dana Sochorova, 
Sukhpreet Gahunia, 
Timothy Andrews, 
Ashley Kehoe, 
Shakil Ahmed, 
the Merseyside Early Rectal Cancer Network</dc:creator>
      <dc:description>Abstract

Aim
Management of the rectal defect after transanal endoscopic microsurgery (TEM) is a matter of debate. Data are lacking on long term outcomes and continence of patients with open or closed rectal defect. We sought to analyse these in a retrospective cohort study.


Methods
Patients undergoing TEM via the Specialist Early Rectal Cancer (SERC) MDT between 2012 and 2019 were included from a prospectively maintained database. These were divided into two groups – open and closed, based on management of rectal defect. Patient demographics and outcomes, including pre‐ and postoperative oncological staging, morbidity, mortality, length of stay and faecal incontinence severity score (FISI) scores were assessed.


Results
A total of 170 matched patients were included (70‐open, 100‐closed rectal defects). Short‐term complications (bleeding, infection, urinary retention and infection, length of stay and pain) were 18.8% with no significant difference between the two groups (22% vs. 16%). Most of the defects were well healed upon endoscopic follow‐up; more unhealed/sinus formation was noticed in the open group (p = 0.01); more strictures were encountered in the closed group (p = 0.04). Comparing the open and closed defect groups, there was no difference in the functional outcome of patients in those who developed sinus (p = 0.87) or stricture (p = 0.79) but a significant difference in post‐TEMS FISI scores in those with healed scar, with those in closed rectal defect group with worsening function (p = 0.02).


Conclusion
There are pros and cons associated with both rectal defect management approaches. Long‐term complications should be expected and actively followed up. Patients should be thoroughly counselled about these and possible deterioration in continence post‐TEM.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15830</dc:identifier>
    </item>
    <item>
      <title>Elective minimally invasive surgery for sigmoid diverticulitis: operative outcomes of patients with complicated versus uncomplicated disease</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15837?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15837</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15837?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2948-2954, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;The aim of this work was to compare the results of elective minimally invasive surgery between patients with complicated sigmoid diverticulitis and those with uncomplicated disease.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;An institutional review board-approved database was searched for all consecutive patients who underwent elective minimally invasive surgery, including laparoscopic, hand-assisted and robotic sigmoidectomy, for diverticulitis between 2010 and 2017; they were classified according to the modified Hinchey classification as having complicated (abscess, fistula, stricture, obstruction, bleeding or previous perforation) versus uncomplicated disease. Data recorded included baseline demographics, indications for surgery, operative details and complications.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Three hundred and twenty-five patients underwent elective sigmoidectomy for complicated (&lt;i&gt;n&lt;/i&gt; = 105) and uncomplicated (&lt;i&gt;n&lt;/i&gt; = 220) diverticulitis. Surgical indications for complicated disease were abscess (&lt;i&gt;n&lt;/i&gt; = 74), stricture (&lt;i&gt;n&lt;/i&gt; = 14), fistula (&lt;i&gt;n&lt;/i&gt; = 28) and bleeding (&lt;i&gt;n&lt;/i&gt; = 7). The two groups were statistically comparable for age, gender, body mass index and American Society of Anesthesiologists score. Patients with complicated disease had higher rates of concomitant loop ileostomy creation (9.5% vs. 0.9%, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001) and synchronous resections (9.5% vs. 2.7%, &lt;i&gt;p&lt;/i&gt; = 0.01), higher volumes of blood loss (177 ± 140 vs. 125 ± 92 ml, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001), longer length of stay (5.6 ± 3 vs. 4.8 ± 2 days, &lt;i&gt;p&lt;/i&gt; = 0.04) and longer operating time (218.2 ± 59 vs. 185.8 ± 63 min, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). There were no significant differences in anastomotic leakage (3% vs. 1%, &lt;i&gt;p&lt;/i&gt; = 0.3), conversion to laparotomy (4.8% vs. 2.3%, &lt;i&gt;p&lt;/i&gt; = 0.3) or overall complications (36% vs. 25.9%, &lt;i&gt;p&lt;/i&gt; = 0.06) for complicated versus uncomplicated disease, respectively.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Minimally invasive surgery for complicated diverticulitis resulted in higher rates of construction of proximal ileostomy and synchronous resections and longer operating times and length of hospital stay. Otherwise, it has outcomes that are not significantly different from the results recorded in patients with uncomplicated disease.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15837</guid>
      <dc:title>Elective minimally invasive surgery for sigmoid diverticulitis: operative outcomes of patients with complicated versus uncomplicated disease</dc:title>
      <dc:creator>Ido Mizrahi, 
Mahmoud Abu‐Gazala, 
Laura M. Fernandez, 
Dimitri Krizzuk, 
Argyrios Ioannidis, 
Steven D. Wexner</dc:creator>
      <dc:description>Abstract

Aim
The aim of this work was to compare the results of elective minimally invasive surgery between patients with complicated sigmoid diverticulitis and those with uncomplicated disease.


Method
An institutional review board‐approved database was searched for all consecutive patients who underwent elective minimally invasive surgery, including laparoscopic, hand‐assisted and robotic sigmoidectomy, for diverticulitis between 2010 and 2017; they were classified according to the modified Hinchey classification as having complicated (abscess, fistula, stricture, obstruction, bleeding or previous perforation) versus uncomplicated disease. Data recorded included baseline demographics, indications for surgery, operative details and complications.


Results
Three hundred and twenty‐five patients underwent elective sigmoidectomy for complicated (n = 105) and uncomplicated (n = 220) diverticulitis. Surgical indications for complicated disease were abscess (n = 74), stricture (n = 14), fistula (n = 28) and bleeding (n = 7). The two groups were statistically comparable for age, gender, body mass index and American Society of Anesthesiologists score. Patients with complicated disease had higher rates of concomitant loop ileostomy creation (9.5% vs. 0.9%, p &lt; 0.001) and synchronous resections (9.5% vs. 2.7%, p = 0.01), higher volumes of blood loss (177 ± 140 vs. 125 ± 92 ml, p &lt; 0.001), longer length of stay (5.6 ± 3 vs. 4.8 ± 2 days, p = 0.04) and longer operating time (218.2 ± 59 vs. 185.8 ± 63 min, p &lt; 0.001). There were no significant differences in anastomotic leakage (3% vs. 1%, p = 0.3), conversion to laparotomy (4.8% vs. 2.3%, p = 0.3) or overall complications (36% vs. 25.9%, p = 0.06) for complicated versus uncomplicated disease, respectively.


Conclusion
Minimally invasive surgery for complicated diverticulitis resulted in higher rates of construction of proximal ileostomy and synchronous resections and longer operating times and length of hospital stay. Otherwise, it has outcomes that are not significantly different from the results recorded in patients with uncomplicated disease.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15837</dc:identifier>
    </item>
    <item>
      <title>Burden of disease experienced by patients following a watch‐and‐wait policy for locally advanced rectal cancer: A qualitative study</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15838?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15838</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15838?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2870-2878, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Patient-reported outcome measures (PROMs) are increasingly being used in routine cancer care to evaluate treatment and monitor symptoms, function and other aspects of quality of life (QoL). There is no suitable PROM for rectal cancer patients following a watch-and-wait (W&amp;W) programme. Insight into patient experiences with this programme is an essential step in the development of a PROM. The aim of this qualitative study was to provide insights into the most important functional outcomes and QoL features experienced by patients during our W&amp;W programme.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;Patients with locally advanced rectal cancer who are enrolled in the W&amp;W programme in the Netherlands were interviewed by telephone using a semistructured interview guide. All interviews were digitally audio-recorded, transcribed verbatim and coded. A thematic approach was used to analyse the data and identify themes and subthemes of importance to patients.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Eighteen patients were interviewed (78% male, mean age 68 years, range 52–83 years). Physical complaints after treatment were present, most notably gastrointestinal problems, neuropathy and fatigue. Furthermore, patients were anxious about a possible recurrence, had a fear of surgery or a stoma, or were experiencing a general feeling of apprehension in daily life. Many patients had different coping mechanisms, such as acceptance, and there were few limitations in daily life.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;We identified important functional outcomes, such as gastrointestinal complaints, fatigue and neuropathy, in patients who were enrolled in this W&amp;W programme. Furthermore, an emotional burden and unmet needs were reported by these patients. These findings can be used to improve clinical practice and inform the development of a PROM.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15838</guid>
      <dc:title>Burden of disease experienced by patients following a watch‐and‐wait policy for locally advanced rectal cancer: A qualitative study</dc:title>
      <dc:creator>Alexander J. Pennings, 
Merel L. Kimman, 
Anke H. C. Gielen, 
Geerard L. Beets, 
Jarno Melenhorst, 
Stephanie O. Breukink</dc:creator>
      <dc:description>Abstract

Aim
Patient‐reported outcome measures (PROMs) are increasingly being used in routine cancer care to evaluate treatment and monitor symptoms, function and other aspects of quality of life (QoL). There is no suitable PROM for rectal cancer patients following a watch‐and‐wait (W&amp;W) programme. Insight into patient experiences with this programme is an essential step in the development of a PROM. The aim of this qualitative study was to provide insights into the most important functional outcomes and QoL features experienced by patients during our W&amp;W programme.


Method
Patients with locally advanced rectal cancer who are enrolled in the W&amp;W programme in the Netherlands were interviewed by telephone using a semistructured interview guide. All interviews were digitally audio‐recorded, transcribed verbatim and coded. A thematic approach was used to analyse the data and identify themes and subthemes of importance to patients.


Results
Eighteen patients were interviewed (78% male, mean age 68 years, range 52–83 years). Physical complaints after treatment were present, most notably gastrointestinal problems, neuropathy and fatigue. Furthermore, patients were anxious about a possible recurrence, had a fear of surgery or a stoma, or were experiencing a general feeling of apprehension in daily life. Many patients had different coping mechanisms, such as acceptance, and there were few limitations in daily life.


Conclusion
We identified important functional outcomes, such as gastrointestinal complaints, fatigue and neuropathy, in patients who were enrolled in this W&amp;W programme. Furthermore, an emotional burden and unmet needs were reported by these patients. These findings can be used to improve clinical practice and inform the development of a PROM.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15838</dc:identifier>
    </item>
    <item>
      <title>Risk of post colonoscopy colorectal cancer following screening colonoscopy with low‐risk or no adenomas: A population‐based study</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15886?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15886</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15886?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2932-2936, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;In the Danish faecal occult blood test based bowel cancer screening programme, the first round was rolled out over 4 years. After roll-out, the planned faecal test recall procedure for individuals with either no or low risk adenomas at colonoscopy is 8 and 2 years, respectively. Here, we aimed to investigate the post colonoscopy colorectal cancer incidence in these two groups.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;All Danish screening individuals from 2014 to 2015 with a positive faecal test and either no or low risk adenomas at colonoscopy were included and followed for 3 years post screening for the event of colorectal cancer through national registries.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Out of 533,023 submitted faecal tests and 36,673 positive tests, 17,627 had no or low risk adenomas. We identified 60 (0.34%) individuals diagnosed with colorectal cancer within 3 years, 18 (0.29%) in the low risk adenoma group, and 42 (0.37%) in the no adenomas group (&lt;i&gt;p&lt;/i&gt; = 0.44). Advancing age (HR = 1.079, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001) and higher faecal test value (HR = 1.001, &lt;i&gt;p&lt;/i&gt; = 0.002) increased hazard of colorectal cancer occurrence, whereas male sex (HR = 1.3, &lt;i&gt;p&lt;/i&gt; = 0.308) and having low risk adenomas (HR = 0.729, &lt;i&gt;p&lt;/i&gt; = 0.264) did not.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;We found no difference in post colonoscopy colorectal cancer occurrence between individuals with either no or low risk adenomas. Instead, advancing age and increased faecal test value was associated with a higher risk of post colonoscopy colorectal cancer.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15886</guid>
      <dc:title>Risk of post colonoscopy colorectal cancer following screening colonoscopy with low‐risk or no adenomas: A population‐based study</dc:title>
      <dc:creator>Jesper Clausen Nielsen, 
Magnus Ploug, 
Gunnar Baatrup, 
Rasmus Kroijer</dc:creator>
      <dc:description>Abstract

Aim
In the Danish faecal occult blood test based bowel cancer screening programme, the first round was rolled out over 4 years. After roll‐out, the planned faecal test recall procedure for individuals with either no or low risk adenomas at colonoscopy is 8 and 2 years, respectively. Here, we aimed to investigate the post colonoscopy colorectal cancer incidence in these two groups.


Methods
All Danish screening individuals from 2014 to 2015 with a positive faecal test and either no or low risk adenomas at colonoscopy were included and followed for 3 years post screening for the event of colorectal cancer through national registries.


Results
Out of 533,023 submitted faecal tests and 36,673 positive tests, 17,627 had no or low risk adenomas. We identified 60 (0.34%) individuals diagnosed with colorectal cancer within 3 years, 18 (0.29%) in the low risk adenoma group, and 42 (0.37%) in the no adenomas group (p = 0.44). Advancing age (HR = 1.079, p &lt; 0.001) and higher faecal test value (HR = 1.001, p = 0.002) increased hazard of colorectal cancer occurrence, whereas male sex (HR = 1.3, p = 0.308) and having low risk adenomas (HR = 0.729, p = 0.264) did not.


Conclusion
We found no difference in post colonoscopy colorectal cancer occurrence between individuals with either no or low risk adenomas. Instead, advancing age and increased faecal test value was associated with a higher risk of post colonoscopy colorectal cancer.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15886</dc:identifier>
    </item>
    <item>
      <title>Evolution of the management of retrorectal masses: A retrospective cohort study</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15893?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15893</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15893?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2988-2998, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Retrorectal masses are abnormalities located anatomically in the retrorectal space. A significant proportion are asymptomatic with no malignant potential while others cause symptoms due to mechanical pressure or malignant infiltration. We reviewed and categorised the retrorectal masses encountered over a 30-year time period in a specialist colorectal hospital and describe our management algorithm for consideration by other multidisciplinary teams (MDT).&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;This was a retrospective analysis of consecutive patients referred between 1984–2019. A detailed review of clinical presentation, imaging features, postoperative histology and impact on morbidity and anorectal function is reported.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A total of 143 patients with median age of 46 years and female preponderance (74%) were reviewed. The commonest presenting symptom was pain (46%) and all malignant cases had symptoms (&lt;i&gt;n&lt;/i&gt; = 17). Over the last decade, more asymptomatic patients have presented with a retrorectal mass (33%, &lt;i&gt;p&lt;/i&gt; = 0.04) and more patients are opting for surveillance rather than resection (33%, &lt;i&gt;p&lt;/i&gt; = 0.013). Increasing age and lesion size were associated with malignancy (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.05). Radiological features associated with malignancy included: solid/heterogeneous component, lobulated borders or locally invasive. Following surgery, complications included chronic pain (40%), poor wound healing (23%) and bowel dysfunction (10%).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;The management of retrorectal masses remains complex. There are features, both clinical and radiological, that can help determine the best management strategy. Management should be in a high-volume tertiary centre and preferably through a complex rectal cancer MDT. Long-term sequelae such as chronic pain must be highlighted to patients. We advocate the establishment of an international registry to further record and characterise these rare, potentially troublesome lesions.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15893</guid>
      <dc:title>Evolution of the management of retrorectal masses: A retrospective cohort study</dc:title>
      <dc:creator>Laura E. Gould, 
Edward T. Pring, 
Alison Corr, 
Jordan Fletcher, 
Janindra Warusavitarne, 
David Burling, 
John M. A. Northover, 
John T. Jenkins, 
the St. Mark's Retrorectal Study Group, St Mark's Hospital</dc:creator>
      <dc:description>Abstract

Aim
Retrorectal masses are abnormalities located anatomically in the retrorectal space. A significant proportion are asymptomatic with no malignant potential while others cause symptoms due to mechanical pressure or malignant infiltration. We reviewed and categorised the retrorectal masses encountered over a 30‐year time period in a specialist colorectal hospital and describe our management algorithm for consideration by other multidisciplinary teams (MDT).


Methods
This was a retrospective analysis of consecutive patients referred between 1984–2019. A detailed review of clinical presentation, imaging features, postoperative histology and impact on morbidity and anorectal function is reported.


Results
A total of 143 patients with median age of 46 years and female preponderance (74%) were reviewed. The commonest presenting symptom was pain (46%) and all malignant cases had symptoms (n = 17). Over the last decade, more asymptomatic patients have presented with a retrorectal mass (33%, p = 0.04) and more patients are opting for surveillance rather than resection (33%, p = 0.013). Increasing age and lesion size were associated with malignancy (p &lt; 0.05). Radiological features associated with malignancy included: solid/heterogeneous component, lobulated borders or locally invasive. Following surgery, complications included chronic pain (40%), poor wound healing (23%) and bowel dysfunction (10%).


Conclusions
The management of retrorectal masses remains complex. There are features, both clinical and radiological, that can help determine the best management strategy. Management should be in a high‐volume tertiary centre and preferably through a complex rectal cancer MDT. Long‐term sequelae such as chronic pain must be highlighted to patients. We advocate the establishment of an international registry to further record and characterise these rare, potentially troublesome lesions.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15893</dc:identifier>
    </item>
    <item>
      <title>SupPoRtive Exercise Programmes for Accelerating REcovery after major ABdominal Cancer surgery trial (PREPARE‐ABC): Pilot phase of a multicentre randomised controlled trial</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15856?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15856</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15856?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3008-3022, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;PREPARE-ABC is a pragmatic multicentre randomised controlled trial including an internal pilot designed to assess the clinical and cost-effectiveness of pre- and postoperative exercise in relation to short- and longer-term postoperative recovery outcomes in colorectal cancer patients undergoing surgical resection. Here, we report on internal pilot phase data for the first 200 patients randomised to the trial, which included prespecified stop-go criteria used to inform the decision to progress to the fully powered trial by the funder.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Eligible and consenting patients are randomly assigned (1:1:1) to hospital-supervised exercise, home-supported exercise or treatment as usual (TAU). Randomisation is concealed but clinical teams providing treatment and participants are unmasked. Primary outcomes are 30-day morbidity (Clavien-Dindo) and 12-month health-related quality of life (Medical Outcomes Study Health Questionnaire). Here, we present findings from the prespecified pilot phase which assessed feasibility of site set up, recruitment, adherence and acceptability of trial processes to patients and site staff.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Between 9 November 2016 and 18 May 2018, 18 sites were set up, with 200 patients randomised to either hospital-supervised exercise (68), home-supported exercise (69) or treatment as usual (TAU) (63). Across the groups, 19 patients did not proceed to surgery or withdrew and 52% experienced a complication. Over half of the participants (57%) in the hospital-supervised group attended ≥6 preoperative sessions and 50% attended ≥5 monthly postoperative exercise “booster sessions”. In the home-supported group, 70% patients engaged with ≥2 telephone support sessions in the preoperative phase and 80% engaged in ≥5 monthly telephone support “booster sessions”. Adverse events were reported by 22 patients and three patients reported a serious adverse event. The majority of complications were Clavien-Dindo grades 1–2; however, 16 patients experienced one or more Clavien-Dindo grade 3–4 complication(s).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Results of the internal pilot phase confirm the feasibility of site set-up and patient recruitment, representativeness of the sample population and adequate adherence to hospital-supervised and home-supported exercise. On the basis of these positive results, progression to the fully-powered trial was authorised by the funder.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15856</guid>
      <dc:title>SupPoRtive Exercise Programmes for Accelerating REcovery after major ABdominal Cancer surgery trial (PREPARE‐ABC): Pilot phase of a multicentre randomised controlled trial</dc:title>
      <dc:creator>On behalf of the PREPARE‐ABC Trial Collaborative, James Hernon, John Saxton, Megan Jones, Gregory Howard, Ann Marie Swart, Allan Clark, Susan Stirling, David Turner, Jamie Murdoch, Jurgens Nortje, Simon Bach, Nicola Fearnhead, Farhat Din, Alan Stephens, Jonathan Lund, Samson Tou, Seamus Kelly, Paul Ziprin, Robert Dennis, Neil Smart, Campbell Roxburgh, Alastair Simpson, Ami Mishra, Katrina Knight, Kerry Dresser</dc:creator>
      <dc:description>Abstract

Aim
PREPARE‐ABC is a pragmatic multicentre randomised controlled trial including an internal pilot designed to assess the clinical and cost‐effectiveness of pre‐ and postoperative exercise in relation to short‐ and longer‐term postoperative recovery outcomes in colorectal cancer patients undergoing surgical resection. Here, we report on internal pilot phase data for the first 200 patients randomised to the trial, which included prespecified stop‐go criteria used to inform the decision to progress to the fully powered trial by the funder.


Methods
Eligible and consenting patients are randomly assigned (1:1:1) to hospital‐supervised exercise, home‐supported exercise or treatment as usual (TAU). Randomisation is concealed but clinical teams providing treatment and participants are unmasked. Primary outcomes are 30‐day morbidity (Clavien‐Dindo) and 12‐month health‐related quality of life (Medical Outcomes Study Health Questionnaire). Here, we present findings from the prespecified pilot phase which assessed feasibility of site set up, recruitment, adherence and acceptability of trial processes to patients and site staff.


Results
Between 9 November 2016 and 18 May 2018, 18 sites were set up, with 200 patients randomised to either hospital‐supervised exercise (68), home‐supported exercise (69) or treatment as usual (TAU) (63). Across the groups, 19 patients did not proceed to surgery or withdrew and 52% experienced a complication. Over half of the participants (57%) in the hospital‐supervised group attended ≥6 preoperative sessions and 50% attended ≥5 monthly postoperative exercise “booster sessions”. In the home‐supported group, 70% patients engaged with ≥2 telephone support sessions in the preoperative phase and 80% engaged in ≥5 monthly telephone support “booster sessions”. Adverse events were reported by 22 patients and three patients reported a serious adverse event. The majority of complications were Clavien‐Dindo grades 1–2; however, 16 patients experienced one or more Clavien‐Dindo grade 3–4 complication(s).


Conclusions
Results of the internal pilot phase confirm the feasibility of site set‐up and patient recruitment, representativeness of the sample population and adequate adherence to hospital‐supervised and home‐supported exercise. On the basis of these positive results, progression to the fully‐powered trial was authorised by the funder.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15856</dc:identifier>
    </item>
    <item>
      <title>An international assessment of the adoption of enhanced recovery after surgery (ERAS®) principles across colorectal units in 2019–2020</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15863?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15863</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15863?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2980-2987, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;The Enhanced Recovery After Surgery (ERAS®) Society guidelines aim to standardize perioperative care in colorectal surgery via 25 principles. We aimed to assess the variation in uptake of these principles across an international network of colorectal units.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;An online survey was circulated amongst European Society of Coloproctology members in 2019–2020. For each ERAS principle, respondents were asked to score how frequently the principle was implemented in their hospital, from 1 (‘rarely’) to 4 (‘always’). Respondents were also asked to recall whether practice had changed since 2017. Subgroup analyses based on hospital characteristics were conducted.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Of hospitals approached, 58% responded to the survey (195/335), with 296 individual responses (multiple responses were received from some hospitals). The majority were European (163/195, 83.6%). Overall, respondents indicated they ‘most often’ or ‘always’ adhered to most individual ERAS principles (18/25, 72%). Variability in the uptake of principles was reported, with universal uptake of some principles (e.g., prophylactic antibiotics; early mobilization) and inconsistency from ‘rarely’ to ‘always’ in others (e.g., no nasogastric intubation; no preoperative fasting and carbohydrate drinks). In alignment with 2018 ERAS guideline updates, adherence to principles for prehabilitation, managing anaemia and postoperative nutrition appears to have increased since 2017.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Uptake of ERAS principles varied across hospitals, and not all 25 principles were equally adhered to. Whilst some principles exhibited a high level of acceptance, others had a wide variability in uptake indicative of controversy or barriers to uptake. Further research into specific principles is required to improve ERAS implementation.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15863</guid>
      <dc:title>An international assessment of the adoption of enhanced recovery after surgery (ERAS®) principles across colorectal units in 2019–2020</dc:title>
      <dc:creator>ESCP Enhanced Recovery Collaborating Group, 
Thomas Pinkney, 
H Taylor, 
C Tong, 
N‐D Schmitz, 
DG Morton, 
TD Pinkney, 
A Bhangu, 
S Blackwell, 
D Dardanov, 
A Dulskas, 
G Gallo, 
J Glasbey, 
J Keatley, 
C Knowles, 
YE Li, 
V McCourt, 
A Minaya‐Bravo, 
P Neary, 
D Nepogodiev, 
F Pata, 
G Pellino, 
E Sivrikoz, 
G Ramshorst, 
O Zmora, 
R Perry, 
EL Magill, 
M Abdalkoddus, 
A Abelevich, 
S Ábraham, 
M Abraham‐Nordling, 
M Adamina, 
C Agalar, 
F Agresta, 
M Ahallat, 
N Ahmad, 
R Aiupov, 
O Akca, 
A Aleksic, 
F Aleotti, 
D Alías, 
J Alonso, 
S Alonso Gonçalves, 
J Alonso Martín, 
A Alonso Poza, 
N Alonso‐Hernández, 
R Alós Company, 
M Al‐Saeedi, 
C Alvarez‐Laso, 
M Alvarez‐Gallego, 
T Amanatidis, 
M Americano, 
E Amorim, 
L Anandan, 
G Anania, 
G Ancans, 
P Andreev, 
P Andrejevic, 
N Antonacci, 
M Anwer, 
P Aonzo, 
B Arencibia, 
S Argeny, 
H Arieli, 
S Arnold, 
M Ashraf, 
M Aslam, 
B Atanasov, 
M Atif, 
J Atladottir, 
S Avital, 
S Awny, 
B Aytac, 
N Azahr, 
S Aznar‐Puig, 
S Bailey, 
D Balalis, 
C Baldi, 
R Baldonedo, 
G Balducci, 
F Balestra, 
R Balestri, 
A Balfour, 
I Baloyiannis, 
B Banky, 
J Baral, 
Z Baranyai, 
N Barbashinov, 
J Bargallo, 
G Barišić, 
G Barugola, 
I Batashki, 
N Battersby, 
N Belev, 
A Belli, 
J Beltrán de Heredia, 
W Bemelman, 
J Benavides Buleje, 
A Benckert, 
J Bernal‐Sprekelsen, 
E Bertocchi, 
M Beuran, 
C Bhan, 
F Bianco, 
S Bilali, 
V Bilali, 
V Bintintan, 
A Birindelli, 
A Birindelli, 
T Birsan, 
F Blanco Antona, 
J Blas, 
T Blasco‐Segura, 
R Blom, 
T Bocchetti, 
E Boerma, 
M Bogdan, 
M Boland, 
B Bomans, 
N Borda, 
M Bowen, 
S Bradulskis, 
G Branagan, 
B Brankovic, 
M Brenna, 
H Brewer, 
J Broadhurst, 
C Bronder, 
R Brouwer, 
P Buccianti, 
N Buchs, 
P Buchwald, 
A Bugatti, 
A Bui, 
T Burcos, 
C Buskens, 
C Bustamante, 
N Caceres, 
C Cagigas Fernández, 
A Calero‐Lillo, 
I Camps, 
A Canda, 
I Caravaca‐García, 
F Carballo, 
P Carcoforo, 
J Carlander, 
S Carlos, 
A Caro, 
A Carpelan, 
M Carrasco Prats, 
M Carrillo López, 
M Carvello, 
E Casal, 
G Casoni Pattacini, 
J Castellvi Valls, 
J Castillo Diego, 
G Cavallesco, 
V Cavenaile, 
L Cayetano, 
A Ceccotti, 
J Cervera‐Aldama, 
A Chabok, 
N Chafai, 
P Chandrasinghe, 
N Chandratreya, 
S Chaudhri, 
Z Chaudhry, 
D Cherdancev, 
A Chernov, 
M Chevallay, 
P Chirletti, 
E Chouillard, 
C Chouliaras, 
N Chowdri, 
M Cillo, 
C Cini, 
C Ciubotaru, 
C Ciuce, 
D Claeys, 
G Cocorullo, 
A Codina‐Cazador, 
E Colak, 
D Coletta, 
F Colombo, 
C Copaescu, 
J Corte Real, 
M Corver, 
J Ćosić, 
S Costa, 
J Costa Pereira, 
C Costa Pereira, 
D Costa‐Navarro, 
E Cotte, 
N Cracco, 
D Cristian, 
M Cuadrado, 
V Cuk, 
V Cuk, 
M Cunha, 
J Cunha, 
R Curinga, 
G Curletti, 
N Curtis, 
D Dabic, 
E Dainius, 
A d'Alessandro, 
I Daniels, 
V Darvin, 
B Dauser, 
G David, 
O Davidova, 
E Davies, 
B Andrés Asenjo, 
S De franciscis, 
E Graaf, 
F De la Portilla, 
E De Luca, 
C De Nisco, 
G De Toma, 
B Defoort, 
F Den Boer, 
F Di Candido, 
S Di Saverio, 
J Diaz Pavon, 
B Dieguez Fernandez, 
M Diez‐Alonso, 
I Dimitrijević, 
G Dindelegan, 
M Djuric, 
H Domingos, 
P Doornebosch, 
M Dos Santos, 
I Drami, 
H Dudarovaska, 
T Dusek, 
H Dzhumabaev, 
Y Eden, 
M Egenvall, 
V Eismiontas, 
M El Sorogy, 
A Elgeidie, 
M Elhemaly, 
A El‐Hussuna, 
S Ellul, 
U Elmore, 
A ElNakeeb, 
M Elrefai, 
S Emile, 
J Enrriquez‐Navascués, 
J Epstein, 
J Escartin, 
D Escola, 
J Escuder, 
E Espin, 
B Espina, 
D Estefania, 
J Etienne, 
S Fabbri, 
A Falato, 
R Fares, 
P Farina, 
M Farkašová, 
R Farrés, 
F Fasolini, 
T Fatayer, 
G Febles, 
F Feliu, 
C Feo, 
D Feoktistov, 
F Fernandez, 
M Fernandez Isart, 
J Fernando, 
G Ferreira, 
R Ferrer, 
C Ferreras García, 
M Ferri, 
N Figueiredo, 
E Finotti, 
J Fitzgerald, 
I Flateh Backe, 
B Flor‐Lorente, 
A Forero‐Torres, 
D Foschi, 
D Francart, 
Y Francois, 
M Frasson, 
C Freil‐Lanter, 
M Frois Borges, 
M Fuzun, 
T Gala, 
R Galleano, 
P Galvez, 
A Galvez Saldaña, 
M Gamundi Cuesta, 
A Garcia Cabrera, 
J Garcia Egea, 
D García Olmo, 
J García‐González, 
Á García‐Granero, 
E García‐Granero, 
J Garcia‐Septiem, 
A Gardea, 
M Garipov, 
R Gefen, 
A Geraghty, 
S Gerkis, 
S Germanos, 
S Ghaffari, 
E Ghilles, 
L Gianotti, 
M Gil Santos, 
C Gilsanz Martin, 
C Gingert, 
A Gklavas, 
O Glehen, 
T Golda, 
N Gómez, 
R Gómez, 
M Gomez Ruiz, 
V Gonzalez Santin, 
B Graham, 
J Grainger, 
F Grama, 
T Gregoir, 
M Gregori, 
T Grolich, 
J Grosek, 
H Guadalajara, 
S Guckenheimer, 
J Guevara, 
G Gulotta, 
S Gupta, 
S Gupta, 
N Gurevich, 
S Gurjar, 
S Haapaniemi, 
D Hahnloser, 
Y Hamad, 
M Hamid, 
A Hanly, 
G Harris, 
L Harsányi, 
N Hartig, 
P Hawkin, 
P Henriques, 
F Herbst, 
N Hermann, 
M Hernandez Garcia, 
J Hoch, 
A Hrora, 
H Huhtinen, 
N Iarumov, 
A Ilkanich, 
C Insua, 
P Ioannidis, 
M Iqbal, 
A Iqbal, 
A Isik, 
M Ismaiel, 
D Ivlev, 
V Jadhav, 
S Jareño, 
C Jehaes, 
V Jimenez, 
M Jiménez‐Toscano, 
J Jimenez‐Miramon, 
R Jimenez‐Rodriguez, 
T Jonsson, 
V Jotautas, 
V Jotautas, 
D Julià, 
J Juloski, 
B Jung, 
Z Kala, 
M Kalayci, 
Y Kara, 
A Karachun, 
S Karagul, 
J Karvonen, 
S Katorkin, 
I Katsoulis, 
D Katsounis, 
M Kaubrys, 
N Kaul, 
E Kefalou, 
M Keijzers, 
M Kelly, 
M Kenic, 
R Kennelly, 
J Khan, 
M Khan, 
H Kho, 
V Kinas, 
J Knight, 
P Kocian, 
T Koeter, 
A Kokobelyan, 
J Konsten, 
L Koolen, 
J Kosir, 
I Kostic, 
I Krdzic, 
E Kreisler Moreno, 
Z Krivokapić, 
P Krstev, 
D Kršul, 
N Kumarasinghe, 
F La Torre, 
F Labarga, 
M Ladra, 
A Lage Laredo, 
N Lahodzich, 
C Lai, 
Z Lakkis, 
R Lal, 
S Lamas, 
T Lang, 
T Latkauskas, 
D Lawes, 
G Lázár, 
K Lebedev, 
M Lebedeva, 
J Lefevre, 
V Lekić Vitlov, 
M Lemma, 
C Leo, 
C Leon, 
S Leventoglu, 
B Levy, 
L Li, 
L Licari, 
P Lizdenis, 
P Loftås, 
M Longhi, 
L Longstaff, 
J Lopez Dominguez, 
M López‐Lara, 
P Lora, 
L Lorenzon, 
D Lorusso, 
I Lozev, 
R Lozoya Trujillo, 
D Lukic, 
R Lunins, 
R Luzan, 
A Luzzi, 
V Maderuelo, 
T Madsbøll, 
D Mahotin, 
M Majbar, 
A Makhmudov, 
K Malik, 
O Maly, 
I Mamaloudis, 
Z Mamedli, 
D Manatakis, 
D Mandi, 
P Mangell, 
T Marharint, 
N Mariani, 
B Maric, 
K Marimuthu, 
F Marinello, 
F Marino, 
S Markiewicz, 
V Marković, 
G Marom, 
N Maroni, 
I Maroulis, 
P Marsanic, 
H Marsman, 
M Martens, 
M Martí, 
L Martinek, 
S Martinez, 
D Martínez, 
Á Martínez Manzano, 
R Martins, 
S Maslyankov, 
K McArdle, 
F McDermott, 
D Mege, 
A Mehraj, 
A Mehta, 
D Mendrila, 
P Menendez, 
P Mercantini, 
I Metwally, 
S Mikalauskas, 
S Mikalauskas, 
M Millan, 
A Minaya‐Bravo, 
A Mingoli, 
B Mirshekar‐Syahkal, 
E Moggia, 
S Mohan, 
P Moller, 
S Mompart Garcia, 
B Monami, 
P Moniz Pereira, 
I Montroni, 
P Morel, 
B Moshev, 
E Mostovoy, 
S Mothe, 
H Mukhtar, 
P Müller, 
S Münch, 
J Muñoz Camarena, 
S Muñoz‐Collado, 
A Muratore, 
F Muscara, 
F Muysoms, 
P Myrelid, 
N N.Lah, 
S Nail, 
A Narayanan, 
K Nastos, 
I Negoi, 
A Nesbakken, 
G Nestler, 
M Nestorovic, 
A Nesytykh, 
K Newton, 
Y Ng, 
J Ngu, 
B Nguyen, 
Y Nijs, 
M Nikberg, 
T Nimmersgern, 
E Nogués, 
G Norcic, 
V Nutautiene, 
J Nygren, 
J O'Brien, 
A Ochogavia Segui, 
J O'Kelly, 
M Oliveira‐Cunha, 
W Omar, 
G Omar, 
S Onishchenko, 
P Ónody, 
E Opocher, 
J Orhalmi, 
A Oshowo, 
J Otero, 
U Ozgen, 
K Pace, 
H Padin, 
I Papaconstantinou, 
A Papadopoulos, 
G Papadopoulos, 
M Papandrea, 
J Paral, 
Y Parc, 
J Paredes, 
M Parmar, 
P Parra Baños, 
F Parray, 
M Pascual Damieta, 
I Pascual Miguelañez, 
G Passot, 
C Pastor, 
A Paszt, 
P Patel, 
H Paterson, 
J Patron Uriburu, 
A Paulos, 
V Pavlov, 
A Pcolkins, 
V Pecic, 
E Peña Ros, 
R Penkov, 
M Pera Roman, 
V Perunicic, 
R Pery, 
D Petrovic, 
F Pezzolla, 
E Photi, 
A Pikarsky, 
B Piramanayagam, 
A Pisani Ceretti, 
P Planellas, 
E Platt, 
P Pletinckx, 
M Podda, 
T Poskus, 
T Poskus, 
E Poskus, 
E Poskus, 
A Pozdnyakov, 
I Pravosudov, 
A Previšić, 
D Prieto, 
V Procházka, 
A Prodan, 
D Proud, 
J Psaila, 
G Psaras, 
F Pulighe, 
F Pullig, 
M Qureshi, 
J Rachadell, 
Z Radovanovic, 
D Radovanovic, 
B Raguan, 
M Rahman, 
M Raiss, 
M Ramirez Faraco, 
J Ramos, 
J Ramos‐Prada, 
A Rantala, 
M Rao, 
A Rasulov, 
K Ratnatunga, 
T Raymond, 
B Refky, 
L Reggiani, 
L Regusci, 
M Reyes Diaz, 
J Richardson, 
G Richiteanu, 
A Ríos, 
F Ris, 
P Rodríguez García, 
N Roffi, 
E Romairone, 
G Romano, 
I Romero, 
A Romero de Diego, 
M Romero‐Simó, 
C Roque, 
R Rosati, 
B Rossi, 
E Rossi, 
R Rossini, 
A Ruano, 
M Rubbini, 
I Rubio‐Perez, 
G Ruffo, 
H Ruiz, 
M Ruiz Carmona, 
O Ryska, 
D Sabia, 
M Sacchi, 
R Sacco, 
A Sakr, 
Z Saladzinskas, 
G Salamone, 
M Salomon, 
S Salvans Ruiz, 
G Sammarco, 
G Sampietro, 
D Samsonov, 
V Samsonyuk, 
J Sanchez, 
A Sanchez Romero, 
L Sánchez‐Guillén, 
G Šantak, 
M Santamaría‐Olabarrieta, 
J Santos, 
F Saraceno, 
Y Saralegui, 
I Sarici, 
G Savino, 
S Scabini, 
J Schäfli, 
B Schiltz, 
A Schofield, 
M Schön, 
R Scurtu, 
E Segalini, 
J Segelman, 
J Segura‐Sampedro, 
R Seicean, 
A Sekulić, 
L Selniahina, 
F Seretis, 
P Serrano Paz, 
I Shaikh, 
M Shalaby, 
N Shams, 
A Sharma, 
G Sharma, 
A Shukla, 
N Shussman, 
Z Shweejawee, 
I Sielezneff, 
H Sigurdsson, 
P Sileri, 
M Silva, 
D Simcikas, 
J Simões, 
Z Simonka, 
B Singh, 
A Sivins, 
G Skroubis, 
A Skull, 
M Slavchev, 
M Slavin, 
N Smart, 
C Smart, 
P Smart, 
K Smedh, 
S Smolarek, 
S Sokmen, 
M Sokolov, 
A Solana Bueno, 
L Solar, 
L Sorrentino, 
O Sotona, 
D Spacca, 
A Spinelli, 
G Stanojevic, 
A Stearns, 
S Stefan, 
A Stift, 
J Stijns, 
V Stoyanov, 
D Straarup, 
K Strupas, 
K Strupas, 
B Stubbs, 
A Subocius, 
A Sudlow, 
C Suero, 
U Sungurtekin, 
S Svagzdys, 
I Syk, 
A Tamelis, 
R Tamhane, 
N Tamini, 
A Tamosiunas, 
P Tanis, 
N Tarasov, 
S Tate, 
A Tennakoon, 
N Teo, 
C Terzi, 
S Tezas, 
W Thabet, 
J Tham, 
N Thavanesan, 
T Theodosopoulos, 
W Thomas, 
E Tiret, 
C Tiselius, 
G Todorov, 
A Tomazic, 
V Tomulescu, 
J Torkington, 
M Totis, 
I Trostchansky, 
N Truan, 
H Tulchinsky, 
R Tutino, 
A Tzivanakis, 
G Tzovaras, 
G Ugolini, 
L Unger, 
I Upanishad, 
L Urbani, 
A Uth Ovesen, 
C Vaizey, 
F Vallribera, 
E Valsdottir, 
I Valverde, 
J Valverde‐Sintas, 
K Van Belle, 
S Van Cleven, 
P Hagen, 
Y Loon, 
O Ruler, 
K Van Wijck, 
A Varabei, 
M Varcada, 
P Varpe, 
M Vartic, 
V Velchuru, 
J Vencius, 
D Venskutonis, 
D Vercher, 
M Vermaas, 
M Vertruyen, 
L Verza, 
G Vescio, 
A Vezakis, 
P Vieira, 
A Vignali, 
V Vigorita, 
M Vila Tura, 
B Vinson‐Bonnet, 
L Viso Pons, 
S Voloshin, 
Y Voronin, 
L Vukušić, 
X Wang, 
J Wang, 
R Wani, 
J Warusavitarne, 
N Wasserberg, 
J Weerts, 
D Weiss, 
A Weizman, 
E Westerduin, 
J Wheat, 
I White, 
T Wik, 
J Wilson, 
D Winter, 
A Wolthuis, 
M Wong, 
S Yahia, 
T Yamamoto, 
A Yanishev, 
C Yao, 
A Yıldız, 
O Yuksel, 
Z Zain, 
A Zakaria, 
Z Zakaria, 
N Zampitis, 
A Zaránd, 
A Zarco‐Pleguezuelos, 
D Zattoni, 
M Zelić, 
P Zeromskas, 
A Zhuravlev, 
D Zimmerman, 
M Zuhdy, 
G Zukanović</dc:creator>
      <dc:description>Abstract

Aim
The Enhanced Recovery After Surgery (ERAS®) Society guidelines aim to standardize perioperative care in colorectal surgery via 25 principles. We aimed to assess the variation in uptake of these principles across an international network of colorectal units.


Method
An online survey was circulated amongst European Society of Coloproctology members in 2019–2020. For each ERAS principle, respondents were asked to score how frequently the principle was implemented in their hospital, from 1 (‘rarely’) to 4 (‘always’). Respondents were also asked to recall whether practice had changed since 2017. Subgroup analyses based on hospital characteristics were conducted.


Results
Of hospitals approached, 58% responded to the survey (195/335), with 296 individual responses (multiple responses were received from some hospitals). The majority were European (163/195, 83.6%). Overall, respondents indicated they ‘most often’ or ‘always’ adhered to most individual ERAS principles (18/25, 72%). Variability in the uptake of principles was reported, with universal uptake of some principles (e.g., prophylactic antibiotics; early mobilization) and inconsistency from ‘rarely’ to ‘always’ in others (e.g., no nasogastric intubation; no preoperative fasting and carbohydrate drinks). In alignment with 2018 ERAS guideline updates, adherence to principles for prehabilitation, managing anaemia and postoperative nutrition appears to have increased since 2017.


Conclusions
Uptake of ERAS principles varied across hospitals, and not all 25 principles were equally adhered to. Whilst some principles exhibited a high level of acceptance, others had a wide variability in uptake indicative of controversy or barriers to uptake. Further research into specific principles is required to improve ERAS implementation.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15863</dc:identifier>
    </item>
    <item>
      <title>Reducing surgical site infection rates in colorectal surgery – a quality improvement approach to implementing a comprehensive bundle</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15875?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15875</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15875?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2999-3007, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Surgical site infections (SSIs) are a preventable cause of morbidity following surgical procedures. Strategies to reduce rates of SSI must address pre-, peri- and postoperative factors and multiple interventions can be combined into ‘bundles’. Adoption of these measures can reduce SSIs, but this is dependent on high levels of compliance. The aim of this work is to assess the change in rates of SSI in elective colorectal surgery after implementing a colorectal SSI bundle.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;This is a single-centre prospective cohort study. All elective colorectal procedures from 2011 until 2018 (inclusive) were included. The primary outcome was inpatient SSI. A multimodal bundle was implemented using quality improvement methodology. The bundle was altered during the timeframe of the study to optimize outcomes. Data were analysed by interrupted time series analysis assessing points at which the bundle was altered.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;In the study period, 1075 elective colorectal procedures were performed. Prior to the introduction of the colorectal SSI bundle, the SSI rate was 16.4%. During the implementation period (2013–2015), the overall rate of SSI fell from 15.9% to 9.4%, with the most significant reduction being in superficial SSI, from 8.6% to 4.7%. In the postimplementation period from 2015–2018, there was a further reduction in the overall rate of SSI (5.1%). In 2018, there were 87 consecutive cases without infection.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;A successful reduction in the rate of SSI following elective colorectal surgery can be achieved by adopting a comprehensive perioperative bundle. This is complemented by a process of continuous measurement and evaluation. The current bundle has achieved a significant reduction in superficial SSI.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15875</guid>
      <dc:title>Reducing surgical site infection rates in colorectal surgery – a quality improvement approach to implementing a comprehensive bundle</dc:title>
      <dc:creator>Rachel Falconer, 
George Ramsay, 
Jemma Hudson, 
Angus Watson, 
the Highland Colorectal SSI Group</dc:creator>
      <dc:description>Abstract

Aim
Surgical site infections (SSIs) are a preventable cause of morbidity following surgical procedures. Strategies to reduce rates of SSI must address pre‐, peri‐ and postoperative factors and multiple interventions can be combined into ‘bundles’. Adoption of these measures can reduce SSIs, but this is dependent on high levels of compliance. The aim of this work is to assess the change in rates of SSI in elective colorectal surgery after implementing a colorectal SSI bundle.


Method
This is a single‐centre prospective cohort study. All elective colorectal procedures from 2011 until 2018 (inclusive) were included. The primary outcome was inpatient SSI. A multimodal bundle was implemented using quality improvement methodology. The bundle was altered during the timeframe of the study to optimize outcomes. Data were analysed by interrupted time series analysis assessing points at which the bundle was altered.


Results
In the study period, 1075 elective colorectal procedures were performed. Prior to the introduction of the colorectal SSI bundle, the SSI rate was 16.4%. During the implementation period (2013–2015), the overall rate of SSI fell from 15.9% to 9.4%, with the most significant reduction being in superficial SSI, from 8.6% to 4.7%. In the postimplementation period from 2015–2018, there was a further reduction in the overall rate of SSI (5.1%). In 2018, there were 87 consecutive cases without infection.


Conclusion
A successful reduction in the rate of SSI following elective colorectal surgery can be achieved by adopting a comprehensive perioperative bundle. This is complemented by a process of continuous measurement and evaluation. The current bundle has achieved a significant reduction in superficial SSI.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15875</dc:identifier>
    </item>
    <item>
      <title>The Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) burden of care study: Analysis of local treatments for lung metastases and systemic chemotherapy in 220 patients in the PulMiCC cohort</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15833?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15833</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15833?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2911-2922, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;The aim of this work was to examine the burden of further treatments in patients with colorectal cancer following a decision about lung metastasectomy.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;Five teams participating in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) study provided details on subsequent local treatments for lung metastases, including the use of chemotherapy. For patients in three groups (no metastasectomy, one metastasectomy or multiple local interventions), baseline factors and selection criteria for additional treatments were examined.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;The five teams recruited 220 patients between October 2010 and January 2017. No lung metastasectomy was performed in 51 patients, 114 patients had one metastasectomy and 55 patients had multiple local interventions. Selection for initial metastasectomy was associated with nonelevated carcinoembryonic antigen, fewer metastases and no prior liver metastasectomy. These patients also had better Eastern Cooperative Oncology Group scores and lung function at baseline. Four sites provided information on chemotherapy in 139 patients: 79 (57%) had one to five courses of chemotherapy, to a total of 179 courses. The patterns of survival after one or multiple metastasectomy interventions showed evidence of guarantee-time bias contributing to an impression of benefit over no metastasectomy. After repeated metastasectomy, a significantly higher risk of death was observed, with no apparent reduction in chemotherapy usage.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Repeated metastasectomy is associated with a higher risk of death without reducing the use of chemotherapy. Continued monitoring without surgery might reassure patients with indolent disease or allow response assessment during systemic treatment. Overall, the carefully collected information from the PulMICC study provides no indication of an important survival benefit from metastasectomy.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15833</guid>
      <dc:title>The Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) burden of care study: Analysis of local treatments for lung metastases and systemic chemotherapy in 220 patients in the PulMiCC cohort</dc:title>
      <dc:creator>Tom Treasure, 
Vern Farewell, 
Fergus Macbeth, 
Tim Batchelor, 
Misel Milosevic, 
Juliet King, 
Yan Zheng, 
Pauline Leonard, 
Norman R. Williams, 
Chris Brew‐Graves, 
Eva Morris, 
Lesley Fallowfield, 
the PulMiCC investigators</dc:creator>
      <dc:description>Abstract

Aim
The aim of this work was to examine the burden of further treatments in patients with colorectal cancer following a decision about lung metastasectomy.


Method
Five teams participating in the Pulmonary Metastasectomy in Colorectal Cancer (PulMiCC) study provided details on subsequent local treatments for lung metastases, including the use of chemotherapy. For patients in three groups (no metastasectomy, one metastasectomy or multiple local interventions), baseline factors and selection criteria for additional treatments were examined.


Results
The five teams recruited 220 patients between October 2010 and January 2017. No lung metastasectomy was performed in 51 patients, 114 patients had one metastasectomy and 55 patients had multiple local interventions. Selection for initial metastasectomy was associated with nonelevated carcinoembryonic antigen, fewer metastases and no prior liver metastasectomy. These patients also had better Eastern Cooperative Oncology Group scores and lung function at baseline. Four sites provided information on chemotherapy in 139 patients: 79 (57%) had one to five courses of chemotherapy, to a total of 179 courses. The patterns of survival after one or multiple metastasectomy interventions showed evidence of guarantee‐time bias contributing to an impression of benefit over no metastasectomy. After repeated metastasectomy, a significantly higher risk of death was observed, with no apparent reduction in chemotherapy usage.


Conclusion
Repeated metastasectomy is associated with a higher risk of death without reducing the use of chemotherapy. Continued monitoring without surgery might reassure patients with indolent disease or allow response assessment during systemic treatment. Overall, the carefully collected information from the PulMICC study provides no indication of an important survival benefit from metastasectomy.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15833</dc:identifier>
    </item>
    <item>
      <title>Time interval between rectal cancer resection and reintervention for anastomotic leakage and the impact of a defunctioning stoma: A Dutch population‐based study</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15878?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15878</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15878?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2937-2947, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;In the Netherlands, a selective policy of faecal diversion after rectal cancer surgery is generally applied. This study aimed to evaluate the timing, type, and short-term outcomes of reoperation for anastomotic leakage after primary rectal cancer resection stratified for a defunctioning stoma.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;Data of all patients who underwent primary rectal cancer surgery with primary anastomosis from 2013–2019 were extracted from the Dutch ColoRectal Audit. Primary outcomes were new stoma construction, mortality, ICU admission, prolonged hospital stay, and readmission.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;In total, 10,772 rectal cancer patients who underwent surgery with primary anastomosis were included, of whom 46.6% received a primary defunctioning stoma. The reintervention rate for anastomotic leakage was 8.2% and 11.6% for patients with and without a defunctioning stoma (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001). Reintervention consisted of reoperation in 44.0% and 85.3% (&lt;i&gt;p&lt;/i&gt; &amp;lt; 0.001), with a median time interval from primary resection to reoperation of seven days (IQR 4–14) vs. five days (IQR 3–13), respectively. In the presence of a defunctioning stoma, early reoperation (&amp;lt;5 days; &lt;i&gt;n&lt;/i&gt; = 47) was associated with significantly more end-colostomy construction (51% vs. 33%) and ICU admission (66% vs. 38%) than late reoperation (≥5 days; &lt;i&gt;n&lt;/i&gt; = 127). Without defunctioning stoma, early reoperation (&lt;i&gt;n&lt;/i&gt; = 252) was associated with significantly higher mortality (4% vs. 1%), and more ICU admissions (52% vs.34%) than late reoperation (&lt;i&gt;n&lt;/i&gt; = 302).&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Early reoperations after rectal cancer resection are associated with worse outcomes reflected by a more frequent ICU admission in general, more colostomy construction, and higher mortality in patients with primary defunctioned and nondefunctioned anastomosis.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15878</guid>
      <dc:title>Time interval between rectal cancer resection and reintervention for anastomotic leakage and the impact of a defunctioning stoma: A Dutch population‐based study</dc:title>
      <dc:creator>Anne‐Loes K. Warps, 
Rob A. E. M. Tollenaar, 
Pieter J. Tanis, 
Jan Willem T. Dekker, 
the Dutch ColoRectal Audit</dc:creator>
      <dc:description>Abstract

Aim
In the Netherlands, a selective policy of faecal diversion after rectal cancer surgery is generally applied. This study aimed to evaluate the timing, type, and short‐term outcomes of reoperation for anastomotic leakage after primary rectal cancer resection stratified for a defunctioning stoma.


Method
Data of all patients who underwent primary rectal cancer surgery with primary anastomosis from 2013–2019 were extracted from the Dutch ColoRectal Audit. Primary outcomes were new stoma construction, mortality, ICU admission, prolonged hospital stay, and readmission.


Results
In total, 10,772 rectal cancer patients who underwent surgery with primary anastomosis were included, of whom 46.6% received a primary defunctioning stoma. The reintervention rate for anastomotic leakage was 8.2% and 11.6% for patients with and without a defunctioning stoma (p &lt; 0.001). Reintervention consisted of reoperation in 44.0% and 85.3% (p &lt; 0.001), with a median time interval from primary resection to reoperation of seven days (IQR 4–14) vs. five days (IQR 3–13), respectively. In the presence of a defunctioning stoma, early reoperation (&lt;5 days; n = 47) was associated with significantly more end‐colostomy construction (51% vs. 33%) and ICU admission (66% vs. 38%) than late reoperation (≥5 days; n = 127). Without defunctioning stoma, early reoperation (n = 252) was associated with significantly higher mortality (4% vs. 1%), and more ICU admissions (52% vs.34%) than late reoperation (n = 302).


Conclusions
Early reoperations after rectal cancer resection are associated with worse outcomes reflected by a more frequent ICU admission in general, more colostomy construction, and higher mortality in patients with primary defunctioned and nondefunctioned anastomosis.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15878</dc:identifier>
    </item>
    <item>
      <title>Defunctioning stomas may reduce chances of a stoma‐free outcome after anterior resection for rectal cancer</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15836?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15836</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15836?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2859-2869, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;To investigate the conflicting consequences of faecal diversion on stoma outcomes and anastomotic leakage in anterior resection for rectal cancer, including interaction effects determined by the extent of mesorectal excision.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;Anterior resections between 2007 and 2016 were identified using the Swedish Colorectal Cancer Registry. National Patient Registry data were added to determine stoma outcome 2 years after surgery. Tumour distance from the anal verge constituted a proxy for extent of mesorectal excision [total mesorectal excision (TME): ≤10 cm; partial mesorectal excision (PME): 13–15 cm]. With confounder-adjusted probit regression, the total effect of defunctioning stoma on permanent stoma, and the interaction effect of extent of mesorectal excision, were estimated together with the indirect effect through anastomotic leakage. Baseline risks, risk differences (RDs) and relative risks (RRs) were reported.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;The main study cohort included 4529 patients. Defunctioning stomas influenced the absolute permanent stoma risk (TME: RD 0.11 [95% CI 0.09–0.13]; PME: RD 0.15 [95% CI 0.13–0.16]). The baseline risk was higher in TME, with a resulting greater RR in PME (2.23 [95% CI 1.43–3.02] vs 4.36 [95% CI 3.05–5.68]). The indirect reduction in permanent stoma rates, due to the alleviating effect of faecal diversion on anastomotic leakage, was small (TME: 0.89 [95% CI 0.81–0.96]; PME: 0.96 [95% CI 0.91–1.00]).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;In anterior resection for rectal cancer, defunctioning stomas may reduce chances of a stoma-free outcome. Considering leakage reduction benefits, consequences of routine diversion in TME might be fairly balanced, while this seems questionable in PME.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15836</guid>
      <dc:title>Defunctioning stomas may reduce chances of a stoma‐free outcome after anterior resection for rectal cancer</dc:title>
      <dc:creator>Klas Holmgren, 
Jenny Häggström, 
Markku M. Haapamäki, 
Peter Matthiessen, 
Jörgen Rutegård, 
Martin Rutegård</dc:creator>
      <dc:description>Abstract

Aim
To investigate the conflicting consequences of faecal diversion on stoma outcomes and anastomotic leakage in anterior resection for rectal cancer, including interaction effects determined by the extent of mesorectal excision.


Method
Anterior resections between 2007 and 2016 were identified using the Swedish Colorectal Cancer Registry. National Patient Registry data were added to determine stoma outcome 2 years after surgery. Tumour distance from the anal verge constituted a proxy for extent of mesorectal excision [total mesorectal excision (TME): ≤10 cm; partial mesorectal excision (PME): 13–15 cm]. With confounder‐adjusted probit regression, the total effect of defunctioning stoma on permanent stoma, and the interaction effect of extent of mesorectal excision, were estimated together with the indirect effect through anastomotic leakage. Baseline risks, risk differences (RDs) and relative risks (RRs) were reported.


Results
The main study cohort included 4529 patients. Defunctioning stomas influenced the absolute permanent stoma risk (TME: RD 0.11 [95% CI 0.09–0.13]; PME: RD 0.15 [95% CI 0.13–0.16]). The baseline risk was higher in TME, with a resulting greater RR in PME (2.23 [95% CI 1.43–3.02] vs 4.36 [95% CI 3.05–5.68]). The indirect reduction in permanent stoma rates, due to the alleviating effect of faecal diversion on anastomotic leakage, was small (TME: 0.89 [95% CI 0.81–0.96]; PME: 0.96 [95% CI 0.91–1.00]).


Conclusion
In anterior resection for rectal cancer, defunctioning stomas may reduce chances of a stoma‐free outcome. Considering leakage reduction benefits, consequences of routine diversion in TME might be fairly balanced, while this seems questionable in PME.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15836</dc:identifier>
    </item>
    <item>
      <title>Quantifying displacement of urogenital organs after abdominoperineal resection for rectal cancer</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15885?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15885</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15885?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2923-2931, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;This study aimed to quantify displacement of urogenital organs after abdominoperineal resection (APR), and to explore patient and treatment characteristics associated with displacement.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;Patients from 16 centres who underwent APR for primary or recurrent rectal cancer (2001–2018) with evaluable preoperative and 6–18 months postoperative radiological imaging were included in the study. Anatomical landmarks on sagittal images were related to a coordinate system based on reference lines between fixed bony structures and absolute displacements were calculated using the Pythagorean theorem. Rotation of landmarks was measured relative to a pubic-S5 reference line.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;There were 248 patients included of which 171 were men and 77 women. The median displacement of the internal urethral orifice was 25 mm in men (maximum 65), and 17 mm in women (maximum 50). Rotation of the internal urethral orifice was in a caudal direction in 160/170 (94%) of men and 65/73 (89%) of women, with a median of 32 degrees (maximum 85) and 33 degrees (maximum 83), respectively. Displacements of the posterior bladder wall, distal end of prostatic urethra and cervix were significantly correlated with the internal urethral orifice. In linear regression analysis, biological mesh reconstruction of the pelvic floor and visceral interposition were significantly associated with increased displacement of the internal urethral orifice, and female gender and any filling of the presacral space with decreased displacement.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Substantial absolute displacement and rotation of urogenital organs after APR for rectal cancer were observed, but with high variability among both men and women, and being significantly associated with reconstructive interventions.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15885</guid>
      <dc:title>Quantifying displacement of urogenital organs after abdominoperineal resection for rectal cancer</dc:title>
      <dc:creator>Sarah Sharabiany, 
Gaby J. Strijk, 
Robin D. Blok, 
Colin G. Ferrett, 
Jaap Stoker, 
Christopher Cunningham, 
Jarmila D. W. Bilt, 
Anna A. W. Geloven, 
Wilhelmus A. Bemelman, 
Roel Hompes, 
Gijsbert D. Musters, 
Pieter J. Tanis</dc:creator>
      <dc:description>Abstract

Aim
This study aimed to quantify displacement of urogenital organs after abdominoperineal resection (APR), and to explore patient and treatment characteristics associated with displacement.


Method
Patients from 16 centres who underwent APR for primary or recurrent rectal cancer (2001–2018) with evaluable preoperative and 6–18 months postoperative radiological imaging were included in the study. Anatomical landmarks on sagittal images were related to a coordinate system based on reference lines between fixed bony structures and absolute displacements were calculated using the Pythagorean theorem. Rotation of landmarks was measured relative to a pubic‐S5 reference line.


Results
There were 248 patients included of which 171 were men and 77 women. The median displacement of the internal urethral orifice was 25 mm in men (maximum 65), and 17 mm in women (maximum 50). Rotation of the internal urethral orifice was in a caudal direction in 160/170 (94%) of men and 65/73 (89%) of women, with a median of 32 degrees (maximum 85) and 33 degrees (maximum 83), respectively. Displacements of the posterior bladder wall, distal end of prostatic urethra and cervix were significantly correlated with the internal urethral orifice. In linear regression analysis, biological mesh reconstruction of the pelvic floor and visceral interposition were significantly associated with increased displacement of the internal urethral orifice, and female gender and any filling of the presacral space with decreased displacement.


Conclusions
Substantial absolute displacement and rotation of urogenital organs after APR for rectal cancer were observed, but with high variability among both men and women, and being significantly associated with reconstructive interventions.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15885</dc:identifier>
    </item>
    <item>
      <title>A semi‐Markov model comparing the lifetime cost‐effectiveness of mesh prophylaxis to prevent parastomal hernia in patients undergoing end colostomy creation for rectal cancer</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15848?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15848</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15848?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2967-2979, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Parastomal hernia (PSH) is a common problem following colostomy. Using prophylactic mesh during end colostomy creation may reduce PSH incidence, but concerns exist regarding the optimal type of mesh, potential long-term complications, and cost-effectiveness of its use. We evaluated the cost-effectiveness of mesh prophylaxis to prevent PSH in patients undergoing end colostomy creation for rectal cancer.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;We developed a decision-analytical model, stratified by rectal cancer stages I–IV, to estimate the lifetime costs, quality-adjusted life-years (QALYs) and net monetary benefits (NMBs) of synthetic, biologic and no mesh from a UK NHS perspective. We pooled the mesh-related relative risks of PSH from 13 randomised controlled trials (RCTs) and superimposed these on the baseline (no mesh) risk from a population-based cohort. Uncertainty was assessed in sensitivity analyses.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Synthetic mesh was less costly and more effective than biologic and no mesh to prevent PSH for all rectal cancer stages. At the willingness-to-pay threshold of £20,000/QALY, the incremental NMBs (95% CI) ranged between £1,706 (£1,692 to £1,720) (stage I) and £684 (£678 to £690) (stage IV) for synthetic versus no mesh, and £2,038 (£1,997 to £2,079) (stage I) and £1,671 (£1,653 to £1,689) (stage IV) for synthetic versus biologic mesh. Synthetic mesh was more cost-effective than no mesh unless the relative risk of PSH was ≥0.95 for stages I–III and ≥0.93 for stage IV. [Correction added on 05 October 2021 after first online publication: The estimation of health outcomes (QALYs) for all three interventions evaluated (synthetic mesh; biologic mesh; no mesh) have been corrected in this version.]&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Synthetic mesh was the most cost-effective strategy to prevent the formation of PSH in patients after end colostomy for any rectal cancer stage; however, conclusions are dependent on which subset of RCTs are considered to provide the most robust evidence.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15848</guid>
      <dc:title>A semi‐Markov model comparing the lifetime cost‐effectiveness of mesh prophylaxis to prevent parastomal hernia in patients undergoing end colostomy creation for rectal cancer</dc:title>
      <dc:creator>Syed Mohiuddin, Barnaby C. Reeves, Neil J. Smart, William Hollingworth, On behalf of the CIPHER study group, Jane Blazeby, Chris Rogers, Thomas Pinkney, Natalie Blencowe, Mark Callaway, Ian Daniels, Amanda Gunning, Angus McNair, Hana Tabusa, Charlotte Murkin</dc:creator>
      <dc:description>Abstract

Aim
Parastomal hernia (PSH) is a common problem following colostomy. Using prophylactic mesh during end colostomy creation may reduce PSH incidence, but concerns exist regarding the optimal type of mesh, potential long‐term complications, and cost‐effectiveness of its use. We evaluated the cost‐effectiveness of mesh prophylaxis to prevent PSH in patients undergoing end colostomy creation for rectal cancer.


Methods
We developed a decision‐analytical model, stratified by rectal cancer stages I–IV, to estimate the lifetime costs, quality‐adjusted life‐years (QALYs) and net monetary benefits (NMBs) of synthetic, biologic and no mesh from a UK NHS perspective. We pooled the mesh‐related relative risks of PSH from 13 randomised controlled trials (RCTs) and superimposed these on the baseline (no mesh) risk from a population‐based cohort. Uncertainty was assessed in sensitivity analyses.


Results
Synthetic mesh was less costly and more effective than biologic and no mesh to prevent PSH for all rectal cancer stages. At the willingness‐to‐pay threshold of £20,000/QALY, the incremental NMBs (95% CI) ranged between £1,706 (£1,692 to £1,720) (stage I) and £684 (£678 to £690) (stage IV) for synthetic versus no mesh, and £2,038 (£1,997 to £2,079) (stage I) and £1,671 (£1,653 to £1,689) (stage IV) for synthetic versus biologic mesh. Synthetic mesh was more cost‐effective than no mesh unless the relative risk of PSH was ≥0.95 for stages I–III and ≥0.93 for stage IV. [Correction added on 05 October 2021 after first online publication: The estimation of health outcomes (QALYs) for all three interventions evaluated (synthetic mesh; biologic mesh; no mesh) have been corrected in this version.]


Conclusions
Synthetic mesh was the most cost‐effective strategy to prevent the formation of PSH in patients after end colostomy for any rectal cancer stage; however, conclusions are dependent on which subset of RCTs are considered to provide the most robust evidence.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15848</dc:identifier>
    </item>
    <item>
      <title>Need to define right mesocolectomy and complete mesocolic excision concept: How, when and why?</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15891?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15891</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15891?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3026-3026, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15891</guid>
      <dc:title>Need to define right mesocolectomy and complete mesocolic excision concept: How, when and why?</dc:title>
      <dc:creator>Gennaro Mazzarella, 
Edoardo Maria Muttillo</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15891</dc:identifier>
    </item>
    <item>
      <title>Reply to letter to the editor to “The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer”</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15897?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15897</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15897?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3025-3025, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15897</guid>
      <dc:title>Reply to letter to the editor to “The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer”</dc:title>
      <dc:creator>Rasmus Dahlin Bojesen, 
Jens Ravn Eriksen, 
Rasmus Peuliche Vogelsang, 
Camilla Grube, 
Julie Lyng Forman, 
Ismail Gogenür</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15897</dc:identifier>
    </item>
    <item>
      <title>Letter to the editor in response to ‘The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer’</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15896?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15896</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15896?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3024-3024, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15896</guid>
      <dc:title>Letter to the editor in response to ‘The dynamic effects of preoperative intravenous iron in anaemic patients undergoing surgery for colorectal cancer’</dc:title>
      <dc:creator>Hayley McMillan, 
Jani Moss, 
Uyen Vo, 
Toby Richards</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15896</dc:identifier>
    </item>
    <item>
      <title>Re: Malignant transformation of tailgut cysts is significantly higher than previously reported: Systematic review of cases in the literature</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15908?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15908</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15908?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3027-3027, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15908</guid>
      <dc:title>Re: Malignant transformation of tailgut cysts is significantly higher than previously reported: Systematic review of cases in the literature</dc:title>
      <dc:creator>Tamara Glyn, 
Peter Sagar, 
Frank Frizelle</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15908</dc:identifier>
    </item>
    <item>
      <title>Letter to the Editor concerning: Kolosov et al: Primary melanoma of the anorectal region: Clinical and histopathological review of 17 cases. A retrospective cohort study. Colorect Dis 2021: DOI: 10.1111/codi.15816</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15913?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15913</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15913?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3028-3028, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15913</guid>
      <dc:title>Letter to the Editor concerning: Kolosov et al: Primary melanoma of the anorectal region: Clinical and histopathological review of 17 cases. A retrospective cohort study. Colorect Dis 2021: DOI: 10.1111/codi.15816</dc:title>
      <dc:creator>Volker Kahlke, 
Tilman Laubert, 
Jessica Schneider, 
Johannes Jongen</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15913</dc:identifier>
    </item>
    <item>
      <title>Response to Kahlke et al</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15915?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15915</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15915?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3029-3029, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15915</guid>
      <dc:title>Response to Kahlke et al</dc:title>
      <dc:creator>Audrius Dulskas</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15915</dc:identifier>
    </item>
    <item>
      <title>Lateral internal sphincterotomy (LIS) using endoanal ultrasound ‐ a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15900?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15900</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15900?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3038-3039, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15900</guid>
      <dc:title>Lateral internal sphincterotomy (LIS) using endoanal ultrasound ‐ a video vignette</dc:title>
      <dc:creator>Helene Perregaard, 
Kikke B. Hagen, 
Peter‐Martin Krarup, 
Andreas Nordholm‐Carstensen</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15900</dc:identifier>
    </item>
    <item>
      <title>Gallstone ileus in an elderly orthopaedic patient managed with enterolithotomy: a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15888?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15888</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15888?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3030-3030, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15888</guid>
      <dc:title>Gallstone ileus in an elderly orthopaedic patient managed with enterolithotomy: a video vignette</dc:title>
      <dc:creator>Jessica M. Ryan, 
Michael Flanagan, 
Tara M. Connelly, 
Fiachra Cooke, 
Peter McCullough, 
Peter Neary</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15888</dc:identifier>
    </item>
    <item>
      <title>Laparoscopic left colic artery preserving sigmoidectomy for diverticulitis in a patient with urinary tract malformation ‐ a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15892?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15892</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15892?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3036-3037, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15892</guid>
      <dc:title>Laparoscopic left colic artery preserving sigmoidectomy for diverticulitis in a patient with urinary tract malformation ‐ a video vignette</dc:title>
      <dc:creator>Marco Milone, 
Michele Manigrasso, 
Alessandra Marello, 
Salvatore d’Angelo, 
Sara Vertaldi, 
Giovanni Domenico De Palma</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15892</dc:identifier>
    </item>
    <item>
      <title>Robotic multivisceral en bloc resection with reconstruction and multidisciplinary treatment of T4 sigmoid colon cancer ‐ a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15894?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15894</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15894?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3047-3048, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15894</guid>
      <dc:title>Robotic multivisceral en bloc resection with reconstruction and multidisciplinary treatment of T4 sigmoid colon cancer ‐ a video vignette</dc:title>
      <dc:creator>Shou‐Fu Liao, 
Hsiang‐Chih Chen, 
Tzu‐Chun Chen, 
Jin‐Tung Liang</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15894</dc:identifier>
    </item>
    <item>
      <title>Stoma‐resection‐reversal strategy for left‐sided obstructive colon cancer ‐ a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15898?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15898</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15898?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3052-3053, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15898</guid>
      <dc:title>Stoma‐resection‐reversal strategy for left‐sided obstructive colon cancer ‐ a video vignette</dc:title>
      <dc:creator>Haiyang Zhou, 
Anqi Wang, 
Ce Bian, 
Jian Zhang</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15898</dc:identifier>
    </item>
    <item>
      <title>Retro‐ileal pull through with confirmatory near‐infrared fluorescence angiogram – a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15859?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15859</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15859?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3044-3045, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15859</guid>
      <dc:title>Retro‐ileal pull through with confirmatory near‐infrared fluorescence angiogram – a video vignette</dc:title>
      <dc:creator>Niall McInerney, 
Jeffrey Dalli, 
Mohammad Faraz Khan, 
Niall Hardy, 
Ronan Cahill</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15859</dc:identifier>
    </item>
    <item>
      <title>Recurrent parastomal hernia after laparoscopic (modified) Sugarbaker: what to do? Robotic retromuscular mesh (Pauli) repair ‐ a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15862?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15862</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15862?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3042-3042, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15862</guid>
      <dc:title>Recurrent parastomal hernia after laparoscopic (modified) Sugarbaker: what to do? Robotic retromuscular mesh (Pauli) repair ‐ a video vignette</dc:title>
      <dc:creator>Alexander L. A. Bloemendaal</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15862</dc:identifier>
    </item>
    <item>
      <title>Robotic colectomy and repair of colovesical fistula due to diverticulitis ‐ a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15903?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15903</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15903?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3045-3046, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15903</guid>
      <dc:title>Robotic colectomy and repair of colovesical fistula due to diverticulitis ‐ a video vignette</dc:title>
      <dc:creator>Charlotte Austin, 
Rosa Jimenez‐Rodriguez, 
Jonathan B. Yuval, 
Jonathan A. Coleman, 
Martin R. Weiser</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15903</dc:identifier>
    </item>
    <item>
      <title>Step‐by‐step robotic lateral lymph node dissection for rectal cancer ‐ a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15909?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15909</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15909?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3051-3052, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15909</guid>
      <dc:title>Step‐by‐step robotic lateral lymph node dissection for rectal cancer ‐ a video vignette</dc:title>
      <dc:creator>Petr Tsarkov, 
Harutyun Babajanyan, 
Angelina Shershneva, 
Kamilla Barskaya, 
Yurii Kitsenko, 
Sergey Efetov</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15909</dc:identifier>
    </item>
    <item>
      <title>Robotic total pelvic exenteration with coloanal anastomosis and enterocystoplasty – a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15871?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15871</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15871?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3049-3049, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15871</guid>
      <dc:title>Robotic total pelvic exenteration with coloanal anastomosis and enterocystoplasty – a video vignette</dc:title>
      <dc:creator>Deena Harji, 
Alexandre Chauvet, 
Julien Pouplin, 
Grégoire Robert, 
Quentin Denost</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15871</dc:identifier>
    </item>
    <item>
      <title>Laparoscopic prophylactic lateral pelvic lymph node dissection in advanced low rectal cancer – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15872?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15872</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15872?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3023-3023, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15872</guid>
      <dc:title>Laparoscopic prophylactic lateral pelvic lymph node dissection in advanced low rectal cancer – A video vignette</dc:title>
      <dc:creator>Katsuji Tokuhara, 
Yosuke Ueyama, 
Kazuhiko Yoshioka, 
Mitsugu Sekimoto</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15872</dc:identifier>
    </item>
    <item>
      <title>Surgical management of giant anorectal condyloma by local excision and V‐Y anoplasty ‐ a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15877?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15877</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15877?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3053-3054, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15877</guid>
      <dc:title>Surgical management of giant anorectal condyloma by local excision and V‐Y anoplasty ‐ a video vignette</dc:title>
      <dc:creator>Natalia Uribe, 
Janine Tabet, 
Zutoia Balciscueta, 
Carmen Martín, 
Manuel López, 
Beatriz Cuneo</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15877</dc:identifier>
    </item>
    <item>
      <title>Laparoscopic dissection of a lateral pelvic Schwannoma‐a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15876?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15876</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15876?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3035-3036, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15876</guid>
      <dc:title>Laparoscopic dissection of a lateral pelvic Schwannoma‐a video vignette</dc:title>
      <dc:creator>Vincenzo Papagni, 
Arcangelo Picciariello, 
Pierantonio Cardinale, 
Leonardo Vincenti</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15876</dc:identifier>
    </item>
    <item>
      <title>Reduced‐port laparoscopic right hemicolectomy assisted by transabdominal suture ‐ a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15879?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15879</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15879?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3043-3044, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15879</guid>
      <dc:title>Reduced‐port laparoscopic right hemicolectomy assisted by transabdominal suture ‐ a video vignette</dc:title>
      <dc:creator>Jun Ying, 
Anqi Wang, 
Ce Bian, 
Haiyang Zhou</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15879</dc:identifier>
    </item>
    <item>
      <title>Robotic Frykman–Goldberg procedure for complete rectal prolapse ‐ a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15914?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15914</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15914?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3046-3047, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15914</guid>
      <dc:title>Robotic Frykman–Goldberg procedure for complete rectal prolapse ‐ a video vignette</dc:title>
      <dc:creator>Antonio Sciuto, 
Raffaele Emmanuele Maria Pirozzi, 
Alfredo Pede, 
Gianluca Lanni, 
Luca Montesarchio, 
Felice Pirozzi</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15914</dc:identifier>
    </item>
    <item>
      <title>Laparoscopic complete mesocolic excision—a combined medial to lateral and caudal to cranial approach ‐ a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15882?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15882</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15882?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3033-3033, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15882</guid>
      <dc:title>Laparoscopic complete mesocolic excision—a combined medial to lateral and caudal to cranial approach ‐ a video vignette</dc:title>
      <dc:creator>Naveena AN Kumar, 
Keshava Rajan, 
Nawaz Usman, 
Preethi S. Shetty, 
Vilas HV Crithic, 
Venkata Rao V Narasimha</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15882</dc:identifier>
    </item>
    <item>
      <title>Interactive 3D vascular reconstruction: A navigation tool to improve safety in laparoscopic D3 right colectomy ‐ a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15881?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15881</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15881?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3030-3032, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15881</guid>
      <dc:title>Interactive 3D vascular reconstruction: A navigation tool to improve safety in laparoscopic D3 right colectomy ‐ a video vignette</dc:title>
      <dc:creator>Lara Pérez‐Corbal, 
Jean Carlos Trujillo‐Diaz, 
Isaías Alarcón, 
Eugenio Licardie, 
Ana Senent, 
Salvador Morales‐Conde</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15881</dc:identifier>
    </item>
    <item>
      <title>Perineal stapled prolapse resection (PSPR) for full thickness external large rectal prolapse in a frail elderly patient; An easy to teach and reproducible novel technique – a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15883?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15883</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15883?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3040-3041, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15883</guid>
      <dc:title>Perineal stapled prolapse resection (PSPR) for full thickness external large rectal prolapse in a frail elderly patient; An easy to teach and reproducible novel technique – a video vignette</dc:title>
      <dc:creator>Akinfemi A. Akingboye, 
Sarah Khalid, 
Riccardo Broggi, 
Antonella Scorza, 
Sofia Todero, 
Pierpaolo Sileri, 
Salomone Di Saverio</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15883</dc:identifier>
    </item>
    <item>
      <title>Robotic transanal minimally invasive surgery ‐ a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15887?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15887</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15887?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3050-3050, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15887</guid>
      <dc:title>Robotic transanal minimally invasive surgery ‐ a video vignette</dc:title>
      <dc:creator>Gerard Feeney, 
Enda Hannan, 
Fahad Ullah, 
Dara Walsh, 
J Calvin Coffey, 
Colin Peirce</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15887</dc:identifier>
    </item>
    <item>
      <title>Laparoscopic D3 lymph node dissection with left colic artery and sigmoid artery preservation in rectal cancer – a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15889?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15889</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15889?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 3034-3035, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15889</guid>
      <dc:title>Laparoscopic D3 lymph node dissection with left colic artery and sigmoid artery preservation in rectal cancer – a video vignette</dc:title>
      <dc:creator>Xing Huang</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15889</dc:identifier>
    </item>
    <item>
      <title>Stop stigmatizing stomas</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15961?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15961</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15961?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">EDITORIAL</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2793-2794, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>EDITORIAL</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15961</guid>
      <dc:title>Stop stigmatizing stomas</dc:title>
      <dc:creator>Deborah S. Keller</dc:creator>
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15961</dc:identifier>
    </item>
    <item>
      <title>Issue Information</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15132?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15132</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15132?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Issue Information</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2789-2791, November 2021.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>Issue Information</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15132</guid>
      <dc:title>Issue Information</dc:title>
      <dc:creator />
      <dc:description />
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15132</dc:identifier>
    </item>
    <item>
      <title>A systematic review and meta‐analysis of variants of the branches of the superior mesenteric artery: the Achilles heel of right hemicolectomy with complete mesocolic excision?</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15861?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15861</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15861?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">META‐ANALYSIS</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2834-2845, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Dissection with subsequent ligation and resection of arteries at their origin (central vascular ligation) is essential for adequate oncological resection during right hemicolectomy with complete mesocolic excision. This technique is technically demanding due to the highly variable arterial pattern of the right colon. Therefore, this study aims to provide a comprehensive evidence-based assessment of the arterial vascular anatomy of the right colon.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A thorough systematic literature search through September 2020 was conducted on the electronic databases PubMed, Scopus and Web of Science to identify studies eligible for inclusion. Data were extracted and pooled into a meta-analysis using MetaXl software.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A total of 41 studies (&lt;i&gt;n&lt;/i&gt; = 4691 patients) were included. The ileocolic artery (ICA), right colic artery (RCA) and middle colic artery (MCA) were present in 99.7% (95% CI 99.4%–99.8%), 72.6% (95% CI 61.3%–82.5%) and 96.9% (95% CI 94.2%–98.8%) respectively of patients. Supernumerary RCA and MCA were observed in 3.2% and 11.4% respectively of all cases. The RCA shared a common trunk with the ICA and MCA in 13.2% and 17.7% respectively of patients. A retro-superior mesenteric vein course of the ICA and RCA was observed in 55.1% and 11.4% respectively of all cases.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;The vascular anatomy of the right colon displays several notable variations, namely the absence of some branches (RCA absent in 27.4% of cases), supernumerary branches, common trunks, and retro-superior mesenteric vein courses. These variations should be taken into consideration during right hemicolectomy with complete mesocolic excision to ensure adequate oncological resection while minimizing intra-operative complications.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>META‐ANALYSIS</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15861</guid>
      <dc:title>A systematic review and meta‐analysis of variants of the branches of the superior mesenteric artery: the Achilles heel of right hemicolectomy with complete mesocolic excision?</dc:title>
      <dc:creator>Roberto Cirocchi, 
Justus Randolph, 
R Justin Davies, 
Isaac Cheruiyot, 
Sara Gioia, 
Brandon Michael Henry, 
Luigi Carlini, 
Annibale Donini, 
Gabriele Anania</dc:creator>
      <dc:description>Abstract

Aim
Dissection with subsequent ligation and resection of arteries at their origin (central vascular ligation) is essential for adequate oncological resection during right hemicolectomy with complete mesocolic excision. This technique is technically demanding due to the highly variable arterial pattern of the right colon. Therefore, this study aims to provide a comprehensive evidence‐based assessment of the arterial vascular anatomy of the right colon.


Methods
A thorough systematic literature search through September 2020 was conducted on the electronic databases PubMed, Scopus and Web of Science to identify studies eligible for inclusion. Data were extracted and pooled into a meta‐analysis using MetaXl software.


Results
A total of 41 studies (n = 4691 patients) were included. The ileocolic artery (ICA), right colic artery (RCA) and middle colic artery (MCA) were present in 99.7% (95% CI 99.4%–99.8%), 72.6% (95% CI 61.3%–82.5%) and 96.9% (95% CI 94.2%–98.8%) respectively of patients. Supernumerary RCA and MCA were observed in 3.2% and 11.4% respectively of all cases. The RCA shared a common trunk with the ICA and MCA in 13.2% and 17.7% respectively of patients. A retro‐superior mesenteric vein course of the ICA and RCA was observed in 55.1% and 11.4% respectively of all cases.


Conclusion
The vascular anatomy of the right colon displays several notable variations, namely the absence of some branches (RCA absent in 27.4% of cases), supernumerary branches, common trunks, and retro‐superior mesenteric vein courses. These variations should be taken into consideration during right hemicolectomy with complete mesocolic excision to ensure adequate oncological resection while minimizing intra‐operative complications.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15861</dc:identifier>
    </item>
    <item>
      <title>Risk factors for developing peritoneal metastases after curative surgery for colorectal cancer: A systematic review and meta‐analysis</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15880?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15880</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15880?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">META‐ANALYSIS</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2846-2858, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Proactive detection and treatment strategies have achieved encouraging survival outcomes for patients with early peritoneal metastases (PM), but these costly and invasive approaches can only be applied to selected high-risk patients. This meta-analysis aimed to identify the risk factors for metachronous PM after curative surgery for colorectal cancer (CRC).&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;The study was registered at PROSPERO (CRD42020219187). Databases were searched for studies comparing clinical and histopathological characteristics between patients with metachronous peritoneal metastases from colorectal cancer (pmCRC) and patients without (non-pmCRC).&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Thirty-six studies were included. Metachronous PM were positively associated with perforation (OR 1.920; 95% CI 1.144–3.223; &lt;i&gt;P&lt;/i&gt; = 0.014), poor differentiation (OR 2.291; 1.603–3.275; &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001), T4 (OR 2.897; 1.248–6.726; &lt;i&gt;P&lt;/i&gt; = 0.013), N1–2 (OR 3.429; 2.684–4.381; &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001), mucinous adenocarcinoma (OR 4.175; 1.798–9.692; &lt;i&gt;P&lt;/i&gt; = 0.001), obstruction (OR 4.467; 1.919–10.398; &lt;i&gt;P&lt;/i&gt; = 0.001), synchronous ovarian metastases (OR 5.005; 1.140–21.977; &lt;i&gt;P&lt;/i&gt; = 0.033), positive peritoneal carcinoembryonic antigen mRNA (OR 9.472; 3.643–24.631; &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001), elevated serum carcinoembryonic antigen (preoperative group, OR 3.545, 1.486–8.459, &lt;i&gt;P&lt;/i&gt; = 0.004; postoperative group, OR 13.673, 2.222–84.129, &lt;i&gt;P&lt;/i&gt; = 0.005), elevated serum cancer antigen 19-9 (preoperative group, OR 5.281, 2.146–12.994, &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001; postoperative group, OR 18.646, 6.429–54.083, &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001) and positive peritoneal cytology (OR 25.884; 11.372–58.913; &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;These evidence-based risk factors are conducive to designing early detection and proactive treatment strategies, enabling precision medicine.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>META‐ANALYSIS</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15880</guid>
      <dc:title>Risk factors for developing peritoneal metastases after curative surgery for colorectal cancer: A systematic review and meta‐analysis</dc:title>
      <dc:creator>Yuanxin Zhang, 
Xiusen Qin, 
Wenle Chen, 
Duo Liu, 
Jian Luo, 
Huaiming Wang, 
Hui Wang</dc:creator>
      <dc:description>Abstract

Aim
Proactive detection and treatment strategies have achieved encouraging survival outcomes for patients with early peritoneal metastases (PM), but these costly and invasive approaches can only be applied to selected high‐risk patients. This meta‐analysis aimed to identify the risk factors for metachronous PM after curative surgery for colorectal cancer (CRC).


Method
The study was registered at PROSPERO (CRD42020219187). Databases were searched for studies comparing clinical and histopathological characteristics between patients with metachronous peritoneal metastases from colorectal cancer (pmCRC) and patients without (non‐pmCRC).


Results
Thirty‐six studies were included. Metachronous PM were positively associated with perforation (OR 1.920; 95% CI 1.144–3.223; P = 0.014), poor differentiation (OR 2.291; 1.603–3.275; P &lt; 0.001), T4 (OR 2.897; 1.248–6.726; P = 0.013), N1–2 (OR 3.429; 2.684–4.381; P &lt; 0.001), mucinous adenocarcinoma (OR 4.175; 1.798–9.692; P = 0.001), obstruction (OR 4.467; 1.919–10.398; P = 0.001), synchronous ovarian metastases (OR 5.005; 1.140–21.977; P = 0.033), positive peritoneal carcinoembryonic antigen mRNA (OR 9.472; 3.643–24.631; P &lt; 0.001), elevated serum carcinoembryonic antigen (preoperative group, OR 3.545, 1.486–8.459, P = 0.004; postoperative group, OR 13.673, 2.222–84.129, P = 0.005), elevated serum cancer antigen 19‐9 (preoperative group, OR 5.281, 2.146–12.994, P &lt; 0.001; postoperative group, OR 18.646, 6.429–54.083, P &lt; 0.001) and positive peritoneal cytology (OR 25.884; 11.372–58.913; P &lt; 0.001).


Conclusion
These evidence‐based risk factors are conducive to designing early detection and proactive treatment strategies, enabling precision medicine.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15880</dc:identifier>
    </item>
    <item>
      <title>An umbrella systematic review of drain fluid analysis in colorectal surgery for the detection of anastomotic leak: Not yet ready to translate research studies into clinical practice</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15844?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15844</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15844?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">SYSTEMATIC REVIEW</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2795-2805, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Anastomotic leak (AL) is the most important complication of intestinal surgery with an anastomosis. Whilst a number of studies have defined risk factors for AL, frustratingly, low-risk patients still develop AL. Studies have looked at drain fluid analysis for detection of AL, but these findings have failed to translate into routine clinical practice. This umbrella systematic review aims to provide an overview of the promising candidate biomarkers (BMs) that show potential to translate into clinical practice.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A systematic literature search was conducted in MEDLINE, EMBASE, and the Cochrane, KSR Evidence and the Epistemonikos databases on the 14 April 2021. Only systematic reviews of cohort or controlled studies measuring drain fluid biomarkers in humans were included. The methodological quality of the reviews was assessed using the AMSTAR 2 instrument. Clinical trial registries were searched for trials actively investigating drain fluid BMs. Candidate BMs were classified, and threshold values investigated.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Nine systematic reviews, published between 2007 and 2020, met the inclusion criteria, and contained a total of 36 cohort studies. A total of 38 different BMs were studied. The most promising category of drain fluid BM was the extravasated intra-luminal substances (EILS) and five registered trials of these BMs were found. Two of nine reviews were of moderate quality.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;The majority of BMs show inconsistent threshold values and are in the experimental stage. A number are not readily available for adoption into routine clinical practice. Most do not state a cut-off value to be considered as diagnostic.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>SYSTEMATIC REVIEW</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15844</guid>
      <dc:title>An umbrella systematic review of drain fluid analysis in colorectal surgery for the detection of anastomotic leak: Not yet ready to translate research studies into clinical practice</dc:title>
      <dc:creator>David A. Clark, 
Daniel Steffens, 
Michael Solomon</dc:creator>
      <dc:description>Abstract

Aim
Anastomotic leak (AL) is the most important complication of intestinal surgery with an anastomosis. Whilst a number of studies have defined risk factors for AL, frustratingly, low‐risk patients still develop AL. Studies have looked at drain fluid analysis for detection of AL, but these findings have failed to translate into routine clinical practice. This umbrella systematic review aims to provide an overview of the promising candidate biomarkers (BMs) that show potential to translate into clinical practice.


Methods
A systematic literature search was conducted in MEDLINE, EMBASE, and the Cochrane, KSR Evidence and the Epistemonikos databases on the 14 April 2021. Only systematic reviews of cohort or controlled studies measuring drain fluid biomarkers in humans were included. The methodological quality of the reviews was assessed using the AMSTAR 2 instrument. Clinical trial registries were searched for trials actively investigating drain fluid BMs. Candidate BMs were classified, and threshold values investigated.


Results
Nine systematic reviews, published between 2007 and 2020, met the inclusion criteria, and contained a total of 36 cohort studies. A total of 38 different BMs were studied. The most promising category of drain fluid BM was the extravasated intra‐luminal substances (EILS) and five registered trials of these BMs were found. Two of nine reviews were of moderate quality.


Conclusions
The majority of BMs show inconsistent threshold values and are in the experimental stage. A number are not readily available for adoption into routine clinical practice. Most do not state a cut‐off value to be considered as diagnostic.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15844</dc:identifier>
    </item>
    <item>
      <title>The learning curve in robotic colorectal surgery compared with laparoscopic colorectal surgery: a systematic review</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15843?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15843</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15843?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">SYSTEMATIC REVIEW</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2806-2820, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;The learning curve has implications for efficient surgical training. Robotic surgery is perceived to have a shorter learning curve than laparoscopy; however, detailed analysis is lacking. The aim of this work was to analyse studies comparing robotic and laparoscopic colorectal learning curves. Simulation studies comparing novices’ learning curves were analysed in order to surmise applicability to colorectal surgery.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;A systematic search of Medline, PubMed, Embase and the Cochrane Library identified colorectal papers (from 1 January 2000 to 3 March 2021) comparing robotic and laparoscopic learning curves where surgeons lacked laparoscopic colorectal experience. Simulation studies comparing learning curves were also included. The learning curve was defined as the period of ongoing improvement in speed and/or accuracy.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;From 576 abstracts reviewed, three operative and 16 simulation studies were included. The robotic learning curve for right colectomy was significantly faster in one study (16 vs. 25 cases) and equal for anterior resection in two studies (44 vs. 41 cases and 55 vs. 55). One study showed fewer complications for robotic patients (14.6% vs. 0%, &lt;i&gt;p&lt;/i&gt; = 0.013). Ten simulation studies reported faster times and eight recorded error rates favouring robotic surgery. Seven studies measured the learning curve. Four favoured laparoscopic surgery, but operating times were faster using the robotic platform.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Operating times for robotic surgery may be faster than laparoscopy when surgeons are inexperienced with both platforms. This may be related to a superior baseline performance rather than a shorter learning curve. Whether a shorter learning curve on the laparoscopic platform will persist for long enough to enable skills to overtake robotic ability needs further investigation.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>SYSTEMATIC REVIEW</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15843</guid>
      <dc:title>The learning curve in robotic colorectal surgery compared with laparoscopic colorectal surgery: a systematic review</dc:title>
      <dc:creator>Julie Flynn, 
José Tomás Larach, 
Joseph C. H. Kong, 
Peadar S. Waters, 
Satish K. Warrier, 
Alexander Heriot</dc:creator>
      <dc:description>Abstract

Aim
The learning curve has implications for efficient surgical training. Robotic surgery is perceived to have a shorter learning curve than laparoscopy; however, detailed analysis is lacking. The aim of this work was to analyse studies comparing robotic and laparoscopic colorectal learning curves. Simulation studies comparing novices’ learning curves were analysed in order to surmise applicability to colorectal surgery.


Method
A systematic search of Medline, PubMed, Embase and the Cochrane Library identified colorectal papers (from 1 January 2000 to 3 March 2021) comparing robotic and laparoscopic learning curves where surgeons lacked laparoscopic colorectal experience. Simulation studies comparing learning curves were also included. The learning curve was defined as the period of ongoing improvement in speed and/or accuracy.


Results
From 576 abstracts reviewed, three operative and 16 simulation studies were included. The robotic learning curve for right colectomy was significantly faster in one study (16 vs. 25 cases) and equal for anterior resection in two studies (44 vs. 41 cases and 55 vs. 55). One study showed fewer complications for robotic patients (14.6% vs. 0%, p = 0.013). Ten simulation studies reported faster times and eight recorded error rates favouring robotic surgery. Seven studies measured the learning curve. Four favoured laparoscopic surgery, but operating times were faster using the robotic platform.


Conclusion
Operating times for robotic surgery may be faster than laparoscopy when surgeons are inexperienced with both platforms. This may be related to a superior baseline performance rather than a shorter learning curve. Whether a shorter learning curve on the laparoscopic platform will persist for long enough to enable skills to overtake robotic ability needs further investigation.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15843</dc:identifier>
    </item>
    <item>
      <title>Use of prophylactic mesh during initial stoma creation to prevent parastomal herniation: a systematic review and meta‐analysis of randomised controlled trials</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15849?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Mon, 01 Nov 2021 00:00:00 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15849</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15849?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">SYSTEMATIC REVIEW</prism:section>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">23</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">11</prism:number>
      <description>Colorectal Disease, Volume 23, Issue 11, Page 2821-2833, November 2021.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Parastomal hernia (PSH) is a common complication following stoma creation. Previous reviews found mesh reinforcement during initial stoma creation beneficial in reducing PSH incidence. Since then, several multicentre randomised controlled trials (RCTs) produced widely ranging results rendering previous findings debatable. This current review assessed whether combining the latest larger multicentre RCTs would alter the previous findings.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;The Cochrane Library, MEDLINE and Embase were searched from the respective dates of inception until 15 January 2021. RCTs were included if they compared mesh with no mesh during initial stoma creation in adult patients to prevent PSH. Included RCTs were summarised narratively and meta-analysed to estimate the relative risk (RR) of PSH incidence (primary analysis), peristomal complications and PSH repair (secondary analyses). Several subgroup analyses were performed, including mesh type (synthetic/biologic), surgical technique (open/laparoscopic) and mesh position (sublay/intraperitoneal).&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Thirteen RCTs were included in the primary meta-analysis (1070 patients); PSH incidence was reduced in patients with mesh compared with patients without mesh at maximal follow-up (RR = 0.54; 95% CI 0.39–0.77; &lt;i&gt;I&lt;/i&gt;
&lt;sup&gt;2&lt;/sup&gt; = 67%; &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.01). The number of PSH repairs was fewer in patients who had mesh (RR = 0.63; 0.35–1.14; &lt;i&gt;I&lt;/i&gt;
&lt;sup&gt;2&lt;/sup&gt; = 6%; &lt;i&gt;P&lt;/i&gt; = 0.39), with no difference in peristomal complications (RR = 0.96; 0.55–1.70; &lt;i&gt;I&lt;/i&gt;
&lt;sup&gt;2&lt;/sup&gt; = 0%; &lt;i&gt;P&lt;/i&gt; = 0.71), comparing with no mesh. Subgroup analyses suggested that placing synthetic mesh using an open sublay technique might be more beneficial.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Prophylactic mesh reinforcement during initial stoma creation reduces PSH incidence and potentially its repair, without an increase in peristomal complications. However, substantial heterogeneity among included RCTs limits confidence in the results.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>SYSTEMATIC REVIEW</category>
      <pubDate>Wed, 24 Nov 2021 09:44:05 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15849</guid>
      <dc:title>Use of prophylactic mesh during initial stoma creation to prevent parastomal herniation: a systematic review and meta‐analysis of randomised controlled trials</dc:title>
      <dc:creator>Syed Mohiuddin, 
William Hollingworth, 
Niroshini Rajaretnam, 
Barnaby C. Reeves, 
Neil J. Smart</dc:creator>
      <dc:description>Abstract

Aim
Parastomal hernia (PSH) is a common complication following stoma creation. Previous reviews found mesh reinforcement during initial stoma creation beneficial in reducing PSH incidence. Since then, several multicentre randomised controlled trials (RCTs) produced widely ranging results rendering previous findings debatable. This current review assessed whether combining the latest larger multicentre RCTs would alter the previous findings.


Methods
The Cochrane Library, MEDLINE and Embase were searched from the respective dates of inception until 15 January 2021. RCTs were included if they compared mesh with no mesh during initial stoma creation in adult patients to prevent PSH. Included RCTs were summarised narratively and meta‐analysed to estimate the relative risk (RR) of PSH incidence (primary analysis), peristomal complications and PSH repair (secondary analyses). Several subgroup analyses were performed, including mesh type (synthetic/biologic), surgical technique (open/laparoscopic) and mesh position (sublay/intraperitoneal).


Results
Thirteen RCTs were included in the primary meta‐analysis (1070 patients); PSH incidence was reduced in patients with mesh compared with patients without mesh at maximal follow‐up (RR = 0.54; 95% CI 0.39–0.77; I2 = 67%; P &lt; 0.01). The number of PSH repairs was fewer in patients who had mesh (RR = 0.63; 0.35–1.14; I2 = 6%; P = 0.39), with no difference in peristomal complications (RR = 0.96; 0.55–1.70; I2 = 0%; P = 0.71), comparing with no mesh. Subgroup analyses suggested that placing synthetic mesh using an open sublay technique might be more beneficial.


Conclusions
Prophylactic mesh reinforcement during initial stoma creation reduces PSH incidence and potentially its repair, without an increase in peristomal complications. However, substantial heterogeneity among included RCTs limits confidence in the results.</dc:description>
      <dc:date>2021-11-24T09:44:05Z</dc:date>
      <dc:identifier>10.1111/codi.15849</dc:identifier>
    </item>
    <item>
      <title>Reply - Letter to the editor: “Energy and protein intake may have an impact on survival in patients with advanced cancer”</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00534-3/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-11-24</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>We thank Dr. Arends for his thoughtful comments on our retrospective study enrolling cancer outpatients [1]. Initially, the manuscript was submitted as a short communication due to the preliminary nature of the results, but then we resubmit it as an original article as suggested during the review process. Dr. Arends’ comments are well taken, since it should be noted that the Brazilian Sistema Único de Saúde does not implement a timely screening of patients, which yields to delayed start of therapies.</description>
      <pubDate>Wed, 24 Nov 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00534-3/fulltext?rss=yes</guid>
      <dc:title>Reply - Letter to the editor: “Energy and protein intake may have an impact on survival in patients with advanced cancer”</dc:title>
      <dc:creator>Gustavo D. Pimentel, Claude Pichard, Renata C. Fernandes, Alessandro Laviano</dc:creator>
      <dc:date>2021-11-24T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.025</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>A simple and noninvasive method to reidentify the left ureter during laparoscopic colorectal surgery – a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15989?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15989</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15989?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Tue, 23 Nov 2021 18:06:26 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15989</guid>
      <dc:title>A simple and noninvasive method to reidentify the left ureter during laparoscopic colorectal surgery – a video vignette</dc:title>
      <dc:creator>Ernesto Melkonian, 
Eduardo Mordojovich, 
Leonardo Espíndola, 
Christian Jensen, 
Aldo Cuneo, 
Daniella Espínola</dc:creator>
      <dc:description />
      <dc:date>2021-11-23T18:06:26Z</dc:date>
      <dc:identifier>10.1111/codi.15989</dc:identifier>
    </item>
    <item>
      <title>Total laparoscopic reversal after open Hartmann's procedure for Hinchey III diverticulitis – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15988?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15988</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15988?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Tue, 23 Nov 2021 18:02:46 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15988</guid>
      <dc:title>Total laparoscopic reversal after open Hartmann's procedure for Hinchey III diverticulitis – A video vignette</dc:title>
      <dc:creator>Wenming Yang, 
Qiang Du, 
Lie Yang</dc:creator>
      <dc:description />
      <dc:date>2021-11-23T18:02:46Z</dc:date>
      <dc:identifier>10.1111/codi.15988</dc:identifier>
    </item>
    <item>
      <title>Refining the art of the robotic TAMIS – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15986?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15986</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15986?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Tue, 23 Nov 2021 17:56:03 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15986</guid>
      <dc:title>Refining the art of the robotic TAMIS – A video vignette</dc:title>
      <dc:creator>Morgan E. Jones, 
Helen M. Mohan, 
Amrish K. S. Rajkomar, 
José Tomás Larach, 
Satish K. Warrier</dc:creator>
      <dc:description />
      <dc:date>2021-11-23T17:56:03Z</dc:date>
      <dc:identifier>10.1111/codi.15986</dc:identifier>
    </item>
    <item>
      <title>Warmed and humidified insufflation to prevent perioperative hypothermia and improve the quality of recovery in elective laparoscopic colorectal resection patients: a feasibility study for a triple‐blind randomized controlled trial</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15984?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15984</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15984?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;The use of standard CO&lt;sub&gt;2&lt;/sub&gt; for insufflation during laparoscopic colorectal surgery may be associated with cooling and drying of the peritoneal cavity, contributing to perioperative hypothermia. The aim of this work was the assess the feasibility of a study to compare insufflation of warmed, humidified CO&lt;sub&gt;2&lt;/sub&gt; (WHCO2) (using HumiGard, Fisher and Paykel Healthcare) with standard measures and its impact on the quality of recovery of surgical patients.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;A single-centre, triple-blind, feasibility, randomized controlled trial (RCT) of adults scheduled for planned laparoscopic colorectal surgery. The primary outcome was recruitment. Secondary outcomes included feasibility of blinding, acceptability to patients and suitability of objective measures: patient-reported quality of recovery using a validated questionnaire (QoR-40), patient pain scores and semi-continuous core temperature measurements.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Thirty-nine participants were randomized to either the WHCO2 group (&lt;i&gt;n&lt;/i&gt; = 19) or standard care alone (&lt;i&gt;n&lt;/i&gt; = 20). Recruitment to the study was successful and acceptable to patients. Blinding of the surgeons, patients and assessors was effective. Response rates to QoR-40 were high but ceiling effects were observed, indicating that the tool was unsuitable in this population. Fewer patients in the WHCO2 group reported postoperative nausea and vomiting (PONV) at days 1 (53% vs. 65%) and 3 (37% vs. 60%). The median hospital length of stay was 5.5 days in the standard care group and 4 days in the WHCO2 group.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;A study of WHCO2 for insufflation in laparoscopic colorectal surgery would be highly acceptable to both patients and researchers. Potential reductions in PONV and hospital length of stay in patients treated with WHCO2 merit further investigation. The design of the full-scale RCT will benefit from this feasibility study.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Tue, 23 Nov 2021 17:45:51 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15984</guid>
      <dc:title>Warmed and humidified insufflation to prevent perioperative hypothermia and improve the quality of recovery in elective laparoscopic colorectal resection patients: a feasibility study for a triple‐blind randomized controlled trial</dc:title>
      <dc:creator>Nicola Reeves, 
Judith White, 
Samuel Bird, 
Michael Shinkwin, 
Julie Cornish, 
Jared Torkington</dc:creator>
      <dc:description>Abstract

Aim
The use of standard CO2 for insufflation during laparoscopic colorectal surgery may be associated with cooling and drying of the peritoneal cavity, contributing to perioperative hypothermia. The aim of this work was the assess the feasibility of a study to compare insufflation of warmed, humidified CO2 (WHCO2) (using HumiGard, Fisher and Paykel Healthcare) with standard measures and its impact on the quality of recovery of surgical patients.


Method
A single‐centre, triple‐blind, feasibility, randomized controlled trial (RCT) of adults scheduled for planned laparoscopic colorectal surgery. The primary outcome was recruitment. Secondary outcomes included feasibility of blinding, acceptability to patients and suitability of objective measures: patient‐reported quality of recovery using a validated questionnaire (QoR‐40), patient pain scores and semi‐continuous core temperature measurements.


Results
Thirty‐nine participants were randomized to either the WHCO2 group (n = 19) or standard care alone (n = 20). Recruitment to the study was successful and acceptable to patients. Blinding of the surgeons, patients and assessors was effective. Response rates to QoR‐40 were high but ceiling effects were observed, indicating that the tool was unsuitable in this population. Fewer patients in the WHCO2 group reported postoperative nausea and vomiting (PONV) at days 1 (53% vs. 65%) and 3 (37% vs. 60%). The median hospital length of stay was 5.5 days in the standard care group and 4 days in the WHCO2 group.


Conclusion
A study of WHCO2 for insufflation in laparoscopic colorectal surgery would be highly acceptable to both patients and researchers. Potential reductions in PONV and hospital length of stay in patients treated with WHCO2 merit further investigation. The design of the full‐scale RCT will benefit from this feasibility study.</dc:description>
      <dc:date>2021-11-23T17:45:51Z</dc:date>
      <dc:identifier>10.1111/codi.15984</dc:identifier>
    </item>
    <item>
      <title>Nodal metastases in small rectal neuroendocrine tumours</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15978?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15978</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15978?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Rectal neuroendocrine tumours (NETs) are the most common type of gastrointestinal NET. European Neuroendocrine Tumour Society guidelines suggest that rectal NETs measuring ≤10 mm are indolent with low risk of spread. In practice, many patients with lesions ≤1 cm do not undergo complete tumour staging. However, the size of the lesion may not be the only risk factor for nodal involvement/metastases. The aim of this study was to determine if MRI ± nuclear medicine imaging alters tumour stage in patients with rectal NETs ≤10 mm.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Patients referred to a tertiary NET centre between 2005 and 2020 who met the inclusion criteria of a rectal NET ≤10 mm, full cross-sectional imaging, primarily an MRI scan and, if abnormal findings were identified, a subsequent &lt;sup&gt;68&lt;/sup&gt;Ga-DOTATATE positron emission tomography scan were included. All patients were followed up at our institution.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;In all, 32 patients with rectal NETs 10 mm or less were included in the study: 16 women; median age 58 years (range 33–71); 47% (&lt;i&gt;n&lt;/i&gt; = 15) were referred from bowel cancer screening procedures. The median size of the lesions was 5 mm (range 2–10 mm). 81% (&lt;i&gt;n&lt;/i&gt; = 26) were World Health Organization Grade 1 tumours with Ki67 &amp;lt;3%. Radiological staging confirmed nodal involvement in 25% (8/32); two cases had distant metastatic disease. Lymphovascular invasion was present in 3% (1/32) of patients but none demonstrated peri-neural invasion.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;This study demonstrates that small rectal NETs can develop nodal metastases; therefore it is important to stage these tumours accurately with MRI at baseline and, if there are concerns regarding potential lymph node metastases, to consider &lt;sup&gt;68&lt;/sup&gt;Ga-DOTATATE positron emission tomography imaging.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Tue, 23 Nov 2021 14:17:21 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15978</guid>
      <dc:title>Nodal metastases in small rectal neuroendocrine tumours</dc:title>
      <dc:creator>Sarah O’Neill, 
Amyn Haji, 
Suzanne Ryan, 
Dominique Clement, 
Konstantinos Sarras, 
Bu Hayee, 
Nicola Mulholland, 
John K. Ramage, 
Rajaventhan Srirajaskanthan</dc:creator>
      <dc:description>Abstract

Aim
Rectal neuroendocrine tumours (NETs) are the most common type of gastrointestinal NET. European Neuroendocrine Tumour Society guidelines suggest that rectal NETs measuring ≤10 mm are indolent with low risk of spread. In practice, many patients with lesions ≤1 cm do not undergo complete tumour staging. However, the size of the lesion may not be the only risk factor for nodal involvement/metastases. The aim of this study was to determine if MRI ± nuclear medicine imaging alters tumour stage in patients with rectal NETs ≤10 mm.


Methods
Patients referred to a tertiary NET centre between 2005 and 2020 who met the inclusion criteria of a rectal NET ≤10 mm, full cross‐sectional imaging, primarily an MRI scan and, if abnormal findings were identified, a subsequent 68Ga‐DOTATATE positron emission tomography scan were included. All patients were followed up at our institution.


Results
In all, 32 patients with rectal NETs 10 mm or less were included in the study: 16 women; median age 58 years (range 33–71); 47% (n = 15) were referred from bowel cancer screening procedures. The median size of the lesions was 5 mm (range 2–10 mm). 81% (n = 26) were World Health Organization Grade 1 tumours with Ki67 &lt;3%. Radiological staging confirmed nodal involvement in 25% (8/32); two cases had distant metastatic disease. Lymphovascular invasion was present in 3% (1/32) of patients but none demonstrated peri‐neural invasion.


Conclusion
This study demonstrates that small rectal NETs can develop nodal metastases; therefore it is important to stage these tumours accurately with MRI at baseline and, if there are concerns regarding potential lymph node metastases, to consider 68Ga‐DOTATATE positron emission tomography imaging.</dc:description>
      <dc:date>2021-11-23T14:17:21Z</dc:date>
      <dc:identifier>10.1111/codi.15978</dc:identifier>
    </item>
    <item>
      <title>Internal hernia through Petersen’s defect 13 years post gastrectomy with Roux‐en‐Y – A Video Vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15976?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15976</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15976?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Tue, 23 Nov 2021 14:13:25 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15976</guid>
      <dc:title>Internal hernia through Petersen’s defect 13 years post gastrectomy with Roux‐en‐Y – A Video Vignette</dc:title>
      <dc:creator>Brian Rigney, 
Michael Flanagan, 
Peter McCullough, 
Peter Neary, 
Fiachra Cooke</dc:creator>
      <dc:description />
      <dc:date>2021-11-23T14:13:25Z</dc:date>
      <dc:identifier>10.1111/codi.15976</dc:identifier>
    </item>
    <item>
      <title>Comment on “Anti-COVID-19 measures threaten our healthy body weight: Changes in sleep and external synchronizers of circadian clocks during confinement” Clinical Nutrition 2021</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00533-1/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-11-23</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>We congratulate Baquerizo-Sedano et al. [1] for the relevant study, which evaluated the impact of 12-week confinement on the body weight of 521 university students aged between 16 and 35 years, considering changes in several external synchronizers of the biological clock.</description>
      <pubDate>Tue, 23 Nov 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00533-1/fulltext?rss=yes</guid>
      <dc:title>Comment on “Anti-COVID-19 measures threaten our healthy body weight: Changes in sleep and external synchronizers of circadian clocks during confinement” Clinical Nutrition 2021</dc:title>
      <dc:creator>Ana Patrícia da Silva Souza, Waleska Maria Almeida Barros, Matheus Santos de Sousa Fernandes, Viviane de Oliveira Nogueira Souza</dc:creator>
      <dc:date>2021-11-23T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.024</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Comment on “effect of dietary vitamins C and E on the risk of Parkinson's disease: A meta-analysis”</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00532-X/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-11-23</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>We read with interest the work done by Chang et al., who systematically reviewed the literature to evaluate the effect of vitamins C and E on the risk of Parkinson's disease. They concluded that vitamin E, rather than vitamin C, might have a protective effect against PD [1]. The authors should be congratulated for performing a well-designed study. In this letter, however, we highlight some methodological aspects that raised our concerns.</description>
      <pubDate>Tue, 23 Nov 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00532-X/fulltext?rss=yes</guid>
      <dc:title>Comment on “effect of dietary vitamins C and E on the risk of Parkinson's disease: A meta-analysis”</dc:title>
      <dc:creator>Chong-Chong Zhao, Hong-Bin Cai, Zhao-Ming Ge</dc:creator>
      <dc:date>2021-11-23T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.023</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Impact of COVID-19 in nutritional and functional status of survivors admitted in intensive care units during the first outbreak. Preliminary results of the NUTRICOVID study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00526-4/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-11-23</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>COVID-19 patients present a high hospitalization rate with a high mortality risk for those requiring intensive care. When these patients have other comorbid conditions and older age, the risk for severe disease and poor outcomes after ICU admission are increased. The present work aims to describe the preliminary results of the ongoing NUTRICOVID study about the nutritional and functional status and the quality of life of adult COVID-19 survivors after ICU discharge, emphasizing the in-hospital and discharge situation of this population.</description>
      <pubDate>Tue, 23 Nov 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00526-4/fulltext?rss=yes</guid>
      <dc:title>Impact of COVID-19 in nutritional and functional status of survivors admitted in intensive care units during the first outbreak. Preliminary results of the NUTRICOVID study</dc:title>
      <dc:creator>Cristina Cuerda, Iván Sánchez López, Carmen Gil Martínez, María Merino Viveros, Cristina Velasco, Vanessa Cevallos Peñafiel, María Maíz Jiménez, Irene Gonzalo, Víctor González-Sánchez, Araceli Ramos Carrasco, Patricia Díaz Guardiola, Clara Marcuello Foncillas, M.A. Sampedro-Núñez, Marina Morato Martínez, Icíar Galicia, Naiara Modroño Móstoles, María Blanca Martínez-Barbeito, Laura Mola Reyes, Cristina Navea Aguilera, Loredana Arhip, Dolores Del Olmo García, Mario Huelves Delgado, Emilia Cáncer-Minchot, María Pastor García, Beatriz Pelegrina-Cortés, Juana Olivar Roldán, Silmary Maichle, Begoña Molina Bahena, Natalia García Vázquez, Elena Atienza, Irene Hoyas Rodríguez, Ángela Amengual Galbarte, Ángela Morales, MªA Valero Zanuy, Pilar Matía-Martín, Carolina Knott, Alexander Agrifoglio Rotaeche, Andrés Ortiz, MªP Gómez Montes, Mercedes Ramírez Ortiz, Marta Ruiz Aguado, Samara Palma Milla, Teresa Montoya Álvarez, Enrique Sanz Martínez, Marta Rodríguez De Codesal, Belén Quesada Bellver, Susana Aceituno, F.J. Pérez-Sádaba, Julia Álvarez-Hernández, NUTRICOVID study research group of SENDIMAD</dc:creator>
      <dc:date>2021-11-23T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.017</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>ESPEN practical guideline: Home enteral nutrition</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00497-0/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-11-23</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ESPEN Guideline</prism:section>
      <description>This ESPEN practical guideline will inform physicians, nurses, dieticians, pharmacists, caregivers and other home enteral nutrition (HEN) providers in a concise way about the indications and contraindications for HEN, as well as its implementation and monitoring. This guideline will also inform interested patients requiring HEN. Home parenteral nutrition is not included but will be addressed in a separate ESPEN guideline. The guideline is based on the ESPEN scientific guideline published before, which consists of 61 recommendations that have been reproduced and renumbered, along with the associated commentaries that have been shorted compared to the scientific guideline.</description>
      <pubDate>Tue, 23 Nov 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00497-0/fulltext?rss=yes</guid>
      <dc:title>ESPEN practical guideline: Home enteral nutrition</dc:title>
      <dc:creator>Stephan C. Bischoff, Peter Austin, Kurt Boeykens, Michael Chourdakis, Cristina Cuerda, Cora Jonkers-Schuitema, Marek Lichota, Ibolya Nyulasi, Stéphane M. Schneider, Zeno Stanga, Loris Pironi</dc:creator>
      <dc:date>2021-11-23T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.018</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Dysphagia and mechanical ventilation in SARS-COV-2 pneumonia: It's real</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00527-6/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-11-22</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>Dysphagia can be a consequence of prolonged hospitalization in intensive care units (ICUs) due to severe SARS-CoV-2 pneumonia. This study aims at Identifying the risk factors for dysphagia in ICU patients with COVID-19 pneumonia requiring invasive mechanical ventilation, and at determining the frequency of postextubation dysphagia in this population.</description>
      <pubDate>Mon, 22 Nov 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00527-6/fulltext?rss=yes</guid>
      <dc:title>Dysphagia and mechanical ventilation in SARS-COV-2 pneumonia: It's real</dc:title>
      <dc:creator>Luisa Bordejé Laguna, Pilar Marcos-Neira, Itziar Martínez de Lagrán Zurbano, Esther Mor Marco, Carlos Pollán Guisasola, Constanza Dolores Viñas Soria, Pilar Ricart Martí</dc:creator>
      <dc:date>2021-11-22T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.018</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Endoscopic management of colovesical and colovaginal fistulas with over‐the‐scope clips: A single‐institution case series</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15987?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15987</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15987?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Conventional surgical management of colovesical and colovaginal fistulas can be morbid and is contraindicated in many patients. Our aim in this work is to evaluate our experience in the management of colovesical and colovaginal fistulas with endoscopic over-the-scope (OTS) clips.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;A retrospective review of all patients who underwent attempted endoscopic OTS clip management of colovesical and colovaginal fistulas between 2013 and 2020 was performed. Preoperative risk factors, operative details and postoperative outcomes are reported.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Ten patients were identified. Fistula types were: colovesical (five), rectovesical (two), colovaginal (two) and rectovaginal (one). The aetiology of the fistula was diverticular disease in seven (70%) cases and surgical complication of pelvic surgery in three (30%). The mean defect age was 157 ± 98 days, the mean defect diameter was 4.5 mm (range 2–10 mm) and the mean fistula length was 15 mm (range 2–25 mm). In nine (90%) cases, fistula identification and cannulation were performed through the nonenteric lumen of the fistula. Initial management with an OTS clip was technically successful in eight (80%) patients. Of the eight patients who underwent OTS clip placement, long-term success (mean follow-up 218 days, range 25–673 days) was achieved after initial intervention in four (50%) patients. One patient underwent serial OTS clip procedures and achieved long-term success after four interventions; three patients have not undergone a repeat procedure after initial failure.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Endoscopic management of colovesical and colovaginal fistulas with OTS clips offers a promising therapeutic option for patients with contraindications to conventional surgical management. Immediate technical success and long-term success rates are similar to other gastrointestinal tract applications of OTS clips.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 17 Nov 2021 18:18:02 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15987</guid>
      <dc:title>Endoscopic management of colovesical and colovaginal fistulas with over‐the‐scope clips: A single‐institution case series</dc:title>
      <dc:creator>Colin G. DeLong, 
Jeffrey S. Scow, 
David J. Morrell, 
John J. Knoedler, 
Vamsi V. Alli, 
Joshua S. Winder, 
Eric M. Pauli</dc:creator>
      <dc:description>Abstract

Aim
Conventional surgical management of colovesical and colovaginal fistulas can be morbid and is contraindicated in many patients. Our aim in this work is to evaluate our experience in the management of colovesical and colovaginal fistulas with endoscopic over‐the‐scope (OTS) clips.


Method
A retrospective review of all patients who underwent attempted endoscopic OTS clip management of colovesical and colovaginal fistulas between 2013 and 2020 was performed. Preoperative risk factors, operative details and postoperative outcomes are reported.


Results
Ten patients were identified. Fistula types were: colovesical (five), rectovesical (two), colovaginal (two) and rectovaginal (one). The aetiology of the fistula was diverticular disease in seven (70%) cases and surgical complication of pelvic surgery in three (30%). The mean defect age was 157 ± 98 days, the mean defect diameter was 4.5 mm (range 2–10 mm) and the mean fistula length was 15 mm (range 2–25 mm). In nine (90%) cases, fistula identification and cannulation were performed through the nonenteric lumen of the fistula. Initial management with an OTS clip was technically successful in eight (80%) patients. Of the eight patients who underwent OTS clip placement, long‐term success (mean follow‐up 218 days, range 25–673 days) was achieved after initial intervention in four (50%) patients. One patient underwent serial OTS clip procedures and achieved long‐term success after four interventions; three patients have not undergone a repeat procedure after initial failure.


Conclusion
Endoscopic management of colovesical and colovaginal fistulas with OTS clips offers a promising therapeutic option for patients with contraindications to conventional surgical management. Immediate technical success and long‐term success rates are similar to other gastrointestinal tract applications of OTS clips.</dc:description>
      <dc:date>2021-11-17T18:18:02Z</dc:date>
      <dc:identifier>10.1111/codi.15987</dc:identifier>
    </item>
    <item>
      <title>The significance of subdivisions of microscopically positive (R1) margins in colorectal cancer: A retrospective study of a national cancer registry</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15971?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15971</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15971?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Microscopically positive (R1) margins are associated with poorer outcomes in patients with colorectal cancer. However, little is known of the differential impact of subdivisions of R1 margins, be they to the primary tumour (R1tumour) or to lymph node metastases/tumour deposits (R1LNM).&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;Patients treated for Stage III colorectal cancer from 1 January 2016 to 31 December 2019 were identified from the Danish national cancer registry. Patients were stratified into three groups according to margin status (R0 vs. R1tumour vs. R1LNM). The primary outcome was overall survival.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;In all, 4186 patients were included, comprising 3012 patients with colon cancer and 1174 patients with rectal cancer. The R1 resection rates were 16.5% and 18.2% in patients with colon and rectum cancer, respectively. In colon cancers, 3-year overall survival was reduced in patients with R1LNM (65.7%, 95% CI 62.8–68.6) or R1tumour margins (51.8%, 95% CI 47.3–56.3) compared with R0 resections (80.8%, 95% CI 79.9–81.6, &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001). A similar impact on survival was seen in rectal cancers (R0, 84.2%, 95% CI 82.9–85.5; R1LNM, 72.2%, 95% CI 67.8–76.6; R1tumour, 56.6%, 95% CI 50.0–63.2, &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001). Margin status was independently prognostic of survival in both colon (R1tumour, hazard ratio 2.08, 95% CI 1.50–2.89, &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001; R1LNM, hazard ratio 1.48, 95% CI 1.11–1.97, &lt;i&gt;P&lt;/i&gt; = 0.008) and rectal cancers (R1tumour, hazard ratio 2.35, 95% CI 1.42–3.90, &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.001; R1LNM, hazard ratio 1.54, 95% CI 0.95–2.48, &lt;i&gt;P&lt;/i&gt; = 0.077).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;R1 subdivisions have distinct impacts on survival in Stage III colorectal cancer. Further focused research in these patient subgroups is warranted.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Wed, 17 Nov 2021 17:44:56 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15971</guid>
      <dc:title>The significance of subdivisions of microscopically positive (R1) margins in colorectal cancer: A retrospective study of a national cancer registry</dc:title>
      <dc:creator>Henry G. Smith, 
Deepthi Chiranth, 
Christiane E. Mortensen, 
Nis H. Schlesinger</dc:creator>
      <dc:description>Abstract

Aim
Microscopically positive (R1) margins are associated with poorer outcomes in patients with colorectal cancer. However, little is known of the differential impact of subdivisions of R1 margins, be they to the primary tumour (R1tumour) or to lymph node metastases/tumour deposits (R1LNM).


Methods
Patients treated for Stage III colorectal cancer from 1 January 2016 to 31 December 2019 were identified from the Danish national cancer registry. Patients were stratified into three groups according to margin status (R0 vs. R1tumour vs. R1LNM). The primary outcome was overall survival.


Results
In all, 4186 patients were included, comprising 3012 patients with colon cancer and 1174 patients with rectal cancer. The R1 resection rates were 16.5% and 18.2% in patients with colon and rectum cancer, respectively. In colon cancers, 3‐year overall survival was reduced in patients with R1LNM (65.7%, 95% CI 62.8–68.6) or R1tumour margins (51.8%, 95% CI 47.3–56.3) compared with R0 resections (80.8%, 95% CI 79.9–81.6, P &lt; 0.001). A similar impact on survival was seen in rectal cancers (R0, 84.2%, 95% CI 82.9–85.5; R1LNM, 72.2%, 95% CI 67.8–76.6; R1tumour, 56.6%, 95% CI 50.0–63.2, P &lt; 0.001). Margin status was independently prognostic of survival in both colon (R1tumour, hazard ratio 2.08, 95% CI 1.50–2.89, P &lt; 0.001; R1LNM, hazard ratio 1.48, 95% CI 1.11–1.97, P = 0.008) and rectal cancers (R1tumour, hazard ratio 2.35, 95% CI 1.42–3.90, P &lt; 0.001; R1LNM, hazard ratio 1.54, 95% CI 0.95–2.48, P = 0.077).


Conclusion
R1 subdivisions have distinct impacts on survival in Stage III colorectal cancer. Further focused research in these patient subgroups is warranted.</dc:description>
      <dc:date>2021-11-17T17:44:56Z</dc:date>
      <dc:identifier>10.1111/codi.15971</dc:identifier>
    </item>
    <item>
      <title>The gospel of patients with ultra‐low rectal cancer: robot‐assisted intersphincteric resection—a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15982?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15982</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15982?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Tue, 16 Nov 2021 20:37:17 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15982</guid>
      <dc:title>The gospel of patients with ultra‐low rectal cancer: robot‐assisted intersphincteric resection—a video vignette</dc:title>
      <dc:creator>Wei Ge, 
Li‐hua Shao, 
Hai‐yan Gong, 
Gang Chen</dc:creator>
      <dc:description />
      <dc:date>2021-11-16T20:37:17Z</dc:date>
      <dc:identifier>10.1111/codi.15982</dc:identifier>
    </item>
    <item>
      <title>Ninety‐day morbidity of robot‐assisted redo surgery for recurrent rectal prolapse, mesh erosion and pelvic pain: lessons learned from 9 years’ experience in a tertiary referral centre</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15979?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15979</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15979?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;With increasing follow-up of patients treated with minimally invasive ventral mesh rectopexy (VMR) more redo surgery can be expected for recurrent rectal prolapse, mesh erosion and pelvic pain. The aim of this study is to evaluate the 90-day morbidity of robot-assisted redo interventions.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;All robot-assisted redo interventions after primary transabdominal repair of rectal prolapse between 2011 and 2019 were retrospectively analysed and compared with the results for patients after primary robot-assisted VMR during the same period. The redo interventions were divided into groups based on the indication for surgery (recurrent prolapse, mesh erosion, pelvic pain). Intraoperative complications and 90-day postoperative morbidity were evaluated.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Three hundred and fifty nine patients were treated with primary VMR, with 73 for recurrent rectal prolapse, 12 for mesh erosion and 14 for pelvic pain. Complications of recurrent prolapse surgeries were comparable to those of primary VMR (&lt;i&gt;p&lt;/i&gt; &amp;gt; 0.05). More intraoperative complications, minor and major complications were seen in redo surgery for erosion compared with primary VMR (23% vs. 3%, &lt;i&gt;p&lt;/i&gt; = 0.01; 31% vs. 11%, &lt;i&gt;p&lt;/i&gt; = 0.055; and 38% vs. 1%, &lt;i&gt;p&lt;/i&gt; &amp;lt; 0.01 respectively). The frequency of intraoperative complications after redo surgery for pelvic pain was 7% with minor and major morbidity rates of 14% and 7% (&lt;i&gt;p&lt;/i&gt; &amp;gt; 0.05). Half of the patients with pelvic pain experienced relief of their symptoms.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Redo surgery for management of recurrent rectal prolapse is safe. Redo surgery for mesh erosion is associated with high morbidity rates. Redo surgery for pelvic pain can have major complications and is only effective in half of the cases.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Tue, 16 Nov 2021 20:33:11 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15979</guid>
      <dc:title>Ninety‐day morbidity of robot‐assisted redo surgery for recurrent rectal prolapse, mesh erosion and pelvic pain: lessons learned from 9 years’ experience in a tertiary referral centre</dc:title>
      <dc:creator>Emma M. Schans, 
Paul M. Verheijen, 
Ivo A. M. J. Broeders, 
Esther C. J. Consten</dc:creator>
      <dc:description>Abstract

Aim
With increasing follow‐up of patients treated with minimally invasive ventral mesh rectopexy (VMR) more redo surgery can be expected for recurrent rectal prolapse, mesh erosion and pelvic pain. The aim of this study is to evaluate the 90‐day morbidity of robot‐assisted redo interventions.


Method
All robot‐assisted redo interventions after primary transabdominal repair of rectal prolapse between 2011 and 2019 were retrospectively analysed and compared with the results for patients after primary robot‐assisted VMR during the same period. The redo interventions were divided into groups based on the indication for surgery (recurrent prolapse, mesh erosion, pelvic pain). Intraoperative complications and 90‐day postoperative morbidity were evaluated.


Results
Three hundred and fifty nine patients were treated with primary VMR, with 73 for recurrent rectal prolapse, 12 for mesh erosion and 14 for pelvic pain. Complications of recurrent prolapse surgeries were comparable to those of primary VMR (p &gt; 0.05). More intraoperative complications, minor and major complications were seen in redo surgery for erosion compared with primary VMR (23% vs. 3%, p = 0.01; 31% vs. 11%, p = 0.055; and 38% vs. 1%, p &lt; 0.01 respectively). The frequency of intraoperative complications after redo surgery for pelvic pain was 7% with minor and major morbidity rates of 14% and 7% (p &gt; 0.05). Half of the patients with pelvic pain experienced relief of their symptoms.


Conclusion
Redo surgery for management of recurrent rectal prolapse is safe. Redo surgery for mesh erosion is associated with high morbidity rates. Redo surgery for pelvic pain can have major complications and is only effective in half of the cases.</dc:description>
      <dc:date>2021-11-16T20:33:11Z</dc:date>
      <dc:identifier>10.1111/codi.15979</dc:identifier>
    </item>
    <item>
      <title>Robotic local excision for rectal cancer using the da Vinci X robotic platform—A Video Vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15983?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15983</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15983?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Tue, 16 Nov 2021 20:25:21 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15983</guid>
      <dc:title>Robotic local excision for rectal cancer using the da Vinci X robotic platform—A Video Vignette</dc:title>
      <dc:creator>Konstantinos Tsimogiannis, 
Lalit Kumar, 
Khadija Tariq, 
Jim Khan</dc:creator>
      <dc:description />
      <dc:date>2021-11-16T20:25:21Z</dc:date>
      <dc:identifier>10.1111/codi.15983</dc:identifier>
    </item>
    <item>
      <title>Use of indocyanine green fluorescence guidance in redo ileocolic resection for Crohn's disease</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15980?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15980</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15980?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Redo ileocolic resection in patients with Crohn's disease (CD) is associated with significant technical challenges that may be associated with high complication rates. The aim of this study was to evaluate the feasibility of near-infrared fluorescence angiography with indocyanine green (ICG), often used to evaluate blood supply to the anastomosis in CD patients undergoing repeat ileocolic resection.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;This study was a retrospective analysis of patients who underwent redo ileocolic resection using ICG bowel perfusion assessment between 2015 and 2021. Patients were matched and compared on a 1:2 basis with a control group undergoing the same procedure without perfusion assessment.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Twelve patients underwent redo ileocolic resection with ICG perfusion assessment (ICG group). These were compared with 24 patients who underwent the procedure without ICG (control group). Both groups were similar in demographics and operative characteristics including median operating time (255 vs. 255.5 min, &lt;i&gt;p&lt;/i&gt; = 0.39) and conversion rate (22% vs. 36.8%, &lt;i&gt;p&lt;/i&gt; = 0.68). Median estimated blood loss was significantly higher in the ICG group [150 (50–400) vs. 100 ml (20–125)]. Successful ICG perfusion assessment was seen in all patients in the ICG group and did not change management in any case. Overall postoperative complication rates were comparable between the groups (58.3% vs. 54.1%, &lt;i&gt;p&lt;/i&gt; = 0.72). No anastomotic leaks occurred in the ICG group compared with one (1/24, 4.2%) in the control group (&lt;i&gt;p&lt;/i&gt; = 0.99).&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Fluorescence ICG perfusion assessment is feasible and safe in redo ileocolic resection in patients with CD. Larger studies are needed to evaluate whether this technique should be routinely used in these complex surgical interventions.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Tue, 16 Nov 2021 20:13:09 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15980</guid>
      <dc:title>Use of indocyanine green fluorescence guidance in redo ileocolic resection for Crohn's disease</dc:title>
      <dc:creator>Michael R. Freund, 
Ilan Kent, 
Samir Agarwal, 
Steven D. Wexner</dc:creator>
      <dc:description>Abstract

Aim
Redo ileocolic resection in patients with Crohn's disease (CD) is associated with significant technical challenges that may be associated with high complication rates. The aim of this study was to evaluate the feasibility of near‐infrared fluorescence angiography with indocyanine green (ICG), often used to evaluate blood supply to the anastomosis in CD patients undergoing repeat ileocolic resection.


Method
This study was a retrospective analysis of patients who underwent redo ileocolic resection using ICG bowel perfusion assessment between 2015 and 2021. Patients were matched and compared on a 1:2 basis with a control group undergoing the same procedure without perfusion assessment.


Results
Twelve patients underwent redo ileocolic resection with ICG perfusion assessment (ICG group). These were compared with 24 patients who underwent the procedure without ICG (control group). Both groups were similar in demographics and operative characteristics including median operating time (255 vs. 255.5 min, p = 0.39) and conversion rate (22% vs. 36.8%, p = 0.68). Median estimated blood loss was significantly higher in the ICG group [150 (50–400) vs. 100 ml (20–125)]. Successful ICG perfusion assessment was seen in all patients in the ICG group and did not change management in any case. Overall postoperative complication rates were comparable between the groups (58.3% vs. 54.1%, p = 0.72). No anastomotic leaks occurred in the ICG group compared with one (1/24, 4.2%) in the control group (p = 0.99).


Conclusion
Fluorescence ICG perfusion assessment is feasible and safe in redo ileocolic resection in patients with CD. Larger studies are needed to evaluate whether this technique should be routinely used in these complex surgical interventions.</dc:description>
      <dc:date>2021-11-16T20:13:09Z</dc:date>
      <dc:identifier>10.1111/codi.15980</dc:identifier>
    </item>
    <item>
      <title>Prolonged postoperative ileus following right‐ versus left‐sided colectomy: A systematic review and meta‐analysis</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15969?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15969</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15969?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">SYSTEMATIC REVIEW</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Prolonged postoperative ileus (PPOI) is a common complication following colonic surgery, and is associated with longer hospital stay, greater risk of complications and substantial cost for patients and hospitals. Some reports have recently suggested that gastrointestinal (GI) recovery varies based on the side of resection (i.e., right-sided vs. left-sided colectomy). This systematic review and meta-analysis aimed to compare GI recovery by resection side.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;The MEDLINE, Embase, Cochrane Library and CENTRAL databases were systematically searched for articles reporting GI recovery outcomes in adults undergoing elective right- versus left-sided colectomy (excluding with ileostomy) of any surgical approach. The primary outcome was PPOI, and secondary outcomes included time to first passage of flatus, stool and tolerance of solid diet, and postoperative complications. Subgroup analyses of laparoscopic procedures and cohorts without inflammatory bowel disease and sensitivity analysis of adjusted multivariate results were also performed.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Nine studies were identified, of which seven were included in the meta-analysis, comprising 29 068 colectomies (14 581 right-sided; 14 487 left-sided). PPOI was heterogeneously defined and was significantly more likely following right-sided compared to left-sided colectomy regardless of the surgical approach (OR 1.78, 95% CI 1.32–2.39; &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.01; &lt;i&gt;I&lt;/i&gt;
&lt;sup&gt;2&lt;/sup&gt; = 51%), as well as on subgroup analyses and adjusted multivariate meta-analysis. Secondary outcomes were reported in only a few small studies; hence meta-analysis did not produce reliable results.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Based on heterogeneous definitions, consistently higher rates of PPOI were observed following right- versus left-sided colectomy. These differences are currently unexplained and highlight the need for further research into the pathophysiology of ileus.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>SYSTEMATIC REVIEW</category>
      <pubDate>Tue, 16 Nov 2021 19:59:51 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15969</guid>
      <dc:title>Prolonged postoperative ileus following right‐ versus left‐sided colectomy: A systematic review and meta‐analysis</dc:title>
      <dc:creator>Sean Ho Beom Seo, 
Daniel A. Carson, 
Sameer Bhat, 
Chris Varghese, 
Cameron I. Wells, 
Ian P. Bissett, 
Greg O'Grady</dc:creator>
      <dc:description>Abstract

Aim
Prolonged postoperative ileus (PPOI) is a common complication following colonic surgery, and is associated with longer hospital stay, greater risk of complications and substantial cost for patients and hospitals. Some reports have recently suggested that gastrointestinal (GI) recovery varies based on the side of resection (i.e., right‐sided vs. left‐sided colectomy). This systematic review and meta‐analysis aimed to compare GI recovery by resection side.


Methods
The MEDLINE, Embase, Cochrane Library and CENTRAL databases were systematically searched for articles reporting GI recovery outcomes in adults undergoing elective right‐ versus left‐sided colectomy (excluding with ileostomy) of any surgical approach. The primary outcome was PPOI, and secondary outcomes included time to first passage of flatus, stool and tolerance of solid diet, and postoperative complications. Subgroup analyses of laparoscopic procedures and cohorts without inflammatory bowel disease and sensitivity analysis of adjusted multivariate results were also performed.


Results
Nine studies were identified, of which seven were included in the meta‐analysis, comprising 29 068 colectomies (14 581 right‐sided; 14 487 left‐sided). PPOI was heterogeneously defined and was significantly more likely following right‐sided compared to left‐sided colectomy regardless of the surgical approach (OR 1.78, 95% CI 1.32–2.39; P &lt; 0.01; I2 = 51%), as well as on subgroup analyses and adjusted multivariate meta‐analysis. Secondary outcomes were reported in only a few small studies; hence meta‐analysis did not produce reliable results.


Conclusion
Based on heterogeneous definitions, consistently higher rates of PPOI were observed following right‐ versus left‐sided colectomy. These differences are currently unexplained and highlight the need for further research into the pathophysiology of ileus.</dc:description>
      <dc:date>2021-11-16T19:59:51Z</dc:date>
      <dc:identifier>10.1111/codi.15969</dc:identifier>
    </item>
    <item>
      <title>Is there a bias against open surgery for colorectal cancer?</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15973?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15973</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15973?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Tue, 16 Nov 2021 19:53:06 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15973</guid>
      <dc:title>Is there a bias against open surgery for colorectal cancer?</dc:title>
      <dc:creator>Pawel Mroczkowski, 
Radoslaw Zajdel</dc:creator>
      <dc:description />
      <dc:date>2021-11-16T19:53:06Z</dc:date>
      <dc:identifier>10.1111/codi.15973</dc:identifier>
    </item>
    <item>
      <title>Outcomes of radical surgical resections for nonmetastatic anorectal melanomas: Experience from a tertiary care centre</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15975?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15975</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15975?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;The outcome of radical surgery in nonmetastatic anorectal melanoma (AM) patients is studied infrequently. Here, we aimed to explore the stage-wise outcomes and the impact of radical resections in these patients.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;In this single-centre retrospective study, data of 154 eligible patients were recorded and analysed. Data were obtained from November 2010 to September 2019 with follow-up until November 2020. Overall survival (OS) and disease-free survival (DFS) was calculated by Kaplan Meir method and univariate analysis of prognostic factors by Cox regression.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Of 154 patients, 110 were metastatic (stage III) and 44 were nonmetastatic (stage I:22, stage II:22) and underwent curative resections. Median follow-up was 48 months (14–119 months). A total of 39 patients underwent total mesorectal excisions (TME) and five transanal excision (TAE) were performed. Seven patients underwent extended resections. Stage I and II patients had 3- and 5-year OS of 40% and 36%; and DFS of 45% and 33.2%, respectively. Median OS and DFS were 31 and 24 months, respectively. Stage II (node-positive) patients had better median OS compared to stage III (21 vs. 4 months; &lt;i&gt;p&lt;/i&gt; = 0.000), and 54.5% patients had recurrences, most commonly both systemic and nodal (45.83%). Median OS of patients without recurrence was 34 months.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;In this large surgical series of AMs, outcome in stage I and II patients was significantly better than stage III and patients with stage II disease can have acceptable oncological outcomes. Radical surgical resections with or without lymphadenectomy could be considered in these patients. The role of adjuvant systemic therapy and radiation needs to be explored as part of multimodality treatment.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Tue, 16 Nov 2021 19:49:20 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15975</guid>
      <dc:title>Outcomes of radical surgical resections for nonmetastatic anorectal melanomas: Experience from a tertiary care centre</dc:title>
      <dc:creator>Ambarish Chatterjee, 
Jitender Rohila, 
Mufaddal Kazi, 
Vivekanand Sharma, 
Ashwin Desouza, 
Vikas Ostwal, 
Jyoti Bajpai, 
Reena Engineer, 
Munita Bal, 
Avanish Saklani</dc:creator>
      <dc:description>Abstract

Aim
The outcome of radical surgery in nonmetastatic anorectal melanoma (AM) patients is studied infrequently. Here, we aimed to explore the stage‐wise outcomes and the impact of radical resections in these patients.


Methods
In this single‐centre retrospective study, data of 154 eligible patients were recorded and analysed. Data were obtained from November 2010 to September 2019 with follow‐up until November 2020. Overall survival (OS) and disease‐free survival (DFS) was calculated by Kaplan Meir method and univariate analysis of prognostic factors by Cox regression.


Results
Of 154 patients, 110 were metastatic (stage III) and 44 were nonmetastatic (stage I:22, stage II:22) and underwent curative resections. Median follow‐up was 48 months (14–119 months). A total of 39 patients underwent total mesorectal excisions (TME) and five transanal excision (TAE) were performed. Seven patients underwent extended resections. Stage I and II patients had 3‐ and 5‐year OS of 40% and 36%; and DFS of 45% and 33.2%, respectively. Median OS and DFS were 31 and 24 months, respectively. Stage II (node‐positive) patients had better median OS compared to stage III (21 vs. 4 months; p = 0.000), and 54.5% patients had recurrences, most commonly both systemic and nodal (45.83%). Median OS of patients without recurrence was 34 months.


Conclusion
In this large surgical series of AMs, outcome in stage I and II patients was significantly better than stage III and patients with stage II disease can have acceptable oncological outcomes. Radical surgical resections with or without lymphadenectomy could be considered in these patients. The role of adjuvant systemic therapy and radiation needs to be explored as part of multimodality treatment.</dc:description>
      <dc:date>2021-11-16T19:49:20Z</dc:date>
      <dc:identifier>10.1111/codi.15975</dc:identifier>
    </item>
    <item>
      <title>Rectal washout during abdominoperineal resection for rectal cancer has no impact on the oncological outcome</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15977?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15977</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15977?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Intraoperative rectal washout is performed to eliminate exfoliated intraluminal cancer cells and thereby decrease the risk of local recurrence. Rectal washout in abdominoperineal resection has not been studied. The aim of this study was to assess the oncological outcome after rectal washout in abdominoperineal resection for rectal cancer and to find evidence as to whether rectal washout should be performed or not.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;Data for all patients registered in the Swedish Colorectal Cancer Registry who underwent elective surgery with abdominoperineal resection for rectal cancer (TNM Stages I–III) between 2007 and 2013 were analysed using multivariable analysis.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;No significant differences were shown between the rectal washout group and the no rectal washout group for local recurrence [10/265 (3.8%) vs. 87/2160 (4.0%), &lt;i&gt;p&lt;/i&gt; = 0.84], distant metastasis [51/265 (19.2%) vs. 476/2160 (22.0%), &lt;i&gt;p&lt;/i&gt; = 0.29] or overall recurrence [53/265 (20.0%) vs. 505/2160 (23.4%), &lt;i&gt;p&lt;/i&gt; = 0.21]. In multivariable analysis, rectal washout did not significantly affect the oncological outcome in terms of local recurrence, distant metastasis, overall recurrence or 5-year overall or relative survival.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Our results do not support routine rectal washout during abdominoperineal resection in order to improve the oncological outcome.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Tue, 16 Nov 2021 19:43:14 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15977</guid>
      <dc:title>Rectal washout during abdominoperineal resection for rectal cancer has no impact on the oncological outcome</dc:title>
      <dc:creator>Rebecca Svensson Neufert, 
Fredrik Jörgren, 
Pamela Buchwald</dc:creator>
      <dc:description>Abstract

Aim
Intraoperative rectal washout is performed to eliminate exfoliated intraluminal cancer cells and thereby decrease the risk of local recurrence. Rectal washout in abdominoperineal resection has not been studied. The aim of this study was to assess the oncological outcome after rectal washout in abdominoperineal resection for rectal cancer and to find evidence as to whether rectal washout should be performed or not.


Method
Data for all patients registered in the Swedish Colorectal Cancer Registry who underwent elective surgery with abdominoperineal resection for rectal cancer (TNM Stages I–III) between 2007 and 2013 were analysed using multivariable analysis.


Results
No significant differences were shown between the rectal washout group and the no rectal washout group for local recurrence [10/265 (3.8%) vs. 87/2160 (4.0%), p = 0.84], distant metastasis [51/265 (19.2%) vs. 476/2160 (22.0%), p = 0.29] or overall recurrence [53/265 (20.0%) vs. 505/2160 (23.4%), p = 0.21]. In multivariable analysis, rectal washout did not significantly affect the oncological outcome in terms of local recurrence, distant metastasis, overall recurrence or 5‐year overall or relative survival.


Conclusion
Our results do not support routine rectal washout during abdominoperineal resection in order to improve the oncological outcome.</dc:description>
      <dc:date>2021-11-16T19:43:14Z</dc:date>
      <dc:identifier>10.1111/codi.15977</dc:identifier>
    </item>
    <item>
      <title>Metabolic positron emission tomography/CT response after induction chemotherapy and chemo(re)irradiation is associated with higher negative resection margin rate in patients with locally recurrent rectal cancer</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15934?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15934</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15934?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Positron emission tomography (PET)/CT can be used to monitor the metabolic changes that occur after intensified treatment with induction chemotherapy and chemo(re)irradiation for locally recurrent rectal cancer (LRRC). This study aimed to analyse the correlation between the PET/CT response and final histopathological outcomes.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;All LRRC patients who underwent induction chemotherapy prior to surgery between January 2010 and July 2020 and were monitored with pretreatment and post-treatment PET/CT were included. Visual qualitative analysis was performed, and patients were scored as having achieved a complete metabolic response (CMR), partial metabolic response (PMR) or no response (NR). The histopathological response was assessed according to the Mandard tumour regression (TRG) score and categorized as major (TRG 1–2), partial (TRG 3) or poor (TRG 4–5). The PET/CT and TRG categories were compared, and possible confounders were analysed.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A total of 106 patients were eligible for analysis; 24 (23%) had a CMR, 54 (51%) had a PMR and 28 (26%) had NR. PET/CT response was a significant predictor of the negative resection margin rate, achieving 96% for CMR, 69% for PMR and 50% for NR. The overall accuracy between PET score and pathological TRG was 45%, and the positive predictive value for CMR was 63%. A longer interval between post-treatment PET/CT and surgery negatively influenced the predictive value.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Metabolic PET/CT response evaluation after neoadjuvant treatment proves to be a complementary diagnostic tool to standard MRI in assessing tumour response, and may play a role for treatment planning in LRRC patients.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Tue, 16 Nov 2021 19:33:27 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15934</guid>
      <dc:title>Metabolic positron emission tomography/CT response after induction chemotherapy and chemo(re)irradiation is associated with higher negative resection margin rate in patients with locally recurrent rectal cancer</dc:title>
      <dc:creator>Desley M. G. I. Zoggel, 
Eva L. K. Voogt, 
Ineke G. Lijnschoten, 
Jeltsje S. Cnossen, 
Geert‐Jan Creemers, 
Joost Nederend, 
Johanne G. Bloemen, 
Grard A. P. Nieuwenhuijzen, 
Pim J. W. A. Burger, 
Sabine G. G. F. Lardenoije, 
Harm J. T. Rutten, 
Mark J. Roef</dc:creator>
      <dc:description>Abstract

Aim
Positron emission tomography (PET)/CT can be used to monitor the metabolic changes that occur after intensified treatment with induction chemotherapy and chemo(re)irradiation for locally recurrent rectal cancer (LRRC). This study aimed to analyse the correlation between the PET/CT response and final histopathological outcomes.


Methods
All LRRC patients who underwent induction chemotherapy prior to surgery between January 2010 and July 2020 and were monitored with pretreatment and post‐treatment PET/CT were included. Visual qualitative analysis was performed, and patients were scored as having achieved a complete metabolic response (CMR), partial metabolic response (PMR) or no response (NR). The histopathological response was assessed according to the Mandard tumour regression (TRG) score and categorized as major (TRG 1–2), partial (TRG 3) or poor (TRG 4–5). The PET/CT and TRG categories were compared, and possible confounders were analysed.


Results
A total of 106 patients were eligible for analysis; 24 (23%) had a CMR, 54 (51%) had a PMR and 28 (26%) had NR. PET/CT response was a significant predictor of the negative resection margin rate, achieving 96% for CMR, 69% for PMR and 50% for NR. The overall accuracy between PET score and pathological TRG was 45%, and the positive predictive value for CMR was 63%. A longer interval between post‐treatment PET/CT and surgery negatively influenced the predictive value.


Conclusion
Metabolic PET/CT response evaluation after neoadjuvant treatment proves to be a complementary diagnostic tool to standard MRI in assessing tumour response, and may play a role for treatment planning in LRRC patients.</dc:description>
      <dc:date>2021-11-16T19:33:27Z</dc:date>
      <dc:identifier>10.1111/codi.15934</dc:identifier>
    </item>
    <item>
      <title>Towards the reduction of surgical site infection rates in colorectal surgery</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15970?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15970</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15970?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Fri, 12 Nov 2021 12:09:40 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15970</guid>
      <dc:title>Towards the reduction of surgical site infection rates in colorectal surgery</dc:title>
      <dc:creator>Nicola Reeves, 
Gethin Williams</dc:creator>
      <dc:description />
      <dc:date>2021-11-12T12:09:40Z</dc:date>
      <dc:identifier>10.1111/codi.15970</dc:identifier>
    </item>
    <item>
      <title>Increased long‐term mortality after open colorectal cancer surgery: a multicentre population‐based study. Response to the letter of Mroczkowski et al.</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15974?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15974</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15974?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Fri, 12 Nov 2021 12:00:06 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15974</guid>
      <dc:title>Increased long‐term mortality after open colorectal cancer surgery: a multicentre population‐based study. Response to the letter of Mroczkowski et al.</dc:title>
      <dc:creator>Milad Fahim, 
Lea M. Dijksman, 
Thijs A. Burghgraef, 
Paul B. Nat, 
Wouter J. M. Derksen, 
Hjalmar C. Santvoort, 
Bareld B. Pultrum, 
Esther C. J. Consten, 
Douwe H. Biesma, 
Anke B. Smits</dc:creator>
      <dc:description />
      <dc:date>2021-11-12T12:00:06Z</dc:date>
      <dc:identifier>10.1111/codi.15974</dc:identifier>
    </item>
    <item>
      <title>Data from the Nielsen et al. study does not support their suggestion</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15967?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15967</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15967?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Fri, 12 Nov 2021 12:00:06 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15967</guid>
      <dc:title>Data from the Nielsen et al. study does not support their suggestion</dc:title>
      <dc:creator>Pernille Thordal Larsen, 
Morten Rasmussen, 
Sisse H. Njor</dc:creator>
      <dc:description />
      <dc:date>2021-11-12T12:00:06Z</dc:date>
      <dc:identifier>10.1111/codi.15967</dc:identifier>
    </item>
    <item>
      <title>Re: Re: Malignant transformation of tailgut cysts is significantly higher than previously reported: Systematic review of cases in the literature (Glyn et al)</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15972?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15972</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15972?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>CORRESPONDENCE</category>
      <pubDate>Fri, 12 Nov 2021 10:39:17 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15972</guid>
      <dc:title>Re: Re: Malignant transformation of tailgut cysts is significantly higher than previously reported: Systematic review of cases in the literature (Glyn et al)</dc:title>
      <dc:creator>Kenneth Nicoll, 
Claire Carden</dc:creator>
      <dc:description />
      <dc:date>2021-11-12T10:39:17Z</dc:date>
      <dc:identifier>10.1111/codi.15972</dc:identifier>
    </item>
    <item>
      <title>Energy and protein intake may have an impact on survival in patients with advanced cancer</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00504-5/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-11-10</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>Malnutrition is associated with decreased survival in patients with advanced cancer [1], however, it is not known which relative roles are played by the inadequate intake of energy and/or specific substrates.</description>
      <pubDate>Wed, 10 Nov 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00504-5/fulltext?rss=yes</guid>
      <dc:title>Energy and protein intake may have an impact on survival in patients with advanced cancer</dc:title>
      <dc:creator>Jann Arends</dc:creator>
      <dc:date>2021-11-10T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.11.003</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Reducing surgical site infection rates in colorectal surgery – A quality improvement approach to implementing a comprehensive bundle (CDI‐01554‐2020.R2)</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15968?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15968</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15968?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">COMMENTARY</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>COMMENTARY</category>
      <pubDate>Tue, 09 Nov 2021 13:00:55 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15968</guid>
      <dc:title>Reducing surgical site infection rates in colorectal surgery – A quality improvement approach to implementing a comprehensive bundle (CDI‐01554‐2020.R2)</dc:title>
      <dc:creator>George Ramsay, 
Angus Watson</dc:creator>
      <dc:description />
      <dc:date>2021-11-09T13:00:55Z</dc:date>
      <dc:identifier>10.1111/codi.15968</dc:identifier>
    </item>
    <item>
      <title>Laparoscopic versus open surgery for left flexure colon cancer: A propensity score matched analysis from an international cohort</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15962?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15962</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15962?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Surgical treatment of splenic flexure cancer (SFC) still presents some debated issues, including the role of laparoscopic surgery. The literature is based on small single-centre series, while randomized controlled studies comparing open and laparoscopic treatment for colon cancer exclude SFC. This study aimed to determine the role of laparoscopic surgery in the treatment of SFC, comparing short- and long-term outcomes with open surgery.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;This was an international multicentre retrospective cohort study that analysed patients from 10 tertiary referral centres. From a cohort of 641 cases, 484 patients with Stage I–III SFC submitted to elective surgery with curative intent were selected. After 1:1 propensity score matching, 130 patients in the laparoscopic group (LapGroup) were compared with 130 patients in the open surgery group (OpenGroup).&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;After propensity score matching, the two groups were comparable for demographic and clinical parameters. OpenGroup presented a higher incidence of overall (&lt;i&gt;P&lt;/i&gt; = 0.02) and surgery-related complications (&lt;i&gt;P&lt;/i&gt; = 0.05) but a similar rate of severe complications (&lt;i&gt;P&lt;/i&gt; = 0.75). Length of stay was notably shorter in the LapGroup (&lt;i&gt;P&lt;/i&gt; = 0.001). Overall (&lt;i&gt;P&lt;/i&gt; = 0.793) as well as cancer-specific survival (&lt;i&gt;P&lt;/i&gt; = 0.63) did not differ between the two groups.&lt;/p&gt;
&lt;h2&gt;Conclusions&lt;/h2&gt;
&lt;p&gt;Elective laparoscopic surgery for Stage I–III SFC is feasible and associated with improved short-term postoperative outcomes compared to open surgery. Moreover, laparoscopic surgery appears to provide excellent long-term cancer outcomes.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Tue, 09 Nov 2021 11:55:15 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15962</guid>
      <dc:title>Laparoscopic versus open surgery for left flexure colon cancer: A propensity score matched analysis from an international cohort</dc:title>
      <dc:creator>Corrado Pedrazzani, 
Giulia Turri, 
Soo Yeun Park, 
Koya Hida, 
Yudai Fukui, 
Jacopo Crippa, 
Giovanni Ferrari, 
Matteo Origi, 
Gaya Spolverato, 
Matteo Zuin, 
Sung Uk Bae, 
Seong Kyu Baek, 
Andrea Costanzi, 
Dario Maggioni, 
Gyung Mo Son, 
Andrea Scala, 
Timothy Rockall, 
David W. Larson, 
Alfredo Guglielmi, 
Gyu Seog Choi</dc:creator>
      <dc:description>Abstract

Aim
Surgical treatment of splenic flexure cancer (SFC) still presents some debated issues, including the role of laparoscopic surgery. The literature is based on small single‐centre series, while randomized controlled studies comparing open and laparoscopic treatment for colon cancer exclude SFC. This study aimed to determine the role of laparoscopic surgery in the treatment of SFC, comparing short‐ and long‐term outcomes with open surgery.


Method
This was an international multicentre retrospective cohort study that analysed patients from 10 tertiary referral centres. From a cohort of 641 cases, 484 patients with Stage I–III SFC submitted to elective surgery with curative intent were selected. After 1:1 propensity score matching, 130 patients in the laparoscopic group (LapGroup) were compared with 130 patients in the open surgery group (OpenGroup).


Results
After propensity score matching, the two groups were comparable for demographic and clinical parameters. OpenGroup presented a higher incidence of overall (P = 0.02) and surgery‐related complications (P = 0.05) but a similar rate of severe complications (P = 0.75). Length of stay was notably shorter in the LapGroup (P = 0.001). Overall (P = 0.793) as well as cancer‐specific survival (P = 0.63) did not differ between the two groups.


Conclusions
Elective laparoscopic surgery for Stage I–III SFC is feasible and associated with improved short‐term postoperative outcomes compared to open surgery. Moreover, laparoscopic surgery appears to provide excellent long‐term cancer outcomes.</dc:description>
      <dc:date>2021-11-09T11:55:15Z</dc:date>
      <dc:identifier>10.1111/codi.15962</dc:identifier>
    </item>
    <item>
      <title>Risk of post‐colonoscopy colorectal cancer following screening colonoscopy with low‐risk or no adenomas: a population‐based study. Response to Larsen et al.</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15966?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15966</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15966?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">COMMENTARY</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>COMMENTARY</category>
      <pubDate>Tue, 09 Nov 2021 11:45:26 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15966</guid>
      <dc:title>Risk of post‐colonoscopy colorectal cancer following screening colonoscopy with low‐risk or no adenomas: a population‐based study. Response to Larsen et al.</dc:title>
      <dc:creator>Jesper Clausen Nielsen, 
Magnus Ploug, 
Gunnar Baatrup, 
Rasmus Kroijer</dc:creator>
      <dc:description />
      <dc:date>2021-11-09T11:45:26Z</dc:date>
      <dc:identifier>10.1111/codi.15966</dc:identifier>
    </item>
    <item>
      <title>C‐reactive protein (CRP) trajectory as a predictor of anastomotic leakage after rectal cancer resection: A multicentre cohort study</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15963?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15963</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15963?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;This study aimed to identify whether CRP-trajectory measurement, including increase in CRP-level of 50 mg/l per day, is an accurate predictor of anastomotic leakage (AL) in patients undergoing resection for rectal cancer.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;A prospective multicentre database was used. CRP was recorded on the first three postoperative days. Sensitivity, specificity, positive and negative predictive values, and area under the receiver operator characteristic (ROC) curve were used to analyse performances of CRP-trajectory measurements between postoperative day (POD) 1–2, 2–3, 1–3 and between any two days.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A total of 271 patients were included in the study. AL was observed in 12.5% (34/271). Increase in CRP-level of 50 mg/l between POD 1–2 had a negative predictive value of 0.92, specificity of 0.71 and sensitivity of 0.57. Changes in CRP-levels between POD 2–3 were associated with a negative predictive value, specificity and sensitivity of 0.89, 0.93 and 0.26, respectively. Changes in CRP-levels between POD 1–3 showed a negative predictive value of 0.94, specificity of 0.76 and sensitivity of 0.65. In addition, 50 mg/l changes between any two days showed a negative predictive value of 0.92, specificity of 0.66 and sensitivity of 0.62. The area under the ROC curve for all CRP-trajectory measurements ranged from 0.593–0.700.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;The present study showed that CRP-trajectory between postoperative days lacks predictive value to singularly rule out AL. Early and safe discharge in patients undergoing rectal surgery for adenocarcinoma cannot be guaranteed based on this parameter. High negative predictive values are mainly caused by the relatively low prevalence of AL.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Sun, 07 Nov 2021 18:19:08 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15963</guid>
      <dc:title>C‐reactive protein (CRP) trajectory as a predictor of anastomotic leakage after rectal cancer resection: A multicentre cohort study</dc:title>
      <dc:creator>Vincent T. Hoek, 
Cloë L. Sparreboom, 
Albert M. Wolthuis, 
Anand G. Menon, 
Gert‐Jan Kleinrensink, 
André D'Hoore, 
Niels Komen, 
Johan F. Lange, 
the APPEAL II collaborators, 
H.L. van Westreenen, 
P.G. Doornebosch, 
J.W.T. Dekker, 
F Daams, 
D. J. Lips, 
W.M.U. van Grevenstein, 
T.M. Karsten</dc:creator>
      <dc:description>Abstract

Aim
This study aimed to identify whether CRP‐trajectory measurement, including increase in CRP‐level of 50 mg/l per day, is an accurate predictor of anastomotic leakage (AL) in patients undergoing resection for rectal cancer.


Methods
A prospective multicentre database was used. CRP was recorded on the first three postoperative days. Sensitivity, specificity, positive and negative predictive values, and area under the receiver operator characteristic (ROC) curve were used to analyse performances of CRP‐trajectory measurements between postoperative day (POD) 1–2, 2–3, 1–3 and between any two days.


Results
A total of 271 patients were included in the study. AL was observed in 12.5% (34/271). Increase in CRP‐level of 50 mg/l between POD 1–2 had a negative predictive value of 0.92, specificity of 0.71 and sensitivity of 0.57. Changes in CRP‐levels between POD 2–3 were associated with a negative predictive value, specificity and sensitivity of 0.89, 0.93 and 0.26, respectively. Changes in CRP‐levels between POD 1–3 showed a negative predictive value of 0.94, specificity of 0.76 and sensitivity of 0.65. In addition, 50 mg/l changes between any two days showed a negative predictive value of 0.92, specificity of 0.66 and sensitivity of 0.62. The area under the ROC curve for all CRP‐trajectory measurements ranged from 0.593–0.700.


Conclusion
The present study showed that CRP‐trajectory between postoperative days lacks predictive value to singularly rule out AL. Early and safe discharge in patients undergoing rectal surgery for adenocarcinoma cannot be guaranteed based on this parameter. High negative predictive values are mainly caused by the relatively low prevalence of AL.</dc:description>
      <dc:date>2021-11-07T18:19:08Z</dc:date>
      <dc:identifier>10.1111/codi.15963</dc:identifier>
    </item>
    <item>
      <title>Transanal suture mucopexy – A nonexcisional cost effective procedure for advanced haemorrhoids: A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15964?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15964</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15964?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Sun, 07 Nov 2021 18:12:11 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15964</guid>
      <dc:title>Transanal suture mucopexy – A nonexcisional cost effective procedure for advanced haemorrhoids: A video vignette</dc:title>
      <dc:creator>Shantikumar Dhondiram Chivate, 
Pankaj Garg</dc:creator>
      <dc:description />
      <dc:date>2021-11-07T18:12:11Z</dc:date>
      <dc:identifier>10.1111/codi.15964</dc:identifier>
    </item>
    <item>
      <title>Evolutionary patterns of chromosomal instability and mismatch repair deficiency in proximal and distal colorectal cancer</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15946?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15946</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15946?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Colorectal carcinomas (CRCs) progress through heterogeneous pathways. The aim of this study was to analyse whether or not the cytogenetic evolution of CRC is linked to tumour site, level of chromosomal imbalance and metastasis.&lt;/p&gt;
&lt;h2&gt;Method&lt;/h2&gt;
&lt;p&gt;A set of therapy-naïve pT3 CRCs comprising 26 proximal and 49 distal pT3 CRCs was studied by combining immunohistochemistry of mismatch repair (MMR) proteins, microsatellite analyses and molecular karyotyping as well as clinical parameters.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;A MMR deficient/microsatellite-unstable (dMMR/MSI-H) status was associated with location of the primary tumour proximal to the splenic flexure, and dMMR/MSI-H tumours presented with significantly lower levels of chromosomal imbalances compared with MMR proficient/microsatellite-stable (pMMR/MSS) tumours. Oncogenetic tree modelling suggested two evolutionary clusters characterized by dMMR/MSI-H and chromosomal instability (CIN), respectively, for both proximal and distal CRCs. In CIN cases, +13q, −18q and +20q were predicted as preferentially early events, and −1p, −4 -and −5q as late events. Separate oncogenetic tree models of proximal and distal cases indicated similar early events independent of tumour site. However, in cases with high CIN defined by more than 10 copy number aberrations, loss of 17p occurred earlier in cytogenetic evolution than in cases showing low to moderate CIN. Differences in the oncogenetic trees were observed for CRCs with lymph node and distant metastasis. Loss of 8p was modelled as an early event in node-positive CRC, while +7p and +8q comprised early events in CRC with distant metastasis.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;CRCs characterized by CIN follow multiple, interconnected genetic pathways in line with the basic ‘Vogelgram’ concept proposed for the progression of CRC that places the accumulation of genetic changes at centre of tumour evolution. However, the timing of specific genetic events may favour metastatic potential.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Fri, 05 Nov 2021 19:42:00 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15946</guid>
      <dc:title>Evolutionary patterns of chromosomal instability and mismatch repair deficiency in proximal and distal colorectal cancer</dc:title>
      <dc:creator>Mariola Monika Golas, 
Bastian Gunawan, 
Meliha Cakir, 
Silke Cameron, 
Christina Enders, 
Torsten Liersch, 
Laszlo Füzesi, 
Bjoern Sander</dc:creator>
      <dc:description>Abstract

Aim
Colorectal carcinomas (CRCs) progress through heterogeneous pathways. The aim of this study was to analyse whether or not the cytogenetic evolution of CRC is linked to tumour site, level of chromosomal imbalance and metastasis.


Method
A set of therapy‐naïve pT3 CRCs comprising 26 proximal and 49 distal pT3 CRCs was studied by combining immunohistochemistry of mismatch repair (MMR) proteins, microsatellite analyses and molecular karyotyping as well as clinical parameters.


Results
A MMR deficient/microsatellite‐unstable (dMMR/MSI‐H) status was associated with location of the primary tumour proximal to the splenic flexure, and dMMR/MSI‐H tumours presented with significantly lower levels of chromosomal imbalances compared with MMR proficient/microsatellite‐stable (pMMR/MSS) tumours. Oncogenetic tree modelling suggested two evolutionary clusters characterized by dMMR/MSI‐H and chromosomal instability (CIN), respectively, for both proximal and distal CRCs. In CIN cases, +13q, −18q and +20q were predicted as preferentially early events, and −1p, −4 ‐and −5q as late events. Separate oncogenetic tree models of proximal and distal cases indicated similar early events independent of tumour site. However, in cases with high CIN defined by more than 10 copy number aberrations, loss of 17p occurred earlier in cytogenetic evolution than in cases showing low to moderate CIN. Differences in the oncogenetic trees were observed for CRCs with lymph node and distant metastasis. Loss of 8p was modelled as an early event in node‐positive CRC, while +7p and +8q comprised early events in CRC with distant metastasis.


Conclusion
CRCs characterized by CIN follow multiple, interconnected genetic pathways in line with the basic ‘Vogelgram’ concept proposed for the progression of CRC that places the accumulation of genetic changes at centre of tumour evolution. However, the timing of specific genetic events may favour metastatic potential.</dc:description>
      <dc:date>2021-11-05T19:42:00Z</dc:date>
      <dc:identifier>10.1111/codi.15946</dc:identifier>
    </item>
    <item>
      <title>Tips and tricks for a minimally invasive approach for complicated ileocaecal Crohn's disease — A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15965?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15965</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15965?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Tue, 02 Nov 2021 14:21:24 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15965</guid>
      <dc:title>Tips and tricks for a minimally invasive approach for complicated ileocaecal Crohn's disease — A video vignette</dc:title>
      <dc:creator>Nicolas Avellaneda, 
Augusto Carrie, 
Analia Potolicchio, 
Ezequiel Ferro, 
Juan Pablo Muñoz</dc:creator>
      <dc:description />
      <dc:date>2021-11-02T14:21:24Z</dc:date>
      <dc:identifier>10.1111/codi.15965</dc:identifier>
    </item>
    <item>
      <title>Robotic total pelvic exenteration with en bloc pelvic side wall clearance and internal iliac artery resection – A Video Vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15960?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15960</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15960?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Tue, 02 Nov 2021 14:19:44 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15960</guid>
      <dc:title>Robotic total pelvic exenteration with en bloc pelvic side wall clearance and internal iliac artery resection – A Video Vignette</dc:title>
      <dc:creator>Emma Cole, 
Dora Huang, 
José Tomás Larach, 
Amrish Rajkomar, 
Keith Chip Farmer, 
Satish Warrier</dc:creator>
      <dc:description />
      <dc:date>2021-11-02T14:19:44Z</dc:date>
      <dc:identifier>10.1111/codi.15960</dc:identifier>
    </item>
    <item>
      <title>Laparoscopic subtotal colectomy with complete mesocolic excision, central vascular ligation – A video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15955?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15955</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15955?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Tue, 02 Nov 2021 14:17:55 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15955</guid>
      <dc:title>Laparoscopic subtotal colectomy with complete mesocolic excision, central vascular ligation – A video vignette</dc:title>
      <dc:creator>Pinak Dasgupta, 
Ajay Pai</dc:creator>
      <dc:description />
      <dc:date>2021-11-02T14:17:55Z</dc:date>
      <dc:identifier>10.1111/codi.15955</dc:identifier>
    </item>
    <item>
      <title>Laparoscopic high anterior resection and en bloc partial cystectomy for locally advanced sigmoid cancer – a video vignette</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15951?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15951</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15951?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">VIDEO CORRESPONDENCE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded />
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>VIDEO CORRESPONDENCE</category>
      <pubDate>Tue, 02 Nov 2021 14:17:11 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15951</guid>
      <dc:title>Laparoscopic high anterior resection and en bloc partial cystectomy for locally advanced sigmoid cancer – a video vignette</dc:title>
      <dc:creator>Sara Saeidi, 
Samuele Colombo, 
Maria Grazia Alberio, 
Paulina Boltuc, 
Giovanni Saredi, 
Salomone Di Saverio</dc:creator>
      <dc:description />
      <dc:date>2021-11-02T14:17:11Z</dc:date>
      <dc:identifier>10.1111/codi.15951</dc:identifier>
    </item>
    <item>
      <title>Gender dysphoria: laparoscopic sigmoid vaginoplasty. Another utility of indocyanine green</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15952?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15952</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15952?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">TECHNICAL NOTE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Gender dysphoria is the disagreement between the gender of birth and the one with which the patient identifies. For its management it is mandatory to have a multidisciplinary team. Gender confirmation surgery with penoscrotal skin flap is the procedure of choice, and a sigmoid vaginoplasty is a feasible alternative. The new technologies and the help of indocyanine green (ICG) fluorescence can help to guarantee a correct neovagina vascularization. The objective of this paper is to present the surgical technique of laparoscopic sigmoid vaginoplasty assisted by ICG.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;We present two patients with gender dysphoria and a history of stricture of the penoscrotal skin flap vaginoplasty. We performed sigmoid vaginoplasty by the laparoscopic approach. We began the procedure with the mobilization and section of 30 cm of sigmoid colon, selective ligation of the vessels assisted by ICG, 180° sigmoid rotation, externalized on antiperistaltic position, construction of colovestibular anastomosis and promontory fixation. We finished the procedure with virtual ileostomy construction and drain placement.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;Patients recovered satisfactorily and were discharged on the seventh day after surgery without complications.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;Sigmoid vaginoplasty is a safe and feasible procedure. ICG has great value, contributing to the selective ligation of the vessels, allowing 180° sigmoid rotation and guaranteeing the irrigation of the neovagina.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>TECHNICAL NOTE</category>
      <pubDate>Tue, 02 Nov 2021 14:15:40 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15952</guid>
      <dc:title>Gender dysphoria: laparoscopic sigmoid vaginoplasty. Another utility of indocyanine green</dc:title>
      <dc:creator>Blas Flor‐Lorente, 
Jose Gerardo Rosciano, 
Teresa Pérez‐Pérez, 
Jorge Sancho‐Muriel, 
Álvaro García‐Granero, 
Francisco Jose Nohales‐Alfonso, 
Vicent Primo‐Romaguera, 
Eduardo Antonio Simón‐Sanz</dc:creator>
      <dc:description>Abstract

Aim
Gender dysphoria is the disagreement between the gender of birth and the one with which the patient identifies. For its management it is mandatory to have a multidisciplinary team. Gender confirmation surgery with penoscrotal skin flap is the procedure of choice, and a sigmoid vaginoplasty is a feasible alternative. The new technologies and the help of indocyanine green (ICG) fluorescence can help to guarantee a correct neovagina vascularization. The objective of this paper is to present the surgical technique of laparoscopic sigmoid vaginoplasty assisted by ICG.


Methods
We present two patients with gender dysphoria and a history of stricture of the penoscrotal skin flap vaginoplasty. We performed sigmoid vaginoplasty by the laparoscopic approach. We began the procedure with the mobilization and section of 30 cm of sigmoid colon, selective ligation of the vessels assisted by ICG, 180° sigmoid rotation, externalized on antiperistaltic position, construction of colovestibular anastomosis and promontory fixation. We finished the procedure with virtual ileostomy construction and drain placement.


Results
Patients recovered satisfactorily and were discharged on the seventh day after surgery without complications.


Conclusion
Sigmoid vaginoplasty is a safe and feasible procedure. ICG has great value, contributing to the selective ligation of the vessels, allowing 180° sigmoid rotation and guaranteeing the irrigation of the neovagina.</dc:description>
      <dc:date>2021-11-02T14:15:40Z</dc:date>
      <dc:identifier>10.1111/codi.15952</dc:identifier>
    </item>
    <item>
      <title>The role of faecal calprotectin in the identification of colorectal neoplasia in patients attending for screening colonoscopy</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.15942?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 12:25:18 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.15942</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.15942?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">ORIGINAL ARTICLE</prism:section>
      <description>Colorectal Disease, EarlyView.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;h2&gt;Aim&lt;/h2&gt;
&lt;p&gt;Although the relationship between colorectal neoplasia and inflammation is well described, the role of faecal calprotectin (FC) in clinical practice to diagnose or screen patients for colorectal neoplasia is less defined. This prospective study characterizes the relationship between FC and colorectal neoplasia in patients within the faecal occult blood testing (FOBT) positive patients in the Scottish Bowel Screening Programme.&lt;/p&gt;
&lt;h2&gt;Methods&lt;/h2&gt;
&lt;p&gt;All FOBT positive patients attending for colonoscopy between February 2016 and July 2017 were invited to participate. Patients provided a stool sample for FC before commencing bowel preparation. All demographics and endoscopic findings were collected prospectively.&lt;/p&gt;
&lt;h2&gt;Results&lt;/h2&gt;
&lt;p&gt;In all, 352 patients were included. 210 patients had FC &amp;gt; 50 µg. Colorectal cancer (CRC) patients had a higher median FC (138.5 μg/g, &lt;i&gt;P&lt;/i&gt; &amp;lt; 0.05), in comparison to those without CRC, and 13/14 had an FC &amp;gt; 50 µg/g (93%). FC had a high sensitivity (92.8%) and negative predictive value (99.3%) for CRC, but with a low specificity (41.7%) and positive predictive value (6.2%). FC sensitivity increased sequentially as neoplasms progressed from non-advanced to malignant neoplasia (48.6% non-advanced adenoma vs. 92.9% CRC). However, no significant relationship was observed between FC and non-cancer neoplasia.&lt;/p&gt;
&lt;h2&gt;Conclusion&lt;/h2&gt;
&lt;p&gt;In an FOBT positive screening population, FC was strongly associated with CRC (sensitivity 92.8%, specificity 41.7% for CRC, at 50 µg/g). However, although sensitive for the detection of CRC, FC failed to show sufficient sensitivity or specificity for the detection of non-cancer neoplasia. Based on these results we cannot recommend routine use of FC in a bowel screening population to detect cancer per se, but it is apparent that, with further optimization, faecal assessments including quantification of haemoglobin and inflammation could form part of a risk assessment tool aimed at refining the selection of patients for colonoscopy in both symptomatic and screening populations.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>ORIGINAL ARTICLE</category>
      <pubDate>Tue, 02 Nov 2021 14:15:01 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.15942</guid>
      <dc:title>The role of faecal calprotectin in the identification of colorectal neoplasia in patients attending for screening colonoscopy</dc:title>
      <dc:creator>Fiona A. Ross, 
James H. Park, 
David Mansouri, 
Cariss Little, 
Domenic G. Di Rollo, 
Emilie Combet, 
Hester Van Wyk, 
Paul G. Horgan, 
Donald C. McMillan, 
Campbell S. D. Roxburgh</dc:creator>
      <dc:description>Abstract

Aim
Although the relationship between colorectal neoplasia and inflammation is well described, the role of faecal calprotectin (FC) in clinical practice to diagnose or screen patients for colorectal neoplasia is less defined. This prospective study characterizes the relationship between FC and colorectal neoplasia in patients within the faecal occult blood testing (FOBT) positive patients in the Scottish Bowel Screening Programme.


Methods
All FOBT positive patients attending for colonoscopy between February 2016 and July 2017 were invited to participate. Patients provided a stool sample for FC before commencing bowel preparation. All demographics and endoscopic findings were collected prospectively.


Results
In all, 352 patients were included. 210 patients had FC &gt; 50 µg. Colorectal cancer (CRC) patients had a higher median FC (138.5 μg/g, P &lt; 0.05), in comparison to those without CRC, and 13/14 had an FC &gt; 50 µg/g (93%). FC had a high sensitivity (92.8%) and negative predictive value (99.3%) for CRC, but with a low specificity (41.7%) and positive predictive value (6.2%). FC sensitivity increased sequentially as neoplasms progressed from non‐advanced to malignant neoplasia (48.6% non‐advanced adenoma vs. 92.9% CRC). However, no significant relationship was observed between FC and non‐cancer neoplasia.


Conclusion
In an FOBT positive screening population, FC was strongly associated with CRC (sensitivity 92.8%, specificity 41.7% for CRC, at 50 µg/g). However, although sensitive for the detection of CRC, FC failed to show sufficient sensitivity or specificity for the detection of non‐cancer neoplasia. Based on these results we cannot recommend routine use of FC in a bowel screening population to detect cancer per se, but it is apparent that, with further optimization, faecal assessments including quantification of haemoglobin and inflammation could form part of a risk assessment tool aimed at refining the selection of patients for colonoscopy in both symptomatic and screening populations.</dc:description>
      <dc:date>2021-11-02T14:15:01Z</dc:date>
      <dc:identifier>10.1111/codi.15942</dc:identifier>
    </item>
    <item>
      <title>Nutritional management and clinical outcome of critically ill patients with COVID-19: A retrospective study in a tertiary hospital</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00499-4/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-11-01</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>Severe COVID-19 infection is characterized by an inflammatory response and lung injury that can evolve into an acute respiratory distress syndrome that needs support treatment in intensive care unit. Nutritional treatment is an important component of the management of critically ill patients and should be started in the first 48 h of ICU admission to avoid malnutrition. This study describes the characteristics of the patients treated in a tertiary hospital in Madrid during the months of March–May 2020 (first wave), the medical nutrition treatment employed and its influence in the clinical outcome of these patients.</description>
      <pubDate>Mon, 01 Nov 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00499-4/fulltext?rss=yes</guid>
      <dc:title>Nutritional management and clinical outcome of critically ill patients with COVID-19: A retrospective study in a tertiary hospital</dc:title>
      <dc:creator>M. Miguélez, C. Velasco, M. Camblor, J. Cedeño, C. Serrano, I. Bretón, L. Arhip, M. Motilla, M.L. Carrascal, A. Morales, N. Brox, C. Cuerda</dc:creator>
      <dc:date>2021-11-01T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.020</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Preoperative abdominal fat distribution and systemic immune inflammation were associated with response to intravesical Bacillus Calmette-Guerin immunotherapy in patients with non-muscle invasive bladder cancer</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00498-2/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-11-01</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5792</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5801</prism:endingPage>
      <description>To investigate the predictors of response to intravesical Bacillus Calmette-Guerin (BCG) immunotherapy for intermediate and high-risk non-muscle invasive bladder cancer (NMIBC) patients.</description>
      <pubDate>Mon, 01 Nov 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00498-2/fulltext?rss=yes</guid>
      <dc:title>Preoperative abdominal fat distribution and systemic immune inflammation were associated with response to intravesical Bacillus Calmette-Guerin immunotherapy in patients with non-muscle invasive bladder cancer</dc:title>
      <dc:creator>Zhi-Bin Ke, Hang Chen, Jia-Yin Chen, Hai Cai, Yun-Zhi Lin, Xiong-Lin Sun, Jin-Bei Huang, Qing-Shui Zheng, Yong Wei, Xue-Yi Xue, Ning Xu</dc:creator>
      <dc:date>2021-11-01T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.019</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Immediate vs. gradual advancement to goal of enteral nutrition after elective abdominal surgery: A multicenter non-inferiority randomized trial</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00490-8/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-30</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Randomized Control Trials</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5802</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5811</prism:endingPage>
      <description>The strategy of increasing the postoperative enteral nutrition dose to the target goal has not yet been clarified. This study aimed to determine whether an immediate goal-dose enteral nutrition (IGEN) strategy is non-inferior to a gradual goal-dose enteral nutrition (GGEN) strategy in reducing infections in patients undergoing abdominal surgery involving the organs of the digestive system.</description>
      <pubDate>Sat, 30 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00490-8/fulltext?rss=yes</guid>
      <dc:title>Immediate vs. gradual advancement to goal of enteral nutrition after elective abdominal surgery: A multicenter non-inferiority randomized trial</dc:title>
      <dc:creator>Li Zhang, Yuxiu Liu, Xuejin Gao, Da Zhou, Yupeng Zhang, Feng Tian, Tingting Gao, Yong Wang, Zhida Chen, Bo Lian, Hao Hu, Zhenyi Jia, Zhigang Xue, Dong Guo, Junde Zhou, Yingchao Gu, Fangyou Gong, Xiaoting Wu, Yun Tang, Mengbin Li, Gang Jin, Huanlong Qin, Jianchun Yu, Yanbing Zhou, Qiang Chi, Hua Yang, Kunhua Wang, Guoli Li, Ning Li, Arthur R.H. van Zanten, Jieshou Li, Xinying Wang</dc:creator>
      <dc:date>2021-10-30T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.014</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Comment on: Maternal vitamin D status and risk of gestational diabetes mellitus: A systematic review and meta-analysis of prospective cohort studies</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00495-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-28</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5751</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5752</prism:endingPage>
      <description>A recently study by Milajerdi et al. searched available databases and conducted a systematic review and meta-analysis to assess the association between maternal serum vitamin D deficiency or insufficiency and risk of gestational diabetes mellitus (GDM), which was published in the recent issue of Clinical Nutrition [1]. They came to the conclusion that a significant association between vitamin D deficiency and an increased risk of GDM was found. Although the results are of great importance, we would like to underline some issues as to identification of the studies, screening process, and data analysis that we feel ought to be considered when interpreting these findings.</description>
      <pubDate>Thu, 28 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00495-7/fulltext?rss=yes</guid>
      <dc:title>Comment on: Maternal vitamin D status and risk of gestational diabetes mellitus: A systematic review and meta-analysis of prospective cohort studies</dc:title>
      <dc:creator>Tingting Zhang</dc:creator>
      <dc:date>2021-10-28T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.016</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Nutritional state assessed by ultrasonography, but not by bioelectric impedance, predicts 28-day mortality in critically ill patients. Prospective cohort study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00491-X/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-27</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5742</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5750</prism:endingPage>
      <description>Malnutrition is a disease associated with unfavorable outcomes and high prevalence among critically ill patients. The primary aim of the study was to correlate the nutritional status of patients recently admitted to the intensive care unit (ICU) with the 28-day mortality rate. The secondary aim was to establish cut-off values for the bioelectrical impedance analysis (BIA) and ultrasonography (USG) methods for the classification of the nutritional status of critically ill patients.</description>
      <pubDate>Wed, 27 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00491-X/fulltext?rss=yes</guid>
      <dc:title>Nutritional state assessed by ultrasonography, but not by bioelectric impedance, predicts 28-day mortality in critically ill patients. Prospective cohort study</dc:title>
      <dc:creator>Liliane Barbosa da Silva Passos, Túlio Augusto Alves Macedo, Daurea Abadia De-Souza</dc:creator>
      <dc:date>2021-10-27T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.015</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Plant-based diet quality and the risk of total and disease-specific mortality: A population-based prospective study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00482-9/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-24</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5718</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5725</prism:endingPage>
      <description>Plant-based diets have been suggested to have health benefits, and risk differs by quality of plant foods. However, evidence on the association between the quality of plant-based diets and mortality are limited. This study examined the associations between 3 different types of plant-based diet indices and risk of total and disease-specific mortality.</description>
      <pubDate>Sun, 24 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00482-9/fulltext?rss=yes</guid>
      <dc:title>Plant-based diet quality and the risk of total and disease-specific mortality: A population-based prospective study</dc:title>
      <dc:creator>Jihye Kim, Hyunju Kim, Edward L. Giovannucci</dc:creator>
      <dc:date>2021-10-24T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.013</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Adherence to Mediterranean diet and its associations with circulating cytokines, musculoskeletal health and incident falls in community-dwelling older men: The Concord Health and Ageing in Men Project</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00479-9/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-23</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5753</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5763</prism:endingPage>
      <description>Mediterranean dietary patterns may exert favourable effects on various health conditions. This study aimed to determine associations of adherence to Mediterranean diet as well as its components, with circulating cytokine levels, musculoskeletal health and incident falls in community-dwelling older men.</description>
      <pubDate>Sat, 23 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00479-9/fulltext?rss=yes</guid>
      <dc:title>Adherence to Mediterranean diet and its associations with circulating cytokines, musculoskeletal health and incident falls in community-dwelling older men: The Concord Health and Ageing in Men Project</dc:title>
      <dc:creator>Mavil May C. Cervo, David Scott, Markus J. Seibel, Robert G. Cumming, Vasi Naganathan, Fiona M. Blyth, David G. Le Couteur, David J. Handelsman, Rosilene V. Ribeiro, Louise M. Waite, Vasant Hirani</dc:creator>
      <dc:date>2021-10-23T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.010</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Phenotype assessment in neurologically impaired paediatric patients: Impact of a nutrition intervention protocol</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00480-5/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-22</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5734</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5741</prism:endingPage>
      <description>Deficits in nutritional status and functional feeding disorders are common in Neurologically Impaired Paediatric Patients (NIPP). Interventions addressing these problems could offer better overall health status and quality of life in this group of patients, but the extent of their effectiveness is yet to be determined. Recent guidelines concerning the nutritional care of NIPP have been published from ESPGHAN but compliance to them has not been assessed.</description>
      <pubDate>Fri, 22 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00480-5/fulltext?rss=yes</guid>
      <dc:title>Phenotype assessment in neurologically impaired paediatric patients: Impact of a nutrition intervention protocol</dc:title>
      <dc:creator>Vasiliki Katseni, Euthymia Vargiami, Thomais Karagiozoglou-Lampoudi, Efstratia Daskalou, Dimitrios Zafeiriou</dc:creator>
      <dc:date>2021-10-22T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.011</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Body mass trajectories and multimorbidity in old age: 12-year results from a population-based study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00481-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-21</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5764</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5770</prism:endingPage>
      <description>Body weight changes reflect and impact several health conditions in older age, but little is known about its relationship with multimorbidity. We aimed to study the association of long-terms trajectories of body mass index (BMI) with contemporaneous changes in multimorbidity −and multimorbidity type− development in a population-based cohort of older adults.</description>
      <pubDate>Thu, 21 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00481-7/fulltext?rss=yes</guid>
      <dc:title>Body mass trajectories and multimorbidity in old age: 12-year results from a population-based study</dc:title>
      <dc:creator>Amaia Calderón-Larrañaga, Xiaonan Hu, Jie Guo, Luigi Ferrucci, Weili Xu, Davide L. Vetrano</dc:creator>
      <dc:date>2021-10-21T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.012</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Effect of the consumption of hesperidin in orange juice on the transcriptomic profile of subjects with elevated blood pressure and stage 1 hypertension: A randomized controlled trial (CITRUS study)</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00478-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-21</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Randomized Control Trials</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5812</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5822</prism:endingPage>
      <description>Hesperidin exerts cardiovascular beneficial effects, but its mechanisms of action remain undefined. In a previous study we demonstrated that a single dose and a 12-week treatment of hesperidin decreased systolic blood pressure. The aim of this study was to ascertain the action mechanisms of hesperidin consumption in subjects with elevated blood pressure or with stage 1 hypertension, by determining their transcriptomic profile after a single dose or a 12-week treatment.</description>
      <pubDate>Thu, 21 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00478-7/fulltext?rss=yes</guid>
      <dc:title>Effect of the consumption of hesperidin in orange juice on the transcriptomic profile of subjects with elevated blood pressure and stage 1 hypertension: A randomized controlled trial (CITRUS study)</dc:title>
      <dc:creator>Laura Pla-Pagà, Rosa M. Valls, Anna Pedret, Lorena Calderón-Pérez, Elisabet Llauradó, Judit Companys, Cristina Domenech-Coca, Nuria Canela, Josep M. del Bas, Antoni Caimari, Francesc Puiggròs, Covas MI, Lluís Arola, Rosa Solà</dc:creator>
      <dc:date>2021-10-21T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.009</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00476-3/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-20</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Communication</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5674</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5677</prism:endingPage>
      <description>Circulating microvesicles (cMV) are both effectors and biomarkers of cardiovascular disease (CVD), and the effects of omega 3 polyunsaturated fatty acids (n3 PUFA) in MV shedding are not yet well known. Therefore, we aimed to investigate the effects of long-term n3 PUFA supplementation on cMV release from cells of the vascular compartment in elderly subjects at very high risk of CVD.</description>
      <pubDate>Wed, 20 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00476-3/fulltext?rss=yes</guid>
      <dc:title>One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction</dc:title>
      <dc:creator>Gemma Chiva-Blanch, Vibeke Bratseth, Kristian Laake, Harald Arnesen, Svein Solheim, Erik Berg Schmidt, Lina Badimon, Ingebjørg Seljeflot</dc:creator>
      <dc:date>2021-10-20T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.007</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>ESPEN guideline on hospital nutrition</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00456-8/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-20</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ESPEN Guideline</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5684</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5709</prism:endingPage>
      <description>In hospitals through Europe and worldwide, the practices regarding hospital diets are very heterogeneous. Hospital diets are rarely prescribed by physicians, and sometimes the choices of diets are based on arbitrary reasons. Often prescriptions are made independently from the evaluation of nutritional status, and without taking into account the nutritional status. Therapeutic diets (low salt, gluten-free, texture and consistency modified, …) are associated with decreased energy delivery (i.e. underfeeding) and increased risk of malnutrition.</description>
      <pubDate>Wed, 20 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00456-8/fulltext?rss=yes</guid>
      <dc:title>ESPEN guideline on hospital nutrition</dc:title>
      <dc:creator>Ronan Thibault, Osman Abbasoglu, Elina Ioannou, Laila Meija, Karen Ottens-Oussoren, Claude Pichard, Elisabet Rothenberg, Diana Rubin, Ulla Siljamäki-Ojansuu, Marie-France Vaillant, Stephan C. Bischoff</dc:creator>
      <dc:date>2021-10-20T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.09.039</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Early supplemental parenteral nutrition is associated with reduced mortality in critically ill surgical patients with high nutritional risk</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00477-5/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-19</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5678</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5683</prism:endingPage>
      <description>Adequate nutritional provision is important for critically ill patients to improve clinical outcomes. Starting enteral nutrition (EN) as early as possible is recommended and preferred to parenteral nutrition (PN). However, patients who undergo emergency abdominal operations may have alterations in their intra-abdominal environment and gastrointestinal motility leading to limitation in starting an enteral diet. Therefore, our study was designed to evaluate the benefit of early supplemental PN to achieve adequate calorie and protein supply in critically ill patients undergoing surgery who are not eligible for early EN.</description>
      <pubDate>Tue, 19 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00477-5/fulltext?rss=yes</guid>
      <dc:title>Early supplemental parenteral nutrition is associated with reduced mortality in critically ill surgical patients with high nutritional risk</dc:title>
      <dc:creator>Joohyun Sim, Jeong Hong, Eun Mi Na, Seorin Doo, Yun Tae Jung</dc:creator>
      <dc:date>2021-10-19T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.008</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>A protein-supplemented very-low-calorie diet does not mitigate reductions in lean mass and resting metabolic rate in subjects with overweight or obesity: A randomized controlled trial</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00475-1/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-18</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5726</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5733</prism:endingPage>
      <description>The European Food Safety Authority recently recommended an increase in the protein content of total diet replacement (TDR) products from 50 to 75 g/day. The rationale was to minimize reductions in lean mass (LM) and resting metabolic rate (RMR) that occur with weight loss, and thereby facilitate maintenance of lost weight. We sought to directly compare the efficacy of TDR regimens with the new vs the current protein requirement.</description>
      <pubDate>Mon, 18 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00475-1/fulltext?rss=yes</guid>
      <dc:title>A protein-supplemented very-low-calorie diet does not mitigate reductions in lean mass and resting metabolic rate in subjects with overweight or obesity: A randomized controlled trial</dc:title>
      <dc:creator>Faidon Magkos, Mads F. Hjorth, Sarah Asping, Maria I. Rosenkrans, Sidse I. Rasmussen, Christian Ritz, Anders Sjödin, Nina R.W. Geiker</dc:creator>
      <dc:date>2021-10-18T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.006</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Impact of synbiotics treatment on bacteremia induced during neoadjuvant chemotherapy for esophageal cancer: A randomised controlled trial</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00473-8/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-12</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Randomized Control Trials</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5781</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5791</prism:endingPage>
      <description>To elucidate the impact of synbiotics on bacterial translocation and subsequent bacteremia during neoadjuvant chemotherapy for esophageal cancer.</description>
      <pubDate>Tue, 12 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00473-8/fulltext?rss=yes</guid>
      <dc:title>Impact of synbiotics treatment on bacteremia induced during neoadjuvant chemotherapy for esophageal cancer: A randomised controlled trial</dc:title>
      <dc:creator>Masahide Fukaya, Yukihiro Yokoyama, Hiroaki Usui, Hironori Fujieda, Yayoi Sakatoku, Takamasa Takahashi, Kazushi Miyata, Mai Niikura, Takuya Sugimoto, Takashi Asahara, Masato Nagino, Tomoki Ebata</dc:creator>
      <dc:date>2021-10-12T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.004</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00474-X/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-11</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Meta-analyses</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5662</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5673</prism:endingPage>
      <description>Epidemiologic studies are inconsistent regarding the association of dietary omega-3 polyunsaturated fatty acids (PUFA) and/or fish intake with risk of age-related macular degeneration (AMD) incidence and progression. The objective was to determine these associations by conducting a meta-analysis of available studies.</description>
      <pubDate>Mon, 11 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00474-X/fulltext?rss=yes</guid>
      <dc:title>Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration</dc:title>
      <dc:creator>Hong Jiang, Xin Shi, Yahui Fan, Duolao Wang, Baoyu Li, Jin Zhou, Cheng Pei, Le Ma</dc:creator>
      <dc:date>2021-10-11T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.005</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Quantity and variety of food groups consumption and the risk of diabetes in adults: A prospective cohort study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00472-6/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-10</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5710</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5717</prism:endingPage>
      <description>Evidence remains inconsistent regarding the association between quantity of food groups and diabetes, and remains scarce regarding the relation of dietary diversity with diabetes.</description>
      <pubDate>Sun, 10 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00472-6/fulltext?rss=yes</guid>
      <dc:title>Quantity and variety of food groups consumption and the risk of diabetes in adults: A prospective cohort study</dc:title>
      <dc:creator>Mengyi Liu, Chengzhang Liu, Zhuxian Zhang, Chun Zhou, Qinqin Li, Panpan He, Yuanyuan Zhang, Huan Li, Xianhui Qin</dc:creator>
      <dc:date>2021-10-10T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.003</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Impact of the level of adherence to the Mediterranean Diet on blood pressure: A systematic review and meta-analysis of observational studies</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00471-4/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-10-09</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Meta-analyses</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5771</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5780</prism:endingPage>
      <description>High blood pressure (BP) constitutes a common and serious medical condition which is rising globally, and is among preventable factors for cardiovascular, renal, brain and other diseases. Modifiable risk factors of high BP include unhealthy dietary patterns, presence of obesity, excess alcohol consumption and lack of physical activity. Data in regard to the different types of diets show that Mediterranean diet (MD) is associated with healthy levels of BP. In this study we aimed to investigate the impact of the level of adherence to MD in BP.</description>
      <pubDate>Sat, 09 Oct 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00471-4/fulltext?rss=yes</guid>
      <dc:title>Impact of the level of adherence to the Mediterranean Diet on blood pressure: A systematic review and meta-analysis of observational studies</dc:title>
      <dc:creator>Dimitra Rafailia Bakaloudi, Lydia Chrysoula, Ioannis Leonida, Evangelia Kotzakioulafi, Xenophon Theodoridis, Michail Chourdakis</dc:creator>
      <dc:date>2021-10-09T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.10.002</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Nutrition therapy in the intensive care unit during the COVID-19 pandemic: Findings from the ISIIC point prevalence study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00450-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-09-27</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>Nutrition therapy for Intensive Care Unit (ICU) patients involves complex decision-making, especially during the COVID-19 pandemic. We investigated the use of nutrition therapy in ICU patients with and without COVID-19 infections.</description>
      <pubDate>Mon, 27 Sep 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00450-7/fulltext?rss=yes</guid>
      <dc:title>Nutrition therapy in the intensive care unit during the COVID-19 pandemic: Findings from the ISIIC point prevalence study</dc:title>
      <dc:creator>Kensuke Nakamura, Keibun Liu, Hajime Katsukawa, Peter Nydahl, Eugene Wesley Ely, Sapna R. Kudchadkar, Shigeaki Inoue, Alan Kawarai Lefor, Osamu Nishida</dc:creator>
      <dc:date>2021-09-27T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.09.033</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Critical comments on the “impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study” by Alvarenga</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00432-5/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-09-17</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5659</prism:startingPage>
      <description>We recently read the published article in “Clinical Nutrition” entitled: “Impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study” by Alvarenga and et al. [1].</description>
      <pubDate>Fri, 17 Sep 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00432-5/fulltext?rss=yes</guid>
      <dc:title>Critical comments on the “impact of curcumin supplementation on expression of inflammatory transcription factors in hemodialysis patients: A pilot randomized, double-blind, controlled study” by Alvarenga</dc:title>
      <dc:creator>Meysam Zarezadeh, Mohammad Nosrati-Oskouie, Ali Tarighat-Esfanjani</dc:creator>
      <dc:date>2021-09-17T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.09.015</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>Comment on “Effectiveness of dietetic intervention for people with type 2 diabetes: A meta-analysis”</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00423-4/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-09-13</prism:publicationDate>
      <prism:volume xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">40</prism:volume>
      <prism:number xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">12</prism:number>
      <prism:issueIdentifier xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">S0261-5614(21)X0012-X</prism:issueIdentifier>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <prism:startingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5660</prism:startingPage>
      <prism:endingPage xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">5661</prism:endingPage>
      <description>It was with great interest that we read the article entitled “Effectiveness of dietetic intervention for people with type 2 diabetes: A meta-analysis”, published in 2021 in the Clin Nutr. The authors performed a systematic review and meta-analysis and aimed to compare the effectiveness of nutrition therapy delivered by dietitians to nutrition advice delivered by other healthcare professionals in adults with type 2 diabetes on metabolic parameters [1]. The authors should be congratulated for performing a well-designed study.</description>
      <pubDate>Mon, 13 Sep 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00423-4/fulltext?rss=yes</guid>
      <dc:title>Comment on “Effectiveness of dietetic intervention for people with type 2 diabetes: A meta-analysis”</dc:title>
      <dc:creator>Xiaomin Luo, Cen Yan, Yuejie Zhang, Wang Lu, Yingmei Feng</dc:creator>
      <dc:date>2021-09-13T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.09.006</dc:identifier>
      <dc:source>Clinical Nutrition 40, 12 (2021)</dc:source>
    </item>
    <item>
      <title>The impact of COVID-19 on diet quality, food security and nutrition in low and middle income countries: A systematic review of the evidence</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00395-2/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-08-26</prism:publicationDate>
      <description>The current global pandemic of Coronavirus (COVID-19), and measures adopted to reduce its spread, threaten the nutritional status of populations in Low- and middle-income countries (LMICs). Documenting how the COVID-19 affects diets, nutrition and food security can help generating evidence-informed recommendations for mitigating interventions and policies.</description>
      <pubDate>Thu, 26 Aug 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00395-2/fulltext?rss=yes</guid>
      <dc:title>The impact of COVID-19 on diet quality, food security and nutrition in low and middle income countries: A systematic review of the evidence</dc:title>
      <dc:creator>Fiorella Picchioni, Luis F. Goulao, Dominique Roberfroid</dc:creator>
      <dc:date>2021-08-26T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.08.015</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Influence of reduced muscle mass and quality on ventilator weaning and complications during intensive care unit stay in COVID-19 patients</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00375-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-08-15</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>Sarcopenia, a loss of muscle mass, quality and function, which is particularly evident in respiratory muscles, has been associated with many clinical adverse outcomes. In this study, we aimed at evaluating the role of reduced muscle mass and quality in predicting ventilation weaning, complications, length of intensive care unit (ICU) and of hospital stay and mortality in patients admitted to ICU for SARS-CoV-2-related pneumonia.</description>
      <pubDate>Sun, 15 Aug 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00375-7/fulltext?rss=yes</guid>
      <dc:title>Influence of reduced muscle mass and quality on ventilator weaning and complications during intensive care unit stay in COVID-19 patients</dc:title>
      <dc:creator>Sarah Damanti, Giulia Cristel, Giuseppe Alvise Ramirez, Enrica Paola Bozzolo, Valentina Da Prat, Agnese Gobbi, Clarissa Centurioni, Ettore Di Gaeta, Andrea Del Prete, Maria Grazia Calabrò, Maria Rosa Calvi, Giovanni Borghi, Alberto Zangrillo, Francesco De Cobelli, Giovanni Landoni, Moreno Tresoldi</dc:creator>
      <dc:date>2021-08-15T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.08.004</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Body mass index and Mini Nutritional Assessment-Short Form as predictors of in-geriatric hospital mortality in older adults with COVID-19</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00360-5/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-07-28</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>Overweight and obesity have been consistently reported to carry an increased risk for poorer outcomes in coronavirus disease 2019 (COVID-19) in adults. Existing reports mainly focus on in-hospital and intensive care unit mortality in patient cohorts usually not representative of the population with the highest mortality, i.e. the very old and frail patients. Accordingly, little is known about the risk patterns related to body mass and nutrition in very old patients. Our aim was to assess the relationship between body mass index (BMI), nutritional status and in-geriatric hospital mortality among geriatric patients treated for COVID-19.</description>
      <pubDate>Wed, 28 Jul 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00360-5/fulltext?rss=yes</guid>
      <dc:title>Body mass index and Mini Nutritional Assessment-Short Form as predictors of in-geriatric hospital mortality in older adults with COVID-19</dc:title>
      <dc:creator>L. Kananen, M. Eriksdotter, A.M. Boström, M. Kivipelto, M. Annetorp, C. Metzner, V. Bäck Jerlardtz, M. Engström, P. Johnson, L.G. Lundberg, E. Åkesson, C. Sühl Öberg, S. Hägg, D. Religa, J. Jylhävä, T. Cederholm</dc:creator>
      <dc:date>2021-07-28T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.07.025</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00316-2/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-06-25</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>To investigate the association between the parameters used in nutritional screening assessment (body mass index [BMI], unintentional weight loss [WL] and reduced food intake) and clinical outcomes in non-critically ill, hospitalized coronavirus disease 2019 (COVID-19) patients.</description>
      <pubDate>Fri, 25 Jun 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00316-2/fulltext?rss=yes</guid>
      <dc:title>Nutritional parameters associated with prognosis in non-critically ill hospitalized COVID-19 patients: The NUTRI-COVID19 study</dc:title>
      <dc:creator>Riccardo Caccialanza, Elena Formisano, Catherine Klersy, Virginia Ferretti, Alessandra Ferrari, Stefania Demontis, Annalisa Mascheroni, Sara Masi, Silvia Crotti, Federica Lobascio, Nadia Cerutti, Paolo Orlandoni, Cloè Dalla Costa, Elena Redaelli, Alessandra Fabbri, Alberto Malesci, Salvatore Corrao, Lorella Bordandini, Emanuele Cereda, NUTRI-COVID19 Collaborative Working Group</dc:creator>
      <dc:date>2021-06-25T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.06.020</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Anti-COVID-19 measures threaten our healthy body weight: Changes in sleep and external synchronizers of circadian clocks during confinement</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00315-0/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-06-25</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>Emergency measures in the face of the recent COVID-19 pandemic have been different among countries, although most have opted for confinement and restrictions on social contact. These measures have generated lifestyle changes with potential effects on individuals' health. The disturbances in daily routines due to confinement and remote work have impacted circadian rhythms and energy balance; however, the consequences of these disruptions have not been studied in depth. The objective was to evaluate the impact of 12-week confinement on body weight, considering changes in several external synchronizers of the biological clock.</description>
      <pubDate>Fri, 25 Jun 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00315-0/fulltext?rss=yes</guid>
      <dc:title>Anti-COVID-19 measures threaten our healthy body weight: Changes in sleep and external synchronizers of circadian clocks during confinement</dc:title>
      <dc:creator>Luis Baquerizo-Sedano, José A. Chaquila, Luis Aguilar, José M. Ordovás, Pedro González-Muniesa, Marta Garaulet</dc:creator>
      <dc:date>2021-06-25T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.06.019</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>COVID-19 is associated with oropharyngeal dysphagia and malnutrition in hospitalized patients during the spring 2020 wave of the pandemic</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00297-1/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-06-14</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>Prevalence and complications of oropharyngeal dysphagia (OD) and malnutrition (MN) in COVID-19 patients is unknown. Our aim was to assess the prevalence, risk factors and clinical outcomes of OD and MN in a general hospital during the first wave of the COVID-19 pandemic.</description>
      <pubDate>Mon, 14 Jun 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00297-1/fulltext?rss=yes</guid>
      <dc:title>COVID-19 is associated with oropharyngeal dysphagia and malnutrition in hospitalized patients during the spring 2020 wave of the pandemic</dc:title>
      <dc:creator>Alberto Martin–Martinez, Omar Ortega, Paula Viñas, Viridiana Arreola, Weslania Nascimento, Alícia Costa, Stephanie A. Riera, Claudia Alarcón, Pere Clavé</dc:creator>
      <dc:date>2021-06-14T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.06.010</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Dietary interventions and blood pressure in overweight or obese individuals: A systematic review and meta-analysis</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00290-9/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-06-10</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Meta-analyses</prism:section>
      <description>Increased fruit and vegetable consumption (FVC) beneficially impacts hypertension, yet researchers have not synthesized the effects of FVC interventions on blood pressure (BP) among overweight or obese individuals. Therefore, we aimed to examine if diets with increased FVC decrease BP in overweight and obese persons and explore effects of moderators, study methods, participants, intervention, and source characteristics.</description>
      <pubDate>Thu, 10 Jun 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00290-9/fulltext?rss=yes</guid>
      <dc:title>Dietary interventions and blood pressure in overweight or obese individuals: A systematic review and meta-analysis</dc:title>
      <dc:creator>Karla Arnotti, Mandy Bamber, Veronica Brewer</dc:creator>
      <dc:date>2021-06-10T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.06.003</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Myosteatosis predicting risk of transition to severe COVID-19 infection</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00281-8/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-06-06</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>About 10–20% of patients with Coronavirus disease 2019 (COVID-19) infection progressed to severe illness within a week or so after initially diagnosed as mild infection. Identification of this subgroup of patients was crucial for early aggressive intervention to improve survival. The purpose of this study was to evaluate whether computer tomography (CT) - derived measurements of body composition such as myosteatosis indicating fat deposition inside the muscles could be used to predict the risk of transition to severe illness in patients with initial diagnosis of mild COVID-19 infection.</description>
      <pubDate>Sun, 06 Jun 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00281-8/fulltext?rss=yes</guid>
      <dc:title>Myosteatosis predicting risk of transition to severe COVID-19 infection</dc:title>
      <dc:creator>Xiaoping Yi, Haipeng Liu, Liping Zhu, Dongcui Wang, Fangfang Xie, Linbo Shi, Ji Mei, Xiaolong Jiang, Qiuhua Zeng, Pingfeng Hu, Yihui Li, Peipei Pang, Jie Liu, Wanxiang Peng, Harrison X. Bai, Weihua Liao, Bihong T. Chen</dc:creator>
      <dc:date>2021-06-06T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.05.031</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Impact of nutritional therapy during the first wave of the COVID-19 pandemic in intensive care patients: A retrospective observational study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00274-0/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-06-04</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>The COVID-19 pandemic has caused major organizational challenges to healthcare systems concerning staff, material and bed availability. Nutrition was not a priority in the intensive care unit (ICU) at the beginning of the pandemic with the need for simplified protocols. We aimed to assess the impact of a simplified nutritional protocol for critically ill COVID-19 patients during the pandemic first wave.</description>
      <pubDate>Fri, 04 Jun 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00274-0/fulltext?rss=yes</guid>
      <dc:title>Impact of nutritional therapy during the first wave of the COVID-19 pandemic in intensive care patients: A retrospective observational study</dc:title>
      <dc:creator>Aude de Watteville, Florencia Montalbano, Hannah Wozniak, Tinh-Hai Collet, Cyril Jaksic, Christophe Le Terrier, Jérôme Pugin, Laurence Genton, Claudia Paula Heidegger</dc:creator>
      <dc:date>2021-06-04T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.05.024</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Neuromuscular blockade administration is associated with altered energy expenditure in critically ill intubated patients with COVID-19</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00259-4/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-05-25</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>ESPEN guidelines advocate that energy needs of critically ill patients with COVID 19 should be assessed using indirect calorimetry, if safely available. This study described energy needs of intubated patients with COVID-19 and explores whether neuromuscular blockade administration (NMBAs) is associated with altered energy expenditure.</description>
      <pubDate>Tue, 25 May 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00259-4/fulltext?rss=yes</guid>
      <dc:title>Neuromuscular blockade administration is associated with altered energy expenditure in critically ill intubated patients with COVID-19</dc:title>
      <dc:creator>D. Karayiannis, A. Maragkouti, T. Mikropoulos, A. Sarri, A. Kanavou, C. Katsagoni, E. Jahaj, A. Kotanidou, Z. Mastora</dc:creator>
      <dc:date>2021-05-25T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.05.009</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Evolution of the nutritional status of COVID-19 critically-ill patients: A prospective observational study from ICU admission to three months after ICU discharge</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00257-0/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-05-24</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>Malnutrition following intensive care unit (ICU) stay is frequent and could be especially prominent in critically ill Coronavirus Disease 2019 (COVID-19) patients as they present prolonged inflammatory state and long length stay. We aimed to determine the prevalence of malnutrition in critically ill COVID-19 patients both at the acute and recovery phases of infection.</description>
      <pubDate>Mon, 24 May 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00257-0/fulltext?rss=yes</guid>
      <dc:title>Evolution of the nutritional status of COVID-19 critically-ill patients: A prospective observational study from ICU admission to three months after ICU discharge</dc:title>
      <dc:creator>C. Rives-Lange, A. Zimmer, A. Merazka, C. Carette, A. Martins-Bexinga, C. Hauw-Berlemont, E. Guerot, A.S. Jannot, J.L. Diehl, S. Czernichow, B. Hermann</dc:creator>
      <dc:date>2021-05-24T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.05.007</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Nutritional management of individuals with obesity and COVID-19: ESPEN expert statements and practical guidance</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00248-X/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-05-10</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">ESPEN Endorsed Recommendation</prism:section>
      <description>The COVID-19 pandemics has created unprecedented challenges and threats to patients and healthcare systems worldwide. Acute respiratory complications that require intensive care unit (ICU) management are a major cause of morbidity and mortality in COVID-19 patients. Among other important risk factors for severe COVID-19 outcomes, obesity has emerged along with undernutrition-malnutrition as a strong predictor of disease risk and severity. Obesity-related excessive body fat may lead to respiratory, metabolic and immune derangements potentially favoring the onset of COVID-19 complications.</description>
      <pubDate>Mon, 10 May 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00248-X/fulltext?rss=yes</guid>
      <dc:title>Nutritional management of individuals with obesity and COVID-19: ESPEN expert statements and practical guidance</dc:title>
      <dc:creator>Rocco Barazzoni, Stephan C. Bischoff, Luca Busetto, Tommy Cederholm, Michael Chourdakis, Cristina Cuerda, Nathalie Delzenne, Laurence Genton, Stephane Schneider, Pierre Singer, Yves Boirie, endorsed by the ESPEN Council</dc:creator>
      <dc:date>2021-05-10T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.05.006</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Impact of COVID-19 on nutritional status during the first wave of the pandemic</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00238-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-05-08</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>Patients affected by COVID-19 may develop disease related malnutrition (DRM) due to the catabolic situation, symptoms that interfere with intake and prolonged hospital stay. This study aims to know the percentage of patients admitted for COVID-19 who required artificial nutrition (AN), their clinical characteristics, as well as the prevalence of DRM and the risk of sarcopenia at hospital discharge and after 6 months.</description>
      <pubDate>Sat, 08 May 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00238-7/fulltext?rss=yes</guid>
      <dc:title>Impact of COVID-19 on nutritional status during the first wave of the pandemic</dc:title>
      <dc:creator>Analía Ramos, Clara Joaquin, Mireia Ros, Mariona Martin, Montserrat Cachero, María Sospedra, Eva Martínez, José Manuel Sánchez Migallón, María-José Sendrós, Berta Soldevila, Manel Puig-Domingo</dc:creator>
      <dc:date>2021-05-08T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.05.001</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Hypozincemia in the early stage of COVID-19 is associated with an increased risk of severe COVID-19</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00234-X/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-05-03</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Short Communication</prism:section>
      <description>Nutritional predisposition to severe coronavirus disease 2019 (COVID-19) remains unclear. Zinc deficiency could be critical since it is associated with a higher susceptibility to infections. We evaluated the prevalence of hypozincemia in the early stage of COVID-19, its association with risk factors for severe COVID-19 and its prognostic value for hospitalization for respiratory complications within 10 days.</description>
      <pubDate>Mon, 03 May 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00234-X/fulltext?rss=yes</guid>
      <dc:title>Hypozincemia in the early stage of COVID-19 is associated with an increased risk of severe COVID-19</dc:title>
      <dc:creator>Julien Fromonot, Mickael Gette, Amin Ben Lassoued, Jean-Louis Guéant, Rosa-Maria Guéant-Rodriguez, Régis Guieu</dc:creator>
      <dc:date>2021-05-03T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.04.042</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>The impact of COVID-19 lockdown on snacking habits, fast-food and alcohol consumption: A systematic review of the evidence</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00212-0/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-04-16</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>The pandemic of coronavirus disease 2019 (COVID-19) and lockdown measures, that were implemented in many countries in order to control the virus transmission, had negatively influenced the lifestyle of millions of people worldwide. In this study we aimed to investigate the impact of the first COVID-19 lockdown period (March–May 2020) on snacking behavior, fast-food and alcohol consumption. A systematic search in PubMed®, Scopus® and Web of Science® databases was conducted and 32 studies were included.</description>
      <pubDate>Fri, 16 Apr 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00212-0/fulltext?rss=yes</guid>
      <dc:title>The impact of COVID-19 lockdown on snacking habits, fast-food and alcohol consumption: A systematic review of the evidence</dc:title>
      <dc:creator>Dimitra Rafailia Bakaloudi, Dhanushya T. Jeyakumar, Ranil Jayawardena, Michail Chourdakis</dc:creator>
      <dc:date>2021-04-16T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.04.020</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Impact of the first COVID-19 lockdown on body weight: A combined systematic review and a meta-analysis</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00207-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-04-13</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>The coronavirus disease 2019 (COVID-19) and the imposed lockdowns in order to control the pandemic, had undoubtedly influenced the lifestyle of millions of people worldwide. The period of confinement, which was characterized by seizing most business activities and allowing only for e-classes at schools and universities, leading also to a lower physical activity, could have affected eating behaviors of people of all ages. In this study we aimed to investigate the impact of the first lockdown period (March–May 2020) on body weight (BW) and on body mass index (BMI) in both adults and adolescents (&gt;16 years old).</description>
      <pubDate>Tue, 13 Apr 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00207-7/fulltext?rss=yes</guid>
      <dc:title>Impact of the first COVID-19 lockdown on body weight: A combined systematic review and a meta-analysis</dc:title>
      <dc:creator>Dimitra Rafailia Bakaloudi, Rocco Barazzoni, Stephan C. Bischoff, Joao Breda, Kremlin Wickramasinghe, Michail Chourdakis</dc:creator>
      <dc:date>2021-04-13T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.04.015</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Nutritional status in post SARS-Cov2 rehabilitation patients</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00205-3/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-04-12</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>After prolonged hospitalization, the assessment of nutritional status and the identification of adequate nutritional support is of paramount importance. In this observational study, we aimed at assessing the presence of a malnutrition condition in SARS-Cov2 patients after the acute phase and the effects of a multidisciplinary rehabilitation program on nutritional and functional status.</description>
      <pubDate>Mon, 12 Apr 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00205-3/fulltext?rss=yes</guid>
      <dc:title>Nutritional status in post SARS-Cov2 rehabilitation patients</dc:title>
      <dc:creator>M. Gobbi, A. Brunani, M. Arreghini, G. Baccalaro, D. Dellepiane, V. La Vela, E. Lucchetti, M. Barbaglia, A. Cova, E. Fornara, S. Galli, V. Cimolin, L. Brugliera, P. Capodaglio</dc:creator>
      <dc:date>2021-04-12T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.04.013</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Mediterranean diet and the risk of COVID-19 in the ‘Seguimiento Universidad de Navarra’ cohort</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00190-4/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-04-09</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>A potential protection against COVID-19 by a high-quality dietary pattern is to be expected given the biological plausibility supporting the beneficial effects of an adequate dietary intake on the immune system. However, knowledge on the relationship between long-term maintained healthy dietary patterns, such as the Mediterranean diet, and the risk of SARS-CoV-2 infection is still sparse. We longitudinally assessed this association in a well-known Mediterranean cohort.</description>
      <pubDate>Fri, 09 Apr 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00190-4/fulltext?rss=yes</guid>
      <dc:title>Mediterranean diet and the risk of COVID-19 in the ‘Seguimiento Universidad de Navarra’ cohort</dc:title>
      <dc:creator>R. Perez-Araluce, M.A. Martinez-Gonzalez, C.I. Fernández-Lázaro, M. Bes-Rastrollo, A. Gea, S. Carlos</dc:creator>
      <dc:date>2021-04-09T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.04.001</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Feeding intolerance in critically ill patients with COVID-19</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00180-1/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-03-29</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>Early reports suggest significant difficulty with enteral feeding in critically ill COVID-19 patients. This study aimed to characterize the prevalence, clinical manifestations, and outcomes of feeding intolerance in critically ill patients with COVID-19.</description>
      <pubDate>Mon, 29 Mar 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00180-1/fulltext?rss=yes</guid>
      <dc:title>Feeding intolerance in critically ill patients with COVID-19</dc:title>
      <dc:creator>Rebecca Liu, Mary Paz, Layla Siraj, Taylor Boyd, Silvia Salamone, Thúy-Lan Võ Lite, Krystle M. Leung, Josue D. Chirinos, Helen H. Shang, Matthew J. Townsend, Junsung Rho, Peiyun Ni, Kushi Ranganath, April D. Violante, Zezhou Zhao, Casey Silvernale, Imama Ahmad, Nira A. Krasnow, Erica S. Barnett, Mukesh Harisinghani, Braden Kuo, Katharine E. Black, Kyle Staller</dc:creator>
      <dc:date>2021-03-29T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.03.033</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Polydatin and COVID-19</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00174-6/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-03-29</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Letter to the Editor</prism:section>
      <description>I would like to share ideas on the publication “Polydatin and its potential protective effect on COVID-19”. Bonucci et al. concluded that “it is reasonable to suggest the phytochemical polydatin as preventative (co-) treatment for individual at risk of COVID-19, as (asymptomatic or pauci-symptomatic) relatives and contacts of swap positive confirmed case [1].” The advantage of plant derived natural products for managing COVID-19 is interesting. Polygonum Cuspidatum is a general plant in many Asian countries (such as China, Korea and Japan) [2].</description>
      <pubDate>Mon, 29 Mar 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00174-6/fulltext?rss=yes</guid>
      <dc:title>Polydatin and COVID-19</dc:title>
      <dc:creator>Viroj Wiwanitkit</dc:creator>
      <dc:date>2021-03-29T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.03.027</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Nutritional risk at hospital admission is associated with prolonged length of hospital stay in old patients with COVID-19</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00156-4/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-03-22</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>To investigate the association of nutritional risk at admission with the length of hospital stay (LOS) and mortality in older patients with COVID-19.</description>
      <pubDate>Mon, 22 Mar 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00156-4/fulltext?rss=yes</guid>
      <dc:title>Nutritional risk at hospital admission is associated with prolonged length of hospital stay in old patients with COVID-19</dc:title>
      <dc:creator>Aline Mendes, Christine Serratrice, François R. Herrmann, Gabriel Gold, Christophe E. Graf, Dina Zekry, Laurence Genton</dc:creator>
      <dc:date>2021-03-22T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.03.017</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Influence of foods and nutrients on COVID-19 recovery: A multivariate analysis of data from 170 countries using a generalized linear model</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00157-6/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-03-19</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>COVID-19 is an emergency public health problem of global importance. This study aimed to investigate the effect of foods and nutrients as complementary approaches on the recovery from COVID-19 in 170 countries, especially considering the complexity of the disease and the current scarcity of active treatments.</description>
      <pubDate>Fri, 19 Mar 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00157-6/fulltext?rss=yes</guid>
      <dc:title>Influence of foods and nutrients on COVID-19 recovery: A multivariate analysis of data from 170 countries using a generalized linear model</dc:title>
      <dc:creator>Alexandre F. Cobre, Monica Surek, Raquel O. Vilhena, Beatriz Böger, Mariana M. Fachi, Danilo R. Momade, Fernanda S. Tonin, Flavia M. Sarti, Roberto Pontarolo</dc:creator>
      <dc:date>2021-03-19T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.03.018</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Vitamin D deficiency in critically ill COVID-19 ARDS patients</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00135-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-03-07</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>Vitamin D's pleiotropic effects include immune modulation, and its supplementation has been shown to prevent respiratory tract infections. The effectivity of vitamin D as a therapeutic intervention in critical illness remains less defined. The current study analyzed clinical and immunologic effects of vitamin D levels in patients suffering from coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS).</description>
      <pubDate>Sun, 07 Mar 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00135-7/fulltext?rss=yes</guid>
      <dc:title>Vitamin D deficiency in critically ill COVID-19 ARDS patients</dc:title>
      <dc:creator>Quirin Notz, Johannes Herrmann, Tobias Schlesinger, Peter Kranke, Magdalena Sitter, Philipp Helmer, Jan Stumpner, Daniel Roeder, Karin Amrein, Christian Stoppe, Christopher Lotz, Patrick Meybohm</dc:creator>
      <dc:date>2021-03-07T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.03.001</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Early caloric deficit is associated with a higher risk of death in invasive ventilated COVID-19 patients</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00094-7/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-03-01</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>The aim of this study was to evaluate the nutritional support management in mechanically ventilated coronavirus disease 2019 (COVID-19) patients and explore the association between early caloric deficit and mortality, taking possible confounders (i.e. obesity) into consideration.</description>
      <pubDate>Mon, 01 Mar 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00094-7/fulltext?rss=yes</guid>
      <dc:title>Early caloric deficit is associated with a higher risk of death in invasive ventilated COVID-19 patients</dc:title>
      <dc:creator>Emanuele Cereda, Amedeo Guzzardella, Catherine Klersy, Mirko Belliato, Andrea Pellegrini, Fabio Sciutti, Silvia Mongodi, Sara Masi, Silvia Crotti, Monica Savioli, Alberto Zanella, Francesco Mojoli, Giacomo Grasselli, Riccardo Caccialanza</dc:creator>
      <dc:date>2021-03-01T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.02.020</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Region-specific COVID-19 risk scores and nutritional status of a high-risk population based on individual vulnerability assessment in the national survey data</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00093-5/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-02-23</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Covid-19</prism:section>
      <description>Coronavirus disease 2019 (COVID-19) is an ongoing pandemic outbreak leading to more than 1 million deaths worldwide as reported in 2020. Several risk assessment tools, including individual vulnerability to COVID-19, have been developed. The present study aimed to characterize a high-risk population using such a tool and examine risk factors and nutritional status in the national survey data and estimate the region-specific population size.</description>
      <pubDate>Tue, 23 Feb 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00093-5/fulltext?rss=yes</guid>
      <dc:title>Region-specific COVID-19 risk scores and nutritional status of a high-risk population based on individual vulnerability assessment in the national survey data</dc:title>
      <dc:creator>Inkyung Baik</dc:creator>
      <dc:date>2021-02-23T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.02.019</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>Phase angle and standardized phase angle from bioelectrical impedance measurements as a prognostic factor for mortality at 90 days in patients with COVID-19: A longitudinal cohort study</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00091-1/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2021-02-16</prism:publicationDate>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Original article</prism:section>
      <description>Severe acute COVID-19 has taken on pandemic proportions with growing interest in identification of prognostic factors for mortality. Standardized bioelectrical impedance (BI) phase angle (SPhA), which is PhA adjusted by age and sex, has been related to mortality in patients with several diseases but never investigated in COVID-19. Inflammation, a consequence of COVID-19 infection, affects fluid status (hydration) and can be identified with PhA. The aim of this study was to determine the predictive role of PhA on 90 days survival of adults with COVID-19.</description>
      <pubDate>Tue, 16 Feb 2021 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(21)00091-1/fulltext?rss=yes</guid>
      <dc:title>Phase angle and standardized phase angle from bioelectrical impedance measurements as a prognostic factor for mortality at 90 days in patients with COVID-19: A longitudinal cohort study</dc:title>
      <dc:creator>Isabel Cornejo-Pareja, Isabel M. Vegas-Aguilar, Jose Manuel García-Almeida, Diego Bellido-Guerrero, Antonio Talluri, Henry Lukaski, Francisco J. Tinahones</dc:creator>
      <dc:date>2021-02-16T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2021.02.017</dc:identifier>
      <dc:source>Clinical Nutrition (2021)</dc:source>
    </item>
    <item>
      <title>WITHDRAWN: Reply - Letter to the Editor - Malnutrition according to the ESPEN definition and falls in general older population: findings in the EPIDOS study-Toulouse cohort</title>
      <link>https://www.clinicalnutritionjournal.com/article/S0261-5614(20)30193-X/fulltext?rss=yes</link>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">Clinical Nutrition</prism:publicationName>
      <prism:publicationDate xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">2020-04-22</prism:publicationDate>
      <description>The Publisher regrets that this article is an accidental duplication of an article that has already been published, https://doi.org/10.1016/j.clnu.2020.02.026. The duplicate article has therefore been withdrawn.The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.</description>
      <pubDate>Wed, 22 Apr 2020 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">https://www.clinicalnutritionjournal.com/article/S0261-5614(20)30193-X/fulltext?rss=yes</guid>
      <dc:title>WITHDRAWN: Reply - Letter to the Editor - Malnutrition according to the ESPEN definition and falls in general older population: findings in the EPIDOS study-Toulouse cohort</dc:title>
      <dc:creator>T. Cederholm, P. Singer</dc:creator>
      <dc:date>2020-04-22T00:00:00Z</dc:date>
      <dc:identifier>10.1016/j.clnu.2020.04.022</dc:identifier>
      <dc:source>Clinical Nutrition (2020)</dc:source>
    </item>
    <item>
      <title>Outcomes for Patients with apparent Chronic Idiopathic Pelvic Pain and associated Pelvic Floor Disorders undergoing Laparoscopic Ventral Mesh Rectopexy</title>
      <link>https://onlinelibrary.wiley.com/doi/10.1111/codi.13805?af=R</link>
      <prism:coverDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDate>
      <prism:coverDisplayDate xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Sun, 12 Sep 2021 10:18:08 -0700</prism:coverDisplayDate>
      <prism:publicationName xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Colorectal Disease</prism:publicationName>
      <prism:doi xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">10.1111/codi.13805</prism:doi>
      <prism:url xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">https://onlinelibrary.wiley.com/doi/10.1111/codi.13805?af=R</prism:url>
      <prism:section xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/">Original Article</prism:section>
      <description>Colorectal Disease, Accepted Article.</description>
      <content:encoded>&lt;h2&gt;Abstract&lt;/h2&gt;
&lt;p&gt;This article has been temporarily withdrawn, with the agreement of all authors and the journal editor, whilst an investigated is being carried out by the North Bristol NHS Trust and the General Medical Council following some concerns raised.&lt;/p&gt;</content:encoded>
      <source url="https://onlinelibrary.wiley.com/journal/14631318?af=R">Wiley: Colorectal Disease: Table of Contents</source>
      <category>Original Article</category>
      <pubDate>Thu, 06 Jul 2017 19:00:00 GMT</pubDate>
      <guid isPermaLink="false">10.1111/codi.13805</guid>
      <dc:title>Outcomes for Patients with apparent Chronic Idiopathic Pelvic Pain and associated Pelvic Floor Disorders undergoing Laparoscopic Ventral Mesh Rectopexy</dc:title>
      <dc:creator>A Newman, 
G L Greenslade, 
K McCarthy, 
A R Dixon</dc:creator>
      <dc:description>Abstract
This article has been temporarily withdrawn, with the agreement of all authors and the journal editor, whilst an investigated is being carried out by the North Bristol NHS Trust and the General Medical Council following some concerns raised.</dc:description>
      <dc:date>2017-07-06T19:00:00Z</dc:date>
      <dc:identifier>10.1111/codi.13805</dc:identifier>
    </item>
    <item>
      <title>ANCHOR Trial Results Are In:  So Where Do We Go From Here?.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00001</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Goldstone, Stephen E. M.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;1-3&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00001]</guid>
    </item>
    <item>
      <title>Are Women Colorectal Surgeons Overrepresented in the Treatment of Pelvic Floor Disorders?.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00002</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Baratta, Vanessa M. M.D., M.H.S.; Kurbatov, Vadim M.D., M.H.S.; Einarsdottir, Hulda M. M.D.; Reddy, Vikram M.D., Ph.D. M.B.A.; Longo, Walter E. M.D.; Pantel, Haddon J. M.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;4-5&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00002]</guid>
    </item>
    <item>
      <title>Planetary Health Care for Colorectal Surgeons.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00003</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Moloo, Husein M.D., M.Sc., M.P.H. 1; MacNeill, Andrea M.D., M.Sc. 2&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;6-7&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00003]</guid>
    </item>
    <item>
      <title>Report from American Society of Clinical Oncology Symposium 2020 and American Society of Clinical Oncology Gastrointestinal Cancer Symposium 2021.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00004</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;You, Y. Nancy M.D., M.H.Sc. 1; Dasari, Arvind M.D., M.S. 2; Chang, George J. M.D., M.S. 1&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;8-10&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00004]</guid>
    </item>
    <item>
      <title>Postoperative Evaluation and Management of Portomesenteric Venous Thrombosis in Patients With IBD.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00005</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Patel, Maitri M.P.H. 1; Hedrick, Traci M.D. 2&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;11-13&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00005]</guid>
    </item>
    <item>
      <title>Expert Commentary on Postoperative Evaluation and Management of Portomesenteric Venous Thrombosis in Patients With Inflammatory Bowel Disease.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00006</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Lightner, Amy L. M.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;14-15&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00006]</guid>
    </item>
    <item>
      <title>Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases:  A Systematic Review.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00007</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Parikh, Manasi S. M.B.B.S, M.S. 1; Johnson, Paul M.D. 1; Romanes, Jonathan Paul B.S. 2; Freitag, Harvey E. B.S. 3; Spring, Mary E. D.O. 4; Garcia-Henriquez, Norbert M.D. 1; Monson, John R.T. M.D. 1&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;16-26&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00007]</guid>
    </item>
    <item>
      <title>Research Perspective on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases:  A Systematic Review.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00008</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Davis, Kurt G. M.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;27&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00008]</guid>
    </item>
    <item>
      <title>Incidence Rate and Risk Factors for Anal Squamous Cell Carcinoma in a Cohort of People Living With HIV from 2004 to 2017:  Implementation of a Screening Program.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00009</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Milanes Guisado, Yusnelkis Ph.D. 1; Sotomayor, Cesar M.D. 1; Fontillon, Maria Ph.D. 2; Dominguez Castano, Ana Ph.D. 3; Espinosa, Nuria M.D., Ph.D. 1; Roca, Cristina M.D. 1; Lopez-Cortes, Luis F. M.D., Ph.D. 1,4; Viciana, Pompeyo M.D., Ph.D. 1; Neukam, Karin Pharm.D., Ph.D. 1,4; On behalf of the SeVIHanal Study Group&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;28-39&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00009]</guid>
    </item>
    <item>
      <title>Evaluation of Urinalysis-Based Screening for Urothelial Carcinoma in Patients With Lynch Syndrome.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00010</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Chouhan, Hanumant M.B.B.S., F.R.A.C.S. 1,2,3; Abbass, Mohammad Ali M.D. 4; Hrabe, Jennifer E. M.D. 1; Ferrandon, Sylvain Ph.D. 5; DeVecchio, Jennifer B.A. 3; Mankaney, Gautam M.D. 2; Burke, Carol A. M.D. 2; Heald, Brandie M.Sc. 2; Ann LaGuardia, Lisa R.N., B.S.N. 2; O'Malley, Margaret B.Sc. 2; Milicia, Susan R.N., B.S.N. 2; Liska, David M.D. 1,2,3; Church, James M.B.Ch.B., F.R.A.C.S. 7; Campbell, Steven C. M.D. 2,6; Kalady, Matthew F. M.D. 5&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;40-45&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00010]</guid>
    </item>
    <item>
      <title>Functional Outcomes and Quality of Life After Transanal Total Mesorectal Excision for Rectal Cancer:  A Prospective Observational Study.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00011</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;de Lacy, F. Borja M.D. 1; Turrado-Rodriguez, Victor M.D. 1; Torroella, Alba M.D. 1; van Laarhoven, Jacqueline M.D., Ph.D. 2; Otero-Pineiro, Ana M.D., Ph.D. 1; Almenara, Raul M.D., Ph.D. 1; Lacima, Gloria M.D., Ph.D. 1; Castells, Antoni M.D. 3; Lacy, Antonio M. M.D., Ph.D. 1&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;46-54&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00011]</guid>
    </item>
    <item>
      <title>What Is the Optimal Elective Colectomy for Splenic Flexure Cancer:  End of the Debate? A Multicenter Study From the GRECCAR Group With a Propensity Score Analysis.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00012</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Manceau, Gilles M.D., Ph.D. 1; Alves, Arnaud M.D., Ph.D. 2; Meillat, Helene M.D. 3; Benhaim, Leonor M.D., Ph.D. 4; Ouaissi, Mehdi M.D., Ph.D. 5; Panis, Yves H. M.D., Ph.D. 6; Tuech, Jean-Jacques M.D., Ph.D. 7; Dousset, Bertrand M.D., Ph.D. 8; Brigand, Cecile M.D., Ph.D. 9; Cotte, Eddy M.D., Ph.D. 10; Lakkis, Zaher M.D., Ph.D. 11; Badic, Bogdan M.D., Ph.D. 12; Marchal, Frederic M.D. 13; Sabbagh, Charles M.D., Ph.D. 14; Diouf, Momar Ph.D. 15; Karoui, Mehdi M.D., Ph.D. 1&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;55-65&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00012]</guid>
    </item>
    <item>
      <title>Cumulative Incidence and Risk Factors of Permanent Stoma After Intersphincteric Resection for Ultralow Rectal Cancer.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00013</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Zhang, Bin M.D.; Zhuo, Guang-Zuan M.D.; Zhao, Ke M.M.; Zhao, Yong M.D.; Gao, Dong-Wei M.D.; Zhu, Jun M.D.; Ding, Jian-Hua M.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;66-75&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00013]</guid>
    </item>
    <item>
      <title>Perianal Fistula After Ileoanal Pouch in Patients With Ulcerative Colitis:  A Review of 475 Patients Operated on at a Major IBD Center.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00014</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Heimann, Tomas M. M.D.; Swaminathan, Santosh M.D.; Slater, Gary I. M.D.; Kurtz, Robert J. M.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;76-82&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00014]</guid>
    </item>
    <item>
      <title>Translumbosacral Anorectal Magnetic Stimulation Test for Fecal Incontinence.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00015</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Yan, Yun M.D., Ph.D.; Sharma, Amol M.D., M.S.; Herekar, Anam A. M.B.B.S.; Jimenez, Enoe M.D.; Hudgi, Amit R. M.B.B.S.; Gu, Qiaochu G. M.D.; Rao, Satish S.C. M.D., Ph.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;83-92&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00015]</guid>
    </item>
    <item>
      <title>The Role of Traditional Acupuncture in Low Anterior Resection Syndrome Treatment:  A Pilot Study.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00016</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Dulskas, Audrius M.D., Ph.D. 1,2; Aukstikalnis, Tomas M.D. 3; Kavaliauskas, Povilas M.D. 2; Samalavicius, Narimantas Evaldas M.D., Ph.D. 2,4,5&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;93-99&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00016]</guid>
    </item>
    <item>
      <title>Effect of Changing Surgical Instruments Before Wound Closure to Prevent Wound Infection in Lower GI Surgery:  A Randomized Controlled Trial.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00017</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Kuwahara, Ryuichi M.D. 1; Uchino, Motoi M.D., Ph.D. 1; Ikeuchi, Hiroki M.D., Ph.D. 1; Bando, Toshihiro M.D. 1; Sasaki, Hirofumi M.D., Ph.D. 1; Yasuhara, Michiko M.D. 2; Kimura, Kei M.D. 2; Goto, Yoshiko M.D., Ph.D. 1; Horio, Yuki M.D., Ph.D. 1; Minagawa, Tomohiro M.D., Ph.D. 1; Ikeda, Masataka M.D., Ph.D. 2; Ueda, Takashi Ph.D. 3; Takesue, Yoshio M.D., Ph.D. 3&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;100-107&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00017]</guid>
    </item>
    <item>
      <title>Incidence and Characterization of Rectal Complications From Fecal Management Systems.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00018</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Kane, William J. M.D. 1; Hassinger, Taryn E. M.D., M.S. 1; Xu, Thomas O. B.S. 2; Kirkner, Allison E. M.S.N., R.N. 1; Maddox, Michele J. R.N., B.S.N. 1; Hoang, Sook C. M.D. 1; Friel, Charles M. M.D. 1; Hedrick, Traci L. M.D., M.S. 1&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;108-116&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00018]</guid>
    </item>
    <item>
      <title>Combination of Enhanced Instructions Improve Quality of Bowel Preparation:  A Prospective, Colonoscopist-Blinded, Randomized, Controlled Study.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00019</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Jung, Da Hyun M.D. 1; Gweon, Tae-Geun M.D., Ph.D. 2; Lee, SeJoon M.D., Ph.D. 3; Son, Nak-Hoon Ph.D. 4; Kim, Byung-Wook M.D., Ph.D. 2; Huh, Cheal Wung M.D., Ph.D. 2,3&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;117-124&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00019]</guid>
    </item>
    <item>
      <title>Abridged Abstracts From the Medical Literature.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00020</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Merchea, Amit M.D.; Schwartzberg, David M. M.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;125-129&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00020]</guid>
    </item>
    <item>
      <title>Transanal Minimally Invasive Surgery for Local Excision of a Rectal Schwannoma.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00021</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Guevara-Martinez, Jenny M.D.; Toribio-Vazquez, Carlos M.D.; Noire, Fernando Prieto-La M.D.; Cantero, Ramon M.D., Ph.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e1-e3&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00021]</guid>
    </item>
    <item>
      <title>Robotic Ventral Mesh Rectopexy.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00022</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Araujo, Sergio Eduardo Alonso M.D., Ph.D.; Seid, Victor Edmond M.D., Ph.D.; Portilho, Ana Sarah M.D.; Marcante, Marcelli T. M.D.; Pandini, Rafael Vaz M.D.; Gerbasi, Lucas S. M.D.; Figueiredo, Marleny N. M.D., Ph.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e4&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00022]</guid>
    </item>
    <item>
      <title>Mesenteric Excision and Exclusion for Ileocolic Crohn's Disease:  Feasibility and Safety of an Innovative, Combined Surgical Approach With Extended Mesenteric Excision and Kono-S Anastomosis.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00023</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Holubar, Stefan D. M.D., M.S. 1; Gunter, Rebecca L. M.D., M.S. 1; Click, Benjamin H. M.D., M.S. 2; Achkar, Jean-Paul M.D. 2; Lightner, Amy L. M.D. 1; Lipman, Jeremy M. M.D. 1; Hull, Tracy L. M.D. 1; Regueiro, Miguel M.D. 2; Rieder, Florian M.D., Ph.D. 2; Steele, Scott R. M.D., M.B.A. 1&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e5-e13&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00023]</guid>
    </item>
    <item>
      <title>Open Left Hemicolectomy for Proximal Sigmoid Cancer.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00024</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Samalavicius, Narimantas E. M.D., Ph.D. 1,2,3; Klimasauskiene, Vita M.D. 4; Dulskas, Audrius M.D., Ph.D. 2,5&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e14-e15&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00024]</guid>
    </item>
    <item>
      <title>Robotic Ventral Mesh Rectopexy and Sacrocolpopexy.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00025</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Brady, Justin T. M.D. 1; Kow, Nathan M.D. 2; deBeche-Adams, Teresa M.D. 1&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e16-e17&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00025]</guid>
    </item>
    <item>
      <title>Robotic NICE Procedure With Natural Orifice-Assisted Small-Bowel Resection and Anastomosis for Complicated Diverticulitis with Enterocolic Fistula.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00026</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Haas, Eric M. M.D. 1,2; Ortiz De Elguea-Lizarraga, Jose I. M.D. 3; Luna-Saracho, Roberto M.D. 1; Secchi del Rio, Roberto M.D. 3; LeFave, Jean-Paul M.D. 2,3&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e18-e20&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00026]</guid>
    </item>
    <item>
      <title>A Missed Chance for Organ Preservation after Watch and Wait.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00027</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Vila, Frenki M.D.; Yuksel, Bulent Cavit Prof., M.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e21&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00027]</guid>
    </item>
    <item>
      <title>cT2N0 Distal Rectal Cancer:  Do Not Believe in Fairy Tales.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00028</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Fernandez, Laura M. M.D. 1; Figueiredo, Nuno M.D., Ph.D. 3; Habr-Gama, Angelita M.D., Ph.D. 2,3; Sao Juliao, Guilherme P. M.D. 2; Vieira, Pedro M.D. 1; Vailati, Bruna B. M.D. 2; Nasir, Irfan M.D. 1; Pares, Oriol M.D. 1; Santiago, Ines M.D. 1; Castillo-Martin, Mireia M.D., Ph.D. 1; Carvalho, Carlos M.D. 1; Parvaiz, Amjad M.D. 1; Perez, Rodrigo O. M.D., Ph.D. 2,3,4&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e22&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00028]</guid>
    </item>
    <item>
      <title>Definitive Surgery on Initial Presentation for Anal Fistula Associated With Acute Anorectal Abscess:  A Definite Way Forward.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00029</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Garg, Pankaj M.B.B.S., M.S. 1; Kaur, Baljit M.B.B.S., M.D. 2&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e23&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00029]</guid>
    </item>
    <item>
      <title>The Authors Reply.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00030</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Sahakitrungruang, Chucheep M.D., M.Sc. 1,2; Malakorn, Songphol M.D. 1,2; Rojanasakul, Arun M.D., Ph.D.(hon). 1,2&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e24&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00030]</guid>
    </item>
    <item>
      <title>Does Sex-Difference Matter for the Decrease in Serum Albumin?.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00031</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Hu, Kang B.M.; Tong, Weidong M.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e25&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00031]</guid>
    </item>
    <item>
      <title>Outcomes of the PILLAR III Trial Reassessed.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00032</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Samadov, Elgun M.D.; Ibrahimli, Arturan M.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e26&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00032]</guid>
    </item>
    <item>
      <title>More Than Lymph Node Dissection Has an Effect on Overall Survival For Right Colon Cancer.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00033</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;Ignjatovic, Dejan M.D., Ph.D.; Stimec, Bojan V. M.D., Ph.D.&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e27&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00033]</guid>
    </item>
    <item>
      <title>January 2022 translations.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00034</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e28-e66&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00034]</guid>
    </item>
    <item>
      <title>Announcements.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00035</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e67&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00035]</guid>
    </item>
    <item>
      <title>Colon and Rectal Surgery Regional Society Meetings.</title>
      <link>http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00036</link>
      <description>&lt;div class="author"&gt;
                    &lt;strong&gt;Author: &lt;/strong&gt;
                    &lt;span&gt;&lt;/span&gt;
                    &lt;/div&gt;
                    &lt;div class="page"&gt;
                    &lt;strong&gt;Page: &lt;/strong&gt;
                    &lt;span&gt;e68-e69&lt;/span&gt;
                    &lt;/div&gt;</description>
      <guid isPermaLink="false">http://ovidsp.dc1.ovid.com/ovidweb.cgi?T=JS&amp;CSC=Y&amp;NEWS=N&amp;PAGE=fulltext&amp;LSLINK=80&amp;D=ovft&amp;AN=00003453-202201000-00036]</guid>
    </item>
  </channel>
</rss>
